isoproterenol has been researched along with Cardiovascular Stroke in 1089 studies
Isoproterenol: Isopropyl analog of EPINEPHRINE; beta-sympathomimetic that acts on the heart, bronchi, skeletal muscle, alimentary tract, etc. It is used mainly as bronchodilator and heart stimulant.
isoprenaline : A secondary amino compound that is noradrenaline in which one of the hydrogens attached to the nitrogen is replaced by an isopropyl group. A sympathomimetic acting almost exclusively on beta-adrenergic receptors, it is used (mainly as the hydrochloride salt) as a bronghodilator and heart stimulant for the management of a variety of cardiac disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Isoproterenol (ISP)-induced myocardial ischemia is a classical model to screen the cardioprotective effects of various pharmacological interventions." | 8.98 | Isoproterenol-induced cardiac ischemia and fibrosis: Plant-based approaches for intervention. ( Allawadhi, P; Godugu, C; Khurana, A; Kumari, P; Sayed, N, 2018) |
| "Myocardial infarction was induced by injecting subcutaneous isoproterenol (5 mg/kg once for 7 consecutive days) to establish an experimental heart failure model." | 8.31 | Comparative Efficacy of Levosimendan, Ramipril, and Sacubitril/ Valsartan in Isoproterenol-induced Experimental Heart Failure: A Hemodynamic and Molecular Approach. ( Afzal, O; Akhtar, MS; Altamimi, A; Hassan, MZ; Hassan, Q; Mohammad, AAS; Sharma, AK; Tabassum, F, 2023) |
| " However, researchers recently investigated the potential cardioprotective effects of taraxerol utilizing an isoproterenol (ISO)-induced cardiotoxicity model among Sprague Dawley rats." | 8.31 | Effects of Taraxerol on Oxidative and Inflammatory Mediators in Isoproterenol-Induced Cardiotoxicity in an Animal Model. ( Alam, A; Alkholifi, FK; Aodah, AH; Devi, S; Foudah, AI; Yusufoglu, HS, 2023) |
| " The objective of this study was to analyze the effect of essential oil of Alpinia zerumbet (EOAz) on cardiovascular and autonomic function in rats with isoproterenol-induced myocardial infarction." | 8.31 | Effect of essential oil of Alpinia zerumbet on cardiovascular and autonomic function in rats with isoproterenol induced acute myocardial infarction. ( Costa, PPC; Fechine, FV; Holanda, TM; Ingram, C; Maia, PHF; Moraes Filho, MO; Moraes, MEA; Rocha, DG; Silveira, JAM, 2023) |
| " The present study aimed to investigate the effect of TQ on apoptotic parameters and MMP-9 expression in isoproterenol (ISP)-induced myocardial infarction (MI)." | 8.12 | Thymoquinone attenuates isoproterenol-induced myocardial infarction by inhibiting cytochrome C and matrix metalloproteinase-9 expression. ( Awad, A; Badr, AM; El-Bakly, WM; El-Demerdash, E; Medhet, M, 2022) |
| "The current study investigated the prophylactic effect of ethyl pyruvate (EP) in Isoproterenol (ISO) - induced myocardial infarction (MI)." | 8.12 | Ethyl pyruvate attenuates isoproterenol-induced myocardial infarction in rats: Insight to TNF-α-mediated apoptotic and necroptotic signaling interplay. ( Ahmed, AAE; Al-Botaty, BM; Elkhoely, A; K El-Sayed, E, 2022) |
| "The present study investigated the cardioprotection of Indole-3-carbinol on isoproterenol (ISO)-induced myocardial infarction in Wistar rats." | 8.12 | Indole-3-carbinol ameliorated the isoproterenol-induced myocardial infarction via multimodal mechanisms in Wistar rats. ( Krishnamurthy, S; Ramakrishna, K, 2022) |
| " No studies were conducted earlier on the effects of (-) epicatechin (EC) on tachycardia, cardiac hypertrophy, and inflammation in MI." | 8.12 | Preventive effects of (-) epicatechin on tachycardia, cardiac hypertrophy, and nuclear factor- κB inflammatory signaling pathway in isoproterenol-induced myocardial infarcted rats. ( Ponnian, SMP, 2022) |
| "Anethole may retain a cardio-protective potential by controlling myocardial oxidative stress (through Nrf2 pathway) and diminishing inflammation and apoptosis via the TLR4/MYD88 pathway." | 8.12 | Anethole's effects against myocardial infarction: The role of TLR4/NFκB and Nrf2/HO1 pathways. ( Mohamed, ME; Younis, NS, 2022) |
| " Rats were induced MI by isoproterenol (100 mg/kg body weight) and then treated with valencene and cardiac sensitive markers, cardiac hypertrophy, oxidative stress, markers of inflammation, nuclear factor- κB inflammatory pathway, and myocardial infarct size was estimated/determined." | 8.12 | Valencene post-treatment exhibits cardioprotection via inhibiting cardiac hypertrophy, oxidative stress, nuclear factor- κB inflammatory pathway, and myocardial infarct size in isoproterenol-induced myocardial infarcted rats; A molecular study. ( Berlin Grace, VM; Shervin Prince, S; Stanely Mainzen Prince, P, 2022) |
| "This study has explored the fact that geraniol prevents isoproterenol (ISO)-induced oxidative stress and inflammation-mediated myocardial infarction (MI) through enhanced expression of peroxiredoxin-1 (Prdx-1) in experimental animal models." | 8.12 | Geraniol enhances peroxiredoxin-1, and prevents isoproterenol-induced oxidative stress and inflammation associated with myocardial infarction in experimental animal models. ( Balupillai, A; David, E; Ranganathan, B; Saravanan, K; Wan, J; Zou, G, 2022) |
| " The present study was designed to investigate the cardioprotective effects of a newly synthesised coumarin, symbolised as 5,6-PhSHC, against cardiac remodelling process in isoproterenol (ISO) induced myocardial infarction (MI) in male Wistar rats by evaluating haematological, biochemical and cardiac biomarkers." | 8.12 | A novel synthetised sulphonylhydrazone coumarin (E)-4-methyl-N'-(1-(3-oxo-3H-benzo[f]chromen-2- yl)ethylidene)benzenesulphonohydrazide protect against isoproterenol-induced myocardial infarction in rats by attenuating oxidative damage, biological changes ( Abid, M; Abid, S; Allouche, N; Ammar, H; Baaziz, I; Elmufti, A; Feriani, A; Ghazouani, L; Hajji, R; Khdhiri, E; Mnafgui, K; Ramazani, A; Tlili, N; Zarei, A, 2022) |
| "Earlier studies reported that long-term treatment with thymoquinone (TQ) at a high dose (20 mg/kg) exerts a cardioprotective effect against isoproterenol (ISO)-triggered myocardial infarction (MI) in rats." | 8.12 | Thymoquinone Produces Cardioprotective Effect in β-Receptor Stimulated Myocardial Infarcted Rats via Subsiding Oxidative Stress and Inflammation. ( Agrawal, Y; Goyal, SN; Nagoor Meeran, MF; Nakhate, KT; Ojha, S; Patil, CR; Rathod, S; Sherikar, A, 2022) |
| " The present study evaluated the effectiveness of rosmarinic acid (RA) against myocardial infarction (MI) in comorbid depression induced by maternal separation in rats." | 8.12 | Evaluation of rosmarinic acid against myocardial infarction in maternally separated rats. ( Bhattacharjee, A; Nayak, PK; Shivavedi, N; Verma, H, 2022) |
| "In the present study, we assessed the therapeutic potential of Biochanin-A (BCA) (10 mg/kg BW/day) pretreatment for 30 days on lipid metabolic abnormalities, proinflammatory cytokines and matrix metalloproteinase expression in isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 8.12 | Attenuation of lipid metabolic abnormalities, proinflammatory cytokines, and matrix metalloproteinase expression by biochanin-A in isoproterenol-induced myocardial infarction in rats. ( Chandrasekaran, P; Jansy Isabella, RAR; Ponmurugan, P; Sangeethadevi, G; Saravanan, G; Sengottuvelu, S; V V, SU; Vadivukkarasi, S, 2022) |
| " The study was conducted to examine the ability of amniotic membrane mesenchymal stem cells (AMSCs) for protection against isoproterenol (ISO)-induced myocardial injury and attempted to show the possible mechanisms by which AMSCs that can be linked to inhibition of inflammation by targeting inflammatory MAPK/NF-κB pathway." | 8.12 | Human amniotic membrane mesenchymal stem cells exert cardioprotective effects against isoproterenol (ISO)-induced myocardial injury through suppression of inflammation and modulation of inflammatory MAPK/NF-κB pathway. ( Aboutaleb, N; Naseroleslami, M, 2022) |
| "The objective of the present paper is to formulate nanostructured lipid carriers (NLCs) of a calcium channel blocker, isradipine, to enhance its oral bioavailability and prolong its antihypertensive effect apart from evaluating efficacy of the formulation in isoproterenol induced myocardial infarction in rats." | 8.12 | Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction. ( Alam, T; Ali, J; Ansari, MA; Baboota, S, 2022) |
| "The study explored the cardioprotective role of the methanolic leaf extract of Nelumbo nucifera and nuciferine against isoproterenol-induced myocardial infarction (MI) in Wistar rats." | 8.12 | Nuciferine from Nelumbo nucifera Gaertn. attenuates isoproterenol-induced myocardial infarction in Wistar rats. ( HarishKumar, R; Selvaraj, CI, 2022) |
| " Ten male NMRI mice were randomly divided into two groups: (1) control (healthy mice) and (2) myocardial infarction (MI)-induced model group (Isoproterenol/subcutaneously injection/single dose of 85 mg/kg)." | 8.02 | Cardiac aorta-derived extracellular matrix scaffold enhances critical mediators of angiogenesis in isoproterenol-induced myocardial infarction mice. ( Abdolmaleki, Z; Beheshtiha, SHS; Hosseinabadi, M, 2021) |
| " The current study has been designed to ascertain their effectiveness against Isoproterenol (ISO)-induced myocardial infarction (MI)." | 8.02 | Pharmacological evaluation of Vitis vinifera and Zingiber zerumbet on electrocardiographic, biochemical alterations and antioxidant status in isoproterenol-induced myocardial infarction in rats. ( Faisal, N; Hanif, M; Hassan Mehmood, M; Munir, I; Naseer, D, 2021) |
| "The present study demonstrated the protective effects of arbutin (ARB) on hyperlipidemia, mitochondrial, and lysosomal membrane damage and on the DNA damage in rats with isoproterenol (ISO)-induced myocardial infarction (MI)." | 8.02 | Arbutin prevents alterations in mitochondrial and lysosomal enzymes in isoproterenol-induced myocardial infarction: An in vivo study. ( Asaikumar, L; Sivasangari, S; Vennila, L, 2021) |
| "This study aimed to investigate the antihyperlipidemic and anti-inflammatory effect of zingiberene (ZBN) on isoproterenol-(ISO) induced myocardial infarction in rats." | 8.02 | Anti-inflammatory and anti-apoptotic effect of zingiberene on isoproterenol-induced myocardial infarction in experimental animals. ( Govindasamy, K; Li, J; Thangaiyan, R; Wei, J, 2021) |
| " This study investigated the therapeutic benefit of adding rosuvastatin to low-dose carvedilol in protection against myocardial infarction (MI)." | 8.02 | Rosuvastatin and low-dose carvedilol combination protects against isoprenaline-induced myocardial infarction in rats: Role of PI3K/Akt/Nrf2/HO-1 signalling. ( Awad, AS; Baraka, SA; El-Demerdash, E; El-Naga, RN; Elsherbini, DA; Tolba, MF, 2021) |
| "As rats develop myocardial infarction (MI) like lesions when injected with large doses of isoproterenol (ISO), this investigation was designed to evaluate the dose-dependent effects of thymoquinone (TQ) on ISO-induced myocardial injury in rats." | 8.02 | Thymoquinone dose-dependently attenuates myocardial injury induced by isoproterenol in rats via integrated modulations of oxidative stress, inflammation, apoptosis, autophagy, and fibrosis. ( Elhadidy, WF; Farag, MM; Khalifa, AA; Rashad, RM, 2021) |
| " In the present study, we report that wogonin nanoparticles (Wog np) protect Isoproterenol (ISO) induced Myocardial Infarction (MI) rats." | 7.96 | Cardio protective role of wogonin loaded nanoparticle against isoproterenol induced myocardial infarction by moderating oxidative stress and inflammation. ( Bei, W; Chen, N; Jing, L, 2020) |
| "The current study enumerates the beneficial role of sciadopitysin (SDN) against isoproternol (ISO)-induced myocardial infarction (MI) in rats." | 7.96 | Protective Effect of Sciadopitysin against Isoproternol-Induced Myocardial Infarction in Rats. ( Cai, Y; Li, Y, 2020) |
| "Our study is aimed at evaluating the effects of pretreatment with Poly(lactic-co-glycolic) acid nanoparticle loaded with resveratrol (RSV PLGA NPs) compared to conventional resveratrol (RSV) on isoproterenol (ISO) induced myocardial infarction (MI) in rats." | 7.96 | Protective role of poly(lactic-co-glycolic) acid nanoparticle loaded with resveratrol against isoproterenol-induced myocardial infarction. ( Hu, Y; Kumar, P; Mishra, A; Moktan, JB; Sreeharsha, N; Sun, L; Wang, L, 2020) |
| "This study determined the effect of Biochanin A (BCA) on isoproterenol (ISO) induced Myocardial Infarction (MI) in male Wistar rats." | 7.96 | Therapeutic Potential of Biochanin-A Against Isoproterenol-Induced Myocardial Infarction in Rats. ( Govindasami, S; Raveendran, N; Sasikumar, V; Uddandrao, VVS, 2020) |
| "HC), a novel potent synthesized coumarin, on isoproterenol- (ISO-) induced myocardial infarction (MI) in rats." | 7.96 | (E)-N'-(1-(7-Hydroxy-2-Oxo-2H-Chromen-3-Yl) Ethylidene) Benzohydrazide, a Novel Synthesized Coumarin, Ameliorates Isoproterenol-Induced Myocardial Infarction in Rats through Attenuating Oxidative Stress, Inflammation, and Apoptosis. ( Abid, S; Allouche, N; Ammar, H; Elmufti, A; Feriani, A; Ghazouani, L; Hajji, R; Khdhiri, E; Mnafgui, K; Tir, M; Tlili, N, 2020) |
| "The present study was aimed to discover novel pyrazole-thiadiazole derivatives as potent NF-ĸB inhibitor and its cardioprotective effect against isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 7.96 | Design and Development of Novel Pyrazole-Thiadiazole Derivatives as NF-ĸB Inhibitor and Cardioprotective Effect against Isoproterenol Induced Myocardial Infarction in Sprague-Dawley Rats. ( Guo, Y; Wang, J; Wu, X; Zhang, Y, 2020) |
| " Long non-coding RNA myocardial infarction associated transcript (LncMIAT) is closely related to heart disease, and here, we were the first to discover that LncMIAT may act as an miR-144 sponge in isoproterenol-induced cardiac hypertrophy." | 7.96 | The Expression of microRNA in Adult Rat Heart with Isoproterenol-Induced Cardiac Hypertrophy. ( Bai, L; Chen, L; Fan, Y; Gan, M; Guo, Z; Hao, X; Jiang, D; Li, X; Shen, L; Tan, Y; Zhang, S; Zhu, L, 2020) |
| " In this study, we investigated the preventive effect of alpha-pinene (AP), a monoterpene, against isoproterenol (ISO)-induced myocardial infarction and inflammation in Wistar rats." | 7.96 | Protective effect of alpha-pinene against isoproterenol-induced myocardial infarction through NF-κB signaling pathway. ( Cao, M; Wang, G; Wang, H; Wang, K; Yang, Z; Zhang, B; Zhao, Y, 2020) |
| "This research was aimed to explore protective effects of allicin on rat model of myocardial infarction via JNK signaling pathway." | 7.96 | Protective Effects of Allicin on ISO-Induced Rat Model of Myocardial Infarction via JNK Signaling Pathway. ( Li, EZ; Li, XP; Liu, YF; Ma, L; Wei, LN; Xu, W; Zhao, J, 2020) |
| " In particular, compound 4i was found to be the most potent ACE inhibitor and was further studied for cardioprotective effects against isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 7.96 | Novel thiazole-pyrazolone hybrids as potent ACE inhibitors and their cardioprotective effect on isoproterenol-induced myocardial infarction. ( Su, G; Su, X; You, H, 2020) |
| "The aim of this study was to evaluate the anti-ischemic effects of SAC through inhibiting neprilysin in isoproterenol (ISO) induced myocardial infarction (MI) in Wistar albino rats." | 7.91 | Sacubitril and valsartan protect from experimental myocardial infarction by ameliorating oxidative damage in Wistar rats. ( Akhtar, M; Akhtar, MS; Hassan, MQ; Imran, M; Najmi, AK; Rahman, O, 2019) |
| "This study was designed to investigate efficacy of Narirutin rich fraction (NRF), obtained from grape fruit peel, in the treatment of isoproterenol induced myocardial infarction in rats." | 7.91 | Attenuation of isoproterenol-induced cardiotoxicity in rats by Narirutin rich fraction from grape fruit. ( Barve, K; Bhatt, LK; Shaikh, S, 2019) |
| " Then, isoproterenol solution was used for induction of myocardial infarction." | 7.91 | The protective impact of betaine on the tissue structure and renal function in isoproterenol-induced myocardial infarction in rat. ( Babaei, G; Ghartavol, MM; Gholizadeh-Ghaleh Aziz, S; Hassan Khadem Ansari, M; Hossein Farjah, G, 2019) |
| " The investigation was conducted to evaluate the cardioprotective efficacy of RPG in rats having acute myocardial infarction (MI) induced by isoproterenol (ISO)." | 7.91 | Cardioprotective Effect of Rhapontigenin in Isoproterenol-Induced Myocardial Infarction in a Rat Model. ( Fan, Y, 2019) |
| "This study was designed to delineate the effect of kaempferol (KF) on heart failure (HF) in diabetic rats." | 7.91 | The protective effect of kaempferol on heart via the regulation of Nrf2, NF-κβ, and PI3K/Akt/GSK-3β signaling pathways in isoproterenol-induced heart failure in diabetic rats. ( Geng, J; Guo, Z; Han, S; Wang, Y; Zhang, L, 2019) |
| "In the present study, the modulatory effect of ursolic acid (UA) on cardiac fibrosis and mitochondrial and lysosomal enzymes activity in isoproterenol-induced myocardial infarction (MI) in rats were examined." | 7.91 | Ursolic acid modulates MMPs, collagen-I, α-SMA, and TGF-β expression in isoproterenol-induced myocardial infarction in rats. ( Pugalendi, KV; Radhiga, T; Senthil, S; Sundaresan, A, 2019) |
| " The present study aimed to elucidate the potential cardioprotective effect provided by ranolazine during myocardial infarction in nondiabetic and diabetic male rats." | 7.91 | Cardioprotective effect of ranolazine in nondiabetic and diabetic male rats subjected to isoprenaline-induced acute myocardial infarction involves modulation of AMPK and inhibition of apoptosis. ( Ameen, AM; Tawfik, MK, 2019) |
| " Our study is aimed at evaluating the effects of pretreatment with curcumin nanoparticles (CCNP) compared to conventional curcumin (CC) on isoproterenol (ISO) induced myocardial infarction (MI) in rats." | 7.91 | Effects of Curcumin Nanoparticles in Isoproterenol-Induced Myocardial Infarction. ( Boarescu, PM; Bocșan, IC; Bolboacă, SD; Bulboacă, AE; Chirilă, I; Gheban, D; Pop, RM, 2019) |
| "Cardioprotective potential of aliskiren against isoproterenol-induced myocardial infarction was evaluated in this study." | 7.88 | Renin Inhibition by Aliskiren Protects Rats Against Isoproterenol Induced Myocardial Infarction. ( Akhtar, M; Hassan, MQ; Khan, V; Najmi, AK, 2018) |
| " Myocardial infarction was induced in Wistar rats via isoproterenol injection in a dose of (85 mg/kg, subcutaneously, twice at an interval of 24 h)." | 7.88 | Novel Mesenchymal Stem Cell Strategy in Alleviating Toll-Like Receptor-4, p53 and Nrf2 Signaling in Isoproterenol-Induced Myocardial Infarction in Rat Model. ( Abdel-Megeed, RM; Kadry, MO, 2018) |
| "The cardioprotective role of raspberry ketone (RK) against isoproterenol (ISO)-induced myocardial infarction (MI) in rats was assessed." | 7.88 | Raspberry ketone protects against isoproterenol-induced myocardial infarction in rats. ( Ali, SM; Bhandari, U; Haque, SE; Khan, V; Sharma, S, 2018) |
| " This study evaluated the cardioprotective effect of rosuvastatin on isoproterenol-induced myocardial infarction injury in rats." | 7.88 | Cardioprotective effect of rosuvastatin against isoproterenol-induced myocardial infarction injury in rats. ( Cang, J; Guo, K; Hu, Y; Jin, L; Yu, Y; Zhuang, Y, 2018) |
| "To investigate the effects and mechanisms of catalpol on cardiac function in rats with isoproterenol (ISO)-induced myocardial infarction (MI)." | 7.88 | Catalpol pretreatment attenuates cardiac dysfunction following myocardial infarction in rats. ( Bi, F; Sun, Q; Xu, Y, 2018) |
| " The present study was directed to investigate the effect of ATV pre- and post-treatment in isoproterenol (ISO)-induced cardiotoxicity in rats." | 7.88 | Paradoxical effects of atorvastatin in isoproterenol-induced cardiotoxicity in rats: Role of oxidative stress and inflammation. ( Ahmed, LA; Attalla, DM; Khattab, MM; Zaki, HF, 2018) |
| "This study examined the effects of aliskiren (Ali) (direct renin inhibitor) on serum cardiac enzymes (LDH and CK-MB), electrocardiography (ECG) changes, myocardial oxidative stress markers (MDA, CAT, and GSH) and the expression of Bcl2, HO-1, and Nrf2 genes in isoproterenol (ISO)-induced myocardial infarction (MI)." | 7.88 | Effects of low dose of aliskiren on isoproterenol-induced acute myocardial infarction in rats. ( Bin-Jaliah, I; Eid, EA; Hussein, AM; Sakr, HF, 2018) |
| "The effect of α-bisabolol on hemodyanimcs, lipid peroxidation, and nonenzymatic antioxidants was evaluated in isoproterenol-induced myocardial infarction in rats." | 7.88 | Protective effects of α-bisabolol on altered hemodynamics, lipid peroxidation, and nonenzymatic antioxidants in isoproterenol-induced myocardial infarction: In vivo and in vitro evidences. ( Al-Taee, H; Azimullah, S; Laham, F; Meeran, MFN; Ojha, S, 2018) |
| "The present study was designed to investigate the protective effect of ferulic acid (FA) against isoproterenol (ISO)-induced cardiac toxicity in rats." | 7.88 | Cardioprotective role of FA against isoproterenol induced cardiac toxicity. ( Jain, PG; Mahajan, UB; Shinde, SD; Surana, SJ, 2018) |
| " This study was performed to investigate the effects of syrigaldehyde (SYD), a phytochemical against isoproterenol (ISO) induced cardiotoxicity model." | 7.88 | Protective effect of syringaldehyde on biomolecular oxidation, inflammation and histopathological alterations in isoproterenol induced cardiotoxicity in rats. ( Akhtar, K; Mateen, S; Moin, S; Mubeena Mariyath, PM; Naeem, SS; Rizvi, W; Shahzad, S, 2018) |
| " Therefore, the current investigation was intended to evaluate the effect of malvidin against myocardial infarction induced by isoproterenol in the rats." | 7.85 | Cardioprotective Effects of Malvidin Against Isoproterenol-Induced Myocardial Infarction in Rats: A Mechanistic Study. ( Cheng, LX; Jiang, LL; Li, H; Peng, YD; Wan, SP; Wei, H; Zeng, QT, 2017) |
| "The present study investigated the protective effect of diethylcarbamazine in inhibiting nuclear factor (NF)-κB activation in isoproterenol‑induced acute myocardial infarction (AMI) rats through the poly ADP ribose polymerase (PARP) pathway." | 7.85 | Protective effect of diethylcarbamazine inhibits NF-κB activation in isoproterenol-induced acute myocardial infarction rat model through the PARP pathway. ( Jia, G; Liu, X; Zao, M, 2017) |
| ", family Arecaceae) on isoproterenol-induced myocardial infarction (MI) in rats." | 7.85 | Cardiopreventive effect of ethanolic extract of Date Palm Pollen against isoproterenol induced myocardial infarction in rats through the inhibition of the angiotensin-converting enzyme. ( Abid, L; Ayadi, F; Belbahri, L; Ben Amar, R; Ben Mefteh, F; Daoud, A; ElFeki, A; Gharsallah, N; Jmal, S; Kadri, A; Mnafgui, K; Rateb, ME; Turki, M, 2017) |
| "The present study was designed to evaluate the cardioprotective effects of nesfatin-1, a novel peptide with anorexigenic properties, in rats with isoproterenol (ISO)-induced myocardial infarction (MI), and to further investigate the role of Akt/GSK-3β signaling pathway in the protective effect of nesfatin-1." | 7.85 | Cardioprotective effect of nesfatin-1 against isoproterenol-induced myocardial infarction in rats: Role of the Akt/GSK-3β pathway. ( Adiguzel, D; Barutcigil, A; Celik-Ozenci, C; Dalaklioglu, S; Kuscu, N; Ozdem, S; Tasatargil, A, 2017) |
| " macroptera peel and pulp against isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 7.85 | Protective effects of ethanolic peel and pulp extracts of Citrus macroptera fruit against isoproterenol-induced myocardial infarction in rats. ( Afroz, R; Das, S; Gan, SH; Hossain, MS; Hossen, MS; Ibrahim Khalil, M; Islam, MA; Paul, S; Saha, M; Tanvir, EM, 2017) |
| "The present study aimed to investigate the cardioprotective effect of hydroxytyrosol (HT) against isoproterenol-induced myocardial infarction in rats." | 7.83 | Protective Effect of Hydroxytyrosol Against Cardiac Remodeling After Isoproterenol-Induced Myocardial Infarction in Rat. ( Allouche, N; Derbali, F; Elfeki, A; Ellefi, H; Gharsallah, N; Hajji, R; Khlif, I; Kraiem, F; Mnafgui, K, 2016) |
| "This study aimed to evaluate the antithrombotic, anti-inflammatory and anti-cardiac remodeling properties of eugenol in isoproterenol-induced myocardial infarction in rats." | 7.83 | Anti-inflammatory, Antithrombotic and Cardiac Remodeling Preventive Effects of Eugenol in Isoproterenol-Induced Myocardial Infarction in Wistar Rat. ( Allouche, N; Derbali, F; Ellefi, H; Gammoudi, A; Gharsallah, N; Hajji, R; Kadri, A; Khabbabi, G; Mnafgui, K, 2016) |
| "The current study investigated the combinatorial effect of pravastatin (PRAV) and bone marrow mononuclear cells (BM-MNC) on acute myocardial infarction (AMI) induced experimentally in rats." | 7.83 | Bone marrow mononuclear cells enhance anti-inflammatory effects of pravastatin against isoproterenol-induced myocardial infarction in rats. ( El-Desouky, KI; El-Mahdy, N; El-Sayad, M; Salem, ML; Zaghow, N, 2016) |
| "In the present study, we investigated whether combination therapy of low-dose benidipine with the potent free radical scavenger edaravone has a cardioprotective effect against isoproterenol (ISO)-induced myocardial infarction (MI) in Wistar rats." | 7.83 | Edaravone, a potent free radical scavenger and a calcium channel blocker attenuate isoproterenol induced myocardial infarction by suppressing oxidative stress, apoptotic signaling and ultrastructural damage. ( Akhtar, M; Akhtar, MS; Ali, J; Haque, SE; Hassan, MQ; Najmi, AK, 2016) |
| "This study evaluates the protective effects of 7-hydroxycoumarin (7-HC) on dyslipidemia and cardiac hypertrophy in isoproterenol (ISO) induced myocardial infarction (MI) in rats." | 7.83 | Protective Effects of 7-Hydroxycoumarin on Dyslipidemia and Cardiac Hypertrophy in Isoproterenol-Induced Myocardial Infarction in Rats. ( Jagadeesh, GS; Nagoor Meeran, MF; Selvaraj, P, 2016) |
| "Subcutaneous injection of isoproterenol (85 mg/kg) on last 2 consecutive days in per se group and 7 days treatment of different groups at 24 h interval induced myocardial infarction in Wistar rats." | 7.83 | Histamine H3 Receptor Agonist Imetit Attenuated Isoproterenol Induced Renin Angiotensin System and Sympathetic Nervous System Overactivity in Myocardial Infarction of Rats. ( Akhtar, M; Hass, C; Khanam, R; Najmi, AK; Panda, BP, 2016) |
| "The present study investigates the cardioprotective activity of the Macrotyloma uniflorum seed extract (MUSE) and its phenolic acids (p-coumaric acid and ferulic acid) in isoproterenol (ISO)-induced myocardial infarction in rats." | 7.83 | Dietary Phenolic Acids of Macrotyloma uniflorum (Horse Gram) Protect the Rat Heart Against Isoproterenol-Induced Myocardial Infarction. ( Laddha, A; Nandave, M; Panda, V; Srinath, S, 2016) |
| " This work investigated the protective effect of pioglitazone on myocardial infarction (MI) in non-diabetic and diabetic rats, focusing on its role on advanced glycated endproducts (AGEs) and cardiac apoptotic machinery." | 7.83 | Cardioprotective effect of pioglitazone in diabetic and non-diabetic rats subjected to acute myocardial infarction involves suppression of AGE-RAGE axis and inhibition of apoptosis. ( Farag, NE; Khodeer, DM; Moustafa, YM; Zaitone, SA, 2016) |
| " This study investigated the combined effect of low doses of fenofibrate and rosuvastatin in isoproterenol-induced experimental myocardial infarction." | 7.83 | Chronic oral administration of low-dose combination of fenofibrate and rosuvastatin protects the rat heart against experimentally induced acute myocardial infarction. ( Balakumar, P; Garg, M; Kalra, S; Khanna, D, 2016) |
| "The present study was designed to investigate the cardioprotective effects of Sundarban honey (SH) in rats with isoproterenol- (ISO-) induced myocardial infarction." | 7.83 | Sundarban Honey Confers Protection against Isoproterenol-Induced Myocardial Infarction in Wistar Rats. ( Afroz, R; Alam, N; Gan, SH; Hossain, MS; Karim, N; Khalil, MI; Tanvir, EM, 2016) |
| " In this paper, the mediation of XKS on the isoproterenol (ISO)-induced myocardial infarction (MI) rat were evaluated based on a tissue-targeted metabonomics in vitro/vivo." | 7.83 | Standardized Chinese Formula Xin-Ke-Shu inhibits the myocardium Ca(2+) overloading and metabolic alternations in isoproterenol-induced myocardial infarction rats. ( Chang, X; Jia, HM; Liu, YT; Zhou, C; Zou, ZM, 2016) |
| "In this study, the ability of KMP to protect heart against isoproterenol (ISO) induced oxidative stress and myocardial infarction was evaluated." | 7.83 | Kampeferol protects against oxidative stress and apoptotic damage in experimental model of isoproterenol-induced cardiac toxicity in rats. ( Arya, DS; Bhatia, J; Gamad, N; Goyal, SN; Malhotra, RK; Malik, S; Suchal, K, 2016) |
| "The effects of benidipine on oxidative stress and myocardial apoptosis were assessed in isoproterenol (ISO)-induced myocardial infarction (MI) in wistar rats." | 7.81 | Benidipine prevents oxidative stress, inflammatory changes and apoptosis related myofibril damage in isoproterenol-induced myocardial infarction in rats. ( Akhtar, M; Akhtar, MS; Ali, J; Ansari, SH; Haque, SE; Hassan, MQ; Najmi, AK, 2015) |
| " Therefore because oxidative stress plays a significant role in the pathophysiology of myocardial infarction (MI), the aim of our study was to investigate whether hydrogen-rich saline has cardioprotective effects against isoproterenol-induced MI in rats." | 7.81 | Cardioprotective Effect of Hydrogen-rich Saline on Isoproterenol-induced Myocardial Infarction in Rats. ( Han, JJ; Jing, L; Qin, SC; Sun, XJ; Wang, Y; Zhao, B; Zhao, XM, 2015) |
| "This study was aimed to evaluate the preventive role of phytic acid on lysosomal enzymes in isoproterenol (ISO)-induced myocardial infarction (MI) in male Wistar rats." | 7.81 | Preventive effect of phytic acid on lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats. ( Brindha, E; Rajasekapandiyan, M, 2015) |
| " alata (LPva) in isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 7.81 | Protective effects of Labisia pumila var. alata on biochemical and histopathological alterations of cardiac muscle cells in isoproterenol-induced myocardial infarction rats. ( Amran, AZ; Dianita, R; Jalil, J; Jantan, I, 2015) |
| "The present study was designed to evaluate the cardioprotective potential of edaravone on oxidative stress, anti-apoptotic, anti-inflammatory and ultrastructure findings in isoproterenol (ISO) induced myocardial infarction (MI) in rats." | 7.81 | Edaravone protects rats against oxidative stress and apoptosis in experimentally induced myocardial infarction: Biochemical and ultrastructural evidence. ( Akhtar, M; Akhtar, MS; Ali, J; Haque, SE; Hassan, MQ; Najmi, AK, 2015) |
| "The present study was designed to evaluate the cardioprotective effect of Tunisian flaxseed oil (Linum usitatissimum) against isoproterenol-induced myocardial infarction in rats by studying hypertensive and cardiac damage markers especially electrocardiographic changes and troponin T serum level." | 7.81 | Cardioprotective effect of linseed oil against isoproterenol-induced myocardial infarction in Wistar rats: a biochemical and electrocardiographic study. ( Affes, M; Allouche, N; Derbali, A; Derbali, F; El Feki, A; Gharsallah, N; Hajji, R; Mnafgui, K, 2015) |
| "Oleuropein offers high preventive effects from cardiac remodeling process in rats with acute myocardial infarction." | 7.81 | Preventive effects of oleuropein against cardiac remodeling after myocardial infarction in Wistar rat through inhibiting angiotensin-converting enzyme activity. ( Allouche, N; Derbali, F; Elfeki, A; Ellefi, H; Gharsallah, N; Hajji, R; Halabalaki, M; Khlif, I; Kraiem, F; Michel, T; Mnafgui, K; Skaltsounis, AL, 2015) |
| "The aim of the present study was to investigate the cardioprotective effects of Timosaponin B II (TB), a main bioactive constituent from Anemarrhenae asphodeloides Bge, on an isoproterenol (ISO)-induced myocardial infarction model in rats and explore its underlying mechanisms." | 7.81 | Cardioprotective effects of timosaponin B II from Anemarrhenae asphodeloides Bge on isoproterenol-induced myocardial infarction in rats. ( Chen, JJ; Deng, XY; Fu, Q; Li, HY; Ma, SP; Ma, ZQ, 2015) |
| " The current study investigated the effect of cardamom on hemodynamic, biochemical, histopathological and ultrastructural changes in isoproterenol (ISO)-induced myocardial infarction." | 7.81 | Protective Effects of Cardamom in Isoproterenol-Induced Myocardial Infarction in Rats. ( Agrawal, YO; Arya, DS; Goyal, SN; Kumari, S; Mahajan, UB; Ojha, S; Patil, CR; Sharma, C, 2015) |
| " In this study, we investigated whether baicalin ameliorates isoproterenol-induced acute myocardial infarction and its mechanism." | 7.81 | Baicalin ameliorates isoproterenol-induced acute myocardial infarction through iNOS, inflammation and oxidative stress in rat. ( Chen, H; Ruan, H; Wang, J; Xu, Y; Zhao, W, 2015) |
| "Myocardial infarction (MI) was induced by subcutaneous injection of isoproterenol (ISO) to investigate the effect of ISO on Coenzyme Q10 (CoQ10) content of myocardium and subsequent effects on lipid peroxidation, electrocardiogram pattern and hemodynamic parameters of the rat's heart." | 7.80 | Reduction of coenzyme q10 content: a possible effect of isoproterenol on heart failure and myocardial infarction in rat. ( Andalib, S; Garjani, A; Ghanbarzadeh, S; Khorrami, A, 2014) |
| " The aim of the present study was to investigate the effects of OxLDL on electrocardiogram and hemodynamic parameters of rat's heart in isoproterenol (ISO)-induced myocardial infarction (MI) model." | 7.80 | Effects of LDL and oxidized LDL on cardiac function in isoproterenol-induced myocardial infarction in rat. ( Andalib, S; Arami, S; Garjani, A; Ghanbarzadeh, S; Khorrami, A; Maleki-Dizaji, N; Ziaee, M, 2014) |
| "Acute treatment with metformin has a protective effect in myocardial infarction by suppression of inflammatory responses due to activation of AMP-activated protein kinase (AMPK)." | 7.80 | Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction. ( Clanachan, AS; Garjani, A; Ghazi-Khansari, M; Maleki-Dizaji, N; Rameshrad, M; Soraya, H, 2014) |
| "Rats were injected with isoproterenol (ISO; 110 mg/kg, ip, 2 doses, 24 h interval) to induce acute myocardial infarction (AMI) and were sacrificed 6 and 24 h after the last ISO injection." | 7.80 | Effects of carnosine on prooxidant-antioxidant status in heart tissue, plasma and erythrocytes of rats with isoproterenol-induced myocardial infarction. ( Develi, S; Doğru-Abbasoğlu, S; Evran, B; Kalaz, EB; Karpuzoğlu, H; Olgaç, V; Soluk-Tekkeşin, M; Uysal, M, 2014) |
| " The other 32 rats were subjected to induction of hypercholesterolemia by high-fat diet for 3 weeks, followed by induction of AMI by subcutaneous injections of isoproterenol (85 mg/kg/day, for 2 days)." | 7.80 | Assessment of the prophylactic role of aspirin and/or clopidogrel on experimentally induced acute myocardial infarction in hypercholesterolemic rats. ( El-Hadidy, WF; Mannaa, HF; Mohamed, AR, 2014) |
| " Herein, we examined the effects of this peptide on isoproterenol (ISO)-induced cardiac remodeling and myocardial infarction (MI) injury." | 7.79 | The novel Mas agonist, CGEN-856S, attenuates isoproterenol-induced cardiac remodeling and myocardial infarction injury in rats. ( Almeida, AP; Beiman, M; Carvalho, MB; Cohen, Y; Cojocaru, G; Ferreira, AJ; Ianzer, D; Marques, FD; Peluso, AA; Rotman, G; Santos, RA; Savergnini, SQ; Silva, GA, 2013) |
| "The present study was designed to evaluate the cardioprotective potential of lycopene (LCP) against isoproterenol (ISP)-induced myocardial infarction (MI), by assessing hemodynamic, biochemical and histopathological parameters." | 7.79 | Cardioprotective effect of lycopene against isoproterenol-induced myocardial infarction in rats. ( Arora, S; Arya, DS; Goyal, S; Kumari, S; Ojha, S; Sharma, C, 2013) |
| " This study aims to evaluate the protective effects of sinapic acid on cardiac hypertrophy, dyslipidaemia and alterations in lipoproteins and electrocardiogram in isoproterenol-induced myocardial infarcted rats." | 7.79 | Protective effects of sinapic acid on cardiac hypertrophy, dyslipidaemia and altered electrocardiogram in isoproterenol-induced myocardial infarcted rats. ( Mainzen Prince, PS; Roy, SJ, 2013) |
| " In the present study, we evaluated the effects of metformin on cardiac function, hemodynamic parameters, and histopathological changes in isoproterenol-induced myocardial infarction (MI)." | 7.78 | Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats. ( Garjani, A; Khorrami, A; Maleki-Dizaji, N; Soraya, H, 2012) |
| "Vitamin A is beneficial in counteracting free radical damage, therefore the present study is designed to investigate the effect of vitamin A against isoproterenol-induced myocardial infarction in rats." | 7.78 | Cardio protective effect of vitamin A against isoproterenol-induced myocardial infarction. ( Pipaliya, H; Vaghasiya, J, 2012) |
| "To assess the protective effects of lycopene on electrocardiographic, hemodynamic, biochemical and apoptotic changes in isoproterenol induced myocardial infarction." | 7.78 | Tomato lycopene attenuates myocardial infarction induced by isoproterenol: electrocardiographic, biochemical and anti-apoptotic study. ( Aman, U; Balaraman, R; Vaibhav, P, 2012) |
| " We examined the effect of Se on LTB(4) synthesis during isoproterenol (ISP)-induced myocardial infarction (MI) in rats." | 7.78 | Impact of selenium on the leukotriene B4 synthesis pathway during isoproterenol-induced myocardial infarction in experimental rats. ( John, F; M, I; Panicker, S; Swathy, SS, 2012) |
| "The aim of this investigation was to evaluate the preventive role of morin, a flavonoid, on cardiac marker enzymes such as aspartate transaminase, lactate dehydrogenase, creatine kinase and creatine kinase-MB, membrane-bound enzymes such as sodium potassium-dependent adenosine triphosphatase, calcium-dependent adenosine triphosphatase and magnesium-dependent adenosine triphosphatase, and glycoproteins such as hexose, hexosamine, fucose and sialic acid in isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 7.78 | Pretreatment with morin, a flavonoid, ameliorates adenosine triphosphatases and glycoproteins in isoproterenol-induced myocardial infarction in rats. ( Al-Numair, KS; Alsaif, MA; Chandramohan, G, 2012) |
| "The present study was designed to evaluate the protective effect of ursolic acid (UA) against isoproterenol-induced myocardial infarction." | 7.78 | Effect of ursolic acid treatment on apoptosis and DNA damage in isoproterenol-induced myocardial infarction. ( Ezhumalai, M; Pugalendi, KV; Radhiga, T; Rajamanickam, C; Sundaresan, A, 2012) |
| "The present investigation was to evaluate the antioxidant, biochemical profile and histological studies of qualitatively standardized ethanolic extract of Terminalia pallida fruits (TpFE) against isoproterenol-induced myocardial infarction in rats." | 7.78 | Cardioprotective effect of HPLC standardized ethanolic extract of Terminalia pallida fruits against isoproterenol-induced myocardial infarction in albino rats. ( Abdul Kareem, M; Lakshmi Devi, K; Rasool, SN; Saayi Krushna, G; Shaik, AH; Vikram Kumar Reddy, A, 2012) |
| "Myocardial infarction was produced in rats with 85 mgkg(-1) isoproterenol administered subcutaneously twice at an interval of 24 h." | 7.78 | Coptisine exert cardioprotective effect through anti-oxidative and inhibition of RhoA/Rho kinase pathway on isoproterenol-induced myocardial infarction in rats. ( Du, GH; Fang, LH; Gong, LL; Li, XX; Qin, HL; Sun, JL; Wang, SB, 2012) |
| " The present study reveals the protective role of ellagic acid in biochemical parameters including serum iron, plasma iron binding capacity, uric acid, glycoprotein, and electrolytes along with hematological parameters." | 7.78 | Protective efficacy of ellagic acid on glycoproteins, hematological parameters, biochemical changes, and electrolytes in myocardial infarcted rats. ( Kannan, MM; Quine, SD; Sangeetha, T, 2012) |
| " The activation of AMPK by metformin prevents cardiac remodeling after myocardial infarction (MI)." | 7.78 | Short-term treatment with metformin suppresses toll like receptors (TLRs) activity in isoproterenol-induced myocardial infarction in rat: are AMPK and TLRs connected? ( Banani, A; Farajnia, S; Garjani, A; Khani, S; Khorrami, A; Maleki-Dizaji, N; Rameshrad, M; Soraya, H, 2012) |
| "The cardioprotective potential of Inula racemosa root hydroalcoholic extract against isoproterenol-induced myocardial infarction was investigated in rats." | 7.77 | Effect of Inula racemosa root extract on cardiac function and oxidative stress against isoproterenol-induced myocardial infarction. ( Arya, DS; Bharti, S; Bhatia, J; Kumari, S; Ojha, S; Rani, N; Sharma, AK, 2011) |
| "Four groups of experimental rats were subcutaneously injected with sesamol (0, 1, 3, or 10 mg/kg) and then, 2 h later, intraperitoneally injected with isoproterenol (100 mg/kg 24 h apart on 2 consecutive days) to induce myocardial infarction." | 7.77 | Sesamol attenuates isoproterenol-induced acute myocardial infarction via inhibition of matrix metalloproteinase-2 and -9 expression in rats. ( Chang, CC; Chen, SY; Liu, MY; Mo, FE; Periasamy, S, 2011) |
| "We investigated the antioxidant preventive effect of betaine on isoprenaline-induced myocardial infarction in male albino rats." | 7.76 | Antioxidant defense of betaine against isoprenaline-induced myocardial infarction in rats. ( Anandan, R; AnbinEzhilan, R; Buddhan, S; Ganesan, B; Sivakumar, R, 2010) |
| " The aim of this study was to investigate the effect of selenium on NFκB activation in rats induced with myocardial infarction by isoproterenol (ISP)." | 7.76 | Impact of selenium on NFκB translocation in isoproterenol-induced myocardial infarction in rats. ( John, F; Madambath, I; Panicker, S; Swathy, SS, 2010) |
| "This study was designed to investigate the cardioprotective effect of sesamol on isoproterenol (ISO)-induced myocardial infarction in adult male albino Wistar rats." | 7.76 | Protective effect of sesamol against myocardial infarction caused by isoproterenol in Wistar rats. ( Pugalendi, KV; Vennila, L, 2010) |
| ") juice (PJ) on heart weight, infarct size, plasma marker enzymes of cardiac damage, lipid peroxidation, endogenous enzymatic and non-enzymatic antioxidants, cardiac ATPases and histopathology of isoproterenol (IP)-induced cardiac necrosis (CN) in rats." | 7.76 | Pomegranate (Punica granatum L.) juice supplementation attenuates isoproterenol-induced cardiac necrosis in rats. ( Devkar, RV; Jadeja, RN; Patel, DK; Ramachandran, AV; Thounaojam, MC, 2010) |
| "The present study was designed to investigate the cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats by studying myocyte injury markers, antioxidant defense system, serum and heart lipid profile, inflammatory markers, electrocardiographic and histopathological changes." | 7.76 | Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: A biochemical, electrocardiographic and histoarchitectural evaluation. ( Balaraman, R; Patel, V; Upaganlawar, A; Zalawadia, R, 2010) |
| " Acute cardiogenic pulmonary edema was induced in C57BL/6J male mice by an increase in heart rate with continuous intravenous infusion of isoproterenol (ISP) (10 mg/kg/h) at 2 weeks after the creation of myocardial infarction by left coronary artery ligation." | 7.76 | Inhibition of secretory phospholipase A2 activity attenuates acute cardiogenic pulmonary edema induced by isoproterenol infusion in mice after myocardial infarction. ( Fujioka, D; Kawabata, K; Kobayashi, T; Kugiyama, K; Mishina, H; Nakamura, T; Obata, JE; Saito, Y; Watanabe, K; Watanabe, Y; Yano, T, 2010) |
| " In this study, cardioprotective activity of fucoidan extracted from Cladosiphon okamuranus was evaluated in isoproterenol induced myocardial infarction in rats." | 7.76 | Cardioprotective activity of Cladosiphon okamuranus fucoidan against isoproterenol induced myocardial infarction in rats. ( Pasanban, B; Rajendran, M; Rengasamy, R; Thomes, P, 2010) |
| " The purpose of the present study was to investigate the effects of CAPE on isoproterenol (ISO) -induced myocardial infarction." | 7.76 | Effects of caffeic acid phenethyl ester on isoproterenol-induced myocardial infarction in rats. ( Alçin, E; Aydin, M; Ilhan, S; Nacar, A; Oktar, S; Yönden, Z, 2010) |
| "The present study was undertaken to evaluate the preventive role of naringin on mitochondrial lipid peroxides, antioxidants and lipids in isoproterenol (ISO)-induced myocardial infarction (MI) in male Wistar rats." | 7.75 | Naringin ameliorates mitochondrial lipid peroxides, antioxidants and lipids in isoproterenol-induced myocardial infarction in Wistar rats. ( Prince, PS; Rajadurai, M, 2009) |
| "The present study was aimed to investigate the combined effects of green tea and vitamin E on heart weight, body weight, serum marker enzymes, lipid peroxidation, endogenous antioxidants and membrane bound ATPases in isoproterenol (ISO)-induced myocardial infarction in rats." | 7.75 | Effect of green tea and vitamin E combination in isoproterenol induced myocardial infarction in rats. ( Balaraman, R; Gandhi, C; Upaganlawar, A, 2009) |
| " This study was designed to evaluate the protective effect of gallic acid on cardiac marker enzymes, troponin-T, LDH-isoenzyme pattern, lipid peroxidation products and antioxidant status in isoproterenol (ISO)-induced myocardial infarction in male Wistar rats." | 7.75 | Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats. ( Prince, PS; Priscilla, DH, 2009) |
| "The study aimed to evaluate the protective role of myricetin obtained from Vitis vinifera (Vitaceae) on heart rate, electrocardiographic (ECG) patterns, vascular reactivity to catecholamines, cardiac marker enzymes, antioxidant enzymes together with morphological and histopathological changes in isoproterenol (ISO) induced myocardial infarction (MI) in male Wistar rats." | 7.75 | Cardioprotective potential of myricetin in isoproterenol-induced myocardial infarction in Wistar rats. ( Ballero, M; Kasture, S; Maxia, A; Mohan, M; Tiwari, R, 2009) |
| " calabura), a medicinal herb, on isoproterenol-induced myocardial infarction (MI) in rat models." | 7.75 | Effects of Muntingia calabura L. on isoproterenol-induced myocardial infarction. ( Brindha, P; Jayasri, J; Nivethetha, M, 2009) |
| " In the present study, we investigated the protective effect of betaine, a potent lipotropic molecule, on changes in the levels of membrane-bound ATPase activities, lipid peroxidation, sulfhydryl activities, and mineral status in isoprenaline-induced myocardial infarction in Wistar rats, an animal model of myocardial infarction in man." | 7.75 | Protective effect of betaine on changes in the levels of membrane-bound ATPase activity and mineral status in experimentally induced myocardial infarction in Wistar rats. ( Anandan, R; Buddhan, S; Ganesan, B; Jeyakumar, R, 2009) |
| "The present study was designed to evaluate the cardioprotective potential of salvianolic acid A on isoproterenol-induced myocardial infarction in rats." | 7.75 | Cardioprotective effect of salvianolic acid A on isoproterenol-induced myocardial infarction in rats. ( Du, GH; Tian, S; Wang, SB; Yang, F; Yang, HG; Yang, XY, 2009) |
| "The goal of this study was to investigate whether sub-chronic anti-oxidant treatment with ascorbic acid (Vit C) is able to protect the heart against myocardial infarction." | 7.75 | Ascorbic acid prevents acute myocardial infarction induced by isoproterenol in rats: role of inducible nitric oxide synthase production. ( Bergamaschi, CT; Buttros, JB; Campos, RR; Oshima, CT; Ribeiro, DA, 2009) |
| "An ultra-performance liquid chromatography/time-of-flight mass spectrometry (UPLC/TOF-MS)-based metabolomic approach was developed to characterize the metabolic profile associated with isoproterenol (ISO)-induced myocardial infarction (MI)." | 7.75 | Metabolomic profiling of rat serum associated with isoproterenol-induced myocardial infarction using ultra-performance liquid chromatography/time-of-flight mass spectrometry and multivariate analysis. ( Chen, X; Hu, P; Liang, QL; Liang, XP; Luo, GA; Wang, YM; Zhang, HY, 2009) |
| "We demonstrated that propranolol reduced the incidence of arrhythmias in a rat model of myocardial infarction by coronary artery occlusion." | 7.75 | MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. ( Dong, D; Li, B; Li, X; Lu, Y; Pan, Z; Qiao, G; Shan, H; Song, W; Xu, C; Yang, B; Zhang, B; Zhang, F; Zhang, Y, 2009) |
| " The present study has been designed to investigate whether telmisartan treatment attenuates the development of acute myocardial infarction in isoproterenol-treated rats by restoring hemodynamic, biochemical, histopathological and ultrastructural changes." | 7.75 | Myocardial salvaging effect of telmisartan in experimental model of myocardial infarction. ( Arora, S; Arya, DS; Goyal, S; Joshi, S; Kumari, S; Mittal, R; Nag, TC; Ray, R, 2009) |
| "In the present study, cardioprotective effect of aqueous extract of fruits of Embelia ribes Burm (ER) was evaluated in a rat model having acute myocardial infarction, induced by isoproterenol (5." | 7.74 | Cardioprotective effect of aqueous extract of Embelia ribes Burm fruits against isoproterenol-induced myocardial infarction in albino rats. ( Ansari, MN; Bhandari, U; Islam, F, 2008) |
| " This study was aimed to evaluate the preventive role of naringin on cardiac troponin T (cTnT), lactate dehydrogenase (LDH)-isoenzyme, cardiac marker enzymes, electrocardiographic (ECG)-patterns and lysosomal enzymes in isoproterenol (ISO)-induced myocardial infarction (MI) in male Wistar rats." | 7.74 | Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats. ( Rajadurai, M; Stanely Mainzen Prince, P, 2007) |
| "The protective effect of PUFA concentrate prepared from fish oil on isoproterenol-induced myocardial infarction in male albino rats was investigated with respect to changes in the levels of diagnostic marker enzymes, cholesterol, triglycerides, free fatty acids, phospholipids, reduced glutathione (GSH) and lipid peroxides (LPO)." | 7.74 | Protective effect of n-3 polyunsaturated fatty acids concentrate on isoproterenol-induced myocardial infarction in rats. ( Anandan, R; Mathew, S; Sankar, TV; Viswanathan Nair, PG, 2007) |
| "The present study was designed to evaluate the preventive role of rutin on lipids, lipoproteins, and ATPases in normal and isoproterenol (ISO)-induced myocardial infarction in rats." | 7.74 | Preventive effect of rutin on lipids, lipoproteins, and ATPases in normal and isoproterenol-induced myocardial infarction in rats. ( Karthick, M; Stanely Mainzen Prince, P, 2007) |
| "In our investigation,we used short-time model of myocardial infarction of rats induced by high dose of isoproterenol (ISP)." | 7.74 | Troponin T and histological characteristics of rat myocardial infarction induced by isoproterenol. ( Hasić, S; Jadrić, R; Kiseljaković, E; Mornjaković, Z; Winterhalter-Jadrić, M, 2007) |
| "Increased oxidative stress and antioxidant deficit have been suggested to play a major role in isoproterenol-induced myocardial infarction." | 7.74 | Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. ( Devi Sampath, P; Vijayaraghavan, K, 2007) |
| " The present study is undertaken to evaluate the preventive role of naringin on mitochondrial enzymes in isoproterenol (ISO)-induced myocardial infarction in male albino Wistar rats." | 7.74 | Preventive effect of naringin on cardiac mitochondrial enzymes during isoproterenol-induced myocardial infarction in rats: a transmission electron microscopic study. ( Prince, PS; Rajadurai, M, 2007) |
| "The present study was designed to investigate whether fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, would attenuate the acute myocardial infarction in isoproterenol-treated rat model via maintaining activities of endogenous antioxidant enzymes." | 7.74 | Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat. ( Dai, G; Xu, Q; Yan, L; Zheng, J; Zheng, P; Zhou, R, 2008) |
| " The aim of the present study was to evaluate the role of aldosterone and angiotensin II on formation of left ventricular fibrosis induced by chronic beta-adrenergic stimulation with isoproterenol (iso) in the rat heart failure model induced by myocardial infarction (MI)." | 7.73 | Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist. ( Bos, R; Findji, L; Lechat, P; Médiani, O; Mougenot, N; Vanhoutte, PM, 2005) |
| "We demonstrate the effect of Aegle marmelos leaf extract (AMLEt) and alpha-tocopherol on plasma lipids, lipid peroxides and marker enzymes in rats with isoproterenol (ISO)-induced myocardial infarction." | 7.73 | Comparative effects of Aegle marmelos extract and alpha-tocopherol on serum lipids, lipid peroxides and cardiac enzyme levels in rats with isoproterenol-induced myocardial infarction. ( Prince, PS; Rajadurai, M, 2005) |
| "We have examined the protective effect of taurine on the myocardial antioxidant defense system in isoprenaline (isoproterenol)-induced myocardial infarction in rats, an animal model of myocardial infarction in man." | 7.73 | Protective effect of taurine on myocardial antioxidant status in isoprenaline-induced myocardial infarction in rats. ( Anandan, R; Devadasan, K; Farvin, KH; Kumar, SH; Shiny, KS, 2005) |
| "Isoproterenol (ISPH) induced myocardial infarction was confirmed by disturbances in serum and heart tissue marker enzymes such as lactate dehydrogenase (LDH), creatine phospho kinase (CPK), aspartate transaminase (AST) and alanine transaminase (ALT), increased level of lipid peroxidation and histopathological changes in the heart of ISPH administered rats." | 7.73 | Cardioprotective effect of mangiferin on isoproterenol induced myocardial infarction in rats. ( Devi, CS; Jainu, M; Prabhu, S; Sabitha, KE, 2006) |
| "In the present study, chronic treatment of atorvastatin was evaluated on isoproterenol-induced myocardial infarction." | 7.73 | Effect of atorvastatin treatment on isoproterenol-induced myocardial infarction in rats. ( Balaraman, R; Bothara, SB; Majithiya, JB; Trivedi, CJ, 2006) |
| " (Anacardiaceae), on isoproterenol (ISPH)-induced myocardial infarction (MI) in rats through its antioxidative mechanism." | 7.73 | Role of mangiferin on biochemical alterations and antioxidant status in isoproterenol-induced myocardial infarction in rats. ( Devi, CS; Jainu, M; Prabhu, S; Sabitha, KE, 2006) |
| "The effect of fish oil treatment on the activities of antioxidants such as superoxide dismutase, catalase, glutathione peroxidase, glutathione-s-transferase, and glutathione, as well as the level of the lipid peroxidation marker thiobarbituric reactive substance was studied in isoproterenol-induced myocardial infarction (MI)." | 7.73 | Modulatory effect of fish oil on the myocardial antioxidant defense system in isoproterenol-induced myocardial infarction. ( Devi, CS; Padma, VV; Ramkumar, KM, 2006) |
| " This study aimed to evaluate the preventive role of rutin on lipid peroxides and antioxidants in normal and isoproterenol-induced myocardial infarction in rats." | 7.73 | Preventive effect of rutin, a bioflavonoid, on lipid peroxides and antioxidants in isoproterenol-induced myocardial infarction in rats. ( Karthick, M; Stanely Mainzen Prince, P, 2006) |
| "Our study evaluates the preventive effect of S-allyl cysteine sulfoxide (SACS) on lipid peroxidative products and enzymic and nonenzymic antioxidants in isoproterenol (ISO) induced myocardial infarction in rats." | 7.73 | Antilipoperoxidative and antioxidant effects of S-allyl cysteine sulfoxide on isoproterenol-induced myocardial infarction in Wistar rats. ( Quine, SD; Sangeetha, T, 2006) |
| "This study was designed to evaluate the preventive effect of naringin in isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 7.73 | Preventive effect of naringin on lipids, lipoproteins and lipid metabolic enzymes in isoproterenol-induced myocardial infarction in Wistar rats. ( Rajadurai, M; Stanely Mainzen Prince, P, 2006) |
| "We studied the cardioprotective effect of squalene on isoprenaline-induced myocardial infarction in male albino rats with respect to changes in the levels of lipid components in plasma and heart tissue." | 7.73 | Cardioprotective effect of squalene on lipid profile in isoprenaline-induced myocardial infarction in rats. ( Anandan, R; Farvin, KH; Kumar, SH; Mathew, S; Nair, PG; Sankar, TV; Shiny, KS, 2006) |
| " Cardiac lesions induced by isoproterenol (ISO) are characterized by myocardial necrosis and exudative infiltration." | 7.72 | Effect of D-003 on isoproterenol-induced myocardial necrosis in rats. ( Arruzazabala, ML; Carbajal, D; González, J; Más, R; Mendoza, S; Molina, V; Noa, M, 2003) |
| "The protective effect of L-arginine and L-lysine on lysosomal enzymes and membrane bound ATPases was examined on isoproterenol induced myocardial infarction in rats." | 7.72 | Effect of L-arginine and L-lysine on lysosomal hydrolases and membrane bound phosphatases in experimentally induced myocardial infarction in rats. ( Devaki, T; Ebenezar, KK; Sathish, V, 2003) |
| "The synergistic protective effect of nicorandil (KATP channel opener) and amlodipine (calcium channel blocker) on mitochondrial respiration and mitochondrial lipid contents were examined on isoproterenol-induced myocardial infarction in rats." | 7.72 | Biochemical changes on the cardioprotective effect of nicorandil and amlodipine during experimental myocardial infarction in rats. ( Devaki, T; Ebenezar, KK; Sathish, V, 2003) |
| "Animals with heart failure exhibited depressions in ventricular function, positive inotropic response to isoproterenol, beta-AR receptor density and basal AC activity; these changes were also attenuated by PLC treatment." | 7.72 | Improvement of cardiac function and beta-adrenergic signal transduction by propionyl L-carnitine in congestive heart failure due to myocardial infarction. ( Dhalla, NS; Ferrari, R; Sethi, R; Wang, X, 2004) |
| "This study was designed to examine the effects of squalene on tissue antioxidant status in isoproterenol-induced myocardial infarction in male albino rats." | 7.72 | Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats. ( Anandan, R; Kumar, SH; Sabeena Farvin, KH; Sankar, TV; Shiny, KS; Thankappan, TK, 2004) |
| "Myocardial infarction was produced by subcutaneous administration of isoproterenol hydrochloride (85 mg/kg b." | 7.72 | Comparative account of certain enzymes in the serum of homo-iothermal vertebrates subjected to production of myocardial infarction by isoproterenol hydrochloride. ( Gaur, M; Kumar, S, 2003) |
| " The aim of the present study is to study the effect of folic acid and Vitamin B(12) supplementation on isoprenaline (ISO)-induced myocardial infarction (MI) in hyperhomocysteinemic rats." | 7.71 | Folic acid and vitamin B(12) supplementation attenuates isoprenaline-induced myocardial infarction in experimental hyperhomocysteinemic rats. ( Hagar, HH, 2002) |
| "Myocardial infarction (MI) was produced in rats with 85, 200 and 300 mg/kg of isoproterenol (ISO) administered subcutaneously (sc) twice at an interval of 24 h." | 7.71 | Cardioprotective potential of ocimum sanctum in isoproterenol induced myocardial infarction in rats. ( Arya, DS; Gupta, SK; Joshi, S; Kishore, K; Sharma, M, 2001) |
| "The synergistic effects of nicorandil (KATP-channel opener) and amlodipine (calcium-channel blocker) on heart mitochondrial enzymes and the mitochondrial antioxidant defence system was examined on isoproterenol-induced myocardial infarction in rats." | 7.71 | Synergistic effect of nicorandil and amlodipine on mitochondrial function during isoproterenol-induced myocardial infarction in rats. ( Devaki, T; Ebenezar, KK; Sathish, V; Vimal, V, 2002) |
| " Male Wistar rats with ligation-induced myocardial infarction were assigned to placebo or treatment with mibefradil (10 mg/kg/day), verapamil (8 mg/kg/day), or amlodipine (4 mg/kg/day) by oral gavage starting 7 days before the induction of myocardial infarction." | 7.70 | Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction. ( Meissner, A; Min, JY; Sandmann, S; Simon, R; Unger, T, 1999) |
| " To examine the status of beta-adrenergic receptors and postadrenergic receptor mechanisms in congestive heart failure due to myocardial infarction, the left coronary artery in rats was ligated for 4 and 8 weeks before studying the hemodynamic and biochemical changes due to isoproterenol, a beta-adrenoceptor agonist, or forskolin, a postreceptor agonist." | 7.69 | Inotropic responses to isoproterenol in congestive heart failure subsequent to myocardial infarction in rats. ( Dhalla, NS; Sethi, R, 1995) |
| "The mechanism of exercise-induced ST-segment elevation in previous myocardial infarction was investigated using isoproterenol infusion with atrial pacing to simulate exercise hemodynamics in seven closed chest dogs with myocardial infarction." | 7.69 | [Isoproterenol induces ST-segment elevation without wall motion aggravation and myocardial ischemia in experimental myocardial infarction]. ( Katori, R; Yamamoto, T, 1995) |
| "The effect of alpha-tocopherol (6 mg/100 g body wt, orally, daily for 90 days) pretreatment in isoproterenol (20 mg/100 g body wt, subcutaneously, twice at an interval of two days at the end of the alpha-tocopherol pretreatment) induced myocardial infarction was studied in rats." | 7.69 | Effect of alpha-tocopherol on isoproterenol induced myocardial infarction in rats--electrocardiographic biochemical and histological evidences. ( Ithayarasi, AP; Padmavathy, VN; Shyamala Devi, C, 1996) |
| "The effect of alpha-tocopherol pretreatment on lipid peroxidation and antioxidant status in isoproterenol induced myocardial infarction was studied in rats." | 7.69 | Effect of alpha-tocopherol on lipid peroxidation in isoproterenol induced myocardial infarction in rats. ( Devi, CS; Ithayarasi, AP, 1997) |
| "Myocardial infarction was induced in albino rats by the subcutaneous administration of isoproterenol." | 7.68 | Collagen levels in isoproterenol induced myocardial infarction in rats. ( Puvanakrishnan, R; Ravichandran, LV, 1993) |
| "2 mg/100 g body wt orally for 30 days) on myocardial infarction induced by isoproterenol (200 mg/kg body wt, subcutaneously for 2 days) has been studied in rats using activities of creatine kinase, aspartate amino transaminase, alanine amino transaminase and lactate dehydrogenase and levels of lipid peroxides as standard markers." | 7.68 | Effect of aspirin on isoproterenol induced myocardial infarction--a pilot study. ( Devi, CS; Geetha, A; Manjula, TS, 1992) |
| "Effects of acute myocardial infarction (48 h) on cardiovascular responses to (+/-)-, (-)-, and (+)-dobutamine were studied in isolated perfused rat hearts." | 7.68 | Cardiovascular responses to the stereoisomers of dobutamine in isolated rat hearts 48 hours after acute myocardial infarction. ( Porsius, AJ; van Rooij, HH; Vleeming, W; Wemer, J, 1991) |
| "The aim was to compare the effects of two novel angiotensin converting enzyme (ACE) inhibitors, spirapril and zofenopril, on cardiac remodelling in rats with congestive heart failure after myocardial infarction." | 7.68 | Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril. ( de Graeff, PA; de Langen, CD; Pinto, YM; van Gilst, WH; van Wijngaarden, J; Wesseling, H, 1991) |
| "Effect of ethanol administration on the severity of myocardial infarction induced by isoproterenol in rats was studied." | 7.68 | Effect of ethanol administration on metabolism of lipids in heart and aorta in isoproterenol induced myocardial infarction in rats. ( Kumari, S; Kurup, PA; Menon, PV; Remla, A, 1991) |
| "Effect of feeding safflower oil and coconut oil in experimental myocardial infarction induced by isoproterenol in rats was studied." | 7.68 | Effect of coconut oil & safflower oil on lipids in isoproterenol induced myocardial infarction in rats. ( Kurup, PA; Menon, PV; Remla, A, 1991) |
| ", beta-glucuronidase, beta-N-acetylglucosaminidase, beta-galactosidase, beta-glucosidase, alpha-glucosidase, alpha-galactosidase, alpha-mannosidase, cathepsin B, cathepsin D, and collagenolytic cathepsin, in serum and heart of rats subject to myocardial infarction with isoproterenol, were studied during the periods of peak infarction and recovery." | 7.68 | Influence of isoproterenol-induced myocardial infarction on certain glycohydrolases and cathepsins in rats. ( Joseph, KT; Puvanakrishnan, R; Ravichandran, LV, 1991) |
| "The alterations in the heart lysosomal stability following isoproterenol induced myocardial infarction were studied in albino rats." | 7.68 | Alterations in the heart lysosomal stability in isoproterenol induced myocardial infarction in rats. ( Joseph, KT; Puvanakrishnan, R; Ravichandran, LV, 1990) |
| "The influence of isoproterenol on induction of ventricular arrhythmias was evaluated in 10 normal dogs and 17 dogs with experimentally induced myocardial infarction." | 7.68 | Effect of isoproterenol on induction of ventricular tachyarrhythmias in the normal and infarcted canine heart. ( Hunt, GB; Ross, DL, 1990) |
| "Beta-Adrenoceptor agonists, such as isoproterenol, produce ventricular fibrillation and myocardial necrosis in rats." | 7.67 | Ventricular fibrillation threshold and myocardial cyclic AMP production in rats sensitive or resistant to isoproterenol. ( Balazs, T; Jordan, AW; Joseph, X, 1984) |
| "The effect of vitamin E administration on the severity of myocardial infarction induced by isoproterenol on rats was studied." | 7.67 | Effect of vitamin E on the severity of myocardial infarction induced by isoproterenol. ( Kumari, SS; Menon, VP; Muraleedharan, D; Varghese, A, 1989) |
| "The effects of the intravenous administration of hyaluronidase (HY; 2,500 IU/kg) and urokinase (UK; 20,000 and 40,000 IU/kg), alone or in combination, on the isoproterenol (ISP) induced myocardial infarction (MI) in rats, were studied." | 7.67 | The co-operative action of hyaluronidase and urokinase on the isoproterenol-induced myocardial infarction in rats. ( Antonetti, F; Borrelli, F; Caprino, L; Martelli, F, 1986) |
| "The effect of administration of carnitine on the severity of myocardial infarction in rats induced by isoproterenol was studied by following histopathological and biochemical parameters." | 7.67 | Effect of administration of carnitine on the severity of myocardial infarction induced by isoproterenol in rats. ( Kurup, PA; Mathew, S; Menon, PV, 1986) |
| " Seven days later, the animals were challenged with a dose of isoproterenol which would produce massive myocardial infarction and 50-60% mortality in non-treated animals." | 7.67 | Prolonged protective effects following propranolol withdrawal against isoproterenol-induced myocardial infarction in normotensive and hypertensive rats. ( Wexler, BC, 1985) |
| "Prophylactic effects of sulfinpyrazone (100 mg/Kg), aspirin (5 mg/Kg, 50 mg/Kg), and propranolol (2 mg/Kg, 10 mg/Kg) on myocardial necrosis and hypertrophy induced by isoproterenol were examined." | 7.66 | Effects of sulfinpyrazone, aspirin and propranolol on the isoproterenol-induced myocardial necrosis. ( Hashimoto, H; Ogawa, K, 1981) |
| "The effect of exercise on the severity of isoproterenol-induced acute myocardial infarction was studied in male rats." | 7.66 | Beneficial effects of exercise on l-isoproterenol induced myocardial infarction in male rats. ( Darrah, MI; Engen, RL, 1982) |
| "To determine the relative effect of body weight and physical inactivity on susceptibility to drug-induced myocardial infarction, randomly selected groups of 100-day-old male Sprague-Dawley rats were subjected to a 10-wk program of exercise training and (or) to caloric restriction followed by two subcutaneous injections of L-isoproterenol." | 7.66 | Relative role of caloric restriction and exercise training upon susceptibility to isoproterenol-induced myocardial infarction in male rats. ( Beitz, DC; Crandall, DL; Feirer, RP; Griffith, DR, 1981) |
| " Some of the animals were treated with the anti-hyperuricemic agent, allopurinol, either before or during the induction of myocardial infarction." | 7.66 | Allopurinol amelioration of the pathophysiology of acute myocardial infarction in rats. ( McMurtry, JP; Wexler, BC, 1981) |
| "Tachycardia- and bradycardia-dependent, left anterior and left posterior hemiblocks as transient phenomena were registered in two patients spontaneously, and especially as a consequence of isoproterenol infusion." | 7.66 | Transient tachycardia- and bradycardia-dependent left anterior and left posterior hemiblocks. Effects of isoproterenol. ( Alvarez, JA; Kretz, A; Leguizamon Palumbo, JR; Martinez Martinez, JA; Suarez, LD, 1981) |
| "The effect of isoproterenol infusion on regional myocardial perfusion and tissue oxygenation during acute myocardial infarction was investigated in anesthetized dogs." | 7.66 | Effect of isoproterenol on regional myocardial perfusion and tissue oxygenation in acute myocardial infarction. ( Grover, FL; Horwitz, LD; Schwartz, DA, 1979) |
| "Adult male and female Sprague-Dawley rats were subjected to an isoproterenol-induced myocardial infarction." | 7.66 | Effect of gonadectomy on isoproterenol-induced myocardial infarction. ( Greenberg, BP; Wexler, BC, 1979) |
| " suggest that the myocardial infarction induced by isoproterenol in the rat may be determined by phenomenons of intracoronaric platelets aggregation." | 7.66 | [The role of the platelets in myocardial infarction induced by isoproterenol in the rat (author's transl)]. ( Cacciapuoti, AA; Genovese, A; Giuffrida, G; Mazza, F; Polverino, W, 1979) |
| "Changes in myocardial zinc level was followed up over a period of 5 days after producing myocardial necrosis in albino rats by subcutaneous injection of isoproterenol, 85 mg/kg body weight." | 7.66 | A temporal profile of myocardial zinc changes after isoproterenol induced cardiac necrosis. ( Ahmad, MS; Hasan, MZ; Jamil, SA; Kumar, S; Mathew, BM; Seth, TD, 1978) |
| "Male and female, arteriosclerotic and non-arteriosclerotic rats were treated with the anti-lipemic agent, clofibrate, for 8 days and then subjected to an acute myocardial infarction by injecting them with two large doses of isoproterenol spaced 24 hours apart." | 7.66 | Protective effects of clofibrate on isoproterenol-induced myocardial infarction in arteriosclerotic and non-arteriosclerotic rats. ( Greenberg, BP; Wexler, BC, 1978) |
| "The effect of exercise on the severity of isoproterenol-induced myocardial infarction was studied in male rats." | 7.65 | Effects of exercise on the severity of isoproterenol-induced myocardial infarction. ( Bonner, HW; Jessup, GT; Landiss, CW; Riggs, CE, 1977) |
| "Trapidil increases the isoprenalin-induced necrosis of the myocardium in the rat." | 7.65 | [Modification of the isoprenaline-induced myocardial necrosis using trapidil]. ( Lampe, D; Lange, B; Mai, I, 1976) |
| "A 39-year-old women inhaled approximately 675 mg of aerosolized isoproterenol in less than three days during an asthmatic attack." | 7.65 | An electrocardiographic pattern of acute myocardial infarction associated with excessive use of aerosolized isoproterenol. ( Aelony, Y; Beall, G; Laks, MM, 1975) |
| "Male and female, arteriosclerotic and nonarteriosclerotic rats were subjected to acute myocardial infarction by two, subcutaneous injections (spaced 24 hr apart) of isoproterenol." | 7.65 | Metabolic and histopathologic changes in arteriosclerotic versus nonarteriosclerotic rats following isoproterenol-induced myocardial infarction with superimposed diabetes. ( Wexler, BC, 1975) |
| "Circulating prolactin levels were monitored in nonarteriosclerotic, arteriosclerotic, and hormonally sterilized male and female Sprague-Dawley rats during the acute necrosis and repair phases of myocardial infarction induced by isoproterenol." | 7.65 | Serum prolactin levels in rats following isoproterenol-induced myocardial infarction. ( Lewis, BK; Wexler, BC, 1975) |
| "Isoproterenol (ISO), a drug which causes an increased strength of myocardial contraction when administered to animals in mug/kg doses, causes myocardial necrosis when given mg/kg doses." | 7.65 | Calcium as mediator of isoproterenol-induced myocardial necrosis. ( Bloom, S; Davis, DL, 1972) |
| "Modern medicine has been used to treat myocardial infarction, a subset of cardiovascular diseases, and have been relatively effective but not without adverse effects." | 6.55 | Molecular understanding of the protective role of natural products on isoproterenol-induced myocardial infarction: A review. ( Ramamurthy, S; Thanikachalam, PV; Wong, ZW, 2017) |
| "Scopoletin pre-treatment with ISO (25 and 50 mg/kg b." | 5.91 | Cardioprotective Role of Scopoletin on Isoproterenol-Induced Myocardial Infarction in Rats. ( Ibrahim, IAA; Rong, N; Yang, R; Zhang, W, 2023) |
| "Protocatechuic acid (PCA) is a polyphenolic compound with various potent biological activities." | 5.91 | Protocatechuic acid reverses myocardial infarction mediated by β-adrenergic agonist via regulation of Nrf2/HO-1 pathway, inflammatory, apoptotic, and fibrotic events. ( Elhefny, MA; Jiang, H; Kassab, RB; Li, L; Lokman, MS; Ma, H; Sberi, HA; Xia, B; Zhang, Y, 2023) |
| "The cardiac mitochondrial damage and cardiac hypertrophy pathways are intimately associated with the pathology of myocardial infarction (MI)." | 5.91 | Protective effects of β-caryophyllene on mitochondrial damage and cardiac hypertrophy pathways in isoproterenol-induced myocardial infarcted rats. ( Ponnian, SMP; Stanely, SP; Yovas, A, 2023) |
| "Isoproterenol (ISO) was used to induce MI injury in mice and H9c2 cells." | 5.91 | Curdione inhibits ferroptosis in isoprenaline-induced myocardial infarction via regulating Keap1/Trx1/GPX4 signaling pathway. ( Cheng, Y; Liang, Q; Liu, Z; Shi, S; Wang, H; Xie, B; Zhang, R, 2023) |
| "Pre-treatment of fraxetin in group IV experimental rats resulted in decreased cardiac weight, diminished level of cardiac markers (cardiac troponin T (cTnT), creatine kinase, creatine kinase-MB, and cardiac troponin I (cTnI)), reduced level of oxidative stress biomarkers (LOOH and TBARS) in the plasma and cardiac tissue, amplified level of enzymes in antioxidant defense system (catalase (CAT), superoxide dismutase (SOD), glutathione (GSH), and glutathione peroxidase (GPx)) in the plasma and heart tissue, and elevated level of ATPase activities." | 5.72 | Effect of Fraxetin on Oxidative Damage Caused by Isoproterenol-Induced Myocardial Infarction in Rats. ( Chen, G; Wang, L; Yin, Y; You, H, 2022) |
| "Visnagin (VIS) is a natural bioactive component of Ammi visnaga, with promising radical scavenging and anti-inflammatory activities." | 5.62 | Visnagin prevents isoproterenol-induced myocardial injury by attenuating oxidative stress and inflammation and upregulating Nrf2 signaling in rats. ( Abukhalil, MH; Al-Amarat, W; Al-Swailmi, FK; Aladaileh, SH; Alanazi, KM; Alfwuaires, MA; Algefare, AI; Althunibat, OY; Hussein, OE; Kamel, EM; Mahmoud, AM; Saghir, SA, 2021) |
| "Ferruginol (FGL) is a major polyphenols and terpenoids with numerous pharmacological activities including antioxidant and anti-inflammatory." | 5.62 | Ameliorative effect of ferruginol on isoprenaline hydrochloride-induced myocardial infarction in rats. ( Ali Alharbi, S; Chen, Y; Deng, Y; Feng, J; Li, H; Li, X; Wang, C; Wang, L; Zhang, X, 2021) |
| "Piperine pretreatment significantly prevented these changes in ISO treated group." | 5.56 | The protective effect of piperine against isoproterenol-induced inflammation in experimental models of myocardial toxicity. ( Aliev, G; Beeraka, NM; Chubarev, VN; Dhivya, V; Gavryushova, LV; Huang, CY; Mikhaleva, LM; Minyaeva, NN; Tarasov, VV; Viswanadha, VP, 2020) |
| "Pretreatment with nimodipine (10 and 15 mg/kg, i." | 5.51 | Effects of nimodipine, vinpocetine and their combination on isoproterenol-induced myocardial infarction in rats. ( Ansari, MA; Ekbbal, R; Haque, SE; Iqubal, A, 2019) |
| " At the end of dosing left ventricular functions was assessed to estimate its effect on cardiac functions." | 5.46 | Cardiaprotective effect of crocetin by attenuating apoptosis in isoproterenol induced myocardial infarction rat model. ( Ge, Z; Li, Y; Zhang, W, 2017) |
| "Piperine pre-treatment decreased the levels of serum markers, lipid peroxidation and PCC with increased antioxidant status in the heart tissues of ISO administered rats." | 5.46 | Piperine modulates isoproterenol induced myocardial ischemia through antioxidant and anti-dyslipidemic effect in male Wistar rats. ( Chirayil, HT; Dhivya, V; Huang, CY; Padma, VV; Priya, LB; Sathiskumar, S, 2017) |
| "Isorhapontigenin is a derivative of stilbene with chemical structure similar to resveratrol." | 5.43 | Cardioprotective effect of resveratrol analogue isorhapontigenin versus omega-3 fatty acids in isoproterenol-induced myocardial infarction in rats. ( Abbas, AM, 2016) |
| "Pre-treatment with ibuprofen (30, 60 and 90mg/kg p." | 5.43 | Inhibition of RhoA/Rho kinase by ibuprofen exerts cardioprotective effect on isoproterenol induced myocardial infarction in rats. ( Gandhi, T; Parikh, M; Patel, P; Shah, H, 2016) |
| "Zingerone pretreatment significantly (P<0." | 5.43 | Anti-inflammatory and anti-thrombotic effects of zingerone in a rat model of myocardial infarction. ( Hemalatha, KL; Stanely Mainzen Prince, P, 2016) |
| "Treatment with tamoxifen significantly controlled dyslipidemia, hypertension, bradycardia, oxidative stress, and reduced serum cardiac markers." | 5.40 | Beneficial role of tamoxifen in isoproterenol-induced myocardial infarction. ( Patel, BM; Rayabarapu, N, 2014) |
| "Isoproterenol (100 mg/kg) was injected subcutaneously for two consecutive days to induce myocardial infarction, and simultaneously tacrolimus was administered orally twice a day for three days." | 5.40 | Tacrolimus ameliorates functional disturbances and oxidative stress in isoproterenol-induced myocardial infarction. ( Garjani, A; Garjani, M; Hammami, M; Khorrami, A; Maleki-Dizaji, N, 2014) |
| "Metoprolol can inhibit the expression of c-fos and has a positive therapeutic effect on rats after AMI; the involvement effect of metoprolol on myocardial infarction might be correlated with its effect on the inhibition of c-fos." | 5.39 | The effect of c-fos on acute myocardial infarction and the significance of metoprolol intervention in a rat model. ( Ge, J; Goldstein, S; He, B; Li, Y; Ruiz, G; Zhang, M; Zhang, S, 2013) |
| "Pre-treatment with morin favorably restored the biochemical and functional parameters to near normal indicating morin to be a significant protective effect on cardiac mitochondrial function against ISO-induced MI in rats." | 5.38 | Protective effect of morin on cardiac mitochondrial function during isoproterenol-induced myocardial infarction in male Wistar rats. ( Al Numair, KS; Alsaif, MA; Baskar, AA; Chandramohan, G, 2012) |
| "Pretreatment with morin regulated the abnormalities in electrocardiograph and biomarkers." | 5.38 | Morin protects heart from beta-adrenergic-stimulated myocardial infarction: an electrocardiographic, biochemical, and histological study in rats. ( Arella, M; Boini, L; Maharajan, MK; Oddepalli, DR; Pogula, BK; Sabarimuthu, DQ, 2012) |
| "Acute myocardial infarction was induced by injecting the rats with two doses of isoproterenol (85 mg/kg/24 h, s." | 5.38 | Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF. ( Abo-Gresha, NM; Zaitone, SA, 2012) |
| "Myocardial infarction was produced in rats with 65, 85, 120 and 200mg/kg of ISO administered subcutaneously (sc) twice at an interval of 24h." | 5.35 | Cardioprotective activity of Ginkgo biloba Phytosomes in isoproterenol-induced myocardial necrosis in rats: a biochemical and histoarchitectural evaluation. ( Naik, SR; Panda, VS, 2008) |
| "Myocardial infarction is the number one killer disease in many parts of the world." | 5.35 | Cardioprotective effect of 'Marutham' a polyherbal formulation on isoproterenol induced myocardial infarction in Wistar rats. ( Devika, PT; Prince, PS; Suman, S; Vaithianathan, M, 2008) |
| "Pretreatment with mangiferin (100 mg/kg body weight, intraperitoneally) for 28 days, significantly prevented the alterations and restored the enzyme activities to near-normal status." | 5.35 | Mechanism of protective action of mangiferin on suppression of inflammatory response and lysosomal instability in rat model of myocardial infarction. ( Devi, CS; Narayan, S; Prabhu, S, 2009) |
| "Myocardial infarction was experimentally induced with ISO (85 mg/kg) twice at 24 h interval." | 5.35 | Antilipoperoxidative and membrane stabilizing effect of diosgenin, in experimentally induced myocardial infarction. ( Jayachandran, KS; Rajamanickam, GV; Vasanthi, HR, 2009) |
| "Pretreatment with betaine daily for a period of 30 days to isoprenaline-induced rats prevented the changes in the activities of these lysosomal enzymes." | 5.35 | Protective effect of betaine on changes in the levels of lysosomal enzyme activities in heart tissue in isoprenaline-induced myocardial infarction in Wistar rats. ( Anandan, R; Ganesan, B, 2009) |
| "Isoproterenol treatment (80 mg/kg given over 2 days in two equal doses) caused arrhythmias and 60% mortality within 24 h of the last injection in the control group (C + ISO) group when compared with the saline control group (saline)." | 5.35 | Exercise training provides cardioprotection via a reduction in reactive oxygen species in rats submitted to myocardial infarction induced by isoproterenol. ( Barbosa, VA; Boeck, CR; Da Luz, G; Da Silva, S; De Pinho, RA; De Souza, CT; Frederico, MJ; Justo, SL; Medeiros, C; Silva, LA, 2009) |
| "Myocardial infarction was induced in rats by subcutaneous injection of isoproterenol (ISO) (150 mg kg(-1)) at an interval of 24 h for 2 days." | 5.35 | Protective effect of S-allyl cysteine sulphoxide (alliin) on glycoproteins and hematology in isoproterenol induced myocardial infarction in male Wistar rats. ( Quine, SD; Sangeetha, T, 2008) |
| "Carvedilol is a combined alpha(1)- and beta-adrenoceptor antagonist." | 5.33 | Carvedilol blockade of alpha1- and beta-adrenoceptor induced inotropic responses in rats with congestive heart failure. ( Bøkenes, J; Osnes, JB; Qvigstad, E; Schiander, I; Sejersted, OM; Sjaastad, I; Skomedal, T; Solberg, L, 2005) |
| " AEC was administered orally to male albino rats (150-200 g), at a dosage of 0." | 5.33 | Pretreatment with alcoholic extract of Crataegus oxycantha (AEC) activates mitochondrial protection during isoproterenol - induced myocardial infarction in rats. ( Devaraj, SN; Jayalakshmi, R; Thirupurasundari, CJ, 2006) |
| "Pretreatment with propranolol or labetalol counteracted the appearance of the myocardial histological alterations and the associated ECG and biochemical lesions." | 5.32 | Isoproterenol-induced myocardial infarction in rabbits. Protection by propranolol or labetalol: a proposed non-invasive procedure. ( Accinni, R; Bonacina, E; Brenna, S; Pinelli, A; Tomasoni, L; Trivulzio, S, 2004) |
| "Myocardial infarction is usually induced in small animals by means of invasive procedures: the aim of this study was to cause heart necrosis lesions by non-invasive means." | 5.32 | Myocardial infarction non-invasively induced in rabbits by administering isoproterenol and vasopressin: protective effects exerted by verapamil. ( Bertolini, B; Bonacina, E; Brenna, S; Pinelli, A; Tomasoni, L; Trivulzio, S; Vignati, S, 2004) |
| "Acute myocardial infarction is the second cause of mortality in most countries, therefore, it is important to know the evolution and sequence of the physiological and biochemical changes involved in this pathology." | 5.30 | Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study. ( Aranda-Fraustro, A; Chagoya de Sánchez, V; Cota-Garza, MD; Cruz, D; Hernández-Muñoz, R; López-Barrera, F; Suárez, J; Vidrio, S; Yañez, L, 1997) |
| "The propranolol treated animals had higher LV end-diastolic pressures (27+/-2* vs 20+/(-3 mmHg) and a more restricted LV diastolic filling pattern (increased ratio of early to late filling velocities and more rapid E wave deceleration rate)." | 5.30 | Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure. ( Douglas, PS; Katz, SE; Litwin, SE; Morgan, JP, 1999) |
| "Mibefradil treatment increased MAP and dP/dtmax and decreased LVEDP and HR in infarcted rats." | 5.30 | Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca(2+)-handling in infarct-induced heart failure in rats. ( Meissner, A; Min, JY; Sandmann, S; Unger, T, 1999) |
| "Nisoldipine was more effective in preventing cardiac necrosis as compared to nitrendipine and nimodipine." | 5.29 | Effect of nitrendipine, nimodipine and nisoldipine on experimentally induced myocardial infarction in rats. ( Kaur, AH; Mathur, SK; Singh, J; Srivastava, RK, 1995) |
| "Aspirin treatment is found to counteract the effect of isoproterenol on lipid and lipid peroxide formation and associated enzyme changes in heart mitochondria." | 5.29 | Effect of aspirin on mitochondrial lipids in experimental myocardial infarction in rats. ( Devi, CS; Manjula, TS, 1993) |
| "Rats treated with isoproterenol (30 mg/100 g body weight) showed a significant increase in serum lysosomal hydrolase activities, which were found to decrease after curcumin treatment." | 5.29 | Effect of curcumin on certain lysosomal hydrolases in isoproterenol-induced myocardial infarction in rats. ( Nirmala, C; Puvanakrishnan, R, 1996) |
| "Curcumin pre- and co-treatment decreased the severity of pathological changes and thus, could have a protective effect against the damage caused by myocardial infarction (MI)." | 5.29 | Protective role of curcumin against isoproterenol induced myocardial infarction in rats. ( Nirmala, C; Puvanakrishnan, R, 1996) |
| "Aspirin treated rats showed lower mortality rate and smaller changes in the myocardium on histopathological examination when compared to corresponding animals given isoproterenol alone." | 5.28 | Protective action of aspirin in experimental myocardial infarction induced by isoproterenol in rats and its effect on lipid peroxidation. ( Menon, VP; Muraleedharan, D; Sushama Kumari, S; Varghese, A, 1990) |
| "Pretreatment with sulfinpyrazone reduced isoproterenol-induced lesions by 42%." | 5.26 | Reduction in the severity of myocardial infarction by sulfinpyrazone. ( Innes, IR; Weisman, H, 1981) |
| "The necrosis was confirmed by ECG changes, increased serum activities of AspAT, AlAT, GPT and LDH, and by histological examination." | 5.26 | A temporal profile of changes in myocardial manganese after isoprenaline induced cardiac necrosis in albino rats. ( Ahmad, M; Hasan, MZ; Jameel, SA; Kumar, S; Mathew, BM; Seth, TD, 1979) |
| "The greater sensitivity of phase 1a arrhythmias to beta-blockade and the lack of a decrease in ventricular fibrillation threshold during phase 1b might indicate differences in the genesis of arrhythmias and fibrillation in phases 1a and 1b." | 5.26 | Prophylaxis of ventricular fibrillation after acute experimental coronary occlusion by chronic beta-adrenoceptor blockade with atenolol. ( Bucher, P; Meesmann, W; Menken, U; Wiegand, V, 1979) |
| " Isoproterenol (ISP)-induced myocardial ischemia is a classical model to screen the cardioprotective effects of various pharmacological interventions." | 4.98 | Isoproterenol-induced cardiac ischemia and fibrosis: Plant-based approaches for intervention. ( Allawadhi, P; Godugu, C; Khurana, A; Kumari, P; Sayed, N, 2018) |
| "Myocardial infarction was induced by injecting subcutaneous isoproterenol (5 mg/kg once for 7 consecutive days) to establish an experimental heart failure model." | 4.31 | Comparative Efficacy of Levosimendan, Ramipril, and Sacubitril/ Valsartan in Isoproterenol-induced Experimental Heart Failure: A Hemodynamic and Molecular Approach. ( Afzal, O; Akhtar, MS; Altamimi, A; Hassan, MZ; Hassan, Q; Mohammad, AAS; Sharma, AK; Tabassum, F, 2023) |
| "This study aimed to investigate the cardioprotective effect of SJP against isoproterenol-induced acute myocardial infarction (AMI) by integrating the gut microbiome and metabolome." | 4.31 | Microbiome-metabolome reveals that the Suxiao Jiuxin pill attenuates acute myocardial infarction associated with fatty acid metabolism. ( Liao, J; Ma, C; Wu, G; Zhang, W; Zhang, Y, 2023) |
| " However, researchers recently investigated the potential cardioprotective effects of taraxerol utilizing an isoproterenol (ISO)-induced cardiotoxicity model among Sprague Dawley rats." | 4.31 | Effects of Taraxerol on Oxidative and Inflammatory Mediators in Isoproterenol-Induced Cardiotoxicity in an Animal Model. ( Alam, A; Alkholifi, FK; Aodah, AH; Devi, S; Foudah, AI; Yusufoglu, HS, 2023) |
| " The objective of this study was to analyze the effect of essential oil of Alpinia zerumbet (EOAz) on cardiovascular and autonomic function in rats with isoproterenol-induced myocardial infarction." | 4.31 | Effect of essential oil of Alpinia zerumbet on cardiovascular and autonomic function in rats with isoproterenol induced acute myocardial infarction. ( Costa, PPC; Fechine, FV; Holanda, TM; Ingram, C; Maia, PHF; Moraes Filho, MO; Moraes, MEA; Rocha, DG; Silveira, JAM, 2023) |
| " This study was conducted to assess the cardioprotective action of TPN against isoproterenol (ISO)-induced cardiotoxicity." | 4.12 | Alpha-terpineol prevents myocardial damage against isoproterenol-MI induced in Wistar-Kyoto rats: new possible to promote cardiovascular integrity. ( Bernardino, AC; de Oliveira, KRV; Machado, MLDP; Oliveira, AP; Paulino, ET; Quintans-Júnior, LJ; Ribeiro, ÊAN; Rodrigues, AKBF, 2022) |
| " The present study aimed to investigate the effect of TQ on apoptotic parameters and MMP-9 expression in isoproterenol (ISP)-induced myocardial infarction (MI)." | 4.12 | Thymoquinone attenuates isoproterenol-induced myocardial infarction by inhibiting cytochrome C and matrix metalloproteinase-9 expression. ( Awad, A; Badr, AM; El-Bakly, WM; El-Demerdash, E; Medhet, M, 2022) |
| "The current study investigated the prophylactic effect of ethyl pyruvate (EP) in Isoproterenol (ISO) - induced myocardial infarction (MI)." | 4.12 | Ethyl pyruvate attenuates isoproterenol-induced myocardial infarction in rats: Insight to TNF-α-mediated apoptotic and necroptotic signaling interplay. ( Ahmed, AAE; Al-Botaty, BM; Elkhoely, A; K El-Sayed, E, 2022) |
| "The present study investigated the cardioprotection of Indole-3-carbinol on isoproterenol (ISO)-induced myocardial infarction in Wistar rats." | 4.12 | Indole-3-carbinol ameliorated the isoproterenol-induced myocardial infarction via multimodal mechanisms in Wistar rats. ( Krishnamurthy, S; Ramakrishna, K, 2022) |
| " No studies were conducted earlier on the effects of (-) epicatechin (EC) on tachycardia, cardiac hypertrophy, and inflammation in MI." | 4.12 | Preventive effects of (-) epicatechin on tachycardia, cardiac hypertrophy, and nuclear factor- κB inflammatory signaling pathway in isoproterenol-induced myocardial infarcted rats. ( Ponnian, SMP, 2022) |
| "In vitro models of vasoconstriction, atrium, and in vivo models of invasive blood pressure measurement and isoproterenol (ISO) induced cardiac hypertrophy in rats were used to understand underlying mechanistic by LC-MS/MS based dynamic metabolomics analysis of the serum and heart samples to be investigated the effect of ethanolic extract of C." | 4.12 | Metabolomics based mechanistic insights to vasorelaxant and cardioprotective effect of ethanolic extract of Citrullus lanatus (Thunb.) Matsum. & Nakai. seeds in isoproterenol induced myocardial infraction. ( Ahmedah, HT; Al-Huqail, AA; Bigiu, N; Chicea, LM; Irimie, M; Marc Vlaic, RA; Moga, M; Pop, OL; Saqib, F; Wahid, M, 2022) |
| "Anethole may retain a cardio-protective potential by controlling myocardial oxidative stress (through Nrf2 pathway) and diminishing inflammation and apoptosis via the TLR4/MYD88 pathway." | 4.12 | Anethole's effects against myocardial infarction: The role of TLR4/NFκB and Nrf2/HO1 pathways. ( Mohamed, ME; Younis, NS, 2022) |
| " Rats were induced MI by isoproterenol (100 mg/kg body weight) and then treated with valencene and cardiac sensitive markers, cardiac hypertrophy, oxidative stress, markers of inflammation, nuclear factor- κB inflammatory pathway, and myocardial infarct size was estimated/determined." | 4.12 | Valencene post-treatment exhibits cardioprotection via inhibiting cardiac hypertrophy, oxidative stress, nuclear factor- κB inflammatory pathway, and myocardial infarct size in isoproterenol-induced myocardial infarcted rats; A molecular study. ( Berlin Grace, VM; Shervin Prince, S; Stanely Mainzen Prince, P, 2022) |
| "This study has explored the fact that geraniol prevents isoproterenol (ISO)-induced oxidative stress and inflammation-mediated myocardial infarction (MI) through enhanced expression of peroxiredoxin-1 (Prdx-1) in experimental animal models." | 4.12 | Geraniol enhances peroxiredoxin-1, and prevents isoproterenol-induced oxidative stress and inflammation associated with myocardial infarction in experimental animal models. ( Balupillai, A; David, E; Ranganathan, B; Saravanan, K; Wan, J; Zou, G, 2022) |
| " The present study was designed to investigate the cardioprotective effects of a newly synthesised coumarin, symbolised as 5,6-PhSHC, against cardiac remodelling process in isoproterenol (ISO) induced myocardial infarction (MI) in male Wistar rats by evaluating haematological, biochemical and cardiac biomarkers." | 4.12 | A novel synthetised sulphonylhydrazone coumarin (E)-4-methyl-N'-(1-(3-oxo-3H-benzo[f]chromen-2- yl)ethylidene)benzenesulphonohydrazide protect against isoproterenol-induced myocardial infarction in rats by attenuating oxidative damage, biological changes ( Abid, M; Abid, S; Allouche, N; Ammar, H; Baaziz, I; Elmufti, A; Feriani, A; Ghazouani, L; Hajji, R; Khdhiri, E; Mnafgui, K; Ramazani, A; Tlili, N; Zarei, A, 2022) |
| "Earlier studies reported that long-term treatment with thymoquinone (TQ) at a high dose (20 mg/kg) exerts a cardioprotective effect against isoproterenol (ISO)-triggered myocardial infarction (MI) in rats." | 4.12 | Thymoquinone Produces Cardioprotective Effect in β-Receptor Stimulated Myocardial Infarcted Rats via Subsiding Oxidative Stress and Inflammation. ( Agrawal, Y; Goyal, SN; Nagoor Meeran, MF; Nakhate, KT; Ojha, S; Patil, CR; Rathod, S; Sherikar, A, 2022) |
| " The present study evaluated the effectiveness of rosmarinic acid (RA) against myocardial infarction (MI) in comorbid depression induced by maternal separation in rats." | 4.12 | Evaluation of rosmarinic acid against myocardial infarction in maternally separated rats. ( Bhattacharjee, A; Nayak, PK; Shivavedi, N; Verma, H, 2022) |
| "This study aims to investigate the protective effects of thymoquinone (THQ) in isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 4.12 | Thymoquinone regulates nitric oxide synthase enzymes and receptor-interacting serine-threonine kinases in isoproterenol-induced myocardial infarcted rats. ( Deger, N; Karabulut, D; Ozmen, R, 2022) |
| "In the present study, we assessed the therapeutic potential of Biochanin-A (BCA) (10 mg/kg BW/day) pretreatment for 30 days on lipid metabolic abnormalities, proinflammatory cytokines and matrix metalloproteinase expression in isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 4.12 | Attenuation of lipid metabolic abnormalities, proinflammatory cytokines, and matrix metalloproteinase expression by biochanin-A in isoproterenol-induced myocardial infarction in rats. ( Chandrasekaran, P; Jansy Isabella, RAR; Ponmurugan, P; Sangeethadevi, G; Saravanan, G; Sengottuvelu, S; V V, SU; Vadivukkarasi, S, 2022) |
| " The study was conducted to examine the ability of amniotic membrane mesenchymal stem cells (AMSCs) for protection against isoproterenol (ISO)-induced myocardial injury and attempted to show the possible mechanisms by which AMSCs that can be linked to inhibition of inflammation by targeting inflammatory MAPK/NF-κB pathway." | 4.12 | Human amniotic membrane mesenchymal stem cells exert cardioprotective effects against isoproterenol (ISO)-induced myocardial injury through suppression of inflammation and modulation of inflammatory MAPK/NF-κB pathway. ( Aboutaleb, N; Naseroleslami, M, 2022) |
| "The objective of the present paper is to formulate nanostructured lipid carriers (NLCs) of a calcium channel blocker, isradipine, to enhance its oral bioavailability and prolong its antihypertensive effect apart from evaluating efficacy of the formulation in isoproterenol induced myocardial infarction in rats." | 4.12 | Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction. ( Alam, T; Ali, J; Ansari, MA; Baboota, S, 2022) |
| "The study explored the cardioprotective role of the methanolic leaf extract of Nelumbo nucifera and nuciferine against isoproterenol-induced myocardial infarction (MI) in Wistar rats." | 4.12 | Nuciferine from Nelumbo nucifera Gaertn. attenuates isoproterenol-induced myocardial infarction in Wistar rats. ( HarishKumar, R; Selvaraj, CI, 2022) |
| " Ten male NMRI mice were randomly divided into two groups: (1) control (healthy mice) and (2) myocardial infarction (MI)-induced model group (Isoproterenol/subcutaneously injection/single dose of 85 mg/kg)." | 4.02 | Cardiac aorta-derived extracellular matrix scaffold enhances critical mediators of angiogenesis in isoproterenol-induced myocardial infarction mice. ( Abdolmaleki, Z; Beheshtiha, SHS; Hosseinabadi, M, 2021) |
| " The current study has been designed to ascertain their effectiveness against Isoproterenol (ISO)-induced myocardial infarction (MI)." | 4.02 | Pharmacological evaluation of Vitis vinifera and Zingiber zerumbet on electrocardiographic, biochemical alterations and antioxidant status in isoproterenol-induced myocardial infarction in rats. ( Faisal, N; Hanif, M; Hassan Mehmood, M; Munir, I; Naseer, D, 2021) |
| "The present study demonstrated the protective effects of arbutin (ARB) on hyperlipidemia, mitochondrial, and lysosomal membrane damage and on the DNA damage in rats with isoproterenol (ISO)-induced myocardial infarction (MI)." | 4.02 | Arbutin prevents alterations in mitochondrial and lysosomal enzymes in isoproterenol-induced myocardial infarction: An in vivo study. ( Asaikumar, L; Sivasangari, S; Vennila, L, 2021) |
| "This study aimed to investigate the antihyperlipidemic and anti-inflammatory effect of zingiberene (ZBN) on isoproterenol-(ISO) induced myocardial infarction in rats." | 4.02 | Anti-inflammatory and anti-apoptotic effect of zingiberene on isoproterenol-induced myocardial infarction in experimental animals. ( Govindasamy, K; Li, J; Thangaiyan, R; Wei, J, 2021) |
| " This study investigated the therapeutic benefit of adding rosuvastatin to low-dose carvedilol in protection against myocardial infarction (MI)." | 4.02 | Rosuvastatin and low-dose carvedilol combination protects against isoprenaline-induced myocardial infarction in rats: Role of PI3K/Akt/Nrf2/HO-1 signalling. ( Awad, AS; Baraka, SA; El-Demerdash, E; El-Naga, RN; Elsherbini, DA; Tolba, MF, 2021) |
| "As rats develop myocardial infarction (MI) like lesions when injected with large doses of isoproterenol (ISO), this investigation was designed to evaluate the dose-dependent effects of thymoquinone (TQ) on ISO-induced myocardial injury in rats." | 4.02 | Thymoquinone dose-dependently attenuates myocardial injury induced by isoproterenol in rats via integrated modulations of oxidative stress, inflammation, apoptosis, autophagy, and fibrosis. ( Elhadidy, WF; Farag, MM; Khalifa, AA; Rashad, RM, 2021) |
| "The study provides the evidence of cardioprotective potentials of esculetin against isoproterenol induced myocardial infarction by antioxidant and myocardial membrane stabilization along with in vitro protection from arsenic induced ROS cell necrosis or apoptosis in H9C2 cells." | 4.02 | Exploring cardioprotective potential of esculetin against isoproterenol induced myocardial toxicity in rats: in vivo and in vitro evidence. ( G V, NK; Kedam, T; Nelson, VK; Pullaiah, CP; Rayapu, S, 2021) |
| " In the present study, we report that wogonin nanoparticles (Wog np) protect Isoproterenol (ISO) induced Myocardial Infarction (MI) rats." | 3.96 | Cardio protective role of wogonin loaded nanoparticle against isoproterenol induced myocardial infarction by moderating oxidative stress and inflammation. ( Bei, W; Chen, N; Jing, L, 2020) |
| "The current study enumerates the beneficial role of sciadopitysin (SDN) against isoproternol (ISO)-induced myocardial infarction (MI) in rats." | 3.96 | Protective Effect of Sciadopitysin against Isoproternol-Induced Myocardial Infarction in Rats. ( Cai, Y; Li, Y, 2020) |
| "Our study is aimed at evaluating the effects of pretreatment with Poly(lactic-co-glycolic) acid nanoparticle loaded with resveratrol (RSV PLGA NPs) compared to conventional resveratrol (RSV) on isoproterenol (ISO) induced myocardial infarction (MI) in rats." | 3.96 | Protective role of poly(lactic-co-glycolic) acid nanoparticle loaded with resveratrol against isoproterenol-induced myocardial infarction. ( Hu, Y; Kumar, P; Mishra, A; Moktan, JB; Sreeharsha, N; Sun, L; Wang, L, 2020) |
| "This study determined the effect of Biochanin A (BCA) on isoproterenol (ISO) induced Myocardial Infarction (MI) in male Wistar rats." | 3.96 | Therapeutic Potential of Biochanin-A Against Isoproterenol-Induced Myocardial Infarction in Rats. ( Govindasami, S; Raveendran, N; Sasikumar, V; Uddandrao, VVS, 2020) |
| "HC), a novel potent synthesized coumarin, on isoproterenol- (ISO-) induced myocardial infarction (MI) in rats." | 3.96 | (E)-N'-(1-(7-Hydroxy-2-Oxo-2H-Chromen-3-Yl) Ethylidene) Benzohydrazide, a Novel Synthesized Coumarin, Ameliorates Isoproterenol-Induced Myocardial Infarction in Rats through Attenuating Oxidative Stress, Inflammation, and Apoptosis. ( Abid, S; Allouche, N; Ammar, H; Elmufti, A; Feriani, A; Ghazouani, L; Hajji, R; Khdhiri, E; Mnafgui, K; Tir, M; Tlili, N, 2020) |
| "The present study was aimed to discover novel pyrazole-thiadiazole derivatives as potent NF-ĸB inhibitor and its cardioprotective effect against isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 3.96 | Design and Development of Novel Pyrazole-Thiadiazole Derivatives as NF-ĸB Inhibitor and Cardioprotective Effect against Isoproterenol Induced Myocardial Infarction in Sprague-Dawley Rats. ( Guo, Y; Wang, J; Wu, X; Zhang, Y, 2020) |
| " Long non-coding RNA myocardial infarction associated transcript (LncMIAT) is closely related to heart disease, and here, we were the first to discover that LncMIAT may act as an miR-144 sponge in isoproterenol-induced cardiac hypertrophy." | 3.96 | The Expression of microRNA in Adult Rat Heart with Isoproterenol-Induced Cardiac Hypertrophy. ( Bai, L; Chen, L; Fan, Y; Gan, M; Guo, Z; Hao, X; Jiang, D; Li, X; Shen, L; Tan, Y; Zhang, S; Zhu, L, 2020) |
| " Isoproterenol was employed for acute myocardial infarction (AMI) and left ventricular hypertrophy (LVH) development and cardioprotective effects of Vt." | 3.96 | Ex vivo and in vivo studies of Viola tricolor Linn. as potential cardio protective and hypotensive agent: Inhibition of voltage-gated Ca ( Aslam, MA; Bobescu, E; Marceanu, L; Modhi, A; Moga, MA; Mujahid, K; Saqib, F, 2020) |
| " In this study, we investigated the preventive effect of alpha-pinene (AP), a monoterpene, against isoproterenol (ISO)-induced myocardial infarction and inflammation in Wistar rats." | 3.96 | Protective effect of alpha-pinene against isoproterenol-induced myocardial infarction through NF-κB signaling pathway. ( Cao, M; Wang, G; Wang, H; Wang, K; Yang, Z; Zhang, B; Zhao, Y, 2020) |
| "This research was aimed to explore protective effects of allicin on rat model of myocardial infarction via JNK signaling pathway." | 3.96 | Protective Effects of Allicin on ISO-Induced Rat Model of Myocardial Infarction via JNK Signaling Pathway. ( Li, EZ; Li, XP; Liu, YF; Ma, L; Wei, LN; Xu, W; Zhao, J, 2020) |
| " In particular, compound 4i was found to be the most potent ACE inhibitor and was further studied for cardioprotective effects against isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 3.96 | Novel thiazole-pyrazolone hybrids as potent ACE inhibitors and their cardioprotective effect on isoproterenol-induced myocardial infarction. ( Su, G; Su, X; You, H, 2020) |
| "The aim of this study was to evaluate the anti-ischemic effects of SAC through inhibiting neprilysin in isoproterenol (ISO) induced myocardial infarction (MI) in Wistar albino rats." | 3.91 | Sacubitril and valsartan protect from experimental myocardial infarction by ameliorating oxidative damage in Wistar rats. ( Akhtar, M; Akhtar, MS; Hassan, MQ; Imran, M; Najmi, AK; Rahman, O, 2019) |
| "This study was designed to investigate efficacy of Narirutin rich fraction (NRF), obtained from grape fruit peel, in the treatment of isoproterenol induced myocardial infarction in rats." | 3.91 | Attenuation of isoproterenol-induced cardiotoxicity in rats by Narirutin rich fraction from grape fruit. ( Barve, K; Bhatt, LK; Shaikh, S, 2019) |
| " Then, isoproterenol solution was used for induction of myocardial infarction." | 3.91 | The protective impact of betaine on the tissue structure and renal function in isoproterenol-induced myocardial infarction in rat. ( Babaei, G; Ghartavol, MM; Gholizadeh-Ghaleh Aziz, S; Hassan Khadem Ansari, M; Hossein Farjah, G, 2019) |
| " The investigation was conducted to evaluate the cardioprotective efficacy of RPG in rats having acute myocardial infarction (MI) induced by isoproterenol (ISO)." | 3.91 | Cardioprotective Effect of Rhapontigenin in Isoproterenol-Induced Myocardial Infarction in a Rat Model. ( Fan, Y, 2019) |
| "This study was designed to delineate the effect of kaempferol (KF) on heart failure (HF) in diabetic rats." | 3.91 | The protective effect of kaempferol on heart via the regulation of Nrf2, NF-κβ, and PI3K/Akt/GSK-3β signaling pathways in isoproterenol-induced heart failure in diabetic rats. ( Geng, J; Guo, Z; Han, S; Wang, Y; Zhang, L, 2019) |
| "In the present study, the modulatory effect of ursolic acid (UA) on cardiac fibrosis and mitochondrial and lysosomal enzymes activity in isoproterenol-induced myocardial infarction (MI) in rats were examined." | 3.91 | Ursolic acid modulates MMPs, collagen-I, α-SMA, and TGF-β expression in isoproterenol-induced myocardial infarction in rats. ( Pugalendi, KV; Radhiga, T; Senthil, S; Sundaresan, A, 2019) |
| " The present study aimed to elucidate the potential cardioprotective effect provided by ranolazine during myocardial infarction in nondiabetic and diabetic male rats." | 3.91 | Cardioprotective effect of ranolazine in nondiabetic and diabetic male rats subjected to isoprenaline-induced acute myocardial infarction involves modulation of AMPK and inhibition of apoptosis. ( Ameen, AM; Tawfik, MK, 2019) |
| " Our study is aimed at evaluating the effects of pretreatment with curcumin nanoparticles (CCNP) compared to conventional curcumin (CC) on isoproterenol (ISO) induced myocardial infarction (MI) in rats." | 3.91 | Effects of Curcumin Nanoparticles in Isoproterenol-Induced Myocardial Infarction. ( Boarescu, PM; Bocșan, IC; Bolboacă, SD; Bulboacă, AE; Chirilă, I; Gheban, D; Pop, RM, 2019) |
| "To evaluate the cardioprotective effects of the hydroalcoholic extract of the leaves of Alpinia zerumbet (AZE) against isoproterenol (ISO)-induced myocardial infarction in rats." | 3.91 | Cardioprotective effects induced by hydroalcoholic extract of leaves of Alpinia zerumbet on myocardial infarction in rats. ( Barros Ferreira, AK; Bortoluzzi, JH; da Silva, JCG; de Araújo-Júnior, JX; Ferreira Costa, CD; Nogueira Ribeiro, ÊA; Paulino, ET; Silva Júnior, EF; Smaniotto, S, 2019) |
| "Several researchers studied the protective effect of the N-acetylcysteine (NAC) when it was given before the induction of myocardial infarction (MI)." | 3.88 | Protective Role of N-Acetylcysteine on Isoprenaline-Induced Myocardial Injury: Histological, Immunohistochemical and Morphometric Study. ( Abdalla, IL; Kaooh, S; Mohamed, EA; Sadik, AOE; Zaki, SM, 2018) |
| "The objective of this study was to investigate the effect of astaxanthin on isoproterenol (ISO)-induced myocardial infarction and cardiac hypertrophy in rats." | 3.88 | Astaxanthin Prevented Oxidative Stress in Heart and Kidneys of Isoproterenol-Administered Aged Rats. ( Alam, MA; Alam, MN; Hossain, MM; Mamun, MAA; Rahman, MM; Reza, HM; Subhan, N; Ulla, A, 2018) |
| "Cardioprotective potential of aliskiren against isoproterenol-induced myocardial infarction was evaluated in this study." | 3.88 | Renin Inhibition by Aliskiren Protects Rats Against Isoproterenol Induced Myocardial Infarction. ( Akhtar, M; Hassan, MQ; Khan, V; Najmi, AK, 2018) |
| " Myocardial infarction was induced in Wistar rats via isoproterenol injection in a dose of (85 mg/kg, subcutaneously, twice at an interval of 24 h)." | 3.88 | Novel Mesenchymal Stem Cell Strategy in Alleviating Toll-Like Receptor-4, p53 and Nrf2 Signaling in Isoproterenol-Induced Myocardial Infarction in Rat Model. ( Abdel-Megeed, RM; Kadry, MO, 2018) |
| "The cardioprotective role of raspberry ketone (RK) against isoproterenol (ISO)-induced myocardial infarction (MI) in rats was assessed." | 3.88 | Raspberry ketone protects against isoproterenol-induced myocardial infarction in rats. ( Ali, SM; Bhandari, U; Haque, SE; Khan, V; Sharma, S, 2018) |
| " In this study, we have investigated the molecular mechanism of ER stress-mediated myocyte death in Isoproterenol (ISO) induced myocardial infarction and its inhibition by a potent anti oxidant and anti-apoptotic bioflavonoid, Vitexin." | 3.88 | Vitexin protects isoproterenol induced post myocardial injury by modulating hipposignaling and ER stress responses. ( Ashokkumar, R; Jamuna, S; Niranjali Devaraj, S; Sakeena Sadullah, MS, 2018) |
| "On the basis of preliminary studies and references of relevant literature about Sheng-Mai-San for myocardial ischemia, we chose three representative components (ginsenoside Rb1 (G), ruscogenin (R) and schisandrin (S)) for the optimization design studies." | 3.88 | A Strategy for Optimizing the Combination of Active Components Based on Chinese Medicinal Formula Sheng-Mai-San for Myocardial Ischemia. ( Chu, C; Fan, XX; Kou, JP; Li, F; Yu, BY; Zhang, Y, 2018) |
| " This study evaluated the cardioprotective effect of rosuvastatin on isoproterenol-induced myocardial infarction injury in rats." | 3.88 | Cardioprotective effect of rosuvastatin against isoproterenol-induced myocardial infarction injury in rats. ( Cang, J; Guo, K; Hu, Y; Jin, L; Yu, Y; Zhuang, Y, 2018) |
| "To investigate the effects and mechanisms of catalpol on cardiac function in rats with isoproterenol (ISO)-induced myocardial infarction (MI)." | 3.88 | Catalpol pretreatment attenuates cardiac dysfunction following myocardial infarction in rats. ( Bi, F; Sun, Q; Xu, Y, 2018) |
| " The present study was directed to investigate the effect of ATV pre- and post-treatment in isoproterenol (ISO)-induced cardiotoxicity in rats." | 3.88 | Paradoxical effects of atorvastatin in isoproterenol-induced cardiotoxicity in rats: Role of oxidative stress and inflammation. ( Ahmed, LA; Attalla, DM; Khattab, MM; Zaki, HF, 2018) |
| "This study examined the effects of aliskiren (Ali) (direct renin inhibitor) on serum cardiac enzymes (LDH and CK-MB), electrocardiography (ECG) changes, myocardial oxidative stress markers (MDA, CAT, and GSH) and the expression of Bcl2, HO-1, and Nrf2 genes in isoproterenol (ISO)-induced myocardial infarction (MI)." | 3.88 | Effects of low dose of aliskiren on isoproterenol-induced acute myocardial infarction in rats. ( Bin-Jaliah, I; Eid, EA; Hussein, AM; Sakr, HF, 2018) |
| "The effect of α-bisabolol on hemodyanimcs, lipid peroxidation, and nonenzymatic antioxidants was evaluated in isoproterenol-induced myocardial infarction in rats." | 3.88 | Protective effects of α-bisabolol on altered hemodynamics, lipid peroxidation, and nonenzymatic antioxidants in isoproterenol-induced myocardial infarction: In vivo and in vitro evidences. ( Al-Taee, H; Azimullah, S; Laham, F; Meeran, MFN; Ojha, S, 2018) |
| "The present study was designed to investigate the protective effect of ferulic acid (FA) against isoproterenol (ISO)-induced cardiac toxicity in rats." | 3.88 | Cardioprotective role of FA against isoproterenol induced cardiac toxicity. ( Jain, PG; Mahajan, UB; Shinde, SD; Surana, SJ, 2018) |
| " This study was performed to investigate the effects of syrigaldehyde (SYD), a phytochemical against isoproterenol (ISO) induced cardiotoxicity model." | 3.88 | Protective effect of syringaldehyde on biomolecular oxidation, inflammation and histopathological alterations in isoproterenol induced cardiotoxicity in rats. ( Akhtar, K; Mateen, S; Moin, S; Mubeena Mariyath, PM; Naeem, SS; Rizvi, W; Shahzad, S, 2018) |
| " Isoproterenol (ISO)-induced cardiotoxicity challenged mice were treated with NY for 28 days at two doses (0." | 3.88 | Nanoyttria attenuates isoproterenol-induced cardiac injury. ( Godugu, C; Khurana, A; Kumari, P, 2018) |
| "We substantiated the role of peroxisome proliferator-activated receptor-γ (PPAR-γ) activation in the protective effect of apigenin against the myocardial infarction (MI) in diabetic rats." | 3.85 | The Protective Effect of Apigenin on Myocardial Injury in Diabetic Rats mediating Activation of the PPAR-γ Pathway. ( Agrawal, YO; Arya, DS; Chandrayan, G; Goyal, SN; Mahajan, UB; Ojha, S; Patil, CR; Suchal, K, 2017) |
| " Therefore, the current investigation was intended to evaluate the effect of malvidin against myocardial infarction induced by isoproterenol in the rats." | 3.85 | Cardioprotective Effects of Malvidin Against Isoproterenol-Induced Myocardial Infarction in Rats: A Mechanistic Study. ( Cheng, LX; Jiang, LL; Li, H; Peng, YD; Wan, SP; Wei, H; Zeng, QT, 2017) |
| "The present study investigated the protective effect of diethylcarbamazine in inhibiting nuclear factor (NF)-κB activation in isoproterenol‑induced acute myocardial infarction (AMI) rats through the poly ADP ribose polymerase (PARP) pathway." | 3.85 | Protective effect of diethylcarbamazine inhibits NF-κB activation in isoproterenol-induced acute myocardial infarction rat model through the PARP pathway. ( Jia, G; Liu, X; Zao, M, 2017) |
| ", family Arecaceae) on isoproterenol-induced myocardial infarction (MI) in rats." | 3.85 | Cardiopreventive effect of ethanolic extract of Date Palm Pollen against isoproterenol induced myocardial infarction in rats through the inhibition of the angiotensin-converting enzyme. ( Abid, L; Ayadi, F; Belbahri, L; Ben Amar, R; Ben Mefteh, F; Daoud, A; ElFeki, A; Gharsallah, N; Jmal, S; Kadri, A; Mnafgui, K; Rateb, ME; Turki, M, 2017) |
| "The present study was designed to evaluate the cardioprotective effects of nesfatin-1, a novel peptide with anorexigenic properties, in rats with isoproterenol (ISO)-induced myocardial infarction (MI), and to further investigate the role of Akt/GSK-3β signaling pathway in the protective effect of nesfatin-1." | 3.85 | Cardioprotective effect of nesfatin-1 against isoproterenol-induced myocardial infarction in rats: Role of the Akt/GSK-3β pathway. ( Adiguzel, D; Barutcigil, A; Celik-Ozenci, C; Dalaklioglu, S; Kuscu, N; Ozdem, S; Tasatargil, A, 2017) |
| "Cardioprotective potential of anthocyanin rich red cabbage extract (ARCE) was assessed in H2O2 treated rat neonatal cardiomyoblasts (H9c2 cells) and isoproterenol (ISO) induced rodent model of myocardial infarction." | 3.85 | Anthocyanin rich extract of Brassica oleracea L. alleviates experimentally induced myocardial infarction. ( Das, S; Devkar, R; Jana, S; Mandal, R; Patel, D; Patel, S; Thadani, J; Upadhyay, K, 2017) |
| " macroptera peel and pulp against isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 3.85 | Protective effects of ethanolic peel and pulp extracts of Citrus macroptera fruit against isoproterenol-induced myocardial infarction in rats. ( Afroz, R; Das, S; Gan, SH; Hossain, MS; Hossen, MS; Ibrahim Khalil, M; Islam, MA; Paul, S; Saha, M; Tanvir, EM, 2017) |
| " The objective of present study is to find out the cardioprotective activity and to explore the underlying mechanisms of quercetin pretreatment (50 mg/kg body weight, orally) for 14 days against isoproterenol (ISO; 100 mg/kg body weight, subcutaneously) induced myocardial infarction in Wistar rats." | 3.85 | Molecular and biochemical evidence on the protective effects of quercetin in isoproterenol-induced acute myocardial injury in rats. ( Bodduluru, LN; Kasala, ER; Kumar, M; Kumar, V; Lahkar, M, 2017) |
| "The present study aimed to investigate the cardioprotective effect of hydroxytyrosol (HT) against isoproterenol-induced myocardial infarction in rats." | 3.83 | Protective Effect of Hydroxytyrosol Against Cardiac Remodeling After Isoproterenol-Induced Myocardial Infarction in Rat. ( Allouche, N; Derbali, F; Elfeki, A; Ellefi, H; Gharsallah, N; Hajji, R; Khlif, I; Kraiem, F; Mnafgui, K, 2016) |
| " The current study evaluated the consequence of AP in isoproterenol (ISO)-induced oxidative stress and myocardial infarction during β-adrenergic receptor stimulus in rats by persistent hemodynamic, biochemical and histopathological changes." | 3.83 | Apigenin Attenuates β-Receptor-Stimulated Myocardial Injury Via Safeguarding Cardiac Functions and Escalation of Antioxidant Defence System. ( Buwa, CC; Goyal, SN; Mahajan, UB; Patil, CR, 2016) |
| "This study aimed to evaluate the antithrombotic, anti-inflammatory and anti-cardiac remodeling properties of eugenol in isoproterenol-induced myocardial infarction in rats." | 3.83 | Anti-inflammatory, Antithrombotic and Cardiac Remodeling Preventive Effects of Eugenol in Isoproterenol-Induced Myocardial Infarction in Wistar Rat. ( Allouche, N; Derbali, F; Ellefi, H; Gammoudi, A; Gharsallah, N; Hajji, R; Kadri, A; Khabbabi, G; Mnafgui, K, 2016) |
| "The current study investigated the combinatorial effect of pravastatin (PRAV) and bone marrow mononuclear cells (BM-MNC) on acute myocardial infarction (AMI) induced experimentally in rats." | 3.83 | Bone marrow mononuclear cells enhance anti-inflammatory effects of pravastatin against isoproterenol-induced myocardial infarction in rats. ( El-Desouky, KI; El-Mahdy, N; El-Sayad, M; Salem, ML; Zaghow, N, 2016) |
| "Mitochondrial dysfunction has been suggested to be one of the important pathological events in isoproterenol (ISO), a synthetic catecholamine and β-adrenergic agonist induced myocardial infarction (MI)." | 3.83 | Thymol, a dietary monoterpene phenol abrogates mitochondrial dysfunction in β-adrenergic agonist induced myocardial infarcted rats by inhibiting oxidative stress. ( Jagadeesh, GS; Nagoor Meeran, MF; Selvaraj, P, 2016) |
| "In the present study, we investigated whether combination therapy of low-dose benidipine with the potent free radical scavenger edaravone has a cardioprotective effect against isoproterenol (ISO)-induced myocardial infarction (MI) in Wistar rats." | 3.83 | Edaravone, a potent free radical scavenger and a calcium channel blocker attenuate isoproterenol induced myocardial infarction by suppressing oxidative stress, apoptotic signaling and ultrastructural damage. ( Akhtar, M; Akhtar, MS; Ali, J; Haque, SE; Hassan, MQ; Najmi, AK, 2016) |
| "This study evaluates the protective effects of 7-hydroxycoumarin (7-HC) on dyslipidemia and cardiac hypertrophy in isoproterenol (ISO) induced myocardial infarction (MI) in rats." | 3.83 | Protective Effects of 7-Hydroxycoumarin on Dyslipidemia and Cardiac Hypertrophy in Isoproterenol-Induced Myocardial Infarction in Rats. ( Jagadeesh, GS; Nagoor Meeran, MF; Selvaraj, P, 2016) |
| "Subcutaneous injection of isoproterenol (85 mg/kg) on last 2 consecutive days in per se group and 7 days treatment of different groups at 24 h interval induced myocardial infarction in Wistar rats." | 3.83 | Histamine H3 Receptor Agonist Imetit Attenuated Isoproterenol Induced Renin Angiotensin System and Sympathetic Nervous System Overactivity in Myocardial Infarction of Rats. ( Akhtar, M; Hass, C; Khanam, R; Najmi, AK; Panda, BP, 2016) |
| " The present study was designed to investigate the protective effect of PDSS on isoproterenol (ISO)-induced myocardial infarction in rats and to elucidate the potential mechanism." | 3.83 | Paeonol and danshensu combination attenuates apoptosis in myocardial infarcted rats by inhibiting oxidative stress: Roles of Nrf2/HO-1 and PI3K/Akt pathway. ( Chen, Y; Dong, QQ; Duan, LR; Li, H; Sheng, JJ; Song, F; Wang, SW; Xie, YH; Yang, Q; Zhang, BL, 2016) |
| "The present study investigates the cardioprotective activity of the Macrotyloma uniflorum seed extract (MUSE) and its phenolic acids (p-coumaric acid and ferulic acid) in isoproterenol (ISO)-induced myocardial infarction in rats." | 3.83 | Dietary Phenolic Acids of Macrotyloma uniflorum (Horse Gram) Protect the Rat Heart Against Isoproterenol-Induced Myocardial Infarction. ( Laddha, A; Nandave, M; Panda, V; Srinath, S, 2016) |
| " This work investigated the protective effect of pioglitazone on myocardial infarction (MI) in non-diabetic and diabetic rats, focusing on its role on advanced glycated endproducts (AGEs) and cardiac apoptotic machinery." | 3.83 | Cardioprotective effect of pioglitazone in diabetic and non-diabetic rats subjected to acute myocardial infarction involves suppression of AGE-RAGE axis and inhibition of apoptosis. ( Farag, NE; Khodeer, DM; Moustafa, YM; Zaitone, SA, 2016) |
| " This study investigated the combined effect of low doses of fenofibrate and rosuvastatin in isoproterenol-induced experimental myocardial infarction." | 3.83 | Chronic oral administration of low-dose combination of fenofibrate and rosuvastatin protects the rat heart against experimentally induced acute myocardial infarction. ( Balakumar, P; Garg, M; Kalra, S; Khanna, D, 2016) |
| "The present study was designed to investigate the cardioprotective effects of Sundarban honey (SH) in rats with isoproterenol- (ISO-) induced myocardial infarction." | 3.83 | Sundarban Honey Confers Protection against Isoproterenol-Induced Myocardial Infarction in Wistar Rats. ( Afroz, R; Alam, N; Gan, SH; Hossain, MS; Karim, N; Khalil, MI; Tanvir, EM, 2016) |
| " In this paper, the mediation of XKS on the isoproterenol (ISO)-induced myocardial infarction (MI) rat were evaluated based on a tissue-targeted metabonomics in vitro/vivo." | 3.83 | Standardized Chinese Formula Xin-Ke-Shu inhibits the myocardium Ca(2+) overloading and metabolic alternations in isoproterenol-induced myocardial infarction rats. ( Chang, X; Jia, HM; Liu, YT; Zhou, C; Zou, ZM, 2016) |
| "Intent of the present study has been made to appraise the cardioprotective effect of chlorogenic acid (CGA) on isoproterenol (ISO) induced myocardial infarction (MI) in male albino Wistar rats." | 3.83 | Chlorogenic acid a dietary polyphenol attenuates isoproterenol induced myocardial oxidative stress in rat myocardium: An in vivo study. ( Akila, P; Vennila, L, 2016) |
| "In this study, the ability of KMP to protect heart against isoproterenol (ISO) induced oxidative stress and myocardial infarction was evaluated." | 3.83 | Kampeferol protects against oxidative stress and apoptotic damage in experimental model of isoproterenol-induced cardiac toxicity in rats. ( Arya, DS; Bhatia, J; Gamad, N; Goyal, SN; Malhotra, RK; Malik, S; Suchal, K, 2016) |
| "The effects of benidipine on oxidative stress and myocardial apoptosis were assessed in isoproterenol (ISO)-induced myocardial infarction (MI) in wistar rats." | 3.81 | Benidipine prevents oxidative stress, inflammatory changes and apoptosis related myofibril damage in isoproterenol-induced myocardial infarction in rats. ( Akhtar, M; Akhtar, MS; Ali, J; Ansari, SH; Haque, SE; Hassan, MQ; Najmi, AK, 2015) |
| " Therefore because oxidative stress plays a significant role in the pathophysiology of myocardial infarction (MI), the aim of our study was to investigate whether hydrogen-rich saline has cardioprotective effects against isoproterenol-induced MI in rats." | 3.81 | Cardioprotective Effect of Hydrogen-rich Saline on Isoproterenol-induced Myocardial Infarction in Rats. ( Han, JJ; Jing, L; Qin, SC; Sun, XJ; Wang, Y; Zhao, B; Zhao, XM, 2015) |
| "This study was aimed to evaluate the preventive role of phytic acid on lysosomal enzymes in isoproterenol (ISO)-induced myocardial infarction (MI) in male Wistar rats." | 3.81 | Preventive effect of phytic acid on lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats. ( Brindha, E; Rajasekapandiyan, M, 2015) |
| " alata (LPva) in isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 3.81 | Protective effects of Labisia pumila var. alata on biochemical and histopathological alterations of cardiac muscle cells in isoproterenol-induced myocardial infarction rats. ( Amran, AZ; Dianita, R; Jalil, J; Jantan, I, 2015) |
| "The present study evaluates the protective effect of the standardized extract of ginger against isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 3.81 | Protective effects of the standardized extract of Zingiber officinale on myocardium against isoproterenol-induced biochemical and histopathological alterations in rats. ( Amran, AZ; Buang, F; Dianita, R; Jantan, I, 2015) |
| "The present study was designed to evaluate the cardioprotective potential of edaravone on oxidative stress, anti-apoptotic, anti-inflammatory and ultrastructure findings in isoproterenol (ISO) induced myocardial infarction (MI) in rats." | 3.81 | Edaravone protects rats against oxidative stress and apoptosis in experimentally induced myocardial infarction: Biochemical and ultrastructural evidence. ( Akhtar, M; Akhtar, MS; Ali, J; Haque, SE; Hassan, MQ; Najmi, AK, 2015) |
| "The present study was designed to evaluate the cardioprotective effect of Tunisian flaxseed oil (Linum usitatissimum) against isoproterenol-induced myocardial infarction in rats by studying hypertensive and cardiac damage markers especially electrocardiographic changes and troponin T serum level." | 3.81 | Cardioprotective effect of linseed oil against isoproterenol-induced myocardial infarction in Wistar rats: a biochemical and electrocardiographic study. ( Affes, M; Allouche, N; Derbali, A; Derbali, F; El Feki, A; Gharsallah, N; Hajji, R; Mnafgui, K, 2015) |
| "Oleuropein offers high preventive effects from cardiac remodeling process in rats with acute myocardial infarction." | 3.81 | Preventive effects of oleuropein against cardiac remodeling after myocardial infarction in Wistar rat through inhibiting angiotensin-converting enzyme activity. ( Allouche, N; Derbali, F; Elfeki, A; Ellefi, H; Gharsallah, N; Hajji, R; Halabalaki, M; Khlif, I; Kraiem, F; Michel, T; Mnafgui, K; Skaltsounis, AL, 2015) |
| "The present study was designed to investigate the cardioprotective effects of Malaysian Tualang honey against isoproterenol- (ISO-) induced myocardial infarction (MI) in rats by investigating changes in the levels of cardiac marker enzymes, cardiac troponin I (cTnI), triglycerides (TG), total cholesterol (TC), lipid peroxidation (LPO) products, and antioxidant defense system combined with histopathological examination." | 3.81 | Cardioprotective Effects of Tualang Honey: Amelioration of Cholesterol and Cardiac Enzymes Levels. ( Afroz, R; Gan, SH; Khalil, MI; Sulaiman, SA; Tanvir, EM, 2015) |
| "The present study was carried out to evaluate the protective effect of different statins on isoproterenol (ISO) induced myocardial necrosis." | 3.81 | Comparative evaluation of HMG CoA reductase inhibitors in experimentally-induced myocardial necrosis: Biochemical, morphological and histological studies. ( Gandhi, HP; Patel, SS; Rathod, SP; Trivedi, JI; Variya, BC, 2015) |
| "In this study, we investigated the cardioprotective effect of one purified polysaccharide (SMP1) from Salvia miltiorrhiza on isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 3.81 | Protective effect of a polysaccharide from Salvia miltiorrhiza on isoproterenol (ISO)-induced myocardial injury in rats. ( Geng, ZH; Huang, L; Song, MB; Song, YM, 2015) |
| "The aim of the present study was to investigate the cardioprotective effects of Timosaponin B II (TB), a main bioactive constituent from Anemarrhenae asphodeloides Bge, on an isoproterenol (ISO)-induced myocardial infarction model in rats and explore its underlying mechanisms." | 3.81 | Cardioprotective effects of timosaponin B II from Anemarrhenae asphodeloides Bge on isoproterenol-induced myocardial infarction in rats. ( Chen, JJ; Deng, XY; Fu, Q; Li, HY; Ma, SP; Ma, ZQ, 2015) |
| " Myocardial infarction was induced by isoproterenol (ISP) (65 mg/kg) and confirmed by biochemical, electrophysiological and histopathological methods." | 3.81 | Anti-platelet effects of nimesulide in isoproterenol-induced myocardial ischaemia and infarction in rabbits. ( Ahmed, S; Dima, L; Gul, S; Moga, M; Ze Jaafar, H; Zia-Ul-Haq, M, 2015) |
| "We investigated the protective role of Withania somnifera leaf extract (WSLEt) on isoproterenol- (ISO-) induced myocardial infarction (MI) in rats." | 3.81 | Amelioration of Isoproterenol-Induced Oxidative Damage in Rat Myocardium by Withania somnifera Leaf Extract. ( Afroz, R; Ahmed, R; Ahmmed, I; Alam, N; Gan, SH; Khalil, MI; Paul, S; Tanvir, EM, 2015) |
| " The current study investigated the effect of cardamom on hemodynamic, biochemical, histopathological and ultrastructural changes in isoproterenol (ISO)-induced myocardial infarction." | 3.81 | Protective Effects of Cardamom in Isoproterenol-Induced Myocardial Infarction in Rats. ( Agrawal, YO; Arya, DS; Goyal, SN; Kumari, S; Mahajan, UB; Ojha, S; Patil, CR; Sharma, C, 2015) |
| " In this study, we investigated whether baicalin ameliorates isoproterenol-induced acute myocardial infarction and its mechanism." | 3.81 | Baicalin ameliorates isoproterenol-induced acute myocardial infarction through iNOS, inflammation and oxidative stress in rat. ( Chen, H; Ruan, H; Wang, J; Xu, Y; Zhao, W, 2015) |
| "Myocardial infarction (MI) was induced by subcutaneous injection of isoproterenol (ISO) to investigate the effect of ISO on Coenzyme Q10 (CoQ10) content of myocardium and subsequent effects on lipid peroxidation, electrocardiogram pattern and hemodynamic parameters of the rat's heart." | 3.80 | Reduction of coenzyme q10 content: a possible effect of isoproterenol on heart failure and myocardial infarction in rat. ( Andalib, S; Garjani, A; Ghanbarzadeh, S; Khorrami, A, 2014) |
| " This study evaluated the protective effect of XKS against isoproterenol (ISO)-induced myocardial infarction (MI)." | 3.80 | Metabolic pathways involved in Xin-Ke-Shu protecting against myocardial infarction in rats using ultra high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry. ( Cai, DY; Chang, X; Cheng, WH; Ding, G; Jia, HM; Liu, YT; Zhang, HW; Zhao, X; Zou, ZM, 2014) |
| "The present study was designed to evaluate the cardioprotective potential of water extract of rhizomes of Acorus gramineus (AGR) against isoproterenol (ISO)-induced myocardial infarction." | 3.80 | Cardioprotective effect of rhizomes of Acorus gramineus against isoproterenol-induced cardiac damage in pigs. ( Antonisamy, P; Bae, H; Chung, HS; Kim, JH; Lee, SR, 2014) |
| " The aim of the present study was to investigate the effects of OxLDL on electrocardiogram and hemodynamic parameters of rat's heart in isoproterenol (ISO)-induced myocardial infarction (MI) model." | 3.80 | Effects of LDL and oxidized LDL on cardiac function in isoproterenol-induced myocardial infarction in rat. ( Andalib, S; Arami, S; Garjani, A; Ghanbarzadeh, S; Khorrami, A; Maleki-Dizaji, N; Ziaee, M, 2014) |
| " The present study was designed to evaluate the cardioprotective potential of RG against isoproterenol (ISO)-induced myocardial infarction (MI), by assessing electrocardiographic, hemodynamic, and biochemical parameters." | 3.80 | Red ginseng (Panax ginseng) decreases isoproterenol-induced cardiac injury via antioxidant properties in porcine. ( Bae, BS; Cho, JY; Kim, B; Kim, JH; Lim, KH, 2014) |
| " This study investigated the cardioprotective effect and possible mechanism of embelin, a major constituent of Embelia ribes Burm, using isoproterenol (ISO)-induced myocardial infarction model in rats." | 3.80 | Cardioprotective effect of embelin on isoproterenol-induced myocardial injury in rats: possible involvement of mitochondrial dysfunction and apoptosis. ( Anubolu, H; Koneru, M; Kumar, JM; Kuncha, M; Rachamalla, SS; Sahu, BD; Sistla, R, 2014) |
| "Acute treatment with metformin has a protective effect in myocardial infarction by suppression of inflammatory responses due to activation of AMP-activated protein kinase (AMPK)." | 3.80 | Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction. ( Clanachan, AS; Garjani, A; Ghazi-Khansari, M; Maleki-Dizaji, N; Rameshrad, M; Soraya, H, 2014) |
| "Rats were injected with isoproterenol (ISO; 110 mg/kg, ip, 2 doses, 24 h interval) to induce acute myocardial infarction (AMI) and were sacrificed 6 and 24 h after the last ISO injection." | 3.80 | Effects of carnosine on prooxidant-antioxidant status in heart tissue, plasma and erythrocytes of rats with isoproterenol-induced myocardial infarction. ( Develi, S; Doğru-Abbasoğlu, S; Evran, B; Kalaz, EB; Karpuzoğlu, H; Olgaç, V; Soluk-Tekkeşin, M; Uysal, M, 2014) |
| " Most importantly, we found that epicardial application of resiniferatoxin largely prevented the elevated left ventricle end-diastolic pressure, lung edema, and cardiac hypertrophy, partially reduced left ventricular dimensions in the failing heart, and increased cardiac contractile reserve in response to β-adrenergic receptor stimulation with isoproterenol in CHF rats." | 3.80 | Cardiac sympathetic afferent denervation attenuates cardiac remodeling and improves cardiovascular dysfunction in rats with heart failure. ( Cornish, KG; Rozanski, GJ; Wang, HJ; Wang, W; Zucker, IH, 2014) |
| " The other 32 rats were subjected to induction of hypercholesterolemia by high-fat diet for 3 weeks, followed by induction of AMI by subcutaneous injections of isoproterenol (85 mg/kg/day, for 2 days)." | 3.80 | Assessment of the prophylactic role of aspirin and/or clopidogrel on experimentally induced acute myocardial infarction in hypercholesterolemic rats. ( El-Hadidy, WF; Mannaa, HF; Mohamed, AR, 2014) |
| "The preventive effects of (-) epicatechin on oxidative stress, cardiac mitochondrial damage, altered membrane bound adenosine triphosphatases and minerals were reported previously in isoproterenol-induced myocardial infarction model." | 3.79 | (-) Epicatechin prevents alterations in lysosomal glycohydrolases, cathepsins and reduces myocardial infarct size in isoproterenol-induced myocardial infarcted rats. ( Prince, PS, 2013) |
| " Herein, we examined the effects of this peptide on isoproterenol (ISO)-induced cardiac remodeling and myocardial infarction (MI) injury." | 3.79 | The novel Mas agonist, CGEN-856S, attenuates isoproterenol-induced cardiac remodeling and myocardial infarction injury in rats. ( Almeida, AP; Beiman, M; Carvalho, MB; Cohen, Y; Cojocaru, G; Ferreira, AJ; Ianzer, D; Marques, FD; Peluso, AA; Rotman, G; Santos, RA; Savergnini, SQ; Silva, GA, 2013) |
| " Rats were pretreated with p-coumaric acid (8 mg/kg body weight) daily for a period of 7 days and then injected with isoproterenol (100mg/kg body weight) on 8th and 9th day to induce myocardial infarction." | 3.79 | Preventive effects of p-coumaric acid on cardiac hypertrophy and alterations in electrocardiogram, lipids, and lipoproteins in experimentally induced myocardial infarcted rats. ( Roy, AJ; Stanely Mainzen Prince, P, 2013) |
| "This study was aimed to evaluate the preventive effect of diosgenin and exercise on tissue antioxidant status in isoproterenol-induced myocardial infarction (MI) in male Wistar rats." | 3.79 | Preconditioning with diosgenin and treadmill exercise preserves the cardiac toxicity of isoproterenol in rats. ( Mohammadi, M; Rashidi, B; Salimeh, A, 2013) |
| "The present study was designed to evaluate the cardioprotective potential of lycopene (LCP) against isoproterenol (ISP)-induced myocardial infarction (MI), by assessing hemodynamic, biochemical and histopathological parameters." | 3.79 | Cardioprotective effect of lycopene against isoproterenol-induced myocardial infarction in rats. ( Arora, S; Arya, DS; Goyal, S; Kumari, S; Ojha, S; Sharma, C, 2013) |
| " This study aims to evaluate the protective effects of sinapic acid on cardiac hypertrophy, dyslipidaemia and alterations in lipoproteins and electrocardiogram in isoproterenol-induced myocardial infarcted rats." | 3.79 | Protective effects of sinapic acid on cardiac hypertrophy, dyslipidaemia and altered electrocardiogram in isoproterenol-induced myocardial infarcted rats. ( Mainzen Prince, PS; Roy, SJ, 2013) |
| "The present study was designed to investigate the cardioprotective effect of neferine against isoproterenol-induced myocardial infarction." | 3.79 | Protective effect of neferine against isoproterenol-induced cardiac toxicity. ( Archanah, A; Lalitha, G; Padma, VV; Poornima, P, 2013) |
| " In the present study, we evaluated the effects of metformin on cardiac function, hemodynamic parameters, and histopathological changes in isoproterenol-induced myocardial infarction (MI)." | 3.78 | Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats. ( Garjani, A; Khorrami, A; Maleki-Dizaji, N; Soraya, H, 2012) |
| "Vitamin A is beneficial in counteracting free radical damage, therefore the present study is designed to investigate the effect of vitamin A against isoproterenol-induced myocardial infarction in rats." | 3.78 | Cardio protective effect of vitamin A against isoproterenol-induced myocardial infarction. ( Pipaliya, H; Vaghasiya, J, 2012) |
| "To assess the protective effects of lycopene on electrocardiographic, hemodynamic, biochemical and apoptotic changes in isoproterenol induced myocardial infarction." | 3.78 | Tomato lycopene attenuates myocardial infarction induced by isoproterenol: electrocardiographic, biochemical and anti-apoptotic study. ( Aman, U; Balaraman, R; Vaibhav, P, 2012) |
| " The present study was evaluated to investigate whether pyruvate attenuates the development of cardiotoxicity in isoproterenol (ISO)-induced myocardial infarction by assessing hemodynamic, biochemical and histopathological parameters." | 3.78 | Pyruvate attenuates cardiac dysfunction and oxidative stress in isoproterenol-induced cardiotoxicity. ( Arya, DS; Goyal, S; Kumari, S; Ojha, S, 2012) |
| " We examined the effect of Se on LTB(4) synthesis during isoproterenol (ISP)-induced myocardial infarction (MI) in rats." | 3.78 | Impact of selenium on the leukotriene B4 synthesis pathway during isoproterenol-induced myocardial infarction in experimental rats. ( John, F; M, I; Panicker, S; Swathy, SS, 2012) |
| "The aim of this investigation was to evaluate the preventive role of morin, a flavonoid, on cardiac marker enzymes such as aspartate transaminase, lactate dehydrogenase, creatine kinase and creatine kinase-MB, membrane-bound enzymes such as sodium potassium-dependent adenosine triphosphatase, calcium-dependent adenosine triphosphatase and magnesium-dependent adenosine triphosphatase, and glycoproteins such as hexose, hexosamine, fucose and sialic acid in isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 3.78 | Pretreatment with morin, a flavonoid, ameliorates adenosine triphosphatases and glycoproteins in isoproterenol-induced myocardial infarction in rats. ( Al-Numair, KS; Alsaif, MA; Chandramohan, G, 2012) |
| "Following induction of acute myocardial infarction in rats by adminstration of isoproterenol, hemodynamic and electrocardiographic parameters were monitored and recorded continuously, cardiac enzymes and parameters of oxidative stress were measured, and histopathological examination of heart tissue was performed." | 3.78 | Cardioprotective effect of water and ethanol extract of Salvia miltiorrhiza in an experimental model of myocardial infarction. ( Chao, RB; Du, JR; He, LF; Li, YJ; Shen, Y; Zhou, R, 2012) |
| "Cardiac hypertrophy was induced by a chronic infusion of isoproterenol (ISO) 15 mg/kg/day for 3 weeks in human apoB transgenic mice (n = 9) and in non-transgenic wild-type mice (n = 10)." | 3.78 | Overexpression of apolipoprotein B attenuates pathologic cardiac remodeling and hypertrophy in response to catecholamines and after myocardial infarction in mice. ( Borén, J; Lindbom, M; Omerovic, E; Råmunddal, T; Shao, Y; Täng, MS, 2012) |
| "The present study was designed to evaluate the protective effect of ursolic acid (UA) against isoproterenol-induced myocardial infarction." | 3.78 | Effect of ursolic acid treatment on apoptosis and DNA damage in isoproterenol-induced myocardial infarction. ( Ezhumalai, M; Pugalendi, KV; Radhiga, T; Rajamanickam, C; Sundaresan, A, 2012) |
| "In this study, the effects of lacidipine (LAC), ramipril (RAM), and valsartan (VAL) on biochemical and histopathologic changes in heart tissue were studied in rats with isoproterenol-induced (ISO-induced) myocardial infarction (MI)." | 3.78 | Comparing effects of lacidipine, ramipril, and valsartan against experimentally induced myocardial infarcted rats. ( Albayrak, A; Bayir, Y; Ferah, I; Halici, Z; Kabalar, E; Karakus, E; Keles, MS; Keles, O; Unal, B, 2012) |
| "This study was designed to evaluate the anti-inflammatory and anti-apoptotic effects of the alcoholic extract of the berries of Crataegus oxyacantha (AEC), a medicinal herb, on isoproterenol-induced myocardial infarction (MI) in a rat model." | 3.78 | Anti-inflammatory and anti-apoptotic effects of Crataegus oxyacantha on isoproterenol-induced myocardial damage. ( Devaraj, SN; Thiruchenduran, M; Vijayan, NA, 2012) |
| "The present investigation was to evaluate the antioxidant, biochemical profile and histological studies of qualitatively standardized ethanolic extract of Terminalia pallida fruits (TpFE) against isoproterenol-induced myocardial infarction in rats." | 3.78 | Cardioprotective effect of HPLC standardized ethanolic extract of Terminalia pallida fruits against isoproterenol-induced myocardial infarction in albino rats. ( Abdul Kareem, M; Lakshmi Devi, K; Rasool, SN; Saayi Krushna, G; Shaik, AH; Vikram Kumar Reddy, A, 2012) |
| "Myocardial infarction was produced in rats with 85 mgkg(-1) isoproterenol administered subcutaneously twice at an interval of 24 h." | 3.78 | Coptisine exert cardioprotective effect through anti-oxidative and inhibition of RhoA/Rho kinase pathway on isoproterenol-induced myocardial infarction in rats. ( Du, GH; Fang, LH; Gong, LL; Li, XX; Qin, HL; Sun, JL; Wang, SB, 2012) |
| " Physical training was considered a physiological condition, while isoproterenol-induced hypertrophy, myocardial infarction and DOCA-salt model of hypertension were used as pathological models of heart injury." | 3.78 | The cardiac expression of Mas receptor is responsive to different physiological and pathological stimuli. ( Almeida, PW; Braga, VB; Campagnole-Santos, MJ; Coutinho, DC; Dias-Peixoto, MF; Ferreira, AJ; Gomes Filho, A; Greco, L; Guatimosim, S; Lima, RF; Melo, DS; Melo, MB; Santos, RA, 2012) |
| " The present study reveals the protective role of ellagic acid in biochemical parameters including serum iron, plasma iron binding capacity, uric acid, glycoprotein, and electrolytes along with hematological parameters." | 3.78 | Protective efficacy of ellagic acid on glycoproteins, hematological parameters, biochemical changes, and electrolytes in myocardial infarcted rats. ( Kannan, MM; Quine, SD; Sangeetha, T, 2012) |
| " The activation of AMPK by metformin prevents cardiac remodeling after myocardial infarction (MI)." | 3.78 | Short-term treatment with metformin suppresses toll like receptors (TLRs) activity in isoproterenol-induced myocardial infarction in rat: are AMPK and TLRs connected? ( Banani, A; Farajnia, S; Garjani, A; Khani, S; Khorrami, A; Maleki-Dizaji, N; Rameshrad, M; Soraya, H, 2012) |
| " The present study was designed to investigate the cardioprotective effects of paeonol and danshensu (representative active ingredient of Cortex Moutan and Radix Salviae Milthiorrhizae, respectively) on isoproterenol-induced myocardial infarction in rats and its underlying mechanisms." | 3.78 | Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats. ( Bi, LL; Cao, W; Hu, J; Li, H; Miao, S; Qiu, PC; Sun, JY; Wang, JB; Wang, SW; Xie, YH; Yang, Q; Zhang, BL; Zhou, XX, 2012) |
| "The protective effect of aspartate and glutamate in isoproterenol induced myocardial infarction (MI) was investigated in experimental animals." | 3.77 | Aspartate and glutamate prevents isoproterenol-induced cardiac toxicity by alleviating oxidative stress in rats. ( Babu, PV; Shyamaladevi, CS; Sivakumar, R, 2011) |
| "The present study evaluated the protective potential of aqueous extract of Oxalis corniculata (OCE) against isoproterenol (ISO) induced myocardial infarction in rats." | 3.77 | Cardioprotective effects of aqueous extract of Oxalis corniculata in experimental myocardial infarction. ( Abhilash, PA; Lijo Cherian, O; Nampoothiri, SV; Nisha, P; Prathapan, A; Raghu, KG; Sunitha, TK, 2011) |
| "To develop a rat model of myocardial infarction induced by isoproterenol (ISO)." | 3.77 | Time-dependent responses of rat troponin I and cardiac injury following isoproterenol administration. ( Hasić, S; Jadrić, R; Kiseljaković, E; Mornjaković, Z; Valjevac, A; Winterhalter-Jadrić, M, 2011) |
| "The present study was designed to evaluate the cardioprotective effects of ellagic acid against isoproterenol induced myocardial infarction in rats by studying electrocardiography, blood pressure, cardiac markers, lipid peroxidation, antioxidant defense system and histological changes." | 3.77 | Ellagic acid ameliorates isoproterenol induced oxidative stress: Evidence from electrocardiological, biochemical and histological study. ( Kannan, MM; Quine, SD, 2011) |
| "The cardioprotective potential of Inula racemosa root hydroalcoholic extract against isoproterenol-induced myocardial infarction was investigated in rats." | 3.77 | Effect of Inula racemosa root extract on cardiac function and oxidative stress against isoproterenol-induced myocardial infarction. ( Arya, DS; Bharti, S; Bhatia, J; Kumari, S; Ojha, S; Rani, N; Sharma, AK, 2011) |
| "Four groups of experimental rats were subcutaneously injected with sesamol (0, 1, 3, or 10 mg/kg) and then, 2 h later, intraperitoneally injected with isoproterenol (100 mg/kg 24 h apart on 2 consecutive days) to induce myocardial infarction." | 3.77 | Sesamol attenuates isoproterenol-induced acute myocardial infarction via inhibition of matrix metalloproteinase-2 and -9 expression in rats. ( Chang, CC; Chen, SY; Liu, MY; Mo, FE; Periasamy, S, 2011) |
| "We investigated the antioxidant preventive effect of betaine on isoprenaline-induced myocardial infarction in male albino rats." | 3.76 | Antioxidant defense of betaine against isoprenaline-induced myocardial infarction in rats. ( Anandan, R; AnbinEzhilan, R; Buddhan, S; Ganesan, B; Sivakumar, R, 2010) |
| "The present work explores suspicious consequence of low molecular weight glycosaminoglycan (LMW-GAG) on oxidative stress and cellular abnormalities in isoproterenol (ISO)-induced myocardial infarction in an experimental model." | 3.76 | Preventive effect of low molecular weight glycosaminoglycan from Amussium pleuronectus (Linne) on oxidative injury and cellular abnormalities in isoproterenol-induced cardiotoxicity in Wistar rats. ( Saravanan, R; Shanmugam, A, 2010) |
| "It is known that various preparations of garlic and angiotensin-converting enzyme (ACE) inhibitor such as captopril (CAP) have beneficial effects on the left ventricular function and cardiovascular events after myocardial infarction (MI) when used individually." | 3.76 | Pharmacodynamic interaction of captopril with garlic in isoproterenol-induced myocardial damage in rat. ( Asdaq, SM; Inamdar, MN, 2010) |
| " After the pretreatment period, isoproterenol (100mg/kg) was injected to rats at an interval of 24h for two days to induce myocardial infarction." | 3.76 | Pretreatment with a combination of quercetin and alpha-tocopherol ameliorates adenosine triphosphatases and lysosomal enzymes in myocardial infarcted rats. ( Prince, PS; Punithavathi, VR, 2010) |
| "The present study evaluated the protective effect of fish oil in isoproterenol-induced myocardial infarction in rats." | 3.76 | Protective effect of fish oil on changes in the activities of membrane-bound ATPases and mineral status in experimentally induced myocardial infarction in Wistar rats. ( Devi, CS; Kalaiselvi, P; Padma, VV, 2010) |
| " The aim of this study was to investigate the effect of selenium on NFκB activation in rats induced with myocardial infarction by isoproterenol (ISP)." | 3.76 | Impact of selenium on NFκB translocation in isoproterenol-induced myocardial infarction in rats. ( John, F; Madambath, I; Panicker, S; Swathy, SS, 2010) |
| "This study was designed to investigate the cardioprotective effect of sesamol on isoproterenol (ISO)-induced myocardial infarction in adult male albino Wistar rats." | 3.76 | Protective effect of sesamol against myocardial infarction caused by isoproterenol in Wistar rats. ( Pugalendi, KV; Vennila, L, 2010) |
| ") juice (PJ) on heart weight, infarct size, plasma marker enzymes of cardiac damage, lipid peroxidation, endogenous enzymatic and non-enzymatic antioxidants, cardiac ATPases and histopathology of isoproterenol (IP)-induced cardiac necrosis (CN) in rats." | 3.76 | Pomegranate (Punica granatum L.) juice supplementation attenuates isoproterenol-induced cardiac necrosis in rats. ( Devkar, RV; Jadeja, RN; Patel, DK; Ramachandran, AV; Thounaojam, MC, 2010) |
| "The present study was designed to investigate the cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats by studying myocyte injury markers, antioxidant defense system, serum and heart lipid profile, inflammatory markers, electrocardiographic and histopathological changes." | 3.76 | Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: A biochemical, electrocardiographic and histoarchitectural evaluation. ( Balaraman, R; Patel, V; Upaganlawar, A; Zalawadia, R, 2010) |
| " Acute cardiogenic pulmonary edema was induced in C57BL/6J male mice by an increase in heart rate with continuous intravenous infusion of isoproterenol (ISP) (10 mg/kg/h) at 2 weeks after the creation of myocardial infarction by left coronary artery ligation." | 3.76 | Inhibition of secretory phospholipase A2 activity attenuates acute cardiogenic pulmonary edema induced by isoproterenol infusion in mice after myocardial infarction. ( Fujioka, D; Kawabata, K; Kobayashi, T; Kugiyama, K; Mishina, H; Nakamura, T; Obata, JE; Saito, Y; Watanabe, K; Watanabe, Y; Yano, T, 2010) |
| " In this study, cardioprotective activity of fucoidan extracted from Cladosiphon okamuranus was evaluated in isoproterenol induced myocardial infarction in rats." | 3.76 | Cardioprotective activity of Cladosiphon okamuranus fucoidan against isoproterenol induced myocardial infarction in rats. ( Pasanban, B; Rajendran, M; Rengasamy, R; Thomes, P, 2010) |
| " The purpose of the present study was to investigate the effects of CAPE on isoproterenol (ISO) -induced myocardial infarction." | 3.76 | Effects of caffeic acid phenethyl ester on isoproterenol-induced myocardial infarction in rats. ( Alçin, E; Aydin, M; Ilhan, S; Nacar, A; Oktar, S; Yönden, Z, 2010) |
| "The present study was undertaken to evaluate the preventive role of naringin on mitochondrial lipid peroxides, antioxidants and lipids in isoproterenol (ISO)-induced myocardial infarction (MI) in male Wistar rats." | 3.75 | Naringin ameliorates mitochondrial lipid peroxides, antioxidants and lipids in isoproterenol-induced myocardial infarction in Wistar rats. ( Prince, PS; Rajadurai, M, 2009) |
| "The present study was aimed to investigate the combined effects of green tea and vitamin E on heart weight, body weight, serum marker enzymes, lipid peroxidation, endogenous antioxidants and membrane bound ATPases in isoproterenol (ISO)-induced myocardial infarction in rats." | 3.75 | Effect of green tea and vitamin E combination in isoproterenol induced myocardial infarction in rats. ( Balaraman, R; Gandhi, C; Upaganlawar, A, 2009) |
| " This study was designed to evaluate the protective effect of gallic acid on cardiac marker enzymes, troponin-T, LDH-isoenzyme pattern, lipid peroxidation products and antioxidant status in isoproterenol (ISO)-induced myocardial infarction in male Wistar rats." | 3.75 | Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats. ( Prince, PS; Priscilla, DH, 2009) |
| "The present study evaluated cardioprotective effect of lyophilized hydroalcoholic extract of Moringa oleifera in the isoproterenol (ISP)-induced model of myocardial infarction." | 3.75 | Moringa oleifera leaf extract prevents isoproterenol-induced myocardial damage in rats: evidence for an antioxidant, antiperoxidative, and cardioprotective intervention. ( Arya, DS; Joshi, S; Kumari, S; Nandave, M; Ojha, SK, 2009) |
| "The study aimed to evaluate the protective role of myricetin obtained from Vitis vinifera (Vitaceae) on heart rate, electrocardiographic (ECG) patterns, vascular reactivity to catecholamines, cardiac marker enzymes, antioxidant enzymes together with morphological and histopathological changes in isoproterenol (ISO) induced myocardial infarction (MI) in male Wistar rats." | 3.75 | Cardioprotective potential of myricetin in isoproterenol-induced myocardial infarction in Wistar rats. ( Ballero, M; Kasture, S; Maxia, A; Mohan, M; Tiwari, R, 2009) |
| " calabura), a medicinal herb, on isoproterenol-induced myocardial infarction (MI) in rat models." | 3.75 | Effects of Muntingia calabura L. on isoproterenol-induced myocardial infarction. ( Brindha, P; Jayasri, J; Nivethetha, M, 2009) |
| " In the present study, we investigated the protective effect of betaine, a potent lipotropic molecule, on changes in the levels of membrane-bound ATPase activities, lipid peroxidation, sulfhydryl activities, and mineral status in isoprenaline-induced myocardial infarction in Wistar rats, an animal model of myocardial infarction in man." | 3.75 | Protective effect of betaine on changes in the levels of membrane-bound ATPase activity and mineral status in experimentally induced myocardial infarction in Wistar rats. ( Anandan, R; Buddhan, S; Ganesan, B; Jeyakumar, R, 2009) |
| "The present study was designed to evaluate the cardioprotective potential of salvianolic acid A on isoproterenol-induced myocardial infarction in rats." | 3.75 | Cardioprotective effect of salvianolic acid A on isoproterenol-induced myocardial infarction in rats. ( Du, GH; Tian, S; Wang, SB; Yang, F; Yang, HG; Yang, XY, 2009) |
| "The goal of this study was to investigate whether sub-chronic anti-oxidant treatment with ascorbic acid (Vit C) is able to protect the heart against myocardial infarction." | 3.75 | Ascorbic acid prevents acute myocardial infarction induced by isoproterenol in rats: role of inducible nitric oxide synthase production. ( Bergamaschi, CT; Buttros, JB; Campos, RR; Oshima, CT; Ribeiro, DA, 2009) |
| " At the end of treatment period, MI was induced by administering isoproterenol (ISO) or by subjecting heart to ischemia reperfusion injury (IRI)." | 3.75 | Role of Sida cordifolia L. leaves on biochemical and antioxidant profile during myocardial injury. ( Asdaq, SM; Kubavat, JB, 2009) |
| "An ultra-performance liquid chromatography/time-of-flight mass spectrometry (UPLC/TOF-MS)-based metabolomic approach was developed to characterize the metabolic profile associated with isoproterenol (ISO)-induced myocardial infarction (MI)." | 3.75 | Metabolomic profiling of rat serum associated with isoproterenol-induced myocardial infarction using ultra-performance liquid chromatography/time-of-flight mass spectrometry and multivariate analysis. ( Chen, X; Hu, P; Liang, QL; Liang, XP; Luo, GA; Wang, YM; Zhang, HY, 2009) |
| "We demonstrated that propranolol reduced the incidence of arrhythmias in a rat model of myocardial infarction by coronary artery occlusion." | 3.75 | MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection. ( Dong, D; Li, B; Li, X; Lu, Y; Pan, Z; Qiao, G; Shan, H; Song, W; Xu, C; Yang, B; Zhang, B; Zhang, F; Zhang, Y, 2009) |
| "This study investigates the cardioprotective activity of a combined treatment of Ginkgo biloba phytosomes (GBP) and Ocimum sanctum extract (Os) in isoproterenol (ISO)-induced myocardial necrosis in rats." | 3.75 | Evaluation of cardioprotective activity of Ginkgo biloba and Ocimum sanctum in rodents. ( N, SR; Panda, VS, 2009) |
| "This study was aimed to evaluate the combined effects of quercetin and alpha-tocopherol on lipid metabolism and glycoprotein components in isoproterenol induced myocardial infarction in Wistar rats." | 3.75 | Combined effects of quercetin and alpha-tocopherol on lipids and glycoprotein components in isoproterenol induced myocardial infarcted Wistar rats. ( Prince, PS; Punithavathi, VR, 2009) |
| " The present study has been designed to investigate whether telmisartan treatment attenuates the development of acute myocardial infarction in isoproterenol-treated rats by restoring hemodynamic, biochemical, histopathological and ultrastructural changes." | 3.75 | Myocardial salvaging effect of telmisartan in experimental model of myocardial infarction. ( Arora, S; Arya, DS; Goyal, S; Joshi, S; Kumari, S; Mittal, R; Nag, TC; Ray, R, 2009) |
| " We investigated the effects of cinaciguat on myocardial infarction induced by isoproterenol in rats." | 3.75 | Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury. ( Barnucz, E; Hirschberg, K; Karck, M; Korkmaz, S; Loganathan, S; Neugebauer, P; Páli, S; Radovits, T; Seidel, B; Szabó, G; Veres, G; Zöllner, S, 2009) |
| " The possible pharmacodynamic interaction between CCBs (verapamil, amlodipine and diltiazem) and BQ/BQT was studied on isoproterenol (ISO)-induced myocardial necrosis in mice." | 3.75 | Influence of betel quid on effect of calcium channel blockers on isoprenaline induced myocardial necrosis in mice. ( Asad, M; Asdaq, SM; Kumar, V, 2009) |
| "The present study was undertaken to evaluate the protective effect of (-)epigallocatechin gallate (EGCG) on mitochondrial lipids, lipid peroxides, Na(+)/K(+) ATPase, calcium and adenosine triphosphate in isoproterenol (ISO) induced myocardial infarction in male Wistar rats." | 3.74 | (-)Epigallocatechingallate protects the mitochondria against the deleterious effects of lipids, calcium and adenosine triphosphate in isoproterenol induced myocardial infarcted male Wistar rats. ( Devika, PT; Stanely Mainzen Prince, P, 2008) |
| "In the present study, cardioprotective effect of aqueous extract of fruits of Embelia ribes Burm (ER) was evaluated in a rat model having acute myocardial infarction, induced by isoproterenol (5." | 3.74 | Cardioprotective effect of aqueous extract of Embelia ribes Burm fruits against isoproterenol-induced myocardial infarction in albino rats. ( Ansari, MN; Bhandari, U; Islam, F, 2008) |
| "This study was aimed to evaluate the preventive role of S-allylcysteine (SAC) on creatine kinase-MB, iron, iron binding capacity, uric acid, total protein, membrane-bound enzymes such as sodium potassium-dependent adenosine triphosphatase, calcium-dependent adenosine triphosphatase and magnesium-dependent adenosine triphosphatase, and glycoproteins such as hexose, hexosamine, fucose and sialic acid in isoproterenol-induced myocardial infarction in rats." | 3.74 | Preventive effect of S-allylcysteine on membrane-bound enzymes and glycoproteins in normal and isoproterenol-induced cardiac toxicity in male Wistar rats. ( Padmanabhan, M; Prince, PS; Rajadurai, M, 2008) |
| " This study was aimed to evaluate the preventive role of naringin on cardiac troponin T (cTnT), lactate dehydrogenase (LDH)-isoenzyme, cardiac marker enzymes, electrocardiographic (ECG)-patterns and lysosomal enzymes in isoproterenol (ISO)-induced myocardial infarction (MI) in male Wistar rats." | 3.74 | Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats. ( Rajadurai, M; Stanely Mainzen Prince, P, 2007) |
| "The protective effect of PUFA concentrate prepared from fish oil on isoproterenol-induced myocardial infarction in male albino rats was investigated with respect to changes in the levels of diagnostic marker enzymes, cholesterol, triglycerides, free fatty acids, phospholipids, reduced glutathione (GSH) and lipid peroxides (LPO)." | 3.74 | Protective effect of n-3 polyunsaturated fatty acids concentrate on isoproterenol-induced myocardial infarction in rats. ( Anandan, R; Mathew, S; Sankar, TV; Viswanathan Nair, PG, 2007) |
| "This study was aimed to evaluate the preventive role of naringin on heart weight, blood glucose, total proteins, albumin/globulin (A/G) ratio, serum uric acid, serum iron, plasma iron binding capacity and membrane bound enzymes such as sodium potassium-dependent adenosine triphosphatase (Na(+)/K(+) ATPase), calcium-dependent adenosine triphosphatase (Ca(2+) ATPase) and magnesium-dependent adenosine triphosphatase (Mg(2+) ATPase) and glycoproteins such as hexose, hexosamine, fucose and sialic acid in isoproterenol (ISO)-induced myocardial infarction (MI) in rats and in vitro free radical scavenging assay." | 3.74 | Preventive effect of naringin on isoproterenol-induced cardiotoxicity in Wistar rats: an in vivo and in vitro study. ( Prince, PS; Rajadurai, M, 2007) |
| "The present study was designed to evaluate the preventive role of rutin on lipids, lipoproteins, and ATPases in normal and isoproterenol (ISO)-induced myocardial infarction in rats." | 3.74 | Preventive effect of rutin on lipids, lipoproteins, and ATPases in normal and isoproterenol-induced myocardial infarction in rats. ( Karthick, M; Stanely Mainzen Prince, P, 2007) |
| "In our investigation,we used short-time model of myocardial infarction of rats induced by high dose of isoproterenol (ISP)." | 3.74 | Troponin T and histological characteristics of rat myocardial infarction induced by isoproterenol. ( Hasić, S; Jadrić, R; Kiseljaković, E; Mornjaković, Z; Winterhalter-Jadrić, M, 2007) |
| "Increased oxidative stress and antioxidant deficit have been suggested to play a major role in isoproterenol-induced myocardial infarction." | 3.74 | Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats. ( Devi Sampath, P; Vijayaraghavan, K, 2007) |
| " The present study is undertaken to evaluate the preventive role of naringin on mitochondrial enzymes in isoproterenol (ISO)-induced myocardial infarction in male albino Wistar rats." | 3.74 | Preventive effect of naringin on cardiac mitochondrial enzymes during isoproterenol-induced myocardial infarction in rats: a transmission electron microscopic study. ( Prince, PS; Rajadurai, M, 2007) |
| "The present study was designed to investigate whether fluvastatin, a 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitor, would attenuate the acute myocardial infarction in isoproterenol-treated rat model via maintaining activities of endogenous antioxidant enzymes." | 3.74 | Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat. ( Dai, G; Xu, Q; Yan, L; Zheng, J; Zheng, P; Zhou, R, 2008) |
| " The aim of the present study was to evaluate the role of aldosterone and angiotensin II on formation of left ventricular fibrosis induced by chronic beta-adrenergic stimulation with isoproterenol (iso) in the rat heart failure model induced by myocardial infarction (MI)." | 3.73 | Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist. ( Bos, R; Findji, L; Lechat, P; Médiani, O; Mougenot, N; Vanhoutte, PM, 2005) |
| "We demonstrate the effect of Aegle marmelos leaf extract (AMLEt) and alpha-tocopherol on plasma lipids, lipid peroxides and marker enzymes in rats with isoproterenol (ISO)-induced myocardial infarction." | 3.73 | Comparative effects of Aegle marmelos extract and alpha-tocopherol on serum lipids, lipid peroxides and cardiac enzyme levels in rats with isoproterenol-induced myocardial infarction. ( Prince, PS; Rajadurai, M, 2005) |
| " Prior to 20 min of global ischemia, mouse hearts were either perfused for 30 min without treatment (control), treated with 10 nmol/L of isoproterenol (ISO) for 5 min followed by 5 min washout, or preconditioned with 4 cycles of 5 min ischemia and 5 min reflow (PC)." | 3.73 | The role of beta-adrenergic receptor signaling in cardioprotection. ( Bernstein, D; Murphy, E; Steenbergen, C; Tong, H, 2005) |
| " The protective effect of DHC-1 in isoproterenol-induced myocardial infarction and cisplatin-induced renal damage were studied." | 3.73 | Antioxidant activity of DHC-1, an herbal formulation, in experimentally-induced cardiac and renal damage. ( Bafna, PA; Balaraman, R, 2005) |
| "Isolated perfused hearts from young (3-5 months) and aging (24-25 months) rats were subjected to 60 min of 50% coronary flow reduction and 30 min of isoproterenol (Iso) stimulation starting at 30 min of ischemia." | 3.73 | Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury. ( Gao, F; Grunwald, Z; Hu, A; Li, D; Liu, H; Ma, XL; Qu, Y; Sharifi-Azad, S; Sun, JZ; Tao, L, 2006) |
| "We have examined the protective effect of taurine on the myocardial antioxidant defense system in isoprenaline (isoproterenol)-induced myocardial infarction in rats, an animal model of myocardial infarction in man." | 3.73 | Protective effect of taurine on myocardial antioxidant status in isoprenaline-induced myocardial infarction in rats. ( Anandan, R; Devadasan, K; Farvin, KH; Kumar, SH; Shiny, KS, 2005) |
| "We have evaluated the preventive effects of an aqueous Aegle marmelos leaf extract (AMLEt) in isoprenaline (isoproterenol)-induced myocardial infarction in rats." | 3.73 | Preventive effect of Aegle marmelos leaf extract on isoprenaline-induced myocardial infarction in rats: biochemical evidence. ( Prince, PS; Rajadurai, M, 2005) |
| "Isoproterenol (ISPH) induced myocardial infarction was confirmed by disturbances in serum and heart tissue marker enzymes such as lactate dehydrogenase (LDH), creatine phospho kinase (CPK), aspartate transaminase (AST) and alanine transaminase (ALT), increased level of lipid peroxidation and histopathological changes in the heart of ISPH administered rats." | 3.73 | Cardioprotective effect of mangiferin on isoproterenol induced myocardial infarction in rats. ( Devi, CS; Jainu, M; Prabhu, S; Sabitha, KE, 2006) |
| "These results indicate that (1) Both IPC and beta-PC elicit protection against apoptosis and necrosis, (2) activation of p38 MAPK is not a trigger of preconditioning against apoptosis and necrosis and (3) activation of p38 MAPK during reperfusion increases necrosis only if ischaemia is used to precondition hearts, but not with pharmacologic preconditioning with isoproterenol." | 3.73 | Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK. ( Hartley, S; Lochner, A; Marais, E; Moolman, JA; Van Wyk, J, 2006) |
| "In the present study, chronic treatment of atorvastatin was evaluated on isoproterenol-induced myocardial infarction." | 3.73 | Effect of atorvastatin treatment on isoproterenol-induced myocardial infarction in rats. ( Balaraman, R; Bothara, SB; Majithiya, JB; Trivedi, CJ, 2006) |
| " (Anacardiaceae), on isoproterenol (ISPH)-induced myocardial infarction (MI) in rats through its antioxidative mechanism." | 3.73 | Role of mangiferin on biochemical alterations and antioxidant status in isoproterenol-induced myocardial infarction in rats. ( Devi, CS; Jainu, M; Prabhu, S; Sabitha, KE, 2006) |
| "The effect of fish oil treatment on the activities of antioxidants such as superoxide dismutase, catalase, glutathione peroxidase, glutathione-s-transferase, and glutathione, as well as the level of the lipid peroxidation marker thiobarbituric reactive substance was studied in isoproterenol-induced myocardial infarction (MI)." | 3.73 | Modulatory effect of fish oil on the myocardial antioxidant defense system in isoproterenol-induced myocardial infarction. ( Devi, CS; Padma, VV; Ramkumar, KM, 2006) |
| " This study aimed to evaluate the preventive role of rutin on lipid peroxides and antioxidants in normal and isoproterenol-induced myocardial infarction in rats." | 3.73 | Preventive effect of rutin, a bioflavonoid, on lipid peroxides and antioxidants in isoproterenol-induced myocardial infarction in rats. ( Karthick, M; Stanely Mainzen Prince, P, 2006) |
| " A novel PARP inhibitor (L-2286) was tested in a rat model of chronic heart failure following isoproterenol-induced myocardial infarction." | 3.73 | PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway. ( Deres, P; Gallyas, F; Halmosi, R; Hanto, K; Hideg, K; Kalai, T; Kulcsar, G; Palfi, A; Sumegi, B; Szabados, E; Szereday, Z; Toth, A; Toth, K, 2006) |
| "Inhibition of the multifunctional Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) or depletion of sarcoplasmic reticulum (SR) Ca(2+) stores protects against apoptosis from excessive isoproterenol (Iso) stimulation in cultured ventricular myocytes, suggesting that CaMKII inhibition could be a novel approach to reducing cell death in conditions of increased adrenergic tone, such as myocardial infarction (MI), in vivo." | 3.73 | Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. ( Anderson, ME; Eren, M; Gleaves, L; Hou, Y; Joiner, ML; Ni, G; Oddis, CV; Price, EE; Vaughan, DE; Xiao, RP; Yang, J; Yang, Y; Zhang, R; Zhu, WZ, 2006) |
| "Our study evaluates the preventive effect of S-allyl cysteine sulfoxide (SACS) on lipid peroxidative products and enzymic and nonenzymic antioxidants in isoproterenol (ISO) induced myocardial infarction in rats." | 3.73 | Antilipoperoxidative and antioxidant effects of S-allyl cysteine sulfoxide on isoproterenol-induced myocardial infarction in Wistar rats. ( Quine, SD; Sangeetha, T, 2006) |
| "This study was designed to evaluate the preventive effect of naringin in isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 3.73 | Preventive effect of naringin on lipids, lipoproteins and lipid metabolic enzymes in isoproterenol-induced myocardial infarction in Wistar rats. ( Rajadurai, M; Stanely Mainzen Prince, P, 2006) |
| " The cardiotoxicity was induced by myocardial infarction through subcutaneous administration of isoproterenol hydrochloride for 2 days using 0." | 3.73 | Efficacy of mangiferin on serum and heart tissue lipids in rats subjected to isoproterenol induced cardiotoxicity. ( Nair, PS; Shyamala Devi, CS, 2006) |
| "This study was designed to evaluate the cardioprotective potential of naringin on lipid peroxides, enzymatic and nonenzymatic antioxidants and histopathological findings in isoproterenol (ISO)-induced myocardial infarction (MI) in rats." | 3.73 | Preventive effect of naringin on lipid peroxides and antioxidants in isoproterenol-induced cardiotoxicity in Wistar rats: biochemical and histopathological evidences. ( Rajadurai, M; Stanely Mainzen Prince, P, 2006) |
| "Pepticare, a herbomineral formulation, was administered orally to rats at the dose levels of 125, 250, 500 and 1000 mg/kg to investigate its effect on isoproterenol-induced myocardial infarction and cisplatin-induced renal damage." | 3.73 | Antioxidant activity of Pepticare, a herbomineral formulation, in experimentally induced renal and cardiac damage. ( Bafna, PA; Balaraman, R, 2006) |
| "We studied the cardioprotective effect of squalene on isoprenaline-induced myocardial infarction in male albino rats with respect to changes in the levels of lipid components in plasma and heart tissue." | 3.73 | Cardioprotective effect of squalene on lipid profile in isoprenaline-induced myocardial infarction in rats. ( Anandan, R; Farvin, KH; Kumar, SH; Mathew, S; Nair, PG; Sankar, TV; Shiny, KS, 2006) |
| "Administration of isoproterenol to mice at a dose of 30 mg/100 g body weight for 3 consecutive days at an interval of 24 h induced lipid peroxidation in cardiac tissue and exhibited a significantly elevated serum glutamate oxaloacetate transaminase (SGOT) level." | 3.72 | Effect of isoproterenol on lipid peroxidation and antioxidant enzymes of myocardial tissue of mice and protection by quinidine. ( Bandyopadhyay, D; Biswas, S; Chattopadhyay, A; Datta, AG; Sarkar, C, 2003) |
| " Cardiac lesions induced by isoproterenol (ISO) are characterized by myocardial necrosis and exudative infiltration." | 3.72 | Effect of D-003 on isoproterenol-induced myocardial necrosis in rats. ( Arruzazabala, ML; Carbajal, D; González, J; Más, R; Mendoza, S; Molina, V; Noa, M, 2003) |
| "The protective effect of L-arginine and L-lysine on lysosomal enzymes and membrane bound ATPases was examined on isoproterenol induced myocardial infarction in rats." | 3.72 | Effect of L-arginine and L-lysine on lysosomal hydrolases and membrane bound phosphatases in experimentally induced myocardial infarction in rats. ( Devaki, T; Ebenezar, KK; Sathish, V, 2003) |
| "The synergistic protective effect of nicorandil (KATP channel opener) and amlodipine (calcium channel blocker) on mitochondrial respiration and mitochondrial lipid contents were examined on isoproterenol-induced myocardial infarction in rats." | 3.72 | Biochemical changes on the cardioprotective effect of nicorandil and amlodipine during experimental myocardial infarction in rats. ( Devaki, T; Ebenezar, KK; Sathish, V, 2003) |
| "Animals with heart failure exhibited depressions in ventricular function, positive inotropic response to isoproterenol, beta-AR receptor density and basal AC activity; these changes were also attenuated by PLC treatment." | 3.72 | Improvement of cardiac function and beta-adrenergic signal transduction by propionyl L-carnitine in congestive heart failure due to myocardial infarction. ( Dhalla, NS; Ferrari, R; Sethi, R; Wang, X, 2004) |
| "This study was designed to examine the effects of squalene on tissue antioxidant status in isoproterenol-induced myocardial infarction in male albino rats." | 3.72 | Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats. ( Anandan, R; Kumar, SH; Sabeena Farvin, KH; Sankar, TV; Shiny, KS; Thankappan, TK, 2004) |
| "Myocardial infarction was produced by subcutaneous administration of isoproterenol hydrochloride (85 mg/kg b." | 3.72 | Comparative account of certain enzymes in the serum of homo-iothermal vertebrates subjected to production of myocardial infarction by isoproterenol hydrochloride. ( Gaur, M; Kumar, S, 2003) |
| "The present study was conducted to elucidate the antioxidant role of garlic oil in isoproterenol (IPL)-induced myocardial infarction in rats." | 3.72 | Effect of garlic (Allium sativum) on lipid peroxidation in experimental myocardial infarction in rats. ( Prakash, J; Saravanan, G, 2004) |
| "Antioxidant role of Arogh in isoproterenol induced myocardial infarction in rats has been studied." | 3.72 | Role of Arogh, a polyherbal formulation to mitigate oxidative stress in experimental myocardial infarction. ( Maheswaran, E; Shyamala Devi, CS; Suchalatha, S; Thirugnanasambandam, P, 2004) |
| " In a randomized prospective trial design, we administered the XO inhibitor allopurinol orally to mice that had undergone massive myocardial infarction (MI)." | 3.72 | Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy. ( Gao, WD; Leppo, MK; Marbán, E; Stull, LB; Szweda, L, 2004) |
| " The aim of the present study is to study the effect of folic acid and Vitamin B(12) supplementation on isoprenaline (ISO)-induced myocardial infarction (MI) in hyperhomocysteinemic rats." | 3.71 | Folic acid and vitamin B(12) supplementation attenuates isoprenaline-induced myocardial infarction in experimental hyperhomocysteinemic rats. ( Hagar, HH, 2002) |
| "ET, CGRP or NO is involved in myocardial infarction caused by isoproterenol." | 3.71 | [Variation of endogeneous ET, CGRP and NO in myocardial ischemia in rats and the regulatory effect of xinshuping]. ( Chen, SZ; Li, CL; Liu, XY; Wang, YY, 2002) |
| "The cardioprotective effect of the ethanol extract of Picrorrhiza kurroa rhizomes and roots (PK) on isoproterenol-induced myocardial infarction in rats with respect to lipid metabolism in serum and heart tissue has been investigated." | 3.71 | Cardioprotective effects of Picrorrhiza kurroa against isoproterenol-induced myocardial stress in rats. ( Anandan, R; Devaki, T; Santhosh Kumar, M; Senthil Kumar, SH, 2001) |
| "Myocardial infarction (MI) was produced in rats with 85, 200 and 300 mg/kg of isoproterenol (ISO) administered subcutaneously (sc) twice at an interval of 24 h." | 3.71 | Cardioprotective potential of ocimum sanctum in isoproterenol induced myocardial infarction in rats. ( Arya, DS; Gupta, SK; Joshi, S; Kishore, K; Sharma, M, 2001) |
| "The effects of SMP-300, an orally active, potent, and selective Na+/H+ exchange inhibitor, were evaluated and compared with those of nifedipine, propranolol, and nicorandil on three experimental angina models and on myocardial infarction in rats." | 3.71 | Effect of an orally active Na+/H+ exchange inhibitor, SMP-300, on experimental angina and myocardial infarction models in rats. ( Matsui, K; Ohashi, N; Sasabe, M; Yamamoto, S, 2002) |
| "The synergistic effects of nicorandil (KATP-channel opener) and amlodipine (calcium-channel blocker) on heart mitochondrial enzymes and the mitochondrial antioxidant defence system was examined on isoproterenol-induced myocardial infarction in rats." | 3.71 | Synergistic effect of nicorandil and amlodipine on mitochondrial function during isoproterenol-induced myocardial infarction in rats. ( Devaki, T; Ebenezar, KK; Sathish, V; Vimal, V, 2002) |
| "The equivalent of the clinically used low (= antiplatelet)-dose aspirin, inhibited collagen deposition in the non-infarcted myocardium in rats with myocardial infarction." | 3.70 | Low-dose aspirin improves in vivo hemodynamics in conscious, chronically infarcted rats. ( Kalkman, EA; Saxena, PR; Schoemaker, RG, 1998) |
| "The effect of alpha-tocopherol pretreatment (6 mg/100 g body wt/day, orally for a period of 90 days) on mitochondrial electron transport in myocardial infarction induced by isoproterenol (20 mg/100 g body wt, subcutaneously for two days) was studied in rats." | 3.70 | Effect of alpha-tocopherol on mitochondrial electron transport in experimental myocardial infarction in rats. ( Ithayarasi, AP; Shyamala Devi, C, 1998) |
| " in isoproterenol-induced myocardial infarction and CCl4-induced hepatotoxicity in rats." | 3.70 | Antioxidant activity of AO-8, a herbal formulation in vitro and in vivo experimental models. ( Gopumadhavan, S; Mitra, SK; Sundaram, R; Venkataranganna, MV, 1999) |
| " Male Wistar rats with ligation-induced myocardial infarction were assigned to placebo or treatment with mibefradil (10 mg/kg/day), verapamil (8 mg/kg/day), or amlodipine (4 mg/kg/day) by oral gavage starting 7 days before the induction of myocardial infarction." | 3.70 | Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction. ( Meissner, A; Min, JY; Sandmann, S; Simon, R; Unger, T, 1999) |
| "We administered oral metoprolol or no therapy to rats for 12 weeks after large myocardial infarction and subsequently examined left ventricular (LV) remodeling; myocardial tumor necrosis factor (TNF)-alpha, interleukin (IL)-1beta, and IL-6 expression; and NO." | 3.70 | beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling. ( Chandrasekar, B; Freeman, GL; Murray, DR; Prabhu, SD, 2000) |
| " To examine the status of beta-adrenergic receptors and postadrenergic receptor mechanisms in congestive heart failure due to myocardial infarction, the left coronary artery in rats was ligated for 4 and 8 weeks before studying the hemodynamic and biochemical changes due to isoproterenol, a beta-adrenoceptor agonist, or forskolin, a postreceptor agonist." | 3.69 | Inotropic responses to isoproterenol in congestive heart failure subsequent to myocardial infarction in rats. ( Dhalla, NS; Sethi, R, 1995) |
| "The mechanism of exercise-induced ST-segment elevation in previous myocardial infarction was investigated using isoproterenol infusion with atrial pacing to simulate exercise hemodynamics in seven closed chest dogs with myocardial infarction." | 3.69 | [Isoproterenol induces ST-segment elevation without wall motion aggravation and myocardial ischemia in experimental myocardial infarction]. ( Katori, R; Yamamoto, T, 1995) |
| "Myocytes isolated from rat hearts that have suffered 35% myocardial infarction (MI) 3 wk prior have lower peak cytosolic Ca2+ concentration ([Ca2+]i) during contraction compared with Sham myocytes, a difference that is amplified by isoproterenol or high extracellular Ca2+ concentration ([Ca2+]o)." | 3.69 | Calcium currents in postinfarction rat cardiac myocytes. ( Cheung, JY; Moore, RL; Tillotson, DL; Zhang, XQ, 1995) |
| " We investigated the regulation of the atrial natriuretic peptide and brain natriuretic peptide genes in a rat model of myocardial infarction induced by isoproterenol (IP rat) and in a rat model of cardiac hypertrophy induced by aorto-caval shunt (AC shunt rat)." | 3.69 | Differential regulation of natriuretic peptide genes in infarcted rat hearts. ( Iwai, N; Kinoshita, M; Shimoike, H, 1997) |
| "The effect of alpha-tocopherol (6 mg/100 g body wt, orally, daily for 90 days) pretreatment in isoproterenol (20 mg/100 g body wt, subcutaneously, twice at an interval of two days at the end of the alpha-tocopherol pretreatment) induced myocardial infarction was studied in rats." | 3.69 | Effect of alpha-tocopherol on isoproterenol induced myocardial infarction in rats--electrocardiographic biochemical and histological evidences. ( Ithayarasi, AP; Padmavathy, VN; Shyamala Devi, C, 1996) |
| "The effect of alpha-tocopherol pretreatment on lipid peroxidation and antioxidant status in isoproterenol induced myocardial infarction was studied in rats." | 3.69 | Effect of alpha-tocopherol on lipid peroxidation in isoproterenol induced myocardial infarction in rats. ( Devi, CS; Ithayarasi, AP, 1997) |
| " Because adrenergic stimulation decreases serum K+ and Mg++, we decided to investigate the effects of a beta-receptor agonist, isoproterenol, on serum K+ and Mg++, and their consequences on the induction of tachycardia." | 3.68 | Effect of isoproterenol on serum potassium and magnesium. ( Beurrier, D; Brembilla-Perrot, B; le Van, D; Terrier de la Chaise, A, 1993) |
| "Myocardial infarction was induced in albino rats by the subcutaneous administration of isoproterenol." | 3.68 | Collagen levels in isoproterenol induced myocardial infarction in rats. ( Puvanakrishnan, R; Ravichandran, LV, 1993) |
| "The amounts of myocardial metallothionein (MT) and heavy metal (Zn, Cu) levels during the early stage of the experimental myocardial infarction model induced by isoproterenol (Isp) administration were measured by an atomic absorption spectrophotometry." | 3.68 | [Changes in myocardial metallothionein on isoproterenol-induced myocardial injury]. ( Akai, F; Hashimoto, S; Kimoto, S; Namikawa, K; Nishida, S; Okazaki, Y; Tomura, T, 1993) |
| "In this study the effect of the angiotensin converting enzyme (ACE) inhibitor captopril on beta-receptor responsiveness was investigated in failing rat hearts after experimental myocardial infarction." | 3.68 | Captopril modifies the response of infarcted rat hearts to isoprenaline stimulation. ( Bartels, H; de Graeff, PA; de Langen, CD; Monnink, SH; van Gilst, WH; van Wijngaarden, J; Wesseling, H, 1992) |
| "2 mg/100 g body wt orally for 30 days) on myocardial infarction induced by isoproterenol (200 mg/kg body wt, subcutaneously for 2 days) has been studied in rats using activities of creatine kinase, aspartate amino transaminase, alanine amino transaminase and lactate dehydrogenase and levels of lipid peroxides as standard markers." | 3.68 | Effect of aspirin on isoproterenol induced myocardial infarction--a pilot study. ( Devi, CS; Geetha, A; Manjula, TS, 1992) |
| "The amount of peroxide lipid in vivo in the early stage of the experimental model of myocardial infarction in a rat induced by the administration of isoproterenol (Isp) was measured as the value of malonic dialdehyde (MDA)." | 3.68 | [Studies on early stage changes of peroxide lipid in isoproterenol-induced myocardial injury]. ( Hashimoto, S; Kadota, E; Namikawa, K; Nishida, S; Okazaki, Y; Tomura, T, 1992) |
| "The DNA synthesis has been studied in the conductive system (CS) myocytes, compared to that in atrial and ventricular myocytes: 1) in the left ventricular myocardial infarction induced in two- and three-week-old and adult rats, 2) after isoproterenol injections to adult rats and mice, and 3) in the hypertrophied human heart." | 3.68 | [The capacity for reactive DNA synthesis of the myocytes in the heart conduction system in experimental and clinical myocardial pathology]. ( Erokhina, IL, 1992) |
| "The prophylactic role of ibuprofen in experimental myocardial infarction has not been reported." | 3.68 | Failure to reduce experimental myocardial infarct size with ibuprofen pre-treatment in rats. ( Lal, A; Sharma, ML, 1992) |
| "Effects of acute myocardial infarction (48 h) on cardiovascular responses to (+/-)-, (-)-, and (+)-dobutamine were studied in isolated perfused rat hearts." | 3.68 | Cardiovascular responses to the stereoisomers of dobutamine in isolated rat hearts 48 hours after acute myocardial infarction. ( Porsius, AJ; van Rooij, HH; Vleeming, W; Wemer, J, 1991) |
| "The aim was to compare the effects of two novel angiotensin converting enzyme (ACE) inhibitors, spirapril and zofenopril, on cardiac remodelling in rats with congestive heart failure after myocardial infarction." | 3.68 | Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril. ( de Graeff, PA; de Langen, CD; Pinto, YM; van Gilst, WH; van Wijngaarden, J; Wesseling, H, 1991) |
| "Effect of ethanol administration on the severity of myocardial infarction induced by isoproterenol in rats was studied." | 3.68 | Effect of ethanol administration on metabolism of lipids in heart and aorta in isoproterenol induced myocardial infarction in rats. ( Kumari, S; Kurup, PA; Menon, PV; Remla, A, 1991) |
| "Effect of feeding safflower oil and coconut oil in experimental myocardial infarction induced by isoproterenol in rats was studied." | 3.68 | Effect of coconut oil & safflower oil on lipids in isoproterenol induced myocardial infarction in rats. ( Kurup, PA; Menon, PV; Remla, A, 1991) |
| ", beta-glucuronidase, beta-N-acetylglucosaminidase, beta-galactosidase, beta-glucosidase, alpha-glucosidase, alpha-galactosidase, alpha-mannosidase, cathepsin B, cathepsin D, and collagenolytic cathepsin, in serum and heart of rats subject to myocardial infarction with isoproterenol, were studied during the periods of peak infarction and recovery." | 3.68 | Influence of isoproterenol-induced myocardial infarction on certain glycohydrolases and cathepsins in rats. ( Joseph, KT; Puvanakrishnan, R; Ravichandran, LV, 1991) |
| "The alterations in the heart lysosomal stability following isoproterenol induced myocardial infarction were studied in albino rats." | 3.68 | Alterations in the heart lysosomal stability in isoproterenol induced myocardial infarction in rats. ( Joseph, KT; Puvanakrishnan, R; Ravichandran, LV, 1990) |
| "The influence of isoproterenol on induction of ventricular arrhythmias was evaluated in 10 normal dogs and 17 dogs with experimentally induced myocardial infarction." | 3.68 | Effect of isoproterenol on induction of ventricular tachyarrhythmias in the normal and infarcted canine heart. ( Hunt, GB; Ross, DL, 1990) |
| "Beta-Adrenoceptor agonists, such as isoproterenol, produce ventricular fibrillation and myocardial necrosis in rats." | 3.67 | Ventricular fibrillation threshold and myocardial cyclic AMP production in rats sensitive or resistant to isoproterenol. ( Balazs, T; Jordan, AW; Joseph, X, 1984) |
| "The changes in plasma level of alpha-atrial natriuretic polypeptide (alpha-ANP) and the relaxing responses to exogenous alpha-ANP of strips of rat aorta pretreated with methoxamine were examined at one, four and eight weeks after myocardial infarction induced by left coronary ligation." | 3.67 | Changes in plasma level of alpha-atrial natriuretic polypeptide (alpha-ANP) and responsiveness of the aorta to exogenous alpha-ANP subsequent to myocardial infarction in rats. ( Hayashi, Y; Nakashima, M; Sato, R; Uematsu, T; Wang, YT, 1989) |
| "The susceptibility of the cardiovascular system to exposure to a high-boiling coal liquid (heavy distillate, HD) was studied in the rat using an isoproterenol (ISO) myocardial infarction model." | 3.67 | Elevated blood pressure and heart rate in rats exposed to a coal-derived complex organic mixture. ( Lundstrom, DL; Mahlum, DD; Sasser, LB; Springer, DL; Zangar, RC, 1989) |
| "The effect of vitamin E administration on the severity of myocardial infarction induced by isoproterenol on rats was studied." | 3.67 | Effect of vitamin E on the severity of myocardial infarction induced by isoproterenol. ( Kumari, SS; Menon, VP; Muraleedharan, D; Varghese, A, 1989) |
| " Radionuclide ventriculograms were obtained in 75 consecutive patients 2 weeks after myocardial infarction, at rest and during intravenous isoproterenol infusion." | 3.67 | The assessment of contractile reserve after thrombolytic therapy for acute myocardial infarction. ( Del Negro, AA; Fox, LM; Goldstein, HA; Green, CE; Kent, KM; Pallas, RS; Pearle, DL; Rackley, CE; Rogers, WJ; Satler, LF, 1986) |
| "Effect of UM-272, a dimethyl propranolol has been studied in experimental myocardial necrosis induced by isoproterenol (ISP, 85 mg/kg, SC X 2 days) in rats." | 3.67 | Alterations in isoproterenol-induced cardiac metabolic changes by a quaternary analog of propranolol, UM-272. ( Gupta, M; Gupta, MP; Manchanda, SC; Seth, SD; Srivastava, LM, 1985) |
| "The effects of the intravenous administration of hyaluronidase (HY; 2,500 IU/kg) and urokinase (UK; 20,000 and 40,000 IU/kg), alone or in combination, on the isoproterenol (ISP) induced myocardial infarction (MI) in rats, were studied." | 3.67 | The co-operative action of hyaluronidase and urokinase on the isoproterenol-induced myocardial infarction in rats. ( Antonetti, F; Borrelli, F; Caprino, L; Martelli, F, 1986) |
| "The effect of administration of carnitine on the severity of myocardial infarction in rats induced by isoproterenol was studied by following histopathological and biochemical parameters." | 3.67 | Effect of administration of carnitine on the severity of myocardial infarction induced by isoproterenol in rats. ( Kurup, PA; Mathew, S; Menon, PV, 1986) |
| " Seven days later, the animals were challenged with a dose of isoproterenol which would produce massive myocardial infarction and 50-60% mortality in non-treated animals." | 3.67 | Prolonged protective effects following propranolol withdrawal against isoproterenol-induced myocardial infarction in normotensive and hypertensive rats. ( Wexler, BC, 1985) |
| "The significance of the test with intravenous injection of isoproterenol in the diagnosis of coronary heart disease (CHD) was evaluated in comparison with the clinical, bicycle ergometry and selective coronarography data obtained in 65 women." | 3.67 | [Intravenous isoproterenol administration for diagnosing ischemic heart disease in women: a comparison with the data from bicycle ergometry and selective coronary angiography]. ( Akhmedzhanov, NM; Liakishev, AA; Matveeva, LS; Sidorenko, BA, 1985) |
| "Prophylactic effects of sulfinpyrazone (100 mg/Kg), aspirin (5 mg/Kg, 50 mg/Kg), and propranolol (2 mg/Kg, 10 mg/Kg) on myocardial necrosis and hypertrophy induced by isoproterenol were examined." | 3.66 | Effects of sulfinpyrazone, aspirin and propranolol on the isoproterenol-induced myocardial necrosis. ( Hashimoto, H; Ogawa, K, 1981) |
| "Two different conditions responsible for cardiac hypertrophy in the rat were investigated: the first one is isoproterenol-induced myocardial infarct, the second is exposure to hypoxia (0." | 3.66 | Myocardial hypertrophy in the rat. Correlation between two experimental models. ( Cacciapuoti, AA; Chiariello, M; Condorelli, M; Ferro, G; Genovese, A, 1980) |
| "Male and female, normotensive, Sprague-Dawley (S-D) rats, and spontaneously hypertensive rats (SHR) were subjected to acute and massive myocardial infarction with isoproterenol." | 3.66 | Hormonal and metabolic changes during acute myocardial infarction in normotensive vs hypertensive rats. ( McMurtry, JP; Wexler, BC, 1983) |
| "The effect of exercise on the severity of isoproterenol-induced acute myocardial infarction was studied in male rats." | 3.66 | Beneficial effects of exercise on l-isoproterenol induced myocardial infarction in male rats. ( Darrah, MI; Engen, RL, 1982) |
| "To determine the relative effect of body weight and physical inactivity on susceptibility to drug-induced myocardial infarction, randomly selected groups of 100-day-old male Sprague-Dawley rats were subjected to a 10-wk program of exercise training and (or) to caloric restriction followed by two subcutaneous injections of L-isoproterenol." | 3.66 | Relative role of caloric restriction and exercise training upon susceptibility to isoproterenol-induced myocardial infarction in male rats. ( Beitz, DC; Crandall, DL; Feirer, RP; Griffith, DR, 1981) |
| " Some of the animals were treated with the anti-hyperuricemic agent, allopurinol, either before or during the induction of myocardial infarction." | 3.66 | Allopurinol amelioration of the pathophysiology of acute myocardial infarction in rats. ( McMurtry, JP; Wexler, BC, 1981) |
| "Tachycardia- and bradycardia-dependent, left anterior and left posterior hemiblocks as transient phenomena were registered in two patients spontaneously, and especially as a consequence of isoproterenol infusion." | 3.66 | Transient tachycardia- and bradycardia-dependent left anterior and left posterior hemiblocks. Effects of isoproterenol. ( Alvarez, JA; Kretz, A; Leguizamon Palumbo, JR; Martinez Martinez, JA; Suarez, LD, 1981) |
| "The effect of phenelzine on isoproterenol-induced myocardial necrosis was studied in rats." | 3.66 | Effect of phenelzine, a monoamine oxidase inhibitor, on isoproterenol-induced myocardial damage. ( Joshi, KC; Singh, KP; Somani, KC; Tariq, M, 1980) |
| "The effect of isoproterenol infusion on regional myocardial perfusion and tissue oxygenation during acute myocardial infarction was investigated in anesthetized dogs." | 3.66 | Effect of isoproterenol on regional myocardial perfusion and tissue oxygenation in acute myocardial infarction. ( Grover, FL; Horwitz, LD; Schwartz, DA, 1979) |
| "Adult male and female Sprague-Dawley rats were subjected to an isoproterenol-induced myocardial infarction." | 3.66 | Effect of gonadectomy on isoproterenol-induced myocardial infarction. ( Greenberg, BP; Wexler, BC, 1979) |
| " suggest that the myocardial infarction induced by isoproterenol in the rat may be determined by phenomenons of intracoronaric platelets aggregation." | 3.66 | [The role of the platelets in myocardial infarction induced by isoproterenol in the rat (author's transl)]. ( Cacciapuoti, AA; Genovese, A; Giuffrida, G; Mazza, F; Polverino, W, 1979) |
| "Changes in myocardial zinc level was followed up over a period of 5 days after producing myocardial necrosis in albino rats by subcutaneous injection of isoproterenol, 85 mg/kg body weight." | 3.66 | A temporal profile of myocardial zinc changes after isoproterenol induced cardiac necrosis. ( Ahmad, MS; Hasan, MZ; Jamil, SA; Kumar, S; Mathew, BM; Seth, TD, 1978) |
| "Male and female, arteriosclerotic and non-arteriosclerotic rats were treated with the anti-lipemic agent, clofibrate, for 8 days and then subjected to an acute myocardial infarction by injecting them with two large doses of isoproterenol spaced 24 hours apart." | 3.66 | Protective effects of clofibrate on isoproterenol-induced myocardial infarction in arteriosclerotic and non-arteriosclerotic rats. ( Greenberg, BP; Wexler, BC, 1978) |
| " Hyaluronidase, insulin, potassium chloride, and isoproterenol increased myocardial tissue damage whereas heparin and prednisolone administration resulted in decreased myocardial tissue damage after induced myocardial infarction in rats." | 3.66 | Effects of pharmacological intervention on infarct size following induced myocardial infarction in rats. ( Barletta, MA; Lau Cam, C; Lynch, VD; Staab, R, 1978) |
| "The cardiovascular effects of halothane-nitrous oxide anesthesia, and beta-receptor blockade with either propranolol or practolol, were studied in 15 dogs in which severe myocardial infarction had been induced ten days earlier." | 3.65 | Interaction of anesthesia, beta-receptor blockade, and blood loss in dogs with induced myocardial infarction. ( Bennett, MJ; Clarke, TN; Foëx, P; Prys-Roberts, C; Roberts, JG; Ryder, WA, 1976) |
| "A brief characteristics of the main therapeutic methods for shock in acute myocardial infarction cases is presented, including fast infusion of plasma-substitutes, noradrenalin, isoproterenol, alpha-adrenergic bocking agents, steroid hormones, intra-aortal balloon counter-pulsation, oxygen therapy, acidbase balance correction, etc." | 3.65 | [Treatment of coronary shock]. ( Gratsianskiĭ, NA, 1975) |
| "The appearance of circulating anti-heart antibodies and myocardium-bound antibodies was demonstrated after experimental myocardial infarction induced by coronary ligation or high doses of isoproterenol in rats." | 3.65 | Immunofluorescent and migration inhibition studies in rats with experimental myocardial infarction. ( Csáky, L; Nosztray, K; Szabó, J; Szegi, J, 1976) |
| "The effect of exercise on the severity of isoproterenol-induced myocardial infarction was studied in male rats." | 3.65 | Effects of exercise on the severity of isoproterenol-induced myocardial infarction. ( Bonner, HW; Jessup, GT; Landiss, CW; Riggs, CE, 1977) |
| "Trapidil increases the isoprenalin-induced necrosis of the myocardium in the rat." | 3.65 | [Modification of the isoprenaline-induced myocardial necrosis using trapidil]. ( Lampe, D; Lange, B; Mai, I, 1976) |
| " The relative amounts of various polyunsaturated fatty acids in cardiac lipids influence markedly the development of myocardial necrosis and mortality following overstimulation with isoproterenol." | 3.65 | The role of myocardial membrane lipids in the development of cardiac necrosis. ( Gudbjarnason, S; Hallgrimsson, J, 1976) |
| "A 39-year-old women inhaled approximately 675 mg of aerosolized isoproterenol in less than three days during an asthmatic attack." | 3.65 | An electrocardiographic pattern of acute myocardial infarction associated with excessive use of aerosolized isoproterenol. ( Aelony, Y; Beall, G; Laks, MM, 1975) |
| "Mature male Sprague-Dawley rats were subjected to an isoproterenol-induced myocardial infarction." | 3.65 | Prolyl hydroxylase and collagen metabolism after experimental mycardial infarction. ( Judd, JT; Wexler, BC, 1975) |
| "Male and female, arteriosclerotic and nonarteriosclerotic rats were subjected to acute myocardial infarction by two, subcutaneous injections (spaced 24 hr apart) of isoproterenol." | 3.65 | Metabolic and histopathologic changes in arteriosclerotic versus nonarteriosclerotic rats following isoproterenol-induced myocardial infarction with superimposed diabetes. ( Wexler, BC, 1975) |
| " Therefore, the myocardial metabolism was studied at different environmental temperatures in albino rats with isoproterenol-induced infarct-like myocardial necrosis." | 3.65 | Myocardial metabolism at different environmental temperatures in experimental myocardial necrosis. ( Ahmad, M; Tajuddin, M; Tariq, M, 1975) |
| "Circulating prolactin levels were monitored in nonarteriosclerotic, arteriosclerotic, and hormonally sterilized male and female Sprague-Dawley rats during the acute necrosis and repair phases of myocardial infarction induced by isoproterenol." | 3.65 | Serum prolactin levels in rats following isoproterenol-induced myocardial infarction. ( Lewis, BK; Wexler, BC, 1975) |
| "Isoproterenol (ISO), a drug which causes an increased strength of myocardial contraction when administered to animals in mug/kg doses, causes myocardial necrosis when given mg/kg doses." | 3.65 | Calcium as mediator of isoproterenol-induced myocardial necrosis. ( Bloom, S; Davis, DL, 1972) |
| "Modern medicine has been used to treat myocardial infarction, a subset of cardiovascular diseases, and have been relatively effective but not without adverse effects." | 2.55 | Molecular understanding of the protective role of natural products on isoproterenol-induced myocardial infarction: A review. ( Ramamurthy, S; Thanikachalam, PV; Wong, ZW, 2017) |
| "Cardiogenic shock is a relatively specific clinical syndrome characterized by decreased cardiac output, elevated left ventricular filling pressure, and arterial hypotension with vital organ hypoperfusion." | 2.36 | Pharmacologic support in cardiogenic shock. ( Rude, RE, 1983) |
| "Scopoletin pre-treatment with ISO (25 and 50 mg/kg b." | 1.91 | Cardioprotective Role of Scopoletin on Isoproterenol-Induced Myocardial Infarction in Rats. ( Ibrahim, IAA; Rong, N; Yang, R; Zhang, W, 2023) |
| "Protocatechuic acid (PCA) is a polyphenolic compound with various potent biological activities." | 1.91 | Protocatechuic acid reverses myocardial infarction mediated by β-adrenergic agonist via regulation of Nrf2/HO-1 pathway, inflammatory, apoptotic, and fibrotic events. ( Elhefny, MA; Jiang, H; Kassab, RB; Li, L; Lokman, MS; Ma, H; Sberi, HA; Xia, B; Zhang, Y, 2023) |
| "The cardiac mitochondrial damage and cardiac hypertrophy pathways are intimately associated with the pathology of myocardial infarction (MI)." | 1.91 | Protective effects of β-caryophyllene on mitochondrial damage and cardiac hypertrophy pathways in isoproterenol-induced myocardial infarcted rats. ( Ponnian, SMP; Stanely, SP; Yovas, A, 2023) |
| "Isoproterenol (ISO) was used to induce MI injury in mice and H9c2 cells." | 1.91 | Curdione inhibits ferroptosis in isoprenaline-induced myocardial infarction via regulating Keap1/Trx1/GPX4 signaling pathway. ( Cheng, Y; Liang, Q; Liu, Z; Shi, S; Wang, H; Xie, B; Zhang, R, 2023) |
| "Pre-treatment of fraxetin in group IV experimental rats resulted in decreased cardiac weight, diminished level of cardiac markers (cardiac troponin T (cTnT), creatine kinase, creatine kinase-MB, and cardiac troponin I (cTnI)), reduced level of oxidative stress biomarkers (LOOH and TBARS) in the plasma and cardiac tissue, amplified level of enzymes in antioxidant defense system (catalase (CAT), superoxide dismutase (SOD), glutathione (GSH), and glutathione peroxidase (GPx)) in the plasma and heart tissue, and elevated level of ATPase activities." | 1.72 | Effect of Fraxetin on Oxidative Damage Caused by Isoproterenol-Induced Myocardial Infarction in Rats. ( Chen, G; Wang, L; Yin, Y; You, H, 2022) |
| "Control of hyperlipidemia is believed to reduce major cardiovascular events such as cardiovascular death, myocardial infarction, nonfatal stroke, hospitalization for unstable angina, and coronary revascularization." | 1.72 | The effect of bempedoic acid an ATP-citrate lyase inhibitor on cardiovascular risk factors in rats with experimentally induced myocardial infarction and hyperlipidemia. ( Mohammed Ali, N; Yaseen, MS, 2022) |
| "Visnagin (VIS) is a natural bioactive component of Ammi visnaga, with promising radical scavenging and anti-inflammatory activities." | 1.62 | Visnagin prevents isoproterenol-induced myocardial injury by attenuating oxidative stress and inflammation and upregulating Nrf2 signaling in rats. ( Abukhalil, MH; Al-Amarat, W; Al-Swailmi, FK; Aladaileh, SH; Alanazi, KM; Alfwuaires, MA; Algefare, AI; Althunibat, OY; Hussein, OE; Kamel, EM; Mahmoud, AM; Saghir, SA, 2021) |
| "Ferruginol (FGL) is a major polyphenols and terpenoids with numerous pharmacological activities including antioxidant and anti-inflammatory." | 1.62 | Ameliorative effect of ferruginol on isoprenaline hydrochloride-induced myocardial infarction in rats. ( Ali Alharbi, S; Chen, Y; Deng, Y; Feng, J; Li, H; Li, X; Wang, C; Wang, L; Zhang, X, 2021) |
| " The ß-adrenergic agonist isoproterenol hydrochloride is used for its cardiac effects in a variety of different dosing regimens with high doses causing acute cardiomyocyte necrosis." | 1.62 | Type 2 MI induced by a single high dose of isoproterenol in C57BL/6J mice triggers a persistent adaptive immune response against the heart. ( Baxan, N; Bedard, O; Benson, L; Boyle, JJ; Branca, J; Forte, E; Harding, SE; Hasham, MG; Ng, FS; Panahi, M; Rosenthal, N; Sattler, S, 2021) |
| " For pharmacodynamic study, histopathological and biochemical analysis were performed to assess the anti-myocardial ischemic effects." | 1.56 | Pharmacodynamics and pharmacokinetics of Danshen in isoproterenol-induced acute myocardial ischemic injury combined with Honghua. ( Bai, JQ; Chen, YY; Duan, JA; Liu, F; Qu, C; Shen, LF; Tang, YP; Wang, XP; Xu, DQ; Yue, SJ; Zhao, BC; Zhou, GS, 2020) |
| "Memantine treatment reduced the expression of cardiac TNF-α in comparison to Iso group." | 1.56 | Cardioprotective effects of memantine in myocardial ischemia: Ex vivo and in vivo studies. ( Abbaszadeh, S; Jannesar, K; Malekinejad, H; Soraya, H, 2020) |
| " This dosing schedule caused daily drug-free periods of at least 6 h as evidenced by propranolol plasma concentrations and cardiac β-adrenergic responsiveness." | 1.56 | Intermittent β-adrenergic blockade downregulates the gene expression of β-myosin heavy chain in the mouse heart. ( Ambrosio, C; Barbagallo, F; Catalano, L; Grò, MC; Maccari, S; Marano, G; Matarrese, P; Molinari, P; Pace, V; Patrizio, M; Rizzi, R; Stati, T; Vezzi, V, 2020) |
| "Ginkgolides are widely used in cardio-protective therapy; however, poor bioavailability currently limits their application." | 1.56 | Preparation of Ginkgolide Solid Dispersions with Low-Molecular-Weight Chitosan and Assessment of their Protective Effect on Isoproterenol- Induced Myocardial Injury. ( Cui, L; Ding, W; Liu, B; Liu, D; Xia, Z; Zhang, L, 2020) |
| "Piperine pretreatment significantly prevented these changes in ISO treated group." | 1.56 | The protective effect of piperine against isoproterenol-induced inflammation in experimental models of myocardial toxicity. ( Aliev, G; Beeraka, NM; Chubarev, VN; Dhivya, V; Gavryushova, LV; Huang, CY; Mikhaleva, LM; Minyaeva, NN; Tarasov, VV; Viswanadha, VP, 2020) |
| "Raspberry ketone (RK) is a red raspberry (Rubusidaeus, Family-Rosaceae) plant constituent, which activates PPAR-α." | 1.51 | Suppression of isoproterenol-induced cardiotoxicity in rats by raspberry ketone via activation of peroxisome proliferator activated receptor-α. ( Bhandari, U; Haque, SE; Khan, V; Rishi, V; Sharma, N; Sharma, S, 2019) |
| "Pretreatment with nimodipine (10 and 15 mg/kg, i." | 1.51 | Effects of nimodipine, vinpocetine and their combination on isoproterenol-induced myocardial infarction in rats. ( Ansari, MA; Ekbbal, R; Haque, SE; Iqubal, A, 2019) |
| "Diosmin pretreatment showed significant preventive effects on all the biochemical parameters, and the structure of mitochondria was evaluated." | 1.48 | Diosmin Prevents Isoproterenol-Induced Heart Mitochondrial Oxidative Stress in Rats. ( John, B; Sharmila Queenthy, S; Stanely Mainzen Prince, P, 2018) |
| "Zingerone pretreatment revealed significant (P<0." | 1.48 | A molecular mechanism on the antiapoptotic effects of zingerone in isoproterenol induced myocardial infarcted rats. ( Hemalatha, KL; Stanely Mainzen Prince, P, 2018) |
| "Pretreatment with kaempferol at highest dose showed mild mononuclear infiltration and degenerative changes in heart tissue section of myocardial injured rats." | 1.48 | Effect of Kaempferol Pretreatment on Myocardial Injury in Rats. ( Kandasamy, A; Kumar, A; Kumar, D; Kumar, T; Lingaraju, MC; Parida, S; Rungsung, S; Singh, TU; Vishwakarma, A, 2018) |
| "Levosimendan has vasorelaxant and anti-aggregatory properties." | 1.48 | Cardioprotective and Anti-Aggregatory Effects of Levosimendan on Isoproterenol-Induced Myocardial Injury in High-Fat-Fed Rats Involves Modulation of PI3K/Akt/mTOR Signaling Pathway and Inhibition of Apoptosis: Comparison to Cilostazol. ( El-Kherbetawy, MK; Makary, S; Tawfik, MK, 2018) |
| " At the end of dosing left ventricular functions was assessed to estimate its effect on cardiac functions." | 1.46 | Cardiaprotective effect of crocetin by attenuating apoptosis in isoproterenol induced myocardial infarction rat model. ( Ge, Z; Li, Y; Zhang, W, 2017) |
| "During arrhythmia provocation induced by catecholamine injections, TG animals were resistant to triggered ventricular arrhythmias." | 1.46 | Phosphodiesterase 2 Protects Against Catecholamine-Induced Arrhythmia and Preserves Contractile Function After Myocardial Infarction. ( Brunner, FJ; Dewenter, M; El-Armouche, A; Fischmeister, R; Geerts, A; Hoffmann, M; Karam, S; Lämmle, S; Lechêne, P; Leroy, J; Lindner, M; Lorenz, K; Mason, FE; Mehel, H; Meinecke, S; Riedel, M; Schanbacher, C; Sossalla, S; Vandecasteele, G; Vettel, C; Wagner, M; Wieland, T; Wunder, F, 2017) |
| "Piperine pre-treatment decreased the levels of serum markers, lipid peroxidation and PCC with increased antioxidant status in the heart tissues of ISO administered rats." | 1.46 | Piperine modulates isoproterenol induced myocardial ischemia through antioxidant and anti-dyslipidemic effect in male Wistar rats. ( Chirayil, HT; Dhivya, V; Huang, CY; Padma, VV; Priya, LB; Sathiskumar, S, 2017) |
| "Acute myocardial infarction is a serious acute cardiac disorder and heart disease is still a major public health problem in adults." | 1.43 | Molecular and biochemical evidence on the protective effects of embelin and carnosic acid in isoproterenol-induced acute myocardial injury in rats. ( Akcilar, R; Altuntas, I; Bayat, Z; Isiklar, OO; Kocak, C; Kocak, FE; Kocak, H; Simsek, H; Taser, F, 2016) |
| "Myocardial infarction was induced into rats by the subcutaneous administration of isoproterenol (100mg/kg body weight) at an interval of 24h daily for a period of two days (7th and 8th day)." | 1.43 | Activation of β1-adrenoceptor triggers oxidative stress mediated myocardial membrane destabilization in isoproterenol induced myocardial infarcted rats: 7-hydroxycoumarin and its counter action. ( Jagadeesh, GS; Nagoor Meeran, MF; Selvaraj, P, 2016) |
| "Isorhapontigenin is a derivative of stilbene with chemical structure similar to resveratrol." | 1.43 | Cardioprotective effect of resveratrol analogue isorhapontigenin versus omega-3 fatty acids in isoproterenol-induced myocardial infarction in rats. ( Abbas, AM, 2016) |
| "Pre-treatment with ibuprofen (30, 60 and 90mg/kg p." | 1.43 | Inhibition of RhoA/Rho kinase by ibuprofen exerts cardioprotective effect on isoproterenol induced myocardial infarction in rats. ( Gandhi, T; Parikh, M; Patel, P; Shah, H, 2016) |
| "Zingerone pretreatment significantly (P<0." | 1.43 | Anti-inflammatory and anti-thrombotic effects of zingerone in a rat model of myocardial infarction. ( Hemalatha, KL; Stanely Mainzen Prince, P, 2016) |
| "Pretreatment with zingerone daily for 14 days revealed significant preventive effects on the electrophoretic and biochemical parameters evaluated in isoproterenol-induced rats." | 1.42 | Preventive effects of zingerone on altered lipid peroxides and nonenzymatic antioxidants in the circulation of isoproterenol-induced myocardial infarcted rats. ( Hemalatha, KL; Prince, PS, 2015) |
| "Pretreatment with zingerone (vanillyl acetone) revealed preventive effects on tachycardia, LVH, ECG, and all the above mentioned biochemical parameters evaluated in isoproterenol induced myocardial infarcted rats." | 1.42 | A biochemical and 2, 3, 5-triphenyl tetrazolium chloride staining study on the preventive effects of zingerone (vanillyl acetone) in experimentally induced myocardial infarcted rats. ( Hemalatha, KL; Stanely Mainzen Prince, P, 2015) |
| "Pretreatment with zingerone prevented hyperlipidaemia and cardiac hypertrophy, by virtue of its antihyperlipidaemic, antihypertrophic, and reducing properties in isoproterenol-induced myocardial infarcted rats." | 1.42 | Antihyperlipidaemic, antihypertrophic, and reducing effects of zingerone on experimentally induced myocardial infarcted rats. ( Hemalatha, KL; Stanely Mainzen Prince, P, 2015) |
| "In isoproterenol-treated rats, Zn(ASA)2 treatment normalized significantly impaired left-ventricular contractility index (Emax 2." | 1.42 | Superiority of zinc complex of acetylsalicylic acid to acetylsalicylic acid in preventing postischemic myocardial dysfunction. ( Atmanli, A; Barnucz, E; Hegedűs, P; Hirschberg, K; Karck, M; Korkmaz, S; Li, S; Loganathan, S; Radovits, T; Szabó, G; Yasui, H; Yoshikawa, Y, 2015) |
| "Myocardial infarction is one of the major public concerns in both developed and developing countries." | 1.42 | Dietary Chitosan Supplementation Ameliorates Isoproterenol-Induced Aberrations in Membrane-Bound ATPases and Mineral Status of Rat Myocardium. ( Anandan, R; Asha, KK; Chatterjee, NS; Ganesan, B; Mathew, S; Sivakumar, R, 2015) |
| "Isoproterenol (ISO) has been reported to inhibit high mobility group box 1 (HMGB1) protein release via heme oxygenase-1 (HO-1) induction in lipopolysaccharide (LPS)-activated RAW 264." | 1.40 | Isoproterenol‑mediated heme oxygenase‑1 induction inhibits high mobility group box 1 protein release and protects against rat myocardial ischemia/reperfusion injury in vivo. ( Fu, W; Hu, X; Jiang, H; Wang, J; Xie, J; Zhou, X, 2014) |
| "Myocardial infarction (MI; "heart attack") can cause injury to or death of heart muscle tissue (myocardium) owing to prolonged ischemia and hypoxia." | 1.40 | Elevated adropin: a candidate diagnostic marker for myocardial infarction in conjunction with troponin-I. ( Aydin, S; Çakmak, T; Eren, MN; Kalayci, M; Kuloglu, T; Yilmaz, M, 2014) |
| "Hesperidin has been shown to possess cardioprotective and anti-diabetic potential." | 1.40 | Hesperidin blunts streptozotocin-isoproternol induced myocardial toxicity in rats by altering of PPAR-γ receptor. ( Agrawal, YO; Arya, DS; Goyal, SN; Sharma, PK; Shrivastava, B, 2014) |
| "Myocardial infarction was manifested by a significant elevation in the level of CK-MB and histopathological findings in isoprenaline group when compared to controls." | 1.40 | The plant histaminase: a promising enzyme with antioxidant properties versus histamine release in isoprenaline-induced myocardial infarction in rats. ( Alirezaei, M; Delfan, B; Dezfoulian, O; Divekan, H; Kheradmand, A; Khonsari, A; Rashidipour, M, 2014) |
| "Treatment with tamoxifen significantly controlled dyslipidemia, hypertension, bradycardia, oxidative stress, and reduced serum cardiac markers." | 1.40 | Beneficial role of tamoxifen in isoproterenol-induced myocardial infarction. ( Patel, BM; Rayabarapu, N, 2014) |
| "Isoproterenol (100 mg/kg) was injected subcutaneously for two consecutive days to induce myocardial infarction, and simultaneously tacrolimus was administered orally twice a day for three days." | 1.40 | Tacrolimus ameliorates functional disturbances and oxidative stress in isoproterenol-induced myocardial infarction. ( Garjani, A; Garjani, M; Hammami, M; Khorrami, A; Maleki-Dizaji, N, 2014) |
| "Rats treated with isoproterenol (ISO, 85 mg/kg, sc, twice at an interval of 24 h) showed a significant increase in heart rate, mean arterial blood pressure, pressure rate index, ST elevation on ECG, and a significant increase in the levels of cardiac marker enzymes- lactate dehydrogenase, and creatine kinase in serum and a significant reduction in superoxide dismutase, and catalase and increase in thiobarbituric acid reactive substance activity in heart tissue." | 1.39 | Intravenous human umbilical cord blood improves electrophysiological and metabolic properties in ISO induced myocardial necrosis in rats. ( Kasturet, S; Mohan, M; Rokade, R, 2013) |
| "Then isoproterenol (100mg/kg) was injected subcutaneously into rats at an interval of 24h for 2 days (on 11th and 12th day)." | 1.39 | Diosmin exhibits anti-hyperlipidemic effects in isoproterenol induced myocardial infarcted rats. ( John, B; Queenthy, SS, 2013) |
| "Isoproterenol treatment caused significant increase in mitochondrial lipid peroxides and lipids except phospholipids with significant decrease in mitochondrial antioxidants." | 1.39 | An in vivo and in vitro study on the protective effects of N-acetylcysteine on mitochondrial dysfunction in isoproterenol treated myocardial infarcted rats. ( Basha, RH; Priscilla, DH, 2013) |
| "Metoprolol can inhibit the expression of c-fos and has a positive therapeutic effect on rats after AMI; the involvement effect of metoprolol on myocardial infarction might be correlated with its effect on the inhibition of c-fos." | 1.39 | The effect of c-fos on acute myocardial infarction and the significance of metoprolol intervention in a rat model. ( Ge, J; Goldstein, S; He, B; Li, Y; Ruiz, G; Zhang, M; Zhang, S, 2013) |
| "Pre-treatment with morin favorably restored the biochemical and functional parameters to near normal indicating morin to be a significant protective effect on cardiac mitochondrial function against ISO-induced MI in rats." | 1.38 | Protective effect of morin on cardiac mitochondrial function during isoproterenol-induced myocardial infarction in male Wistar rats. ( Al Numair, KS; Alsaif, MA; Baskar, AA; Chandramohan, G, 2012) |
| "Pretreatment with morin regulated the abnormalities in electrocardiograph and biomarkers." | 1.38 | Morin protects heart from beta-adrenergic-stimulated myocardial infarction: an electrocardiographic, biochemical, and histological study in rats. ( Arella, M; Boini, L; Maharajan, MK; Oddepalli, DR; Pogula, BK; Sabarimuthu, DQ, 2012) |
| "Isoproterenol (ISO) was used to induce AMI." | 1.38 | Increased expression of calcium-sensing receptors in atherosclerosis confers hypersensitivity to acute myocardial infarction in rats. ( Guo, J; Li, GW; Li, HZ; Wang, LC; Wang, R; Xing, WJ; Xu, CQ; Zhang, WH, 2012) |
| "Acute myocardial infarction was induced by injecting the rats with two doses of isoproterenol (85 mg/kg/24 h, s." | 1.38 | Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF. ( Abo-Gresha, NM; Zaitone, SA, 2012) |
| "Gliclazide or saline was given q12 h for 48 h to rats received isoprenaline." | 1.38 | Blockers of sulfonylureas receptor 1 subunits may lead to cardiac protection against isoprenaline-induced injury in obese rats. ( Bao, Y; Shuyuan, L; Sun, X; Yang, W; Yerong, Y, 2012) |
| "Myocardial ischemia was induced by subcutaneous injection of ISO (85 mg/kg BW) twice at an interval of 24 h, for two consecutive days." | 1.38 | Effect of ursolic acid on cardiac marker enzymes, lipid profile and macroscopic enzyme mapping assay in isoproterenol-induced myocardial ischemic rats. ( Pugalendi, KV; Radhiga, T; Rajamanickam, C; Senthil, S, 2012) |
| "Sesamol is a potent phenolic antioxidant contained only in processed sesame oil and possesses potent chemopreventive, antimutagenic, antihepatotoxic and antioxidation properties." | 1.38 | Efficacy of sesamol on plasma and tissue lipids in isoproterenol-induced cardiotoxicity in Wistar rats. ( Pugalendi, KV; Vennila, L, 2012) |
| "Vanillic acid pretreated isoproterenol-induced rats positively altered all the above-mentioned biochemical parameters." | 1.37 | Preventive effects of vanillic acid on lipids, bax, bcl-2 and myocardial infarct size on isoproterenol-induced myocardial infarcted rats: a biochemical and in vitro study. ( Dhanasekar, K; Prince, PS; Rajakumar, S, 2011) |
| "Isoproterenol (2 mg/kg, IP) was administered daily for 7 days." | 1.37 | An oral formulation of angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats. ( Almeida, AP; Caliari, MV; Ferreira, AJ; Irigoyen, MC; Jacoby, BA; Marques, FD; Melo, MB; Nadu, AP; Santos, RA; Silva, GA; Sinisterra, RD; Sousa, FB; Souza, LE, 2011) |
| "Pretreatment with ellagic acid restored the activities of lysosomal enzymes and membrane bound ATPases." | 1.37 | Pharmacodynamics of ellagic acid on cardiac troponin-T, lyosomal enzymes and membrane bound ATPases: mechanistic clues from biochemical, cytokine and in vitro studies. ( Darlin Quine, S; Mari Kannan, M, 2011) |
| "Myocardial infarction affects a large population in the world." | 1.36 | Protective effect of caffeic acid on cardiac markers and lipid peroxide metabolism in cardiotoxic rats: an in vivo and in vitro study. ( Kumaran, KS; Prince, PS, 2010) |
| "Melatonin has virtually no toxicity which raises the possibility of this indole being a therapeutic treatment for ischemic heart disease." | 1.36 | Melatonin protects against isoproterenol-induced myocardial injury in the rat: antioxidative mechanisms. ( Bandyopadhyay, A; Bandyopadhyay, D; Basu, A; Chattopadhyay, A; Ghosh, AK; Mitra, E; Mukherjee, D; Reiter, RJ; Roy, SG, 2010) |
| "Verapamil response was significantly correlated with cTnI." | 1.36 | Drug-disease interaction: reduced verapamil response in isoproterenol-induced myocardial injury in rats. ( El-Kadi, AO; Hanafy, S; Jamali, F, 2010) |
| "Myocardial infarction was produced in rats with 65, 85, 120 and 200mg/kg of ISO administered subcutaneously (sc) twice at an interval of 24h." | 1.35 | Cardioprotective activity of Ginkgo biloba Phytosomes in isoproterenol-induced myocardial necrosis in rats: a biochemical and histoarchitectural evaluation. ( Naik, SR; Panda, VS, 2008) |
| "Myocardial infarction is the number one killer disease in many parts of the world." | 1.35 | Cardioprotective effect of 'Marutham' a polyherbal formulation on isoproterenol induced myocardial infarction in Wistar rats. ( Devika, PT; Prince, PS; Suman, S; Vaithianathan, M, 2008) |
| "Melatonin has potent cardioprotective properties." | 1.35 | Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions. ( Genade, S; Genis, A; Huisamen, B; Lochner, A; Ytrehus, K, 2008) |
| "Pretreatment with mangiferin (100 mg/kg body weight, intraperitoneally) for 28 days, significantly prevented the alterations and restored the enzyme activities to near-normal status." | 1.35 | Mechanism of protective action of mangiferin on suppression of inflammatory response and lysosomal instability in rat model of myocardial infarction. ( Devi, CS; Narayan, S; Prabhu, S, 2009) |
| "Myocardial infarction was experimentally induced with ISO (85 mg/kg) twice at 24 h interval." | 1.35 | Antilipoperoxidative and membrane stabilizing effect of diosgenin, in experimentally induced myocardial infarction. ( Jayachandran, KS; Rajamanickam, GV; Vasanthi, HR, 2009) |
| "Myocardial infarction was induced by subcutaneous injection of ISO (150 mg/kg) once a day for 2 days." | 1.35 | Preventive effect of S-allyl cysteine sulphoxide (Alliin) on mitochondrial dysfunction in normal and isoproterenol induced cardiotoxicity in male Wistar rats: a histopathological study. ( Darlin Quine, S; Sangeetha, T, 2009) |
| "Pretreatment with betaine daily for a period of 30 days to isoprenaline-induced rats prevented the changes in the activities of these lysosomal enzymes." | 1.35 | Protective effect of betaine on changes in the levels of lysosomal enzyme activities in heart tissue in isoprenaline-induced myocardial infarction in Wistar rats. ( Anandan, R; Ganesan, B, 2009) |
| "Pretreatment with gallic acid (15 mg/kg) to isoproterenol treated rats significantly (P<0." | 1.35 | Gallic acid prevents lysosomal damage in isoproterenol induced cardiotoxicity in Wistar rats. ( Devika, PT; Priscilla, H; Stanely Mainzen Prince, P, 2009) |
| "Isoproterenol treatment (80 mg/kg given over 2 days in two equal doses) caused arrhythmias and 60% mortality within 24 h of the last injection in the control group (C + ISO) group when compared with the saline control group (saline)." | 1.35 | Exercise training provides cardioprotection via a reduction in reactive oxygen species in rats submitted to myocardial infarction induced by isoproterenol. ( Barbosa, VA; Boeck, CR; Da Luz, G; Da Silva, S; De Pinho, RA; De Souza, CT; Frederico, MJ; Justo, SL; Medeiros, C; Silva, LA, 2009) |
| "Amiodarone was administered to groups of rats once per day for 30 days." | 1.35 | Preventive effect of amiodarone during acute period in isoproterenol-induced myocardial injury in Wistar rats. ( Albayrak, F; Bakan, E; Bayir, Y; Bayram, E; Halici, Z; Kabalar, E; Keles, MS; Kurt, M; Ozturk, C; Suleyman, H, 2009) |
| "Myocardial infarction was induced in rats by subcutaneous injection of isoproterenol (ISO) (150 mg kg(-1)) at an interval of 24 h for 2 days." | 1.35 | Protective effect of S-allyl cysteine sulphoxide (alliin) on glycoproteins and hematology in isoproterenol induced myocardial infarction in male Wistar rats. ( Quine, SD; Sangeetha, T, 2008) |
| " By 48 hours the hearts of rats dosed with 125-500 mug/kg Iso had developed interstitial fibrosis, and serum cTnT had declined to near control levels (0." | 1.35 | Isoproterenol-induced cardiotoxicity in sprague-dawley rats: correlation of reversible and irreversible myocardial injury with release of cardiac troponin T and roles of iNOS in myocardial injury. ( Herman, EH; Knapton, A; Lipshultz, SE; Weaver, JL; Zhang, J, 2008) |
| "Isoproterenol (ISO) has been found to cause severe injury in the myocardium." | 1.35 | Protective effects of N-acetylcysteine in isoproterenol-induced myocardium injury in rats. ( Fu, J; Li, H; Li, W; Li, Y; Liu, B; Liu, P; Wang, Z, 2009) |
| "Rats with congestive heart failure (CHF) develop ventricular inotropic responsiveness to serotonin (5-HT), mediated through 5-HT(2A) and 5-HT(4) receptors." | 1.34 | Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes. ( Birkeland, JA; Enger, U; Levy, FO; Lunde, PK; Qvigstad, E; Sejersted, OM; Sjaastad, I; Swift, F; Tovsrud, N, 2007) |
| "Carvedilol is a combined alpha(1)- and beta-adrenoceptor antagonist." | 1.33 | Carvedilol blockade of alpha1- and beta-adrenoceptor induced inotropic responses in rats with congestive heart failure. ( Bøkenes, J; Osnes, JB; Qvigstad, E; Schiander, I; Sejersted, OM; Sjaastad, I; Skomedal, T; Solberg, L, 2005) |
| "Isoproterenol treatment of first passage scar myofibroblasts increased protein synthesis and induced BNP mRNA expression, whereas ANP mRNA levels remained unchanged." | 1.33 | Scar myofibroblasts of the infarcted rat heart express natriuretic peptides. ( Bel-Hadj, S; Calderone, A; Clement, R; Drapeau, J; El-Helou, V; Gosselin, H; Villeneuve, L, 2006) |
| "An arrhythmia was identified as preceding the syncope in 27 patients (45%): ventricular tachycardia (VT) n = 16, supraventricular tachycardia (n = 5), 2nd or 3rd degree AV block (n = 3), vaso-vagal reaction (n = 3): 3 subjects developed coronary ischaemia." | 1.33 | [Significance of isuprel infusion in unexplained syncope after myocardial infarction]. ( Belhakem, H; Brembilla-Perrot, B; Claudon, O; Ernst, Y; Louis, P; Muhanna, I; Nippert, M; Selton, O; Terrier de la Chaise, A, 2006) |
| "Pretreatment with mangiferin (100 mg/kg b." | 1.33 | Effect of mangiferin on mitochondrial energy production in experimentally induced myocardial infarcted rats. ( Jainu, M; Prabhu, S; Sabitha, KE; Shyamala Devi, CS, 2006) |
| " AEC was administered orally to male albino rats (150-200 g), at a dosage of 0." | 1.33 | Pretreatment with alcoholic extract of Crataegus oxycantha (AEC) activates mitochondrial protection during isoproterenol - induced myocardial infarction in rats. ( Devaraj, SN; Jayalakshmi, R; Thirupurasundari, CJ, 2006) |
| "Isoproterenol-treated rats showed lower maximal rate of increase and decrease of left-ventricle pressure development (+/-left-ventricle dp/dtmax) and higher left-ventricle end-diastolic pressure (all P<0." | 1.33 | Intermedin1-53 protects the heart against isoproterenol-induced ischemic injury in rats. ( Chang, JK; Geng, B; Gerns, H; Jia, YX; Pan, CS; Qi, YF; Tang, CS; Wen, JK; Xiao, Y; Yang, J; Yang, JH; Zhang, J; Zhao, J, 2006) |
| "Myocardial infarction was induced in rats by occluding the left coronary artery for 8 and 24 weeks." | 1.33 | Differential changes in beta-adrenoceptor signal transduction in left and right ventricles of infarcted rats. ( Babick, A; Dhalla, NS; Elimban, V; Saini, HK; Sethi, R; Wang, X, 2006) |
| "Because heart failure is a progressive disease that often evolves from hypertrophy, we analyzed the RyR2 macromolecular complex in several animal models of cardiomyopathy that lead to heart failure, including hypertrophy, and at different stages of disease progression." | 1.32 | Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol. ( Burkhoff, D; D'Armiento, J; Gaburjakova, M; Gomez, AM; Guatimosim, S; Lederer, WJ; Marks, AR; Reiken, S; Vassort, G; Wang, J, 2003) |
| "The isoproterenol-stimulated increase in I Ca(L) was significantly smaller in postinfarction myocytes (Emax: 63." | 1.32 | Impaired beta-adrenergic response and decreased L-type calcium current of hypertrophied left ventricular myocytes in postinfarction heart failure. ( Chedid, NG; Díaz G, LE; Masuda, MO; Quintero H, CC; Saraiva, RM, 2003) |
| "A suppression of arrhythmia by Pro and CPU86017 resulted from a regression of the dispersion and depression of RyR2 and SERCA2." | 1.32 | Dispersion of ventricular mRNA of RyR2 and SERCA2 associated with arrhythmogenesis in rats. ( Dai, DZ; Gao, E; Lu, F; Wang, HL; Zhang, YP, 2004) |
| " Ws on chronic administration markedly augmented antioxidants (GSH, GSHPx, SOD, CAT) while Vit E did not stimulate the synthesis of endogenous antioxidants compared to sham." | 1.32 | Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment. ( Arya, DS; Bansal, P; Dinda, A; Gupta, SK; Joshi, S; Mohanty, I; Saxena, A; Talwar, KK, 2004) |
| "Moreover, scar size was significantly smaller (16 +/- 6% vs." | 1.32 | Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction. ( Fuke, S; Kohno, M; Kondo, I; Namba, T; Noma, T; Ohmori, K; Oshita, A; Shinomiya, K; Takeuchi, H, 2004) |
| "Pretreatment with propranolol or labetalol counteracted the appearance of the myocardial histological alterations and the associated ECG and biochemical lesions." | 1.32 | Isoproterenol-induced myocardial infarction in rabbits. Protection by propranolol or labetalol: a proposed non-invasive procedure. ( Accinni, R; Bonacina, E; Brenna, S; Pinelli, A; Tomasoni, L; Trivulzio, S, 2004) |
| "Since heart failure is also associated with attenuated responses to catecholamines, we examined the effects of imidapril, an ACE inhibitor, on the beta-adrenoceptor (beta-AR) signal transduction in the failing heart." | 1.32 | Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system. ( Dhalla, NS; Ren, B; Saini, HK; Sethi, R; Shao, Q; Takeda, N, 2004) |
| "Myocardial infarction is usually induced in small animals by means of invasive procedures: the aim of this study was to cause heart necrosis lesions by non-invasive means." | 1.32 | Myocardial infarction non-invasively induced in rabbits by administering isoproterenol and vasopressin: protective effects exerted by verapamil. ( Bertolini, B; Bonacina, E; Brenna, S; Pinelli, A; Tomasoni, L; Trivulzio, S; Vignati, S, 2004) |
| "Ischemia-induced ventricular arrhythmias were mostly reduced." | 1.31 | Reduction of infarct size by selective stimulation of prostaglandin EP(3)receptors in the reperfused ischemic pig heart. ( Hohlfeld, T; Meyer-Kirchrath, J; Schrör, K; Vogel, YC, 2000) |
| "Heart failure is associated with alterations in contractile parameters and accompanied by abnormalities in intracellular calcium homeostasis." | 1.31 | Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity. ( Bøkenes, J; Christensen, G; Hoen, IB; Holt, E; Lunde, PK; Sande, JB; Sjaastad, I; Tønnessen, T, 2002) |
| "Acute myocardial infarction is the second cause of mortality in most countries, therefore, it is important to know the evolution and sequence of the physiological and biochemical changes involved in this pathology." | 1.30 | Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study. ( Aranda-Fraustro, A; Chagoya de Sánchez, V; Cota-Garza, MD; Cruz, D; Hernández-Muñoz, R; López-Barrera, F; Suárez, J; Vidrio, S; Yañez, L, 1997) |
| "The propranolol treated animals had higher LV end-diastolic pressures (27+/-2* vs 20+/(-3 mmHg) and a more restricted LV diastolic filling pattern (increased ratio of early to late filling velocities and more rapid E wave deceleration rate)." | 1.30 | Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure. ( Douglas, PS; Katz, SE; Litwin, SE; Morgan, JP, 1999) |
| "Mibefradil treatment increased MAP and dP/dtmax and decreased LVEDP and HR in infarcted rats." | 1.30 | Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca(2+)-handling in infarct-induced heart failure in rats. ( Meissner, A; Min, JY; Sandmann, S; Unger, T, 1999) |
| "Isoproterenol was used as a drug which, when administered in high doses, is able to induce lysosomal enzyme activity changes in in vivo conditions." | 1.30 | Comparison of isoproterenol-induced changes in lysosomal enzyme activity in vivo and in vitro. ( Horáková, K; Macicková, T; Navarová, J; Urbancíkova, M, 1999) |
| "Nisoldipine was more effective in preventing cardiac necrosis as compared to nitrendipine and nimodipine." | 1.29 | Effect of nitrendipine, nimodipine and nisoldipine on experimentally induced myocardial infarction in rats. ( Kaur, AH; Mathur, SK; Singh, J; Srivastava, RK, 1995) |
| "Acute myocardial infarction was induced in New Zealand male albino rabbits." | 1.29 | Oligotide, a new single-stranded oligodeoxyribonucleotide, preserves postsynaptic beta-adrenergic and cholinergic receptor functions in rabbit hearts after acute infarction. ( Bernareggi, M; Berti, F; Berti, M; Ferro, L; Pescador, R; Porta, R; Rossoni, G; Trento, F, 1995) |
| "The resulting necrosis is believed to result, at least in part, from the leakage of lysosomal enzymes into the cytoplasm." | 1.29 | Isoproterenol-induced redistribution of endosomes in cardiac myocytes. ( Gruenberg, J; Marjomäki, V; Ritamäki, V, 1994) |
| "Pretreatment with oxodipine significantly reduced the infarct size in the apical and basal myocardium (P < 0." | 1.29 | Effects of oxodipine and nitrendipine on the size of experimental myocardial infarct in the rat. ( Gil-Loyzaga, P; Merchàn-Pérez, A; Pérez-Cao, A; Tamargo, J, 1994) |
| "Regional myocardial ischemia is associated with increased levels of adenosine and norepinephrine, factors that may alter activation of the beta-adrenergic receptor (beta AR)-G protein-adenylyl cyclase pathway in the heart." | 1.29 | Regional myocardial downregulation of the inhibitory guanosine triphosphate-binding protein (Gi alpha 2) and beta-adrenergic receptors in a porcine model of chronic episodic myocardial ischemia. ( Hammond, HK; McKirnan, MD; Ping, P; Roth, DA, 1993) |
| "Aspirin treatment is found to counteract the effect of isoproterenol on lipid and lipid peroxide formation and associated enzyme changes in heart mitochondria." | 1.29 | Effect of aspirin on mitochondrial lipids in experimental myocardial infarction in rats. ( Devi, CS; Manjula, TS, 1993) |
| "Rats treated with isoproterenol (30 mg/100 g body weight) showed a significant increase in serum lysosomal hydrolase activities, which were found to decrease after curcumin treatment." | 1.29 | Effect of curcumin on certain lysosomal hydrolases in isoproterenol-induced myocardial infarction in rats. ( Nirmala, C; Puvanakrishnan, R, 1996) |
| "Curcumin pre- and co-treatment decreased the severity of pathological changes and thus, could have a protective effect against the damage caused by myocardial infarction (MI)." | 1.29 | Protective role of curcumin against isoproterenol induced myocardial infarction in rats. ( Nirmala, C; Puvanakrishnan, R, 1996) |
| "Isoproterenol was titrated to achieve a heart rate of 130% of baseline." | 1.28 | Autonomic manipulation influences both temporal and frequency analyses of late potentials. ( Caracciolo, E; Chinitz, L; Demopoulos, L; Perez, J; Schrem, S; Schwartzman, D; Slater, W, 1992) |
| "Treatment with captopril for 5 weeks, beginning 1 week after infarction (n = 14), resulted in reduction of left ventricular filling pressures and partial normalization of myocardial contractility and Ca2+i handling." | 1.28 | Captopril enhances intracellular calcium handling and beta-adrenergic responsiveness of myocardium from rats with postinfarction failure. ( Litwin, SE; Morgan, JP, 1992) |
| "Aspirin treated rats showed marked reversal of these metabolic changes." | 1.28 | Effect of aspirin on serum lipoprotein profile in rats subjected to myocardial stress by isoproterenol. ( Devi, CS; Manjula, TS; Prema, A, 1992) |
| "Thus, triggered arrhythmias dependent upon adrenergic stimulation can either be potentiated or inhibited by the biochemical derangements of acute ischemia." | 1.28 | [Variations in arrhythmogenic response to catecholamines in acute myocardial ischemia]. ( Corr, PB; Priori, SG, 1991) |
| "Aspirin treated rats showed lower mortality rate and smaller changes in the myocardium on histopathological examination when compared to corresponding animals given isoproterenol alone." | 1.28 | Protective action of aspirin in experimental myocardial infarction induced by isoproterenol in rats and its effect on lipid peroxidation. ( Menon, VP; Muraleedharan, D; Sushama Kumari, S; Varghese, A, 1990) |
| "Myocardial infarction was produced by ligating the left main coronary artery." | 1.27 | Effects of chronic myocardial infarction on responsiveness to isoprenaline and the state of myocardial beta adrenoceptors in rats. ( Burkard, W; Clozel, JP; Da Prada, MD; Holck, M; Osterrieder, W, 1987) |
| "This hypokalemia is not mediated by insulin, renin or aldosterone." | 1.27 | Hypokalemia from beta 2-receptor stimulation by circulating epinephrine. ( Brown, MJ, 1985) |
| "Defibrotide is a polydeoxyribonucleotide of mammalian origin which possesses profibrinolytic effect and PGI2-releasing capacity." | 1.27 | Beneficial effects of defibrotide against myocardial ischemia and decline of beta-adrenoceptor function in the rabbit. ( Berti, F; Mandelli, C; Niada, R; Omini, C; Pretolani, M; Rossoni, G, 1986) |
| "The alprazolam treated group had a significantly smaller proportion of infarcted tissue in the ventricular section (2." | 1.27 | Alprazolam decreases isoproterenol induced myocardial damage in the rat. ( Berkowitz, K; Conahan, S; Vogel, WH, 1988) |
| "Isoproterenol (ISO) was injected in 5 mg/kg i." | 1.27 | Cardioprotective effect of prostacyclin and 7-oxo-PGI2 in rats against chronic isoproterenol damage. ( Körmöczy, PS; Kovács, G; Mikus, E; Tardos, L; Vértesi, C, 1987) |
| "5 mg) given intracoronary, a dose that shifted the isoproterenol dose-response curve to the right, slowed ventricular tachycardia from 174 +/- 7." | 1.27 | Autonomic control of ventricular tachycardia: direct effects of beta-adrenergic blockade in 24 hour old canine myocardial infarction. ( Constantin, L; Martins, JB, 1987) |
| " Three days post-AMI the dose-response curve for isoproterenol of right ventricular dP/dtmax was significantly depressed, while the inotropic effect of histamine was not impaired." | 1.26 | Impaired beta-adrenergic stimulation in the uninvolved ventricle post-acute myocardial infarction: reversible defect due to excessive circulating catecholamine-induced decline in number and affinity of beta-receptors. ( Baumann, G; Blömer, H; Blümel, G; Erhardt, WD; Felix, SB; Ludwig, L; Riess, G, 1981) |
| "Pretreatment with sulfinpyrazone reduced isoproterenol-induced lesions by 42%." | 1.26 | Reduction in the severity of myocardial infarction by sulfinpyrazone. ( Innes, IR; Weisman, H, 1981) |
| "Experimental myocardial infarction has been induced in rats by isoprenaline pretreatment and progress of the lesions has been observed histologically at intervals over a period of 6 weeks." | 1.26 | Abnormal electrocardiographic activity revealed by isolated rat heart preparations at various times after experimental myocardial infarction. ( Hicks, R; Sahyoun, HA, 1981) |
| " Particularly with the primarily cardioselective beta-stimulating agent dobutamine a marked positive inotropic effect can be achieved in a range of dosage not significantly affecting heart rate and peripheral resistance." | 1.26 | [Catecholamines for treatment of severe heart failure (author's transl)]. ( Kübler, W; Mäurer, W; Tillmanns, H, 1979) |
| "The latter group of arrhythmias was characterized by sinus arrest or severe sinus bradycardia (90%) and complete A-V block (10%)." | 1.26 | Prehospital brady-asystolic cardiac arrest. ( Humphrey, SB; Iseri, LT; Siner, EJ, 1978) |
| "Massive myocardial infarction was then induced in intact and CCL4-treated animals." | 1.26 | Effect of CCL4-induced cirrhosis on the pathophysiologic course of acute myocardial infarction in nonarteriosclerotic vs arteriosclerotic male rats. ( Greenberg, BP; Wexler, BC, 1979) |
| "The necrosis was confirmed by ECG changes, increased serum activities of AspAT, AlAT, GPT and LDH, and by histological examination." | 1.26 | A temporal profile of changes in myocardial manganese after isoprenaline induced cardiac necrosis in albino rats. ( Ahmad, M; Hasan, MZ; Jameel, SA; Kumar, S; Mathew, BM; Seth, TD, 1979) |
| "The greater sensitivity of phase 1a arrhythmias to beta-blockade and the lack of a decrease in ventricular fibrillation threshold during phase 1b might indicate differences in the genesis of arrhythmias and fibrillation in phases 1a and 1b." | 1.26 | Prophylaxis of ventricular fibrillation after acute experimental coronary occlusion by chronic beta-adrenoceptor blockade with atenolol. ( Bucher, P; Meesmann, W; Menken, U; Wiegand, V, 1979) |
| "Isoprenaline dosed 50 mg/kg was injected intraperitoneally into rats aged 42 days, 3 months, and 18 months." | 1.26 | Age-dependent variations in the intensity of isoprenaline-induced myocardial lesions in rats. ( Kalincák, M; Kohút, A; Machán, V; Nicák, A; Vilcek, S, 1978) |
| "Pretreatment with verapamil 25 mg/Kg s." | 1.26 | Effect of verapamil on the transmural energy metabolism in the isoproterenol-induced myocardial lesion. ( Higuchi, M; Takenaka, F, 1978) |
| "Myocardial infarction was produced by subcutaneous injection of isoproterenol, 85 mg/kg body weight, on 2 consecutive days." | 1.25 | Effect of conditioning on myocardial metabolism after myocardial infarction. ( Ahmad, M; Tajuddin, M; Tariq, M, 1975) |
| " The dose-response curve of TM was parallel to that of nitroglycerin and papaverine and steeper than that of dipyridamol or adenosine." | 1.25 | [Pharmacology of cornary dilator agent, trapymin. (2) Analysis of its mode of action]. ( Ogawa, N; Ohnishi, H; Tsukuda, S; Yamaguchi, K, 1975) |
| "Myocardial infarction was produced by occlusion of the left anterior descending coronary artery in open-chest dogs." | 1.25 | Effect of inhibition of lipolysis on infarct size after experimental coronary artery occlusion. ( Kjekshus, JK; Mjos, OD, 1973) |
| "Clinical signs of congestive heart failure significantly correlated with a fall in FEV and FEF(25-75%), the development of frequency dependence of R(T), and elevation of the pulmonary wedge pressure." | 1.25 | Interrelation between alterations in pulmonary mechanics and hemodynamics in acute myocardial infarction. ( Hodges, M; Hyde, RW; Interiano, B; Yu, PN, 1973) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 456 (41.87) | 18.7374 |
| 1990's | 76 (6.98) | 18.2507 |
| 2000's | 170 (15.61) | 29.6817 |
| 2010's | 274 (25.16) | 24.3611 |
| 2020's | 113 (10.38) | 2.80 |
| Authors | Studies |
|---|---|
| Abukhalil, MH | 1 |
| Hussein, OE | 1 |
| Aladaileh, SH | 1 |
| Althunibat, OY | 1 |
| Al-Amarat, W | 1 |
| Saghir, SA | 1 |
| Alfwuaires, MA | 1 |
| Algefare, AI | 1 |
| Alanazi, KM | 1 |
| Al-Swailmi, FK | 1 |
| Kamel, EM | 1 |
| Mahmoud, AM | 1 |
| Asdaq, SMB | 1 |
| Alamri, AS | 1 |
| Alsanie, WF | 1 |
| Alhomrani, M | 1 |
| Emran, T | 1 |
| Chowdhury, NI | 1 |
| Sarker, M | 1 |
| Bepari, AK | 1 |
| Hossain, M | 1 |
| Rahman, GMS | 2 |
| Reza, HM | 3 |
| Demir, M | 1 |
| Altinoz, E | 1 |
| Elbe, H | 1 |
| Bicer, Y | 1 |
| Yigitturk, G | 1 |
| Karayakali, M | 1 |
| Ballur, AFH | 1 |
| Liu, C | 1 |
| Li, B | 2 |
| Yan, Q | 1 |
| Niu, S | 1 |
| Zhao, Y | 3 |
| Xiong, C | 1 |
| Zhang, T | 2 |
| Wei, J | 2 |
| Cinar, I | 2 |
| Yayla, M | 1 |
| Tavaci, T | 1 |
| Toktay, E | 1 |
| Ugan, RA | 1 |
| Bayram, P | 1 |
| Halici, H | 1 |
| Oglakci-Ilhan, A | 1 |
| Kusat-Ol, K | 1 |
| Uzuner, K | 2 |
| Uysal, O | 1 |
| Sogut, I | 1 |
| Yucel, F | 1 |
| Kanbak, G | 2 |
| El-Shaer, NO | 1 |
| El Gazzar, WB | 1 |
| Allam, MM | 2 |
| Anwer, HM | 1 |
| Hosseinabadi, M | 1 |
| Abdolmaleki, Z | 1 |
| Beheshtiha, SHS | 1 |
| Paulino, ET | 2 |
| Rodrigues, AKBF | 1 |
| Machado, MLDP | 1 |
| de Oliveira, KRV | 1 |
| Bernardino, AC | 1 |
| Quintans-Júnior, LJ | 1 |
| Oliveira, AP | 1 |
| Ribeiro, ÊAN | 1 |
| Medhet, M | 1 |
| El-Bakly, WM | 1 |
| Badr, AM | 1 |
| Awad, A | 1 |
| El-Demerdash, E | 2 |
| Munir, I | 1 |
| Hassan Mehmood, M | 1 |
| Faisal, N | 1 |
| Hanif, M | 1 |
| Naseer, D | 1 |
| Al-Botaty, BM | 1 |
| Elkhoely, A | 1 |
| K El-Sayed, E | 1 |
| Ahmed, AAE | 1 |
| Spasov, AA | 1 |
| Kucheryavenko, AF | 1 |
| Khaliullin, FA | 1 |
| Gurova, NA | 1 |
| Sirotenko, VS | 1 |
| Samorodov, AV | 1 |
| Gaidukova, KA | 1 |
| Pavlov, VN | 1 |
| Gonçalves, MSS | 1 |
| Silva, EAP | 1 |
| Santos, DM | 1 |
| Santana, IR | 1 |
| Souza, DS | 3 |
| Araujo, AM | 1 |
| Heimfarth, L | 1 |
| Vasconcelos, CML | 2 |
| Santos, VCO | 2 |
| Santos, MRV | 2 |
| de S S Barreto, R | 1 |
| Quintans Júnior, LJ | 1 |
| Barreto, AS | 1 |
| Thomas, J | 2 |
| Anderson, T | 1 |
| James-Green, T | 1 |
| Nwokocha, M | 2 |
| Palacios, J | 2 |
| Pepple, D | 1 |
| Nwokocha, C | 2 |
| Ramakrishna, K | 1 |
| Krishnamurthy, S | 1 |
| Wahid, M | 2 |
| Saqib, F | 3 |
| Chicea, L | 1 |
| Ahmedah, HT | 2 |
| Sajer, BH | 1 |
| Marc Vlaic, RA | 2 |
| Pop, OL | 2 |
| Moga, M | 3 |
| Gavris, C | 1 |
| Hosseini, A | 1 |
| Rajabian, A | 1 |
| Sobhanifar, MA | 1 |
| Alavi, MS | 1 |
| Taghipour, Z | 1 |
| Hasanpour, M | 1 |
| Iranshahi, M | 1 |
| Boroumand-Noughabi, S | 1 |
| Banach, M | 1 |
| Sahebkar, A | 1 |
| Ponnian, SMP | 4 |
| Al-Huqail, AA | 1 |
| Bigiu, N | 1 |
| Irimie, M | 1 |
| Chicea, LM | 1 |
| Younis, NS | 5 |
| Mohamed, ME | 5 |
| Shervin Prince, S | 1 |
| Stanely Mainzen Prince, P | 23 |
| Berlin Grace, VM | 1 |
| Khalifa, AA | 2 |
| El Sokkary, NH | 1 |
| Elblehi, SS | 1 |
| Diab, MA | 1 |
| Ali, MA | 1 |
| Zou, G | 1 |
| Wan, J | 1 |
| Balupillai, A | 1 |
| David, E | 1 |
| Ranganathan, B | 1 |
| Saravanan, K | 1 |
| Tóth, K | 2 |
| Oroszi, T | 1 |
| van der Zee, EA | 1 |
| Nyakas, C | 1 |
| Schoemaker, RG | 3 |
| Ghazouani, L | 4 |
| Khdhiri, E | 4 |
| Elmufti, A | 3 |
| Zarei, A | 1 |
| Feriani, A | 5 |
| Baaziz, I | 2 |
| Hajji, R | 8 |
| Abid, M | 2 |
| Ammar, H | 4 |
| Abid, S | 4 |
| Allouche, N | 7 |
| Mnafgui, K | 10 |
| Ramazani, A | 1 |
| Tlili, N | 3 |
| Tir, M | 3 |
| Aldahmash, W | 1 |
| Hichem, A | 1 |
| Gómez-Caravaca, AM | 1 |
| Del Mar Contreras, M | 1 |
| Taamalli, A | 1 |
| Alwasel, S | 1 |
| Segura-Carretero, A | 1 |
| Harrath, AH | 1 |
| Yin, Y | 1 |
| Wang, L | 4 |
| Chen, G | 1 |
| You, H | 2 |
| Rathod, S | 1 |
| Agrawal, Y | 1 |
| Sherikar, A | 1 |
| Nakhate, KT | 1 |
| Patil, CR | 4 |
| Nagoor Meeran, MF | 8 |
| Ojha, S | 9 |
| Goyal, SN | 7 |
| Yang, Y | 2 |
| Han, J | 1 |
| Lilly, RG | 1 |
| Yang, Q | 3 |
| Guo, Y | 2 |
| Rhana, P | 2 |
| Barros, GM | 1 |
| Costa, AD | 1 |
| Santos, DMD | 1 |
| Fernandes-Braga, W | 1 |
| Durço, AO | 1 |
| Roman-Campos, D | 2 |
| Cruz, JS | 2 |
| Verma, H | 1 |
| Bhattacharjee, A | 1 |
| Shivavedi, N | 1 |
| Nayak, PK | 1 |
| Deger, N | 1 |
| Ozmen, R | 1 |
| Karabulut, D | 1 |
| Yovas, A | 3 |
| Manjusha, WA | 1 |
| Akhtar, MS | 6 |
| Hassan, Q | 1 |
| Afzal, O | 1 |
| Altamimi, A | 1 |
| Hassan, MZ | 1 |
| Sharma, AK | 4 |
| Mohammad, AAS | 1 |
| Tabassum, F | 1 |
| Zhang, M | 3 |
| Chen, J | 1 |
| Wang, Y | 5 |
| Kang, G | 1 |
| Zhang, Y | 8 |
| Han, X | 1 |
| Rong, N | 1 |
| Yang, R | 1 |
| Ibrahim, IAA | 1 |
| Zhang, W | 4 |
| Li, L | 1 |
| Ma, H | 1 |
| Jiang, H | 2 |
| Xia, B | 1 |
| Sberi, HA | 1 |
| Elhefny, MA | 1 |
| Lokman, MS | 1 |
| Kassab, RB | 1 |
| Beyazcicek, E | 1 |
| Beyazcicek, O | 1 |
| Moreno, KGT | 1 |
| de Almeida, TL | 1 |
| Marques, AAM | 1 |
| Donadel, G | 1 |
| Lourenço, ELB | 1 |
| de Almeida, DAT | 1 |
| Gasparotto, A | 1 |
| Elseweidy, MM | 1 |
| Ali, SI | 1 |
| Shaheen, MA | 1 |
| Abdelghafour, AM | 1 |
| Hammad, SK | 1 |
| Hassan, GM | 1 |
| Ebrahim, RH | 1 |
| Liao, J | 1 |
| Ma, C | 2 |
| Wu, G | 1 |
| Yaseen, MS | 1 |
| Mohammed Ali, N | 1 |
| Stanely, SP | 2 |
| Aodah, AH | 1 |
| Devi, S | 2 |
| Alkholifi, FK | 1 |
| Yusufoglu, HS | 1 |
| Foudah, AI | 1 |
| Alam, A | 1 |
| Wang, H | 2 |
| Xie, B | 1 |
| Shi, S | 1 |
| Zhang, R | 2 |
| Liang, Q | 2 |
| Liu, Z | 1 |
| Cheng, Y | 2 |
| Mi, X | 1 |
| Zhang, Z | 1 |
| Cheng, J | 2 |
| Xu, Z | 2 |
| Zhu, K | 1 |
| Ren, Y | 1 |
| Holanda, TM | 1 |
| Rocha, DG | 1 |
| Silveira, JAM | 1 |
| Costa, PPC | 1 |
| Maia, PHF | 1 |
| Ingram, C | 1 |
| Moraes, MEA | 1 |
| Fechine, FV | 1 |
| Moraes Filho, MO | 1 |
| Zhang, X | 4 |
| Zhao, X | 2 |
| Zhang, J | 5 |
| Diao, J | 1 |
| Jia, S | 1 |
| Feng, P | 1 |
| Yu, P | 1 |
| Cheng, G | 1 |
| Jghef, MM | 1 |
| Boukholda, K | 1 |
| Chtourou, Y | 1 |
| Fiebich, BL | 1 |
| Kebieche, M | 1 |
| Soulimani, R | 1 |
| Chigr, F | 1 |
| Fetoui, H | 1 |
| Issac, R | 1 |
| Ben Mansour, H | 1 |
| Barchukov, VV | 1 |
| Tsorin, IB | 1 |
| Likhosherstov, AM | 1 |
| Vititnova, MB | 1 |
| Mokrov, GV | 1 |
| Gudasheva, TA | 1 |
| Kryzhanovskii, SA | 1 |
| Panda, V | 2 |
| Bhandare, N | 1 |
| Mistry, K | 1 |
| S, S | 1 |
| Dande, P | 1 |
| Qu, C | 1 |
| Xu, DQ | 1 |
| Yue, SJ | 1 |
| Shen, LF | 1 |
| Zhou, GS | 1 |
| Chen, YY | 1 |
| Wang, XP | 1 |
| Bai, JQ | 1 |
| Liu, F | 1 |
| Tang, YP | 1 |
| Zhao, BC | 1 |
| Duan, JA | 1 |
| Zhang, JC | 1 |
| Xia, L | 1 |
| Jiang, Y | 2 |
| Wu, DQ | 1 |
| Liu, SC | 1 |
| Zhou, XN | 1 |
| Zhang, FX | 1 |
| Bei, W | 1 |
| Jing, L | 2 |
| Chen, N | 1 |
| Cai, Y | 1 |
| Li, Y | 6 |
| Dang, M | 1 |
| Lin, X | 1 |
| Sun, L | 2 |
| Hu, Y | 2 |
| Mishra, A | 1 |
| Sreeharsha, N | 1 |
| Moktan, JB | 1 |
| Kumar, P | 1 |
| Sultan, F | 1 |
| Kaur, R | 1 |
| Mir, AH | 1 |
| Maqbool, I | 1 |
| Lonare, M | 1 |
| Singh, D | 1 |
| Rampal, S | 1 |
| Dar, JA | 1 |
| Govindasami, S | 1 |
| Uddandrao, VVS | 1 |
| Raveendran, N | 1 |
| Sasikumar, V | 1 |
| Alabi, B | 1 |
| Omobowale, T | 1 |
| Badejo, J | 1 |
| Adedapo, A | 1 |
| Fagbemi, O | 1 |
| Iwalewa, O | 1 |
| Halici, Z | 5 |
| Dincer, B | 1 |
| Sirin, B | 1 |
| Cadirci, E | 1 |
| Wang, J | 4 |
| Wu, X | 2 |
| Sun, JH | 1 |
| Yang, HX | 1 |
| Yao, TT | 1 |
| Ruan, L | 1 |
| Xu, GR | 1 |
| Zhang, C | 2 |
| Guo, GX | 1 |
| Li, AY | 1 |
| Ahmed, LA | 2 |
| Hassan, OF | 1 |
| Galal, O | 1 |
| Mansour, DF | 1 |
| El-Khatib, A | 1 |
| Vorkapić, M | 1 |
| Savić, A | 1 |
| Janković, M | 1 |
| Useinović, N | 1 |
| Isaković, M | 1 |
| Puškaš, N | 1 |
| Stanojlović, O | 1 |
| Hrnčić, D | 1 |
| Gan, M | 1 |
| Zhang, S | 3 |
| Fan, Y | 2 |
| Tan, Y | 1 |
| Guo, Z | 2 |
| Chen, L | 1 |
| Bai, L | 1 |
| Jiang, D | 1 |
| Hao, X | 1 |
| Li, X | 5 |
| Shen, L | 1 |
| Zhu, L | 1 |
| Khalaf, HM | 1 |
| Abdalla, AM | 1 |
| Ahmed, AF | 1 |
| Abdel-Aziz, AM | 1 |
| Mujahid, K | 1 |
| Aslam, MA | 1 |
| Modhi, A | 1 |
| Moga, MA | 1 |
| Bobescu, E | 1 |
| Marceanu, L | 1 |
| Zhou, FT | 1 |
| Ma, K | 1 |
| Jannesar, K | 1 |
| Abbaszadeh, S | 1 |
| Malekinejad, H | 1 |
| Soraya, H | 5 |
| Zhang, H | 2 |
| Chen, H | 2 |
| Li, J | 3 |
| Bian, Y | 1 |
| Song, Y | 2 |
| Li, Z | 1 |
| He, F | 1 |
| Liu, S | 2 |
| Tsai, Y | 1 |
| Maccari, S | 1 |
| Pace, V | 1 |
| Barbagallo, F | 1 |
| Stati, T | 1 |
| Ambrosio, C | 1 |
| Grò, MC | 1 |
| Molinari, P | 1 |
| Vezzi, V | 1 |
| Catalano, L | 1 |
| Matarrese, P | 1 |
| Patrizio, M | 1 |
| Rizzi, R | 1 |
| Marano, G | 1 |
| Zhang, B | 3 |
| Yang, Z | 1 |
| Cao, M | 1 |
| Wang, K | 2 |
| Wang, G | 1 |
| Zhang, L | 2 |
| Xia, Z | 1 |
| Liu, B | 2 |
| Cui, L | 1 |
| Ding, W | 1 |
| Liu, D | 1 |
| Dey, P | 1 |
| Roy, SJ | 3 |
| Sivasangari, S | 1 |
| Asaikumar, L | 1 |
| Vennila, L | 4 |
| Xu, W | 1 |
| Li, XP | 1 |
| Li, EZ | 1 |
| Liu, YF | 1 |
| Zhao, J | 4 |
| Wei, LN | 1 |
| Ma, L | 1 |
| Su, X | 1 |
| Su, G | 1 |
| Ravindran, S | 1 |
| Gopalakrishnan, S | 1 |
| Kurian, GA | 1 |
| Viswanadha, VP | 1 |
| Dhivya, V | 2 |
| Beeraka, NM | 1 |
| Huang, CY | 2 |
| Gavryushova, LV | 1 |
| Minyaeva, NN | 1 |
| Chubarev, VN | 1 |
| Mikhaleva, LM | 1 |
| Tarasov, VV | 1 |
| Aliev, G | 1 |
| Karimkhani, H | 1 |
| Özkoç, M | 1 |
| Shojaolsadati, P | 1 |
| Donmez, DB | 1 |
| Krasina, ME | 1 |
| Kosheleva, NV | 1 |
| Lipina, TV | 1 |
| Karganov, MY | 1 |
| Medvedeva, YS | 1 |
| Lebedeva, MA | 1 |
| Zurina, IM | 1 |
| Saburina, IN | 1 |
| Wang, C | 1 |
| Li, H | 5 |
| Chen, Y | 2 |
| Feng, J | 1 |
| Ali Alharbi, S | 1 |
| Deng, Y | 1 |
| Simko, F | 1 |
| Baka, T | 1 |
| Repova, K | 1 |
| Aziriova, S | 1 |
| Krajcirovicova, K | 1 |
| Paulis, L | 1 |
| Adamcova, M | 1 |
| Tapa, S | 1 |
| Francis Stuart, SD | 1 |
| Wang, Z | 2 |
| Habecker, BA | 1 |
| Ripplinger, CM | 1 |
| Thangaiyan, R | 1 |
| Govindasamy, K | 1 |
| Forte, E | 1 |
| Panahi, M | 1 |
| Baxan, N | 1 |
| Ng, FS | 1 |
| Boyle, JJ | 1 |
| Branca, J | 1 |
| Bedard, O | 1 |
| Hasham, MG | 1 |
| Benson, L | 1 |
| Harding, SE | 1 |
| Rosenthal, N | 1 |
| Sattler, S | 1 |
| Audigane, L | 1 |
| Persello, A | 1 |
| Piriou, N | 1 |
| Ferron, M | 1 |
| Trochu, JN | 1 |
| Lauzier, B | 1 |
| Gauthier, C | 1 |
| Rozec, B | 1 |
| Lu, Y | 3 |
| Yang, M | 1 |
| Peng, M | 1 |
| Xie, L | 1 |
| Shen, A | 1 |
| Lin, S | 1 |
| Huang, B | 1 |
| Chu, J | 1 |
| Peng, J | 1 |
| Huang, J | 1 |
| Shen, H | 1 |
| Jiang, M | 1 |
| Huang, L | 2 |
| Yuan, Y | 2 |
| Wang, Q | 1 |
| Chelluri, LK | 1 |
| Mohanram, Y | 1 |
| Jain, R | 1 |
| Mallarpu, CS | 1 |
| Ponnana, M | 1 |
| Kumar, D | 2 |
| Krishna Venuganti, VV | 1 |
| Kancherla, R | 1 |
| Papineni, RV | 1 |
| Towner, R | 1 |
| Ghosal, P | 1 |
| Zaafan, MA | 2 |
| Abdelhamid, AM | 2 |
| Ncir, M | 1 |
| Jallouli, D | 1 |
| Jamoussi, K | 1 |
| Meeran, MFN | 2 |
| Azimullah, S | 3 |
| Adeghate, E | 1 |
| Sangeethadevi, G | 1 |
| V V, SU | 1 |
| Jansy Isabella, RAR | 1 |
| Saravanan, G | 3 |
| Ponmurugan, P | 2 |
| Chandrasekaran, P | 1 |
| Sengottuvelu, S | 1 |
| Vadivukkarasi, S | 1 |
| Naseroleslami, M | 1 |
| Aboutaleb, N | 1 |
| Alam, T | 1 |
| Ansari, MA | 2 |
| Baboota, S | 1 |
| Ali, J | 4 |
| Ilic, A | 1 |
| Todorovic, D | 1 |
| Mutavdzin, S | 1 |
| Boricic, N | 1 |
| Bozic Nedeljkovic, B | 1 |
| Stankovic, S | 1 |
| Simic, T | 1 |
| Stevanovic, P | 1 |
| Celic, V | 1 |
| Djuric, D | 1 |
| Soumya, RS | 1 |
| Raj, KB | 1 |
| Abraham, A | 1 |
| Maleki Dizaji, N | 1 |
| Garjani, A | 9 |
| Mousavi, S | 1 |
| Mohammadi, M | 2 |
| Vaez, H | 1 |
| HarishKumar, R | 1 |
| Selvaraj, CI | 1 |
| Elasoru, SE | 1 |
| de Oliveira Barreto, T | 1 |
| Naves de Souza, DL | 1 |
| Menezes-Filho, JER | 1 |
| Loes Moreira, MV | 1 |
| Gomes Campos, MT | 1 |
| Adedosu, OT | 1 |
| Melo, MM | 1 |
| Baraka, SA | 1 |
| Tolba, MF | 1 |
| Elsherbini, DA | 1 |
| El-Naga, RN | 1 |
| Awad, AS | 1 |
| Mangali, S | 1 |
| Bhat, A | 1 |
| Dasari, D | 1 |
| Sriram, D | 1 |
| Dhar, A | 1 |
| Farag, MM | 1 |
| Elhadidy, WF | 1 |
| Rashad, RM | 1 |
| Pullaiah, CP | 1 |
| Nelson, VK | 1 |
| Rayapu, S | 1 |
| G V, NK | 1 |
| Kedam, T | 1 |
| Abdelmonem, M | 1 |
| Ibrahim, SM | 1 |
| Essam, RM | 1 |
| Amin, HAA | 1 |
| Abd-Elmawla, MA | 1 |
| Simirgiotis, MJ | 1 |
| Young, L | 1 |
| Thompson, R | 1 |
| Cifuentes, F | 1 |
| Paredes, A | 1 |
| Delgoda, R | 1 |
| Liu, J | 3 |
| Sun, M | 1 |
| Lin, L | 1 |
| Miao, L | 1 |
| Ge, Z | 2 |
| Yang, B | 2 |
| Mahajan, UB | 4 |
| Chandrayan, G | 1 |
| Arya, DS | 16 |
| Suchal, K | 2 |
| Agrawal, YO | 3 |
| Zaki, SM | 1 |
| Abdalla, IL | 1 |
| Sadik, AOE | 1 |
| Mohamed, EA | 1 |
| Kaooh, S | 1 |
| Wei, H | 1 |
| Wan, SP | 1 |
| Zeng, QT | 1 |
| Cheng, LX | 1 |
| Jiang, LL | 1 |
| Peng, YD | 1 |
| Alam, MN | 1 |
| Hossain, MM | 1 |
| Rahman, MM | 2 |
| Subhan, N | 2 |
| Mamun, MAA | 1 |
| Ulla, A | 1 |
| Alam, MA | 2 |
| Althaf Hussain, S | 1 |
| Kareem, MA | 3 |
| Rasool, SN | 3 |
| Al Omar, SY | 1 |
| Saleh, A | 1 |
| Al-Fwuaires, MA | 1 |
| Daddam, JR | 1 |
| Devi, KL | 2 |
| Krushna, GS | 2 |
| Shivaranjani, VL | 1 |
| Umamaheswari, J | 1 |
| Srinivasulu, C | 2 |
| Hussain, SA | 1 |
| Reddy, VD | 1 |
| Ali, D | 1 |
| Lokhande, KB | 1 |
| Swamy, KV | 1 |
| Kodidhela, LD | 2 |
| E, MP | 1 |
| Mopuri, R | 1 |
| Pulaganti, M | 1 |
| Islam, MS | 1 |
| K R, DG | 1 |
| Irene, M | 1 |
| Jia, G | 1 |
| Zao, M | 1 |
| Liu, X | 3 |
| Daoud, A | 1 |
| Ben Mefteh, F | 1 |
| Turki, M | 1 |
| Jmal, S | 1 |
| Ben Amar, R | 1 |
| Ayadi, F | 1 |
| ElFeki, A | 3 |
| Abid, L | 1 |
| Rateb, ME | 1 |
| Belbahri, L | 1 |
| Kadri, A | 2 |
| Gharsallah, N | 5 |
| Tasatargil, A | 1 |
| Kuscu, N | 1 |
| Dalaklioglu, S | 1 |
| Adiguzel, D | 1 |
| Celik-Ozenci, C | 1 |
| Ozdem, S | 2 |
| Barutcigil, A | 1 |
| Jana, S | 1 |
| Patel, D | 1 |
| Patel, S | 1 |
| Upadhyay, K | 1 |
| Thadani, J | 1 |
| Mandal, R | 1 |
| Das, S | 2 |
| Devkar, R | 1 |
| Paul, S | 2 |
| Tanvir, EM | 4 |
| Hossen, MS | 1 |
| Saha, M | 1 |
| Afroz, R | 4 |
| Islam, MA | 1 |
| Hossain, MS | 2 |
| Gan, SH | 4 |
| Ibrahim Khalil, M | 1 |
| Sharmila Queenthy, S | 1 |
| John, B | 2 |
| Wong, ZW | 1 |
| Thanikachalam, PV | 1 |
| Ramamurthy, S | 1 |
| Sözmen, M | 2 |
| Devrim, AK | 2 |
| Kabak, YB | 2 |
| Devrim, T | 2 |
| Sudagidan, M | 2 |
| Nour, MS | 1 |
| Sarhan, NR | 1 |
| Mazroa, SA | 1 |
| Gawish, SA | 1 |
| Tanriverdi, LH | 1 |
| Parlakpinar, H | 1 |
| Ozhan, O | 1 |
| Ermis, N | 1 |
| Polat, A | 1 |
| Vardi, N | 1 |
| Tanbek, K | 1 |
| Yildiz, A | 1 |
| Acet, A | 1 |
| Khan, V | 3 |
| Hassan, MQ | 6 |
| Akhtar, M | 7 |
| Najmi, AK | 7 |
| Hemalatha, KL | 5 |
| Rathinavel, A | 1 |
| Sankar, J | 1 |
| Mohammed Sadullah, SS | 1 |
| Niranjali Devaraj, S | 4 |
| Kadry, MO | 1 |
| Abdel-Megeed, RM | 1 |
| Ivey, MJ | 1 |
| Kuwabara, JT | 1 |
| Pai, JT | 1 |
| Moore, RE | 1 |
| Sun, Z | 1 |
| Tallquist, MD | 1 |
| Cui, XH | 1 |
| Wang, HL | 2 |
| Wu, R | 1 |
| Yao, PA | 1 |
| Wei, KZ | 1 |
| Gao, JP | 1 |
| Cinar, M | 1 |
| Sharma, S | 2 |
| Bhandari, U | 5 |
| Ali, SM | 1 |
| Haque, SE | 6 |
| Darwesh, AM | 1 |
| El-Azab, MF | 1 |
| Abo-Gresha, NM | 2 |
| El-Sayed, NM | 1 |
| Moustafa, YM | 2 |
| Vishwakarma, A | 1 |
| Singh, TU | 1 |
| Rungsung, S | 1 |
| Kumar, T | 1 |
| Kandasamy, A | 1 |
| Parida, S | 1 |
| Lingaraju, MC | 1 |
| Kumar, A | 3 |
| Ashokkumar, R | 1 |
| Jamuna, S | 1 |
| Sakeena Sadullah, MS | 1 |
| Houson, HA | 1 |
| Nkepang, GN | 1 |
| Hedrick, AF | 1 |
| Awasthi, V | 1 |
| Xu, Y | 4 |
| Wu, L | 1 |
| Chen, A | 1 |
| Xu, C | 2 |
| Feng, Q | 1 |
| Li, F | 1 |
| Fan, XX | 1 |
| Chu, C | 1 |
| Kou, JP | 1 |
| Yu, BY | 2 |
| El Agaty, SM | 1 |
| Yu, Y | 1 |
| Jin, L | 1 |
| Zhuang, Y | 1 |
| Cang, J | 1 |
| Guo, K | 1 |
| Imran, M | 2 |
| Rahman, O | 1 |
| Ibrahim, MA | 1 |
| Geddawy, A | 1 |
| Abdel-Wahab, S | 1 |
| Tawfik, MK | 2 |
| El-Kherbetawy, MK | 1 |
| Makary, S | 1 |
| Nahar, K | 1 |
| Kabir, F | 1 |
| Islam, P | 1 |
| Al Mamun, MA | 1 |
| Faruk, M | 1 |
| Bi, F | 1 |
| Sun, Q | 1 |
| Attalla, DM | 1 |
| Zaki, HF | 1 |
| Khattab, MM | 1 |
| Bakir, EM | 2 |
| El Semary, NA | 2 |
| Taneja, G | 1 |
| Nagaich, U | 1 |
| Deep, A | 1 |
| Datusalia, AK | 1 |
| Rajput, SK | 1 |
| Bin-Jaliah, I | 1 |
| Hussein, AM | 1 |
| Sakr, HF | 1 |
| Eid, EA | 1 |
| Allawadhi, P | 1 |
| Khurana, A | 2 |
| Sayed, N | 1 |
| Kumari, P | 2 |
| Godugu, C | 2 |
| Khwaja, S | 1 |
| Mahmood, T | 1 |
| Siddiqui, HH | 1 |
| Laham, F | 2 |
| Al-Taee, H | 1 |
| Jain, PG | 1 |
| Shinde, SD | 1 |
| Surana, SJ | 1 |
| Ali, SS | 1 |
| Mohamed, SFA | 1 |
| Rozalei, NH | 1 |
| Boon, YW | 1 |
| Zainalabidin, S | 1 |
| Tariq, S | 1 |
| Iqbal, R | 1 |
| Jairajpuri, Z | 1 |
| Shahzad, S | 1 |
| Mateen, S | 1 |
| Mubeena Mariyath, PM | 1 |
| Naeem, SS | 1 |
| Akhtar, K | 1 |
| Rizvi, W | 1 |
| Moin, S | 1 |
| Ibrar, M | 1 |
| Khan, MA | 1 |
| Nisar, M | 1 |
| Khan, M | 1 |
| Nabofa, WEE | 1 |
| Alashe, OO | 1 |
| Oyeyemi, OT | 1 |
| Attah, AF | 1 |
| Oyagbemi, AA | 1 |
| Omobowale, TO | 1 |
| Adedapo, AA | 1 |
| Alada, ARA | 1 |
| Sharma, N | 1 |
| Rishi, V | 1 |
| Erten, M | 1 |
| Çimenci, İG | 1 |
| Kuloğlu, T | 2 |
| Kalaycı, M | 2 |
| Erten, F | 1 |
| Saranya, S | 1 |
| Baskaran, R | 1 |
| Poornima, P | 2 |
| Vijaya Padma, V | 1 |
| Feng, L | 1 |
| Ren, J | 1 |
| Yang, G | 1 |
| Kang, L | 1 |
| Yang, L | 1 |
| Qi, Z | 1 |
| Guo, X | 1 |
| Han, Y | 1 |
| Tian, E | 1 |
| Iqubal, A | 1 |
| Ekbbal, R | 1 |
| Verma, VK | 1 |
| Malik, S | 2 |
| Narayanan, SP | 1 |
| Mutneja, E | 1 |
| Sahu, AK | 1 |
| Bhatia, J | 5 |
| Shaikh, S | 1 |
| Bhatt, LK | 1 |
| Barve, K | 1 |
| Çetin, E | 1 |
| Ishizue, N | 1 |
| Niwano, S | 1 |
| Niwano, H | 1 |
| Oikawa, J | 1 |
| Nakamura, H | 1 |
| Hashikata, T | 1 |
| Igarashi, T | 1 |
| Fujiishi, T | 1 |
| Yoshizawa, T | 1 |
| Kishihara, J | 1 |
| Satoh, A | 1 |
| Fukaya, H | 1 |
| Ako, J | 1 |
| Ghartavol, MM | 1 |
| Gholizadeh-Ghaleh Aziz, S | 1 |
| Babaei, G | 1 |
| Hossein Farjah, G | 1 |
| Hassan Khadem Ansari, M | 1 |
| Geng, J | 1 |
| Han, S | 1 |
| Zhu, C | 1 |
| Li, W | 2 |
| Wang, X | 3 |
| Xue, J | 1 |
| Zhao, L | 1 |
| Zhou, T | 1 |
| Ding, M | 1 |
| Guan, L | 1 |
| Yang, P | 1 |
| Yang, H | 1 |
| Radhiga, T | 3 |
| Senthil, S | 2 |
| Sundaresan, A | 2 |
| Pugalendi, KV | 5 |
| Ardjmand, A | 2 |
| Shahaboddin, ME | 2 |
| Mazoochi, T | 2 |
| Ghavipanjeh, G | 2 |
| Dejea, H | 1 |
| Garcia-Canadilla, P | 1 |
| Cook, AC | 1 |
| Guasch, E | 1 |
| Zamora, M | 1 |
| Crispi, F | 1 |
| Stampanoni, M | 1 |
| Bijnens, B | 1 |
| Bonnin, A | 1 |
| Singh, PK | 1 |
| Gari, M | 1 |
| Choudhury, S | 1 |
| Shukla, A | 1 |
| Gangwar, N | 1 |
| Garg, SK | 1 |
| Ameen, AM | 1 |
| Heydari, A | 1 |
| Boarescu, PM | 1 |
| Chirilă, I | 1 |
| Bulboacă, AE | 1 |
| Bocșan, IC | 1 |
| Pop, RM | 1 |
| Gheban, D | 1 |
| Bolboacă, SD | 1 |
| Barros Ferreira, AK | 1 |
| da Silva, JCG | 1 |
| Ferreira Costa, CD | 1 |
| Smaniotto, S | 1 |
| de Araújo-Júnior, JX | 1 |
| Silva Júnior, EF | 1 |
| Bortoluzzi, JH | 1 |
| Nogueira Ribeiro, ÊA | 1 |
| Khorrami, A | 6 |
| Maleki-Dizaji, N | 6 |
| Pipaliya, H | 1 |
| Vaghasiya, J | 1 |
| Richards, DA | 1 |
| Bao, W | 1 |
| Rambo, MV | 1 |
| Burgert, M | 1 |
| Jucker, BM | 1 |
| Lenhard, SC | 1 |
| Prince, PS | 18 |
| Savergnini, SQ | 1 |
| Ianzer, D | 1 |
| Carvalho, MB | 1 |
| Ferreira, AJ | 3 |
| Silva, GA | 2 |
| Marques, FD | 2 |
| Peluso, AA | 1 |
| Beiman, M | 1 |
| Cojocaru, G | 1 |
| Cohen, Y | 1 |
| Almeida, AP | 2 |
| Rotman, G | 1 |
| Santos, RA | 3 |
| Aman, U | 1 |
| Vaibhav, P | 1 |
| Balaraman, R | 6 |
| Roy, AJ | 1 |
| Mohan, M | 2 |
| Rokade, R | 1 |
| Kasturet, S | 1 |
| Wang, YQ | 1 |
| Zhang, JQ | 1 |
| Liu, CH | 1 |
| Zhu, DN | 1 |
| Ojha, SK | 3 |
| Sharma, C | 3 |
| Golechha, MJ | 1 |
| Kumari, S | 9 |
| Fan, Q | 1 |
| Chen, M | 1 |
| Zuo, L | 1 |
| Shang, X | 1 |
| Huang, MZ | 1 |
| Ciccarelli, M | 2 |
| Raake, P | 1 |
| Brinks, H | 1 |
| Chuprun, KJ | 1 |
| Dorn, GW | 1 |
| Koch, WJ | 5 |
| Gao, E | 4 |
| Moltzau, LR | 1 |
| Aronsen, JM | 2 |
| Meier, S | 1 |
| Nguyen, CH | 1 |
| Hougen, K | 1 |
| Ørstavik, Ø | 1 |
| Sjaastad, I | 7 |
| Christensen, G | 2 |
| Skomedal, T | 5 |
| Osnes, JB | 4 |
| Levy, FO | 4 |
| Qvigstad, E | 4 |
| Suchalatha, S | 3 |
| Wei, B | 1 |
| You, MG | 1 |
| Ling, JJ | 1 |
| Wei, LL | 1 |
| Li, WW | 1 |
| Chen, T | 1 |
| Du, QM | 1 |
| Ji, H | 1 |
| Ghanbarzadeh, S | 2 |
| Andalib, S | 2 |
| Queenthy, SS | 1 |
| Liu, YT | 3 |
| Jia, HM | 3 |
| Chang, X | 3 |
| Ding, G | 2 |
| Zhang, HW | 2 |
| Zou, ZM | 3 |
| Yousefi, K | 1 |
| Fathiazad, F | 1 |
| Hamedeyazdan, S | 1 |
| Poliachenko, IuV | 1 |
| Habriielian, AV | 1 |
| Domans'kyĭ, TM | 1 |
| Smorzhevskyĭ, VĬ | 1 |
| Onishchenko, VF | 1 |
| Mazur, AP | 1 |
| Romanova, SV | 1 |
| Kudlaĭ, IV | 1 |
| Iakushev, AV | 1 |
| Klymenko, PP | 1 |
| Kuchuk, OV | 1 |
| Kyryk, VM | 1 |
| Kuchma, MD | 1 |
| Lobyntseva, HS | 1 |
| Saliutin, RV | 1 |
| Shabliĭ, VA | 1 |
| Cheng, WH | 1 |
| Cai, DY | 1 |
| Shukla, SK | 2 |
| Sharma, SB | 2 |
| Singh, UR | 2 |
| Ahmad, S | 1 |
| Maheshwari, A | 1 |
| Misro, M | 1 |
| Dwivedi, S | 1 |
| Al-Rasheed, NM | 2 |
| Attia, HA | 1 |
| Mohamed, RA | 1 |
| Al-Amin, MA | 1 |
| Kim, JH | 2 |
| Chung, HS | 1 |
| Antonisamy, P | 1 |
| Lee, SR | 1 |
| Bae, H | 1 |
| Ziaee, M | 1 |
| Arami, S | 1 |
| Joukar, S | 2 |
| Najafipour, H | 2 |
| Dabiri, S | 2 |
| Sheibani, M | 2 |
| Sharokhi, N | 1 |
| Lim, KH | 1 |
| Cho, JY | 1 |
| Kim, B | 1 |
| Bae, BS | 1 |
| Hu, X | 1 |
| Fu, W | 1 |
| Xie, J | 1 |
| Zhou, X | 1 |
| Shrestha, A | 1 |
| Krishnamurthy, PT | 1 |
| Thomas, P | 1 |
| Hammock, BD | 1 |
| Hwang, SH | 1 |
| Panasiuk, OS | 1 |
| Shysh, AM | 1 |
| Moĭbenko, OO | 1 |
| Sahu, BD | 1 |
| Anubolu, H | 1 |
| Koneru, M | 1 |
| Kumar, JM | 1 |
| Kuncha, M | 1 |
| Rachamalla, SS | 1 |
| Sistla, R | 1 |
| Clanachan, AS | 1 |
| Rameshrad, M | 2 |
| Ghazi-Khansari, M | 1 |
| Evran, B | 1 |
| Karpuzoğlu, H | 1 |
| Develi, S | 1 |
| Kalaz, EB | 1 |
| Soluk-Tekkeşin, M | 1 |
| Olgaç, V | 1 |
| Doğru-Abbasoğlu, S | 1 |
| Uysal, M | 1 |
| Aydin, S | 2 |
| Yilmaz, M | 1 |
| Çakmak, T | 1 |
| Eren, MN | 1 |
| Sener, MT | 1 |
| Karakus, E | 2 |
| Akpinar, E | 1 |
| Topcu, A | 1 |
| Kok, AN | 1 |
| Sharma, PK | 1 |
| Shrivastava, B | 1 |
| Wang, HJ | 1 |
| Wang, W | 1 |
| Cornish, KG | 1 |
| Rozanski, GJ | 1 |
| Zucker, IH | 1 |
| Toldo, S | 1 |
| Mezzaroma, E | 1 |
| Bressi, E | 1 |
| Marchetti, C | 1 |
| Carbone, S | 1 |
| Sonnino, C | 1 |
| Van Tassell, BW | 1 |
| Abbate, A | 1 |
| İlhan, S | 2 |
| Yılmaz, N | 1 |
| Nacar, E | 1 |
| Motor, S | 1 |
| Oktar, S | 2 |
| Şahna, E | 1 |
| Zheng, P | 3 |
| Mai, S | 1 |
| Dai, G | 3 |
| Alirezaei, M | 1 |
| Delfan, B | 1 |
| Dezfoulian, O | 1 |
| Kheradmand, A | 1 |
| Divekan, H | 1 |
| Rashidipour, M | 1 |
| Khonsari, A | 1 |
| Mohamed, AR | 1 |
| El-Hadidy, WF | 1 |
| Mannaa, HF | 1 |
| Rayabarapu, N | 1 |
| Patel, BM | 1 |
| Ansari, SH | 1 |
| Hammami, M | 1 |
| Garjani, M | 1 |
| Song, B | 1 |
| Liu, Y | 2 |
| Parman, T | 1 |
| Miller, JK | 1 |
| Tanga, MJ | 1 |
| Mirsalis, J | 1 |
| Zhao, XM | 1 |
| Zhao, B | 1 |
| Han, JJ | 1 |
| Qin, SC | 1 |
| Sun, XJ | 1 |
| Brindha, E | 1 |
| Rajasekapandiyan, M | 1 |
| Kikuchi, C | 1 |
| Bienengraeber, M | 1 |
| Canfield, S | 1 |
| Koopmeiner, A | 1 |
| Schäfer, R | 1 |
| Bosnjak, ZJ | 1 |
| Bai, X | 1 |
| Jacobs, G | 1 |
| Oosterlinck, W | 1 |
| Dresselaers, T | 1 |
| Geenens, R | 1 |
| Kerselaers, S | 1 |
| Himmelreich, U | 1 |
| Herijgers, P | 1 |
| Vennekens, R | 1 |
| Fernandes, AA | 1 |
| Ribeiro, RF | 1 |
| de Moura, VG | 1 |
| Siman, FD | 1 |
| Dias, FM | 1 |
| Zoghaib, J | 1 |
| Vassallo, PF | 1 |
| Vassallo, DV | 4 |
| Stefanon, I | 4 |
| Korkmaz, S | 2 |
| Atmanli, A | 1 |
| Li, S | 1 |
| Radovits, T | 2 |
| Hegedűs, P | 1 |
| Barnucz, E | 2 |
| Hirschberg, K | 2 |
| Loganathan, S | 2 |
| Yoshikawa, Y | 1 |
| Yasui, H | 1 |
| Karck, M | 2 |
| Szabó, G | 2 |
| Garg, V | 1 |
| Taylor, T | 1 |
| Warren, M | 1 |
| Venable, P | 1 |
| Sciuto, K | 1 |
| Shibayama, J | 1 |
| Zaitsev, A | 1 |
| Jagadeesh, GS | 4 |
| Selvaraj, P | 4 |
| Otsuki, Y | 1 |
| Nakamura, Y | 1 |
| Harada, S | 1 |
| Yamamoto, Y | 1 |
| Ogino, K | 1 |
| Morikawa, K | 1 |
| Ninomiya, H | 1 |
| Miyagawa, S | 1 |
| Sawa, Y | 1 |
| Hisatome, I | 2 |
| Nishimura, M | 1 |
| Anandan, R | 9 |
| Chatterjee, NS | 1 |
| Sivakumar, R | 4 |
| Mathew, S | 9 |
| Asha, KK | 1 |
| Ganesan, B | 4 |
| Kay, M | 1 |
| Kuzmiak-Glancy, S | 1 |
| Rogers, J | 1 |
| Dianita, R | 2 |
| Jantan, I | 2 |
| Amran, AZ | 2 |
| Jalil, J | 1 |
| Svennerholm, K | 1 |
| Haney, M | 1 |
| Biber, B | 1 |
| Ulfhammer, E | 1 |
| Saluveer, O | 1 |
| Larsson, P | 1 |
| Omerovic, E | 2 |
| Jern, S | 1 |
| Bergh, N | 1 |
| Derbali, F | 4 |
| Khlif, I | 2 |
| Kraiem, F | 2 |
| Ellefi, H | 3 |
| Buang, F | 1 |
| Derbali, A | 1 |
| Affes, M | 1 |
| El Feki, A | 1 |
| Michel, T | 1 |
| Halabalaki, M | 1 |
| Skaltsounis, AL | 1 |
| Khalil, MI | 3 |
| Sulaiman, SA | 1 |
| Variya, BC | 1 |
| Patel, SS | 1 |
| Trivedi, JI | 1 |
| Gandhi, HP | 1 |
| Rathod, SP | 1 |
| Buwa, CC | 1 |
| Geng, ZH | 1 |
| Song, MB | 1 |
| Song, YM | 1 |
| Tse, HF | 1 |
| Le, XC | 1 |
| Rong, J | 1 |
| Deng, XY | 1 |
| Chen, JJ | 1 |
| Li, HY | 1 |
| Ma, ZQ | 1 |
| Ma, SP | 1 |
| Fu, Q | 1 |
| Gammoudi, A | 1 |
| Khabbabi, G | 1 |
| Ahmed, S | 3 |
| Gul, S | 1 |
| Ze Jaafar, H | 1 |
| Zia-Ul-Haq, M | 1 |
| Dima, L | 1 |
| Asadipour, H | 1 |
| Ahmmed, I | 1 |
| Ahmed, R | 1 |
| Alam, N | 2 |
| El-Mahdy, N | 1 |
| Salem, ML | 1 |
| El-Sayad, M | 1 |
| El-Desouky, KI | 1 |
| Zaghow, N | 1 |
| Zhao, W | 1 |
| Ruan, H | 1 |
| Lakomkin, VL | 1 |
| Abramov, AA | 1 |
| Lukoshkova, EV | 1 |
| Lakomkin, SV | 1 |
| Gramovich, VV | 1 |
| Vyborov, ON | 1 |
| Undrovinas, NA | 1 |
| Ermishkin, VV | 1 |
| Tsyplenkova, VG | 1 |
| Shirinsky, VP | 1 |
| Kapelko, VI | 1 |
| Kavitha, S | 1 |
| John, F | 3 |
| Indira, M | 1 |
| Kocak, C | 1 |
| Kocak, FE | 1 |
| Akcilar, R | 1 |
| Isiklar, OO | 1 |
| Kocak, H | 1 |
| Bayat, Z | 1 |
| Simsek, H | 1 |
| Taser, F | 1 |
| Altuntas, I | 1 |
| Canan, BD | 1 |
| Haizlip, KM | 1 |
| Monasky, MM | 1 |
| Hiranandani, N | 1 |
| Milani-Nejad, N | 1 |
| Varian, KD | 1 |
| Slabaugh, JL | 1 |
| Schultz, EJ | 1 |
| Fedorov, VV | 1 |
| Billman, GE | 5 |
| Janssen, PM | 1 |
| Ghoneim, MA | 1 |
| Hassan, AI | 1 |
| Mahmoud, MG | 1 |
| Asker, MS | 1 |
| Hass, C | 1 |
| Panda, BP | 1 |
| Khanam, R | 1 |
| Song, F | 1 |
| Duan, LR | 1 |
| Sheng, JJ | 1 |
| Xie, YH | 2 |
| Dong, QQ | 1 |
| Zhang, BL | 2 |
| Wang, SW | 2 |
| Laddha, A | 1 |
| Nandave, M | 3 |
| Srinath, S | 1 |
| Khodeer, DM | 1 |
| Zaitone, SA | 2 |
| Farag, NE | 1 |
| Garg, M | 1 |
| Khanna, D | 1 |
| Kalra, S | 1 |
| Balakumar, P | 1 |
| Abbas, AM | 1 |
| Song, Q | 1 |
| Chu, X | 1 |
| Bao, Y | 2 |
| Guo, H | 1 |
| Liu, H | 2 |
| Chu, L | 1 |
| Zheng, H | 1 |
| Sharma, NM | 1 |
| Patel, KP | 1 |
| Karim, N | 1 |
| Zhou, C | 1 |
| Kumar, M | 1 |
| Kasala, ER | 1 |
| Bodduluru, LN | 1 |
| Kumar, V | 2 |
| Lahkar, M | 1 |
| Patel, P | 1 |
| Parikh, M | 1 |
| Shah, H | 1 |
| Gandhi, T | 1 |
| Akila, P | 1 |
| Smith, SB | 1 |
| Novitskaya, T | 1 |
| Chepurko, E | 1 |
| Pu, XA | 1 |
| Wheeler, DG | 1 |
| Ziolo, M | 1 |
| Gumina, RJ | 1 |
| Gamad, N | 1 |
| Malhotra, RK | 1 |
| Vettel, C | 1 |
| Lindner, M | 1 |
| Dewenter, M | 1 |
| Lorenz, K | 1 |
| Schanbacher, C | 1 |
| Riedel, M | 1 |
| Lämmle, S | 1 |
| Meinecke, S | 1 |
| Mason, FE | 1 |
| Sossalla, S | 1 |
| Geerts, A | 1 |
| Hoffmann, M | 1 |
| Wunder, F | 1 |
| Brunner, FJ | 1 |
| Wieland, T | 1 |
| Mehel, H | 1 |
| Karam, S | 1 |
| Lechêne, P | 1 |
| Leroy, J | 1 |
| Vandecasteele, G | 1 |
| Wagner, M | 1 |
| Fischmeister, R | 1 |
| El-Armouche, A | 1 |
| Othman, AI | 1 |
| Elkomy, MM | 1 |
| El-Missiry, MA | 1 |
| Dardor, M | 1 |
| Priya, LB | 1 |
| Chirayil, HT | 1 |
| Sathiskumar, S | 1 |
| Padma, VV | 5 |
| El-Gohary, OA | 1 |
| Panda, VS | 2 |
| Naik, SR | 2 |
| Devika, PT | 7 |
| Suman, S | 1 |
| Vaithianathan, M | 1 |
| Wei, M | 1 |
| Zhu, W | 1 |
| Han, B | 2 |
| Genade, S | 1 |
| Genis, A | 1 |
| Ytrehus, K | 1 |
| Huisamen, B | 1 |
| Lochner, A | 3 |
| Ansari, MN | 2 |
| Islam, F | 1 |
| Anandh Babu, PV | 1 |
| Shyamaladevi, CS | 2 |
| Rajadurai, M | 9 |
| Arora, S | 4 |
| Mehra, RD | 1 |
| Joshi, S | 6 |
| Narang, R | 1 |
| Upaganlawar, A | 2 |
| Gandhi, C | 1 |
| Asai, M | 1 |
| Tsukamoto, O | 1 |
| Minamino, T | 1 |
| Asanuma, H | 1 |
| Fujita, M | 1 |
| Asano, Y | 1 |
| Takahama, H | 1 |
| Sasaki, H | 1 |
| Higo, S | 1 |
| Asakura, M | 1 |
| Takashima, S | 1 |
| Hori, M | 1 |
| Kitakaze, M | 1 |
| Padmanabhan, M | 2 |
| Gao, HC | 1 |
| Ren, LQ | 1 |
| Yu, XY | 1 |
| Sun, B | 1 |
| Miao, CS | 1 |
| Shi, Y | 1 |
| Li, XJ | 1 |
| Wang, D | 1 |
| Priscilla, DH | 2 |
| Hussain, RI | 2 |
| Birkeland, JA | 3 |
| Eikemo, H | 1 |
| Glende, A | 1 |
| Krobert, KA | 2 |
| Prabhu, S | 4 |
| Narayan, S | 1 |
| Devi, CS | 10 |
| Jayachandran, KS | 2 |
| Vasanthi, HR | 2 |
| Rajamanickam, GV | 1 |
| Sangeetha, T | 5 |
| Darlin Quine, S | 3 |
| Buddhan, S | 2 |
| AnbinEzhilan, R | 1 |
| Keles, MS | 3 |
| Bayir, Y | 3 |
| Suleyman, H | 2 |
| Tiwari, R | 1 |
| Kasture, S | 1 |
| Maxia, A | 1 |
| Ballero, M | 1 |
| Nivethetha, M | 1 |
| Jayasri, J | 1 |
| Brindha, P | 1 |
| Jeyakumar, R | 1 |
| Ma, Y | 1 |
| Cheng, WT | 1 |
| Wu, S | 1 |
| Wong, TM | 1 |
| Wang, SB | 3 |
| Tian, S | 1 |
| Yang, F | 1 |
| Yang, HG | 1 |
| Yang, XY | 1 |
| Du, GH | 2 |
| Priscilla, H | 1 |
| Ribeiro, DA | 2 |
| Buttros, JB | 2 |
| Oshima, CT | 1 |
| Bergamaschi, CT | 2 |
| Campos, RR | 2 |
| Fracalossi, AC | 1 |
| Kubavat, JB | 1 |
| Asdaq, SM | 3 |
| Zhang, HY | 2 |
| Chen, X | 4 |
| Hu, P | 1 |
| Liang, QL | 2 |
| Liang, XP | 2 |
| Wang, YM | 2 |
| Luo, GA | 2 |
| Shan, H | 1 |
| Pan, Z | 1 |
| Zhang, F | 1 |
| Dong, D | 1 |
| Song, W | 1 |
| Qiao, G | 1 |
| N, SR | 1 |
| Punithavathi, VR | 2 |
| Yoo, B | 1 |
| Lemaire, A | 1 |
| Mangmool, S | 1 |
| Wolf, MJ | 1 |
| Curcio, A | 1 |
| Mao, L | 1 |
| Rockman, HA | 1 |
| Goyal, S | 3 |
| Mittal, R | 1 |
| Nag, TC | 1 |
| Ray, R | 2 |
| Neugebauer, P | 1 |
| Veres, G | 1 |
| Páli, S | 1 |
| Seidel, B | 1 |
| Zöllner, S | 1 |
| Frederico, MJ | 1 |
| Justo, SL | 1 |
| Da Luz, G | 1 |
| Da Silva, S | 1 |
| Medeiros, C | 1 |
| Barbosa, VA | 1 |
| Silva, LA | 1 |
| Boeck, CR | 1 |
| De Pinho, RA | 1 |
| De Souza, CT | 1 |
| Béguin, PC | 1 |
| El-Helou, V | 3 |
| Assimakopoulos, J | 1 |
| Clément, R | 2 |
| Gosselin, H | 3 |
| Brugada, R | 1 |
| Villeneuve, L | 3 |
| Rohlicek, CV | 1 |
| Del Duca, D | 1 |
| Lapointe, N | 1 |
| Rouleau, JL | 1 |
| Calderone, A | 3 |
| Albayrak, F | 1 |
| Kabalar, E | 2 |
| Bayram, E | 1 |
| Ozturk, C | 1 |
| Kurt, M | 1 |
| Bakan, E | 1 |
| Saravanan, R | 1 |
| Shanmugam, A | 1 |
| Mladenka, P | 2 |
| Hrdina, R | 2 |
| Bobrovová, Z | 1 |
| Semecky, V | 2 |
| Vávrová, J | 2 |
| Holecková, M | 2 |
| Palicka, V | 2 |
| Mazurová, Y | 1 |
| Nachtigal, P | 1 |
| Heather, LC | 1 |
| Catchpole, AF | 1 |
| Stuckey, DJ | 1 |
| Cole, MA | 1 |
| Carr, CA | 1 |
| Clarke, K | 1 |
| Inamdar, MN | 1 |
| Asad, M | 1 |
| Babu, PV | 1 |
| Kalaiselvi, P | 1 |
| Kumaran, KS | 2 |
| Panicker, S | 2 |
| Swathy, SS | 2 |
| Madambath, I | 1 |
| Mukherjee, D | 1 |
| Roy, SG | 1 |
| Bandyopadhyay, A | 1 |
| Chattopadhyay, A | 2 |
| Basu, A | 1 |
| Mitra, E | 1 |
| Ghosh, AK | 1 |
| Reiter, RJ | 1 |
| Bandyopadhyay, D | 2 |
| Abhilash, PA | 1 |
| Nisha, P | 1 |
| Prathapan, A | 1 |
| Nampoothiri, SV | 1 |
| Lijo Cherian, O | 1 |
| Sunitha, TK | 1 |
| Raghu, KG | 1 |
| Jadeja, RN | 1 |
| Thounaojam, MC | 1 |
| Patel, DK | 1 |
| Devkar, RV | 1 |
| Ramachandran, AV | 1 |
| Zhou, R | 3 |
| Yan, L | 2 |
| Wu, Y | 1 |
| Xiao, X | 1 |
| Patel, V | 2 |
| Zalawadia, R | 1 |
| Kawabata, K | 1 |
| Fujioka, D | 1 |
| Kobayashi, T | 1 |
| Saito, Y | 1 |
| Obata, JE | 1 |
| Nakamura, T | 1 |
| Yano, T | 1 |
| Watanabe, K | 1 |
| Watanabe, Y | 1 |
| Mishina, H | 1 |
| Kugiyama, K | 1 |
| Thomes, P | 1 |
| Rajendran, M | 1 |
| Pasanban, B | 1 |
| Rengasamy, R | 1 |
| Aydin, M | 1 |
| Yönden, Z | 1 |
| Alçin, E | 1 |
| Nacar, A | 1 |
| Hanafy, S | 1 |
| El-Kadi, AO | 1 |
| Jamali, F | 1 |
| Akinmoladun, AC | 1 |
| Obuotor, EM | 1 |
| Barthwal, MK | 1 |
| Dikshit, M | 1 |
| Farombi, EO | 1 |
| Rajamanickama, GV | 1 |
| Panda, S | 1 |
| Kar, A | 1 |
| Dhanasekar, K | 1 |
| Rajakumar, S | 1 |
| Song, H | 1 |
| Hwang, HJ | 1 |
| Chang, W | 1 |
| Song, BW | 1 |
| Cha, MJ | 1 |
| Kim, IK | 1 |
| Lim, S | 1 |
| Choi, EJ | 1 |
| Ham, O | 1 |
| Lee, CY | 1 |
| Park, JH | 1 |
| Lee, SY | 1 |
| Choi, E | 1 |
| Lee, C | 1 |
| Lee, M | 1 |
| Lee, MH | 1 |
| Kim, SH | 1 |
| Jang, Y | 1 |
| Hwang, KC | 1 |
| Periasamy, S | 2 |
| Chen, SY | 2 |
| Hsu, DZ | 1 |
| Liu, MY | 2 |
| Hasić, S | 2 |
| Jadrić, R | 2 |
| Kiseljaković, E | 2 |
| Valjevac, A | 1 |
| Mornjaković, Z | 2 |
| Winterhalter-Jadrić, M | 2 |
| M, I | 1 |
| Sinisterra, RD | 1 |
| Jacoby, BA | 1 |
| Sousa, FB | 1 |
| Caliari, MV | 1 |
| Melo, MB | 2 |
| Nadu, AP | 1 |
| Souza, LE | 1 |
| Irigoyen, MC | 1 |
| Kannan, MM | 2 |
| Quine, SD | 4 |
| Bharti, S | 1 |
| Rani, N | 1 |
| Mo, FE | 1 |
| Chang, CC | 1 |
| Meng, Q | 1 |
| Li, Q | 1 |
| Bi, Y | 1 |
| Jiang, N | 1 |
| Basha, RH | 1 |
| Al-Numair, KS | 1 |
| Chandramohan, G | 2 |
| Alsaif, MA | 2 |
| Mari Kannan, M | 1 |
| Sudheesh, NP | 1 |
| Ajith, TA | 1 |
| Janardhanan, KK | 1 |
| He, LF | 1 |
| Li, YJ | 1 |
| Shen, Y | 1 |
| Chao, RB | 1 |
| Du, JR | 1 |
| Hidhayath Basha, R | 1 |
| Belevych, AE | 1 |
| Terentyev, D | 1 |
| Terentyeva, R | 1 |
| Ho, HT | 1 |
| Gyorke, I | 1 |
| Bonilla, IM | 1 |
| Carnes, CA | 1 |
| Györke, S | 1 |
| Ramos, GC | 1 |
| Dalbó, S | 1 |
| Leite, DP | 1 |
| Goldfeder, E | 1 |
| Carvalho, CR | 1 |
| Vaz, NM | 1 |
| Assreuy, J | 1 |
| Haleagrahara, N | 1 |
| Chakravarthi, S | 1 |
| Mathews, L | 1 |
| Råmunddal, T | 1 |
| Lindbom, M | 1 |
| Täng, MS | 1 |
| Shao, Y | 1 |
| Borén, J | 1 |
| Rajamanickam, C | 2 |
| Ezhumalai, M | 1 |
| Xie, YY | 1 |
| Zhang, RL | 1 |
| Gao, R | 1 |
| Cheng, YJ | 1 |
| Wu, J | 2 |
| Xu, QB | 1 |
| Xiao, QZ | 1 |
| Lv, SF | 1 |
| Fan, XM | 1 |
| Zhang, QL | 1 |
| Albayrak, A | 1 |
| Ferah, I | 1 |
| Keles, O | 1 |
| Unal, B | 1 |
| Al Numair, KS | 1 |
| Baskar, AA | 1 |
| Vaseghi, M | 1 |
| Lux, RL | 1 |
| Mahajan, A | 1 |
| Shivkumar, K | 1 |
| Vijayan, NA | 1 |
| Thiruchenduran, M | 1 |
| Devaraj, SN | 2 |
| Shaik, AH | 1 |
| Vikram Kumar Reddy, A | 1 |
| Abdul Kareem, M | 2 |
| Saayi Krushna, G | 1 |
| Lakshmi Devi, K | 1 |
| Liang, X | 1 |
| Luo, G | 1 |
| Gong, LL | 1 |
| Fang, LH | 1 |
| Sun, JL | 1 |
| Qin, HL | 1 |
| Li, XX | 1 |
| Pogula, BK | 1 |
| Maharajan, MK | 1 |
| Oddepalli, DR | 1 |
| Boini, L | 1 |
| Arella, M | 1 |
| Sabarimuthu, DQ | 1 |
| Zatloukalová, L | 1 |
| Filipský, T | 1 |
| Macáková, K | 1 |
| Dias-Peixoto, MF | 1 |
| Almeida, PW | 1 |
| Braga, VB | 1 |
| Coutinho, DC | 1 |
| Melo, DS | 1 |
| Gomes Filho, A | 1 |
| Greco, L | 1 |
| Campagnole-Santos, MJ | 1 |
| Lima, RF | 1 |
| Guatimosim, S | 2 |
| Guo, J | 1 |
| Li, HZ | 1 |
| Wang, LC | 1 |
| Zhang, WH | 1 |
| Li, GW | 1 |
| Xing, WJ | 1 |
| Wang, R | 1 |
| Xu, CQ | 1 |
| Sun, X | 1 |
| Yerong, Y | 1 |
| Shuyuan, L | 1 |
| Yang, W | 1 |
| Salie, R | 1 |
| Moolman, JA | 2 |
| Krishnamurthy, M | 1 |
| Selvaraju, M | 1 |
| Tamilarasan, M | 1 |
| Hussain Shaik, A | 1 |
| Akhtar, PM | 1 |
| Meeran, MF | 1 |
| Salimeh, A | 1 |
| Rashidi, B | 1 |
| Ramadan, G | 1 |
| El-Beih, NM | 1 |
| Arafa, NM | 1 |
| Zahra, MM | 1 |
| Goldstein, S | 1 |
| Ge, J | 1 |
| He, B | 1 |
| Ruiz, G | 1 |
| Farajnia, S | 1 |
| Khani, S | 1 |
| Banani, A | 1 |
| Wang, JB | 1 |
| Cao, W | 1 |
| Bi, LL | 1 |
| Sun, JY | 1 |
| Miao, S | 1 |
| Hu, J | 1 |
| Zhou, XX | 1 |
| Qiu, PC | 1 |
| Jyoti Roy, A | 1 |
| Mainzen Prince, PS | 3 |
| Afzal, F | 1 |
| Lalitha, G | 1 |
| Archanah, A | 1 |
| Hagar, HH | 1 |
| Min, JY | 4 |
| Sullivan, MF | 2 |
| Yan, X | 1 |
| Feng, X | 1 |
| Chu, V | 2 |
| Wang, JF | 2 |
| Amende, I | 2 |
| Morgan, JP | 4 |
| Philipson, KD | 2 |
| Hampton, TG | 2 |
| Reiken, S | 1 |
| Gaburjakova, M | 1 |
| Gomez, AM | 1 |
| D'Armiento, J | 1 |
| Burkhoff, D | 1 |
| Vassort, G | 2 |
| Lederer, WJ | 1 |
| Marks, AR | 2 |
| Brouri, F | 1 |
| Findji, L | 2 |
| Mediani, O | 2 |
| Mougenot, N | 2 |
| Hanoun, N | 1 |
| Le Naour, G | 1 |
| Hamon, M | 1 |
| Lechat, P | 2 |
| Biswas, S | 1 |
| Sarkar, C | 1 |
| Datta, AG | 1 |
| Saraiva, RM | 1 |
| Chedid, NG | 1 |
| Quintero H, CC | 1 |
| Díaz G, LE | 1 |
| Masuda, MO | 1 |
| Adamson, PB | 1 |
| Vanoli, E | 1 |
| Shibano, T | 1 |
| Foreman, RD | 1 |
| Schwartz, PJ | 2 |
| Liu, XY | 1 |
| Wang, YY | 1 |
| Chen, SZ | 1 |
| Li, CL | 1 |
| Carbajal, D | 1 |
| Noa, M | 1 |
| Molina, V | 1 |
| Arruzazabala, ML | 1 |
| Más, R | 1 |
| Mendoza, S | 1 |
| González, J | 1 |
| Sethi, R | 4 |
| Dhalla, NS | 5 |
| Ebenezar, KK | 3 |
| Sathish, V | 3 |
| Devaki, T | 7 |
| Acikel, M | 2 |
| Buyukokuroglu, ME | 2 |
| Aksoy, H | 2 |
| Erdogan, F | 2 |
| Erol, MK | 1 |
| SOLARZ, SD | 1 |
| BERKSON, DM | 1 |
| PICK, A | 1 |
| RONA, G | 10 |
| CHAPPEL, CI | 6 |
| BALAZS, T | 4 |
| GAUDRY, R | 3 |
| GALE, HH | 1 |
| ENFROY, HL | 1 |
| VOGEL, JH | 1 |
| FABRE, J | 1 |
| RUDHARDT, M | 1 |
| MICHEL, B | 1 |
| LACOURT, G | 1 |
| JEANDET, J | 1 |
| HANDFORTH, CP | 1 |
| KAHN, DS | 5 |
| ZBINDEN, G | 2 |
| AMELIN, AZ | 2 |
| ANSHELEVICH, IuV | 2 |
| MELZOBS, MIa | 2 |
| HADEN, RF | 1 |
| LANGSJOEN, PH | 1 |
| RAPOPORT, MI | 1 |
| MCNERNEY, JJ | 1 |
| PRIORESCHI, P | 1 |
| BAGDON, RE | 1 |
| GADBOYS, HL | 1 |
| WISOFF, G | 1 |
| LITWAK, RS | 1 |
| FERRANS, VJ | 1 |
| HIBBS, RG | 1 |
| BLACK, WC | 1 |
| WEILBAECHER, DG | 1 |
| LILLEHEI, CW | 1 |
| LEVY, MJ | 1 |
| BONNABEAU, RC | 1 |
| LONG, DM | 1 |
| SELLERS, RD | 1 |
| SCHUERHOLZ, K | 1 |
| FOLDENAUER, A | 1 |
| STUMPF, P | 1 |
| BOEHM, P | 1 |
| SAKAMOTO, T | 1 |
| KUSUKAWA, R | 1 |
| MACCANON, DM | 1 |
| LUISADA, AA | 1 |
| MACLEAN, LD | 2 |
| DUFF, JH | 2 |
| SCOTT, HM | 1 |
| PERETZ, DI | 1 |
| WEXLER, BC | 37 |
| KITTINGER, GW | 3 |
| DUSEK, J | 2 |
| JEZDINSKA, V | 1 |
| HERON, JR | 1 |
| ANDERSON, EG | 1 |
| NOBLE, IM | 1 |
| STRUBELT, O | 1 |
| BREINING, H | 1 |
| SELYE, H | 1 |
| VEILLEUX, R | 1 |
| GRASSO, S | 1 |
| Takahashi, T | 1 |
| Anzai, T | 1 |
| Yoshikawa, T | 1 |
| Maekawa, Y | 1 |
| Mahara, K | 1 |
| Iwata, M | 1 |
| Hammond, HK | 2 |
| Ogawa, S | 1 |
| Hardt, SE | 1 |
| Tomita, H | 1 |
| Katus, HA | 1 |
| Sadoshima, J | 1 |
| Banerjee, SK | 1 |
| Sood, S | 1 |
| Dinda, AK | 1 |
| Das, TK | 1 |
| Maulik, SK | 1 |
| Wehrens, XH | 1 |
| Lehnart, SE | 1 |
| Reiken, SR | 1 |
| Janssens, S | 1 |
| Pokreisz, P | 1 |
| Schoonjans, L | 1 |
| Pellens, M | 1 |
| Vermeersch, P | 1 |
| Tjwa, M | 1 |
| Jans, P | 1 |
| Scherrer-Crosbie, M | 1 |
| Picard, MH | 1 |
| Szelid, Z | 1 |
| Gillijns, H | 1 |
| Van de Werf, F | 1 |
| Collen, D | 1 |
| Bloch, KD | 1 |
| Rossow, CF | 1 |
| Minami, E | 1 |
| Chase, EG | 1 |
| Murry, CE | 1 |
| Santana, LF | 1 |
| Ralay Ranaivo, H | 1 |
| Diebolt, M | 1 |
| Andriantsitohaina, R | 1 |
| Dai, DZ | 1 |
| Zhang, YP | 1 |
| Lu, F | 1 |
| Ahmed, KK | 1 |
| Rana, AC | 1 |
| Dixit, VK | 1 |
| Ferrari, R | 1 |
| Sabeena Farvin, KH | 1 |
| Kumar, SH | 3 |
| Shiny, KS | 3 |
| Sankar, TV | 3 |
| Thankappan, TK | 1 |
| Gupta, SK | 3 |
| Mohanty, I | 1 |
| Talwar, KK | 2 |
| Dinda, A | 1 |
| Bansal, P | 1 |
| Saxena, A | 1 |
| Jayalakshmi, R | 3 |
| Gaur, M | 1 |
| Kumar, S | 4 |
| Prakash, J | 1 |
| Shyamala Devi, CS | 4 |
| Thirugnanasambandam, P | 1 |
| Maheswaran, E | 1 |
| Kondo, I | 1 |
| Ohmori, K | 1 |
| Oshita, A | 1 |
| Takeuchi, H | 1 |
| Fuke, S | 1 |
| Shinomiya, K | 1 |
| Noma, T | 1 |
| Namba, T | 1 |
| Kohno, M | 1 |
| Spooner, PH | 1 |
| Thai, HM | 1 |
| Goldman, S | 3 |
| Gaballa, MA | 3 |
| Bendall, JK | 1 |
| Damy, T | 1 |
| Ratajczak, P | 1 |
| Loyer, X | 1 |
| Monceau, V | 1 |
| Marty, I | 1 |
| Milliez, P | 1 |
| Robidel, E | 1 |
| Marotte, F | 1 |
| Samuel, JL | 1 |
| Heymes, C | 1 |
| Pinelli, A | 2 |
| Trivulzio, S | 2 |
| Tomasoni, L | 2 |
| Brenna, S | 2 |
| Bonacina, E | 2 |
| Accinni, R | 1 |
| Stull, LB | 1 |
| Leppo, MK | 1 |
| Szweda, L | 1 |
| Gao, WD | 1 |
| Marbán, E | 1 |
| Shao, Q | 1 |
| Ren, B | 1 |
| Saini, HK | 2 |
| Takeda, N | 1 |
| Bertolini, B | 1 |
| Vignati, S | 1 |
| Pasumarthi, KB | 1 |
| Nakajima, H | 1 |
| Nakajima, HO | 1 |
| Soonpaa, MH | 1 |
| Field, LJ | 1 |
| Krenz, M | 1 |
| Robbins, J | 1 |
| Bos, R | 1 |
| Vanhoutte, PM | 1 |
| Bozkurt, E | 1 |
| Senocak, H | 1 |
| Tong, H | 1 |
| Bernstein, D | 1 |
| Murphy, E | 1 |
| Steenbergen, C | 1 |
| Dun, W | 2 |
| Boyden, PA | 4 |
| Ferrier, G | 1 |
| Howlett, S | 1 |
| Bjørnerheim, R | 1 |
| Wasserstrom, JA | 1 |
| Sejersted, OM | 3 |
| Barbhaiya, C | 1 |
| Ter Keurs, HE | 1 |
| Bøkenes, J | 2 |
| Schiander, I | 1 |
| Solberg, L | 1 |
| Bafna, PA | 2 |
| Sun, Y | 1 |
| Weber, KT | 1 |
| Li, D | 1 |
| Qu, Y | 1 |
| Tao, L | 1 |
| Hu, A | 2 |
| Gao, F | 1 |
| Sharifi-Azad, S | 2 |
| Grunwald, Z | 2 |
| Ma, XL | 2 |
| Sun, JZ | 2 |
| Thirupurasundari, CJ | 2 |
| Farvin, KH | 2 |
| Devadasan, K | 1 |
| Bel-Hadj, S | 1 |
| Drapeau, J | 1 |
| Yogeeta, SK | 3 |
| Gnanapragasam, A | 3 |
| Kumar, SS | 1 |
| Subhashini, R | 3 |
| Sathivel, A | 1 |
| Jainu, M | 3 |
| Sabitha, KE | 3 |
| Hartley, S | 1 |
| Van Wyk, J | 1 |
| Marais, E | 1 |
| Brembilla-Perrot, B | 2 |
| Muhanna, I | 1 |
| Terrier de la Chaise, A | 2 |
| Louis, P | 1 |
| Nippert, M | 1 |
| Claudon, O | 1 |
| Belhakem, H | 1 |
| Selton, O | 1 |
| Ernst, Y | 1 |
| Trivedi, CJ | 1 |
| Majithiya, JB | 1 |
| Bothara, SB | 1 |
| Jiao, X | 1 |
| Hanumantra, RB | 1 |
| Senthilkumar, S | 2 |
| Chauhan, GM | 1 |
| Ramkumar, KM | 1 |
| Karthick, M | 2 |
| Palfi, A | 1 |
| Toth, A | 1 |
| Hanto, K | 1 |
| Deres, P | 1 |
| Szabados, E | 1 |
| Szereday, Z | 1 |
| Kulcsar, G | 1 |
| Kalai, T | 1 |
| Hideg, K | 1 |
| Gallyas, F | 1 |
| Sumegi, B | 1 |
| Halmosi, R | 1 |
| Díaz-Muñoz, M | 1 |
| Alvarez-Pérez, MA | 1 |
| Yáñez, L | 2 |
| Vidrio, S | 2 |
| Martínez, L | 1 |
| Rosas, G | 1 |
| Yáñez, M | 1 |
| Ramírez, S | 1 |
| de Sánchez, VC | 1 |
| Zhu, WZ | 1 |
| Joiner, ML | 1 |
| Oddis, CV | 1 |
| Hou, Y | 1 |
| Yang, J | 2 |
| Price, EE | 1 |
| Gleaves, L | 1 |
| Eren, M | 1 |
| Ni, G | 1 |
| Vaughan, DE | 1 |
| Xiao, RP | 1 |
| Anderson, ME | 1 |
| Jia, YX | 1 |
| Yang, JH | 1 |
| Pan, CS | 1 |
| Geng, B | 1 |
| Xiao, Y | 1 |
| Gerns, H | 1 |
| Chang, JK | 1 |
| Wen, JK | 1 |
| Tang, CS | 1 |
| Qi, YF | 1 |
| Elimban, V | 1 |
| Babick, A | 1 |
| Nair, PS | 1 |
| Saeed, SA | 2 |
| Nair, PG | 1 |
| Pillai, KK | 3 |
| Giuberti, K | 1 |
| Pereira, RB | 1 |
| Bianchi, PR | 1 |
| Paigel, AS | 2 |
| Viswanathan Nair, PG | 1 |
| Pinto, VD | 1 |
| Cutini, GJ | 1 |
| Sartório, CL | 1 |
| Peer, PA | 1 |
| Trivedi, PC | 1 |
| Nigade, PB | 1 |
| Ghaisas, MM | 1 |
| Deshpande, AD | 1 |
| Swift, F | 1 |
| Tovsrud, N | 1 |
| Enger, U | 1 |
| Lunde, PK | 2 |
| Norton, GR | 1 |
| Veliotes, DG | 1 |
| Osadchii, O | 1 |
| Woodiwiss, AJ | 1 |
| Thomas, DP | 1 |
| Devi Sampath, P | 1 |
| Vijayaraghavan, K | 1 |
| Leosco, D | 1 |
| Rengo, G | 1 |
| Iaccarino, G | 1 |
| Golino, L | 1 |
| Marchese, M | 1 |
| Fortunato, F | 1 |
| Zincarelli, C | 1 |
| Sanzari, E | 1 |
| Galasso, G | 1 |
| Altobelli, GG | 1 |
| Conti, V | 1 |
| Matrone, G | 1 |
| Cimini, V | 1 |
| Ferrara, N | 1 |
| Filippelli, A | 1 |
| Rengo, F | 1 |
| DeGeorge, BR | 1 |
| Boucher, M | 1 |
| Vinge, LE | 1 |
| Martini, JS | 1 |
| Raake, PW | 1 |
| Chuprun, JK | 1 |
| Harris, DM | 1 |
| Kim, GW | 1 |
| Soltys, S | 1 |
| Eckhart, AD | 1 |
| Knapton, A | 1 |
| Lipshultz, SE | 1 |
| Weaver, JL | 1 |
| Herman, EH | 1 |
| Kráľová, E | 1 |
| Mokráň, T | 1 |
| Murín, J | 1 |
| Stankovičová, T | 1 |
| Nazam Ansari, M | 1 |
| Xu, Q | 1 |
| Zheng, J | 1 |
| Liu, P | 1 |
| Fu, J | 1 |
| Mikaelian, I | 1 |
| Coluccio, D | 1 |
| Morgan, KT | 1 |
| Johnson, T | 1 |
| Ryan, AL | 1 |
| Rasmussen, E | 1 |
| Nicklaus, R | 1 |
| Kanwal, C | 1 |
| Hilton, H | 1 |
| Frank, K | 1 |
| Fritzky, L | 1 |
| Wheeldon, EB | 1 |
| Kernohan, RJ | 1 |
| Ross, J | 5 |
| Langhorne, WH | 2 |
| Bajusz, E | 2 |
| Homburger, F | 1 |
| Smith, HJ | 2 |
| Oriol, A | 1 |
| Morch, J | 1 |
| McGregor, M | 1 |
| Cronin, RF | 1 |
| Kuhn, LA | 3 |
| Slama, R | 2 |
| Motte, G | 2 |
| Guérot, C | 2 |
| Bouvrain, Y | 2 |
| Dennison, AD | 1 |
| Storer, WR | 1 |
| Gunnar, RM | 6 |
| Loeb, HS | 6 |
| Pietras, RJ | 2 |
| Tobin, JR | 2 |
| Eichna, LW | 1 |
| Roberts, R | 1 |
| Maroko, PR | 11 |
| Ribeiro, LG | 1 |
| Goldberg, S | 1 |
| Baumann, G | 2 |
| Riess, G | 2 |
| Erhardt, WD | 2 |
| Felix, SB | 2 |
| Ludwig, L | 2 |
| Blümel, G | 1 |
| Blömer, H | 2 |
| Schrader, J | 1 |
| Heidecke, CD | 1 |
| Loher, U | 1 |
| Sebening, F | 1 |
| Hashimoto, H | 1 |
| Ogawa, K | 1 |
| Milei, J | 5 |
| Vazquez, A | 1 |
| Bolomo, NJ | 1 |
| Arita, M | 2 |
| Kiyosue, T | 1 |
| Joseph, X | 1 |
| Jordan, AW | 1 |
| Rude, RE | 2 |
| Rardon, DP | 1 |
| Bailey, JC | 1 |
| Bourdarias, JP | 2 |
| Dubourg, O | 1 |
| Gueret, P | 1 |
| Ferrier, A | 1 |
| Bardet, J | 1 |
| McCarty, MF | 1 |
| Zimmer, HG | 1 |
| Ibel, H | 1 |
| Steinkopff, G | 1 |
| Genovese, A | 8 |
| Chiariello, M | 6 |
| Ferro, G | 2 |
| Cacciapuoti, AA | 6 |
| Condorelli, M | 5 |
| Buxton, AE | 1 |
| Marchlinski, FE | 1 |
| Doherty, JU | 1 |
| Cassidy, DM | 1 |
| Vassallo, JA | 1 |
| Flores, BT | 1 |
| Josephson, ME | 1 |
| Asha Devi, S | 2 |
| Kirk, ES | 3 |
| Factor, S | 1 |
| Sonnenblick, EH | 3 |
| Latte, S | 4 |
| de Alfieri, W | 5 |
| Onorati, AM | 1 |
| von Philipsborn, G | 1 |
| Gries, J | 1 |
| Hofmann, HP | 1 |
| Kreiskott, H | 1 |
| Kretzschmar, R | 1 |
| Müller, CD | 1 |
| Raschack, M | 1 |
| Teschendorf, HJ | 1 |
| Kurup, PA | 10 |
| Hu, ZW | 1 |
| Tang, XL | 1 |
| Shen, N | 1 |
| Remla, A | 4 |
| Menon, PV | 9 |
| Boutet, M | 3 |
| Turcotte, H | 1 |
| Bazin, M | 1 |
| Bourque, L | 1 |
| Kloner, RA | 1 |
| Khuri, S | 1 |
| Karaffa, S | 1 |
| DeBoer, LW | 1 |
| Braunwald, E | 10 |
| Zmbova, B | 1 |
| Stojanova, D | 1 |
| Stakic, D | 1 |
| Tadzer, I | 1 |
| Bogdanova, V | 1 |
| Hirsch, LJ | 1 |
| Rone, AS | 1 |
| McMurtry, JP | 2 |
| Hüttner, I | 2 |
| Karmazyn, M | 2 |
| Moffat, MP | 1 |
| Beamish, RE | 1 |
| Woolf, N | 1 |
| Davies, MJ | 1 |
| Sasaki, T | 1 |
| Kojima, S | 1 |
| Kubodera, A | 1 |
| Cooper, MW | 1 |
| Lombardini, JB | 1 |
| Davis, J | 1 |
| Glassman, R | 1 |
| Wit, AL | 1 |
| Darrah, MI | 1 |
| Engen, RL | 1 |
| Onitsuka, T | 1 |
| Koga, Y | 1 |
| Shibata, K | 1 |
| Sakoda, K | 1 |
| Maeda, T | 1 |
| Agarwal, OP | 1 |
| Banu, N | 1 |
| Ojha, JK | 1 |
| Malhotra, OP | 1 |
| Udupa, KN | 1 |
| Crandall, DL | 1 |
| Feirer, RP | 1 |
| Griffith, DR | 1 |
| Beitz, DC | 1 |
| Innes, IR | 1 |
| Weisman, H | 1 |
| Sahyoun, HA | 1 |
| Hicks, R | 1 |
| Seth, SD | 2 |
| Gupta, MP | 2 |
| Kaur, AH | 3 |
| Basu, AK | 1 |
| Abraham, AS | 1 |
| Bar-On, E | 1 |
| Eylath, U | 1 |
| Polverino, W | 4 |
| Romano, M | 1 |
| Kretz, A | 1 |
| Suarez, LD | 1 |
| Alvarez, JA | 1 |
| Leguizamon Palumbo, JR | 1 |
| Martinez Martinez, JA | 1 |
| Nicita-Mauro, V | 1 |
| Barbera, N | 1 |
| Ciraolo, O | 1 |
| Carrozza, G | 1 |
| Nicotina, PA | 1 |
| Grosso, M | 1 |
| Lasco, A | 1 |
| Squadrito, G | 1 |
| Singh, KP | 1 |
| Joshi, KC | 1 |
| Somani, KC | 1 |
| Tariq, M | 3 |
| Ahmad, M | 4 |
| Mathew, BM | 3 |
| Seth, TD | 3 |
| Hasan, MZ | 3 |
| Mahdi, SQ | 1 |
| Sharov, VG | 1 |
| Jennings, RB | 1 |
| Hawkins, HK | 1 |
| Yamamoto, T | 1 |
| Katori, R | 1 |
| Avendano, CE | 1 |
| Zhang, XQ | 2 |
| Moore, RL | 2 |
| Tenhave, T | 1 |
| Cheung, JY | 2 |
| van Veldhuisen, DJ | 2 |
| Brodde, OE | 1 |
| van Gilst, WH | 4 |
| Schulze, C | 2 |
| Hegeman, H | 1 |
| Anthonio, RL | 1 |
| Scholtens, E | 1 |
| de Graeff, PA | 3 |
| Wesseling, H | 3 |
| Lie, KI | 2 |
| Singh, J | 4 |
| Srivastava, RK | 1 |
| Mathur, SK | 1 |
| Rossoni, G | 2 |
| Berti, F | 2 |
| Berti, M | 1 |
| Bernareggi, M | 1 |
| Trento, F | 1 |
| Porta, R | 1 |
| Pescador, R | 1 |
| Ferro, L | 1 |
| le Van, D | 1 |
| Beurrier, D | 1 |
| Steinberg, SF | 1 |
| Pak, E | 1 |
| Pagnotta, G | 1 |
| Marjomäki, V | 1 |
| Ritamäki, V | 1 |
| Gruenberg, J | 1 |
| Pérez-Cao, A | 2 |
| Gil-Loyzaga, P | 2 |
| Merchàn-Pérez, A | 2 |
| Tamargo, J | 2 |
| Cherng, WJ | 1 |
| Liang, CS | 1 |
| Hood, WB | 5 |
| Kataoka, H | 1 |
| Roth, DA | 1 |
| McKirnan, MD | 1 |
| Ping, P | 1 |
| Ravichandran, LV | 4 |
| Puvanakrishnan, R | 6 |
| Namikawa, K | 2 |
| Okazaki, Y | 2 |
| Nishida, S | 2 |
| Kimoto, S | 1 |
| Akai, F | 1 |
| Tomura, T | 2 |
| Hashimoto, S | 2 |
| Manjula, TS | 3 |
| Nirmala, C | 2 |
| Tillotson, DL | 1 |
| Sanbe, A | 2 |
| Takeo, S | 2 |
| Aggarwal, R | 1 |
| Lefroy, DC | 1 |
| Crake, T | 1 |
| Del Monte, F | 1 |
| Vescovo, G | 1 |
| Dalla Libera, L | 1 |
| Harding, S | 1 |
| Poole-Wilson, PA | 1 |
| Kirstein, M | 1 |
| Katzer, A | 1 |
| Hu, K | 1 |
| Gaudron, P | 1 |
| Ertl, G | 1 |
| Langenfeld, H | 1 |
| Kochsiek, K | 1 |
| Nasa, Y | 1 |
| Toyoshima, H | 1 |
| Ohaku, H | 1 |
| Hashizume, Y | 1 |
| Shimoike, H | 1 |
| Iwai, N | 1 |
| Kinoshita, M | 1 |
| Ithayarasi, AP | 3 |
| Padmavathy, VN | 1 |
| Shyamala Devi, C | 2 |
| de Meester, A | 1 |
| Chaudron, JM | 1 |
| de Roy, L | 1 |
| Ahmed, MW | 1 |
| Kadish, AH | 1 |
| Inbar, S | 1 |
| Goldberger, JJ | 1 |
| Akiyama, K | 1 |
| Akopian, G | 1 |
| Jinadasa, P | 1 |
| Gluckman, TL | 1 |
| Terhakopian, A | 1 |
| Massey, B | 1 |
| Bing, RJ | 2 |
| Saxena, PR | 2 |
| Kalkman, EA | 2 |
| Chagoya de Sánchez, V | 1 |
| Hernández-Muñoz, R | 1 |
| López-Barrera, F | 1 |
| Suárez, J | 1 |
| Cota-Garza, MD | 1 |
| Aranda-Fraustro, A | 1 |
| Cruz, D | 1 |
| Kiefer, CR | 1 |
| McKenney, JB | 1 |
| Trainor, JF | 1 |
| Lambrecht, RW | 1 |
| Bonkovsky, HL | 1 |
| Lifshitz, LM | 1 |
| Valeri, CR | 1 |
| Snyder, LM | 1 |
| Kompa, AR | 1 |
| Gu, XH | 1 |
| Evans, BA | 1 |
| Summers, RJ | 1 |
| Mitra, SK | 1 |
| Venkataranganna, MV | 1 |
| Sundaram, R | 1 |
| Gopumadhavan, S | 1 |
| Litwin, SE | 3 |
| Katz, SE | 1 |
| Douglas, PS | 1 |
| Grosjean, SA | 1 |
| Arstall, MA | 1 |
| Mitchell, RN | 1 |
| Klappacher, GW | 1 |
| Kelly, RA | 1 |
| Pfeffer, MA | 1 |
| Pfeffer, JM | 1 |
| Aimond, F | 1 |
| Alvarez, JL | 1 |
| Rauzier, JM | 1 |
| Lorente, P | 1 |
| Raya, TE | 1 |
| Hoover, CA | 1 |
| Sandmann, S | 2 |
| Meissner, A | 2 |
| Unger, T | 2 |
| Simon, R | 1 |
| Naik, P | 1 |
| Malati, T | 1 |
| Ratnakar, KS | 1 |
| Naidu, MU | 1 |
| Rajasekhar, A | 1 |
| Yoshida, H | 1 |
| Wildhirt, SM | 1 |
| Weismueller, S | 1 |
| Conrad, N | 1 |
| Kornberg, A | 1 |
| Reichart, B | 1 |
| Macicková, T | 1 |
| Navarová, J | 1 |
| Urbancíkova, M | 1 |
| Horáková, K | 1 |
| Hohlfeld, T | 1 |
| Meyer-Kirchrath, J | 1 |
| Vogel, YC | 1 |
| Schrör, K | 1 |
| Van Kerckhoven, R | 1 |
| Prabhu, SD | 1 |
| Chandrasekar, B | 1 |
| Murray, DR | 1 |
| Freeman, GL | 1 |
| Palmgren, J | 1 |
| Zhang, D | 1 |
| Bridge, JH | 1 |
| Eckhart, A | 1 |
| Senthil Kumar, SH | 1 |
| Santhosh Kumar, M | 1 |
| Houle, MS | 1 |
| Altschuld, RA | 1 |
| Przyklenk, K | 1 |
| Li, G | 1 |
| Whittaker, P | 1 |
| Sharma, M | 1 |
| Kishore, K | 1 |
| Yamamoto, S | 1 |
| Matsui, K | 1 |
| Sasabe, M | 1 |
| Ohashi, N | 1 |
| Sande, JB | 1 |
| Hoen, IB | 1 |
| Tønnessen, T | 1 |
| Holt, E | 1 |
| Vimal, V | 1 |
| Arteaga de Murphy, C | 1 |
| Ferro-Flores, G | 1 |
| Villanueva-Sanchez, O | 1 |
| Murphy-Stack, E | 1 |
| Pedraza-López, M | 1 |
| Meléndez-Alafort, L | 1 |
| Molina-Trinidad, E | 1 |
| Singh, U | 1 |
| Lynch, JJ | 2 |
| Salata, JJ | 1 |
| Wallace, AA | 1 |
| Stump, GL | 1 |
| Gilberto, DB | 1 |
| Jahansouz, H | 1 |
| Liverton, NJ | 1 |
| Selnick, HG | 1 |
| Claremon, DA | 1 |
| Thomas, M | 2 |
| Kostka-Trabka, E | 2 |
| Chiche, P | 2 |
| Baligadoo, S | 1 |
| Prys-Roberts, C | 1 |
| Roberts, JG | 1 |
| Foëx, P | 1 |
| Clarke, TN | 1 |
| Bennett, MJ | 1 |
| Ryder, WA | 1 |
| Lubbe, WF | 2 |
| Killip, T | 1 |
| Miyagishima, Y | 1 |
| Kannengiesser, GJ | 1 |
| Opie, LH | 1 |
| Collins, P | 2 |
| Billings, CG | 2 |
| Barer, GR | 1 |
| Daly, JJ | 1 |
| Jolly, A | 1 |
| Hollander, W | 1 |
| Prusty, S | 1 |
| Kirkpatrick, B | 1 |
| Paddock, J | 1 |
| Nagraj, S | 1 |
| Sakellariou, G | 1 |
| Atsalakis, E | 1 |
| Vrettos, I | 1 |
| Sakellariou, B | 1 |
| Volonakis, M | 1 |
| Strange, RC | 1 |
| Rowe, MJ | 2 |
| Mjos, OD | 3 |
| Oliver, MF | 2 |
| Mäurer, W | 1 |
| Tillmanns, H | 1 |
| Kübler, W | 1 |
| Gratsianskiĭ, NA | 2 |
| Eliot, RS | 3 |
| Clayton, FC | 2 |
| Pieper, GM | 2 |
| Todd, GL | 2 |
| Hillis, LD | 1 |
| Vainsel, H | 1 |
| Dodion, L | 1 |
| Bernard, R | 1 |
| Denolin, H | 1 |
| Iseri, LT | 1 |
| Humphrey, SB | 1 |
| Siner, EJ | 1 |
| Dixon, DW | 1 |
| Schwartz, DA | 1 |
| Grover, FL | 1 |
| Horwitz, LD | 1 |
| Loegering, DJ | 1 |
| Feintuch, JJ | 1 |
| Carr, FK | 1 |
| Inagaki, Y | 1 |
| Saito, T | 2 |
| Shukuya, M | 1 |
| Greenberg, BP | 5 |
| Jameel, SA | 1 |
| Roan, P | 1 |
| Scales, F | 1 |
| Saffer, S | 1 |
| Buja, LM | 1 |
| Willerson, JT | 2 |
| Saxena, KK | 1 |
| Gupta, B | 1 |
| Srivastava, VK | 1 |
| Kulshrestha, VK | 1 |
| Prasad, DN | 1 |
| Menken, U | 1 |
| Wiegand, V | 1 |
| Bucher, P | 1 |
| Meesmann, W | 1 |
| Forsberg, SA | 1 |
| Juul-Möller, S | 1 |
| Giuffrida, G | 1 |
| Mazza, F | 1 |
| Lureti, GF | 1 |
| Melloni, GF | 1 |
| Minoja, GM | 1 |
| Melloni, CF | 1 |
| Núñez, RG | 1 |
| Rapaport, M | 3 |
| Ahmad, MS | 1 |
| Jamil, SA | 1 |
| Matilla, A | 1 |
| González-Campora, R | 1 |
| Carrascal, E | 1 |
| Galera, H | 1 |
| Kung, HF | 1 |
| Blau, M | 1 |
| Barletta, MA | 1 |
| Staab, R | 1 |
| Lau Cam, C | 1 |
| Lynch, VD | 1 |
| Lanovaia, NI | 1 |
| Nicák, A | 1 |
| Machán, V | 1 |
| Vilcek, S | 1 |
| Kalincák, M | 1 |
| Kohút, A | 1 |
| Higuchi, M | 1 |
| Takenaka, F | 1 |
| da Luz, P | 1 |
| Weil, MH | 2 |
| Shubin, H | 2 |
| Csáky, L | 3 |
| Szabó, J | 3 |
| Nosztray, K | 1 |
| Szegi, J | 2 |
| Zacharoulis, AA | 1 |
| Evans, TR | 1 |
| Ziady, GM | 1 |
| Coltart, DJ | 1 |
| Shillingford, JP | 1 |
| Chvapil, M | 1 |
| Owen, JA | 1 |
| Ramanathan, KB | 1 |
| Bodenheimer, MM | 1 |
| Banka, VS | 1 |
| Raina, S | 1 |
| Helfant, RH | 1 |
| Foerster, JM | 1 |
| Vera, Z | 1 |
| Janzen, DA | 1 |
| Foerster, SJ | 1 |
| Mason, DT | 1 |
| Tuttle, RR | 1 |
| Pollock, GD | 1 |
| Todd, G | 1 |
| MacDonald, B | 1 |
| Tust, R | 1 |
| Dusenberry, W | 1 |
| Riggs, CE | 1 |
| Landiss, CW | 1 |
| Jessup, GT | 1 |
| Bonner, HW | 1 |
| Trappler, B | 1 |
| Abkiewicz, SR | 1 |
| Millar, RN | 1 |
| Obel, IW | 1 |
| Rickards, AF | 1 |
| Seabra-Gomes, R | 1 |
| Parker, DJ | 1 |
| Matsuura, H | 1 |
| Cohen, MV | 1 |
| Mai, I | 1 |
| Lampe, D | 1 |
| Lange, B | 1 |
| Tsuboi, T | 1 |
| Fujitani, B | 1 |
| Takeno, K | 1 |
| Yoshida, K | 1 |
| Shimizu, M | 1 |
| Leder, O | 4 |
| Gudbjarnason, S | 2 |
| Hallgrimsson, J | 1 |
| Kjekshus, JK | 6 |
| Nuñez, R | 1 |
| Pernod, J | 1 |
| Kermarec, J | 1 |
| Richard, D | 1 |
| Chenille, E | 1 |
| Hoffman, JI | 2 |
| Buckberg, GD | 1 |
| Janke, J | 2 |
| Fleckenstein, A | 2 |
| Döring, HJ | 2 |
| Lewis, BK | 2 |
| Muller, JE | 1 |
| Jansen, W | 1 |
| Jacobi, H | 1 |
| Aelony, Y | 1 |
| Laks, MM | 1 |
| Beall, G | 1 |
| Flowers, NC | 1 |
| McGrath, JJ | 3 |
| Martin, LG | 1 |
| Judd, JT | 10 |
| Slezák, J | 2 |
| Tribulová, N | 2 |
| Girotti, AL | 1 |
| Halpern, MS | 1 |
| Elizari, MV | 1 |
| Rosenbaum, MB | 1 |
| Tajuddin, M | 2 |
| Vorbeck, ML | 1 |
| Malewski, EF | 1 |
| Erhart, LS | 1 |
| Martin, AP | 1 |
| Norris, RM | 1 |
| Singh, BN | 2 |
| Nisbet, H | 1 |
| John, MB | 1 |
| Hurley, PJ | 1 |
| Juhász-Nagy, A | 1 |
| Kudász, J | 1 |
| Lehr, D | 1 |
| Steinbach, K | 1 |
| Ohnishi, H | 1 |
| Tsukuda, S | 1 |
| Yamaguchi, K | 1 |
| Ogawa, N | 1 |
| Lesch, M | 1 |
| Schwartzman, D | 1 |
| Demopoulos, L | 1 |
| Schrem, S | 1 |
| Caracciolo, E | 1 |
| Perez, J | 1 |
| Chinitz, L | 1 |
| Slater, W | 1 |
| van Wijngaarden, J | 2 |
| Monnink, SH | 1 |
| Bartels, H | 1 |
| de Langen, CD | 2 |
| Wiesfeld, AC | 1 |
| Crijns, HJ | 1 |
| Geetha, A | 1 |
| Kadota, E | 1 |
| Erokhina, IL | 1 |
| Aghi, M | 1 |
| Husain, Z | 1 |
| Qadry, JS | 1 |
| Balani, DK | 1 |
| Prema, A | 1 |
| Lal, A | 2 |
| Sharma, ML | 2 |
| Rote, WE | 1 |
| Connor, JD | 1 |
| Winslow, E | 1 |
| Campbell, JK | 1 |
| Barron, E | 1 |
| Vleeming, W | 2 |
| van Rooij, HH | 2 |
| Wemer, J | 2 |
| Porsius, AJ | 2 |
| Rana, GC | 1 |
| Venkatesh, N | 1 |
| Uprichard, AC | 1 |
| Kitzen, JM | 1 |
| Lucchesi, BR | 3 |
| Humbert, T | 1 |
| Luu-Duc, C | 1 |
| Comet, M | 1 |
| Demenge, P | 1 |
| Pinto, YM | 1 |
| Priori, SG | 1 |
| Corr, PB | 2 |
| Joseph, KT | 2 |
| Mill, JG | 1 |
| Leite, CM | 1 |
| Zuanetti, G | 1 |
| Hoyt, RH | 1 |
| Hunt, GB | 1 |
| Ross, DL | 1 |
| Sushama Kumari, S | 1 |
| Varghese, A | 2 |
| Muraleedharan, D | 2 |
| Menon, VP | 3 |
| Lewin, RF | 1 |
| Kusniec, J | 1 |
| Sclarovsky, S | 1 |
| Strasberg, B | 1 |
| Arditti, A | 1 |
| Pinchas, A | 1 |
| Agmon, J | 1 |
| Storino, R | 1 |
| Stets, VR | 1 |
| Tishkin, VS | 1 |
| Evdokimov, EI | 1 |
| Wang, YT | 1 |
| Uematsu, T | 1 |
| Sato, R | 1 |
| Hayashi, Y | 1 |
| Nakashima, M | 1 |
| Sasser, LB | 1 |
| Lundstrom, DL | 1 |
| Zangar, RC | 1 |
| Springer, DL | 1 |
| Mahlum, DD | 1 |
| van der Wouw, PA | 1 |
| te Biesebeek, JD | 1 |
| Collins, MN | 1 |
| Kumari, SS | 2 |
| Garg, KN | 2 |
| Garg, D | 2 |
| Chugh, K | 1 |
| Lal, H | 2 |
| Kaul, S | 1 |
| Kapoor, NK | 1 |
| Johnstone, DE | 1 |
| Janes, RD | 1 |
| Klassen, GA | 1 |
| Armour, JA | 1 |
| Clozel, JP | 1 |
| Holck, M | 1 |
| Osterrieder, W | 1 |
| Burkard, W | 1 |
| Da Prada, MD | 1 |
| Brown, MJ | 1 |
| Bhalla, S | 1 |
| Barar, FS | 1 |
| Kahn, JP | 1 |
| Perumal, AS | 1 |
| Gully, RJ | 1 |
| Smith, TM | 1 |
| Cooper, TB | 1 |
| Klein, DF | 1 |
| Bora, PS | 1 |
| Srivastava, LM | 2 |
| Bhatt, SD | 1 |
| Satler, LF | 1 |
| Kent, KM | 1 |
| Fox, LM | 1 |
| Goldstein, HA | 1 |
| Green, CE | 1 |
| Rogers, WJ | 1 |
| Pallas, RS | 1 |
| Del Negro, AA | 1 |
| Pearle, DL | 1 |
| Rackley, CE | 2 |
| Niada, R | 1 |
| Omini, C | 1 |
| Pretolani, M | 1 |
| Mandelli, C | 1 |
| Bloom, S | 3 |
| Karliner, JS | 1 |
| Stevens, M | 1 |
| Grattan, M | 1 |
| Woloszyn, W | 1 |
| Honbo, N | 1 |
| Gøtzsche, O | 1 |
| Slepushkin, VD | 1 |
| Pavlenko, VS | 1 |
| Khavinson, VKh | 1 |
| Morozov, VG | 1 |
| Gupta, M | 1 |
| Manchanda, SC | 1 |
| Berkowitz, K | 1 |
| Conahan, S | 1 |
| Vogel, WH | 1 |
| Körmöczy, PS | 1 |
| Vértesi, C | 1 |
| Mikus, E | 1 |
| Tardos, L | 1 |
| Kovács, G | 1 |
| Vogel, WM | 1 |
| Apstein, CS | 1 |
| Sugawara, M | 1 |
| Nakano, K | 1 |
| Fang, DC | 1 |
| Yang, XM | 1 |
| Jiang, MX | 1 |
| Borrelli, F | 1 |
| Antonetti, F | 1 |
| Martelli, F | 1 |
| Caprino, L | 1 |
| Surawicz, B | 3 |
| Golino, P | 1 |
| Carew, TE | 1 |
| Constantin, L | 1 |
| Martins, JB | 1 |
| Brugada, P | 1 |
| Wellens, HJ | 1 |
| Asha, S | 1 |
| Radha, E | 1 |
| Singh, M | 1 |
| Jain, K | 1 |
| Tokutake, E | 1 |
| Watanabe, I | 1 |
| Hibiya, K | 1 |
| Takahasi, N | 1 |
| Ogura, T | 1 |
| Yumikura, S | 1 |
| Nagasawa, M | 1 |
| Saito, S | 1 |
| Ozawa, Y | 1 |
| Liakishev, AA | 1 |
| Sidorenko, BA | 1 |
| Akhmedzhanov, NM | 1 |
| Matveeva, LS | 1 |
| Jewitt, D | 1 |
| Birkhead, J | 1 |
| Mitchell, A | 1 |
| Dollery, C | 1 |
| Narusawa, T | 1 |
| Uchijima, H | 1 |
| Hasegawa, T | 1 |
| Saito, O | 1 |
| Suzuki, Y | 1 |
| Rahimtoola, SH | 2 |
| Misra, SN | 1 |
| Kezdi, P | 1 |
| Gettes, LS | 2 |
| Büchner, M | 1 |
| Effert, S | 1 |
| Raynaud, R | 3 |
| Brochier, M | 3 |
| Néel, JL | 1 |
| Fauchier, JP | 3 |
| Raynaud, P | 3 |
| Benaim, R | 1 |
| Chapelle, M | 1 |
| Drouin, B | 1 |
| Senikies, A | 1 |
| Theroux, P | 1 |
| Franklin, D | 1 |
| Kemper, WS | 1 |
| Hatle, L | 3 |
| Saeterhaug, A | 1 |
| Rokseth, R | 3 |
| Iakovleva, AI | 1 |
| Sorokina, MN | 1 |
| Aschenbrenner, V | 1 |
| Mĕstan, J | 1 |
| Turek, Z | 3 |
| Jelínek, J | 1 |
| Kalus, M | 2 |
| Poupa, O | 2 |
| Guy, CR | 1 |
| Mizutani, T | 1 |
| Hazeki, T | 1 |
| Moret, PR | 1 |
| Megevand, R | 1 |
| Gemperle, M | 1 |
| Morand, P | 2 |
| Pairolero, PC | 2 |
| McCallister, BD | 2 |
| Hallermann, FJ | 2 |
| Titus, JL | 2 |
| Ellis, FH | 2 |
| Meerson, FZ | 1 |
| Gomazkov, OA | 1 |
| Kones, RJ | 1 |
| Méhes, G | 1 |
| Rajkovits, K | 1 |
| Papp, G | 1 |
| Muscholl, E | 1 |
| Rahn, KH | 1 |
| Preti, M | 2 |
| Carpi, C | 2 |
| Dyduszyński, A | 1 |
| Schuster, DP | 1 |
| Nobel, NL | 1 |
| Mimnaugh, MN | 1 |
| Counsell, RE | 1 |
| Kniffen, FJ | 1 |
| Vaisrub, S | 1 |
| Dighton, DH | 1 |
| el-Sherif, N | 1 |
| Scherlag, BJ | 1 |
| Lazzara, R | 1 |
| Hope, R | 1 |
| Williams, DO | 1 |
| Samet, P | 1 |
| Vyden, JK | 2 |
| Nagasawa, K | 1 |
| Rabinowitz, B | 1 |
| Parmley, WW | 1 |
| Tomoda, H | 1 |
| Corday, E | 2 |
| Swan, HJ | 3 |
| Willen, D | 1 |
| Mir, MA | 1 |
| Rees, S | 1 |
| Yahya, AM | 1 |
| Williams, JD | 1 |
| Reeves, TL | 1 |
| Marshall, RJ | 2 |
| Parratt, JR | 2 |
| Most, AS | 1 |
| Capone, RJ | 1 |
| Szydlik, P | 1 |
| Bruno, CA | 1 |
| DeVona, TS | 1 |
| Branzi, A | 1 |
| Binetti, G | 1 |
| Zannoli, R | 1 |
| Magnani, B | 1 |
| Morita, Y | 1 |
| Ishiyama, T | 1 |
| Tsukamoto, N | 1 |
| Yamamura, Y | 1 |
| Tekeres, M | 1 |
| Mezey, B | 1 |
| Kellényi, L | 1 |
| Asai, Y | 1 |
| Mueller, H | 3 |
| Ayres, SM | 3 |
| Giannelli, S | 3 |
| Conklin, EF | 2 |
| Mazzara, JT | 2 |
| Grace, WJ | 3 |
| Doshchitsin, VL | 1 |
| Eremina, GA | 1 |
| Moran, JM | 1 |
| Mulet, J | 1 |
| Caralps, JM | 1 |
| Pifarre, R | 1 |
| Rotman, M | 1 |
| Wagner, GS | 1 |
| Wallace, AG | 1 |
| Scheinman, MM | 1 |
| Evans, GT | 1 |
| Rosen, KM | 1 |
| Ehsani, A | 1 |
| Shimizu, R | 1 |
| Williams, JF | 1 |
| Steele, PP | 1 |
| Van Dyke, D | 1 |
| Trow, RS | 1 |
| Anger, HO | 1 |
| Davies, H | 1 |
| Libby, P | 3 |
| Wiener, L | 1 |
| Johnson, SA | 1 |
| Marchal, C | 1 |
| Bleser, F | 1 |
| Sztuka, JC | 1 |
| Malingrey, L | 1 |
| Benichoux, R | 1 |
| Daoud, FS | 1 |
| Jacobsen, JR | 1 |
| Perret, C | 1 |
| Enrico, JF | 1 |
| Poli, S | 1 |
| Amacker, JJ | 1 |
| Gill, C | 1 |
| Wechsler, AS | 1 |
| Lutmer, RJ | 1 |
| Saroff, J | 3 |
| Seelig, MS | 1 |
| Christiansen, I | 1 |
| Haghfelt, T | 1 |
| Amtorp, O | 1 |
| Shell, WE | 3 |
| Sobel, BE | 5 |
| Rivier, JL | 2 |
| Jaeger, M | 2 |
| Jonas, N | 1 |
| Interiano, B | 1 |
| Hyde, RW | 1 |
| Hodges, M | 1 |
| Yu, PN | 1 |
| Bleifeld, W | 1 |
| Irnich, W | 1 |
| Lavelle, JF | 1 |
| Covell, JW | 4 |
| Chung, EK | 1 |
| Ledingham, IM | 1 |
| Ramdohr, B | 1 |
| Lutmer, RF | 4 |
| Kaplinsky, E | 1 |
| Lown, B | 3 |
| Lekven, J | 1 |
| Mijös, OD | 1 |
| Mazzoni, S | 1 |
| Codreanu, R | 1 |
| Bramante, PO | 1 |
| Nirdlinger, EL | 1 |
| Gagossi, M | 1 |
| Coppi, G | 1 |
| Bonardi, G | 1 |
| Bravi, A | 1 |
| Volpi, G | 1 |
| Pupillo, A | 1 |
| De Luca, FM | 1 |
| Tuveri, A | 1 |
| Humphries, JO | 1 |
| Puri, PS | 2 |
| Schneider, JA | 1 |
| Sperelakis, N | 1 |
| Sapsford, RN | 1 |
| Blackstone, EH | 1 |
| Kirklin, JW | 1 |
| Karp, RB | 1 |
| Kouchoukos, NT | 1 |
| Pacifico, AD | 1 |
| Roe, CR | 1 |
| Bradley, EL | 1 |
| Moyer, JH | 1 |
| Mills, LC | 1 |
| Stavrakos, C | 1 |
| Blackford, JM | 1 |
| Bowers, JD | 1 |
| Heydinger, DK | 1 |
| Cranston, WI | 1 |
| Jacovella, G | 1 |
| Milazzotto, F | 1 |
| Masini, V | 1 |
| Forrester, JS | 1 |
| Danzig, R | 3 |
| Allen, HN | 1 |
| Haddy, FJ | 1 |
| Camillo, OS | 1 |
| Lemberg, L | 1 |
| Castellanos, A | 1 |
| Arcebal, AG | 1 |
| Iyengar, RN | 1 |
| Sloman, G | 1 |
| Dowling, J | 1 |
| Vohra, J | 1 |
| McLean, AP | 1 |
| Patton, RD | 1 |
| Körge, K | 1 |
| Hanson, H | 1 |
| Hering, L | 1 |
| Lipso, E | 1 |
| Maramaa, S | 1 |
| Velbri, S | 1 |
| Selve, H | 1 |
| McCarthy, B | 2 |
| Jouve, A | 1 |
| Delaage, M | 1 |
| Torresani, J | 1 |
| Nicolai, P | 1 |
| Heuillet, G | 1 |
| Pinas, E | 1 |
| McLean, KH | 2 |
| Wynn, A | 1 |
| Marriott, HJ | 1 |
| Pilny, J | 1 |
| Kiefer, G | 1 |
| Sandritter, W | 1 |
| Abbondati, G | 1 |
| Foucault, JP | 1 |
| Nicolas, G | 1 |
| Bonhour, JB | 1 |
| Potier, JC | 1 |
| Guilleman, D | 1 |
| Godin, JF | 1 |
| Kobayashi, K | 1 |
| Ratshin, RA | 1 |
| Russell, RO | 1 |
| Kizer, DE | 2 |
| Howell, BA | 2 |
| Krasnow, N | 1 |
| Rohl, D | 1 |
| Liu, CK | 1 |
| Lee, JY | 1 |
| Griminger, P | 1 |
| Woie, L | 1 |
| Aksnes, EG | 1 |
| Bernstein, EF | 1 |
| DeLaria, GA | 1 |
| Beregovich, J | 2 |
| Reicher-Reiss, H | 1 |
| Grishman, A | 1 |
| Kobayakawa, T | 1 |
| Heikkilä, J | 1 |
| Tabakin, BS | 1 |
| Hugenholtz, PG | 1 |
| Davis, DL | 1 |
| Bregman, D | 1 |
| Goetz, RH | 1 |
| Summers, DN | 1 |
| Richmond, S | 1 |
| Wechsler, BM | 1 |
| Meltzer, Y | 1 |
| Guschwan, A | 2 |
| Trenckmann, H | 1 |
| Herbinger, W | 1 |
| Bonilla, CA | 1 |
| Fiero, MK | 1 |
| Novak, J | 1 |
| Ino, T | 1 |
| Langley, RB | 1 |
| Wilson, DF | 1 |
| Turner, AS | 1 |
| Alpern, H | 1 |
| Mihail, A | 1 |
| Popescu, P | 1 |
| Fenig, S | 1 |
| Lasser, J | 1 |
| Allen, D | 1 |
| Cohn, JN | 1 |
| Leon, AS | 1 |
| Bloor, CM | 1 |
| Pitt, B | 1 |
| Letac, B | 1 |
| Gregory, JJ | 1 |
| Kaya, K | 1 |
| Hiraiwa, T | 1 |
| Sato, M | 1 |
| Gazes, PC | 1 |
| Kumar, R | 1 |
| Joison, J | 1 |
| Norman, JC | 1 |
| Brown, ML | 1 |
| Bădărău, G | 1 |
| Ganelina, IE | 1 |
| Brikker, VN | 1 |
| Vol'pert, VI | 1 |
| Mogilev, AM | 1 |
| Nagornev, VA | 1 |
| Watanabe, T | 1 |
| Dhurandhar, RW | 1 |
| Teasdale, SJ | 1 |
| Mahon, WA | 1 |
| Tremblay, GM | 1 |
| Charland, R | 1 |
| Roy, P | 1 |
| Primeau, R | 1 |
| Robelli, F | 1 |
| De Vita, C | 1 |
| Cadel, A | 1 |
| Taylor, SH | 1 |
| Majid, PA | 1 |
| Dykes, JR | 1 |
| Sharma, B | 1 |
| Saxton, C | 1 |
| Buonanno, C | 1 |
| Nidasio, G | 1 |
| Zanini, S | 1 |
| Rossi, R | 1 |
| Meltzer, H | 1 |
| Nager, F | 2 |
| Steinbrunn, W | 2 |
| Mann, D | 1 |
| Hecht, A | 1 |
| Sajkiewicz, K | 1 |
| Lassers, BW | 1 |
| Julian, DG | 1 |
| Bernreiter, M | 1 |
| Fearon, RE | 1 |
| Richmond, DR | 1 |
| Mitchell, AS | 1 |
| Berstein, L | 1 |
| Meyer, J | 2 |
| Shillingford, J | 1 |
| Saltups, A | 1 |
| Mushin, G | 1 |
| Criscitiello, MG | 1 |
| McHenry, MM | 1 |
| Hopkins, DM | 1 |
| Giuffrida, JG | 1 |
| Bizzarri, DV | 1 |
| Lagman, L | 1 |
| Grimaldi, RD | 1 |
| Barbagallo, E | 1 |
| Rapisarda, C | 1 |
| Tamburino, G | 1 |
| Gavrilescu, S | 1 |
| Cotoi, S | 1 |
| Riviş, I | 1 |
| Samson, M | 1 |
| Friedberg, CK | 1 |
| Kline, HJ | 1 |
| Goodman, P | 1 |
| Johnson, CD | 1 |
| Marano, AJ | 1 |
| Affolter, H | 2 |
| Debrunner, F | 2 |
| Mannhart, M | 1 |
| Ritz, R | 2 |
| Zipes, DP | 1 |
| Lichtlen, P | 1 |
| Rösli, R | 1 |
| Gutschmidt, A | 1 |
| Reutter, F | 1 |
| Blankart, R | 1 |
| Reichmuth, J | 1 |
| Burger, H | 1 |
| Uehlinger, A | 1 |
| Meyer, HA | 1 |
| Stutz, DR | 1 |
| Winfield, RA | 1 |
| Sanmarco, ME | 1 |
| Marquez, LA | 1 |
| Hall, C | 1 |
| Philips, CM | 1 |
| Gash, A | 1 |
| Davila, JC | 1 |
| Gorlin, R | 1 |
| Taylor, WJ | 1 |
| Lang, TW | 1 |
| Boszormenyi, E | 1 |
| Carvalho, M | 1 |
| Gold, H | 1 |
| Goldman, A | 1 |
| Rosselot, E | 1 |
| Vick, RL | 1 |
| Krofta, K | 1 |
| Schröder, R | 1 |
| Dissmann, W | 1 |
| Buschmann, HJ | 1 |
| Schneider, J | 1 |
| Sykes, MK | 1 |
| Orr, DS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Scheme of Primary Prevention of Infection by COVID-19, in Workers: Phase II Controlled Clinical Trial, to be Carried Out in Medellín-Antioquia[NCT04420260] | 152 participants (Actual) | Interventional | 2021-03-18 | Completed | |||
| Effect of Moringa Oleifera on Bone Density in Post-Menopausal Women[NCT03026660] | 20 participants (Actual) | Interventional | 2015-07-31 | Completed | |||
| Phase III Study of Metabolic Intervention With Glutamate in Coronary Surgery II[NCT02592824] | Phase 3 | 321 participants (Actual) | Interventional | 2015-11-15 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Postoperative mortality was defined as mortality within 30 days of surgery. (NCT02592824)
Timeframe: up to 30 days
| Intervention | Participants (Count of Participants) |
|---|---|
| Intravenous Glutamate Infusion | 1 |
| Intravenous Saline Infusion | 6 |
suspected unexpected serious adverse reaction (NCT02592824)
Timeframe: within 24 hours from infusion
| Intervention | Participants (Count of Participants) |
|---|---|
| Intravenous Glutamate Infusion | 0 |
| Intravenous Saline Infusion | 0 |
"Postoperative stroke was defined as neurological or cognitive deficit with a cerebral injury verified on (Computed Tomography) CT-scan. All suspected cases of stroke underwent CT-scan.~Stroke within 24 h of surgery was defined as a stroke that occurred within 24 h of surgery or signs of a stroke, when first assessable in deeply sedated patients on a ventilator." (NCT02592824)
Timeframe: within 24 hours from surgery
| Intervention | Participants (Count of Participants) |
|---|---|
| Intravenous Glutamate Infusion | 0 |
| Intravenous Saline Infusion | 4 |
"Postoperative increase of NT-proBNP reflects postoperative myocardial dysfunction sustained in association with surgery. NT-proBNP usually peaks on the third to fourth postoperative day after coronary artery bypass surgery.~In the first GLUTAMICS trial a good agreement between hemodynamic criteria for postoperative heart failure and postoperative NT-proBNP was found." (NCT02592824)
Timeframe: from the day before surgery to the third postoperative day
| Intervention | ng/L (Mean) |
|---|---|
| Intravenous Glutamate Infusion | 5390 |
| Intravenous Saline Infusion | 6452 |
"Postoperative increase of NT-proBNP reflects postoperative myocardial dysfunction sustained in association with surgery. NT-proBNP usually peaks on the third to fourth postoperative day after coronary artery bypass surgery.~Previous observations suggest a blunted effect of glutamate in diabetic hearts." (NCT02592824)
Timeframe: from preoperative level to the third postoperative day
| Intervention | ng/L (Mean) |
|---|---|
| Intravenous Glutamate Infusion | 4503 |
| Intravenous Saline Infusion | 6825 |
Postoperative NT-proBNP reflects postoperative myocardial dysfunction. (NCT02592824)
Timeframe: first postoperative day
| Intervention | ng/L (Mean) |
|---|---|
| Intravenous Glutamate Infusion | 4438 |
| Intravenous Saline Infusion | 4420 |
Postoperative NT-proBNP reflects postoperative myocardial dysfunction. (NCT02592824)
Timeframe: third postoperative day
| Intervention | ng/L (Mean) |
|---|---|
| Intravenous Glutamate Infusion | 8055 |
| Intravenous Saline Infusion | 8804 |
49 reviews available for isoproterenol and Cardiovascular Stroke
| Article | Year |
|---|---|
Molecular understanding of the protective role of natural products on isoproterenol-induced myocardial infarction: A review.
Topics: Animals; Biological Products; Humans; Isoproterenol; Lipid Peroxidation; Myocardial Infarction; Oxid | 2017 |
Isoproterenol-induced cardiac ischemia and fibrosis: Plant-based approaches for intervention.
Topics: Alkaloids; Animals; Fibrosis; Flavonoids; Glycosides; Heart; Humans; Isoproterenol; Myocardial Infar | 2018 |
EXPERIMENTAL CARDIAC NECROSIS.
Topics: Chlorides; Desoxycorticosterone; Dihydrotachysterol; Heart; Humans; Hypokalemia; Isoproterenol; Magn | 1963 |
STUDIES ON INFARCT-LIKE MYOCARDIAL NECROSIS PRODUCED BY ISOPROTERENOL: A REVIEW.
Topics: Desoxycorticosterone; Dogs; Epinephrine; Heart Diseases; Hyperthyroidism; Hypokalemia; Isoproterenol | 1963 |
The role of diuretics and inotropic therapy in failure associated with myocardial infarction.
Topics: Acute Disease; Blood Pressure; Cardiac Complexes, Premature; Cardiotonic Agents; Chronic Disease; Di | 1984 |
Acute myocardial infarction--coronary thrombosis and salvage of the ischemic myocardium.
Topics: Adrenergic beta-Antagonists; Calcium Channel Blockers; Collateral Circulation; Coronary Circulation; | 1983 |
Pharmacologic support in cardiogenic shock.
Topics: Animals; Cardiotonic Agents; Diagnosis, Differential; Digitalis Glycosides; Diuretics; Dobutamine; D | 1983 |
Parasympathetic effects on electrophysiologic properties of cardiac ventricular tissue.
Topics: Acetylcholine; Action Potentials; Animals; Arrhythmias, Cardiac; Atropine; Catecholamines; Cats; Dig | 1983 |
Inotropic agents in the treatment of cardiogenic shock.
Topics: Cardiac Output, Low; Cardiac Tamponade; Cardiotonic Agents; Catecholamines; Digitalis; Dobutamine; D | 1983 |
Right precordial coved ST-T segment elevation in a healthy subject evaluated by isoproterenol infusion test. A case report.
Topics: Aged; Chest Pain; Diagnosis, Differential; Electrocardiography; Female; Humans; Isoproterenol; Myoca | 1994 |
Clinical usefulness of the beta-adrenergic antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Angina Pectoris; Antihypertensive Agents; Anx | 1978 |
Influence of environmental stress on pathogenesis of sudden cardiac death.
Topics: Adenosine Triphosphate; Animals; Catecholamines; Coronary Circulation; Coronary Disease; Death, Sudd | 1977 |
Myocardial ischemia (second of three parts).
Topics: Acute Disease; Animals; Coronary Disease; Creatine Kinase; Dogs; Fatty Acids; Fatty Acids, Nonesteri | 1977 |
[Experimental models for the pharmacologic study of anti-arrhythmia drugs].
Topics: Aconitine; Animals; Anti-Arrhythmia Agents; Aprindine; Coronary Vessels; Dogs; Drug Evaluation, Prec | 1977 |
Use of catecholamines in acute myocardial infarction.
Topics: Animals; Blood Volume; Catecholamines; Dobutamine; Dogs; Dopamine; Epinephrine; Hemodynamics; Humans | 1979 |
Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion.
Topics: Anaerobiosis; Animals; Dogs; Humans; Hyaluronoglucosaminidase; Hydrocortisone; Insulin; Isoprotereno | 1976 |
Current concepts on mechanisms and treatment of cardiogenic shock.
Topics: Adrenal Cortex Hormones; Aged; Blood Pressure Determination; Cardiac Output; Coronary Vessels; Digit | 1976 |
Dynamics of n-3 and n-6 fatty acids in phospholipids of heart muscle.
Topics: Aging; Animals; Animals, Newborn; Catecholamines; Death, Sudden; Dietary Fats; Fatty Acids, Unsatura | 1989 |
Effects of magnesium deficiency on the pathogenesis of myocardial infarction.
Topics: Action Potentials; Animals; Arteritis; Calcium; Cardiomyopathies; Cricetinae; Dogs; Electrolytes; Is | 1986 |
Early abnormalities in myocardial cell function in experimental diabetes.
Topics: Adenosine Triphosphate; Adult; Animals; Blood Glucose; Calcium; Calcium-Transporting ATPases; Catech | 1986 |
Magnesium deficiency cardiomyopathy.
Topics: Animals; Cardiomyopathies; Coronary Vessels; Humans; Isoproterenol; Magnesium Deficiency; Myocardial | 1988 |
Practical considerations in the management of shock complicating acute myocardial infarction. A summary of current practice.
Topics: Acute Disease; Arrhythmias, Cardiac; Atropine; Blood Pressure Determination; Central Venous Pressure | 1970 |
[Treatment of arrhythmia at coronary care units].
Topics: Adult; Aged; Ajmaline; Animals; Arrhythmias, Cardiac; Atropine; Bretylium Compounds; Cardiac Complex | 1974 |
The failing myocardium. I. Drug management.
Topics: Adrenergic alpha-Antagonists; Adult; Aged; Atropine; Blood Pressure; Blood Volume; Cardiac Output; D | 1973 |
Beta adrenergic blocking drugs in the treatment of cardiac arrhythmias.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillatio | 1970 |
The pathophysiologic vulnerability of the subendocardium of the left ventricle.
Topics: Arrhythmias, Cardiac; Capillaries; Cardiomegaly; Coronary Disease; Coronary Vessels; Endocardium; He | 1973 |
[Role of the sympathetic factor in the pathogenesis of myocardial infarct and isoproterenol necrosis].
Topics: Adenosine Monophosphate; Adenosine Triphosphate; Catecholamines; Cyclic AMP; Humans; Isoproterenol; | 1971 |
Cardiogenic shock. Recent advances in pharmacologic management. II.
Topics: Adenylyl Cyclases; Adrenal Cortex Hormones; Catecholamines; Cyclic AMP; Depression, Chemical; Digita | 1973 |
[Adrenergic alpha and beta receptors and their specific inhibitors].
Topics: Action Potentials; Angina Pectoris; Arrhythmias, Cardiac; Blood Circulation; Cardiomyopathy, Hypertr | 1968 |
Bradyarrhythmias in acute myocardial infarction.
Topics: Atropine; Bradycardia; Coronary Circulation; Coronary Vessels; Heart Block; Heart Conduction System; | 1972 |
Myocardial infarction complicated by conduction defect.
Topics: Atropine; Coronary Circulation; Electrocardiography; Heart Block; Heart Conduction System; Heart Rat | 1973 |
[Shock and MDF].
Topics: Aged; Animals; Arrhythmias, Cardiac; Cats; Dogs; Electrocardiography; Female; Glucagon; Heart; Human | 1972 |
New developments and therapeutic applications of cardiac stimulating agents.
Topics: Cardiac Output; Catecholamines; Digitalis Glycosides; Digitoxin; Digoxin; Dopamine; Glucagon; Heart; | 1973 |
Reduction of infarct size following coronary occlusion.
Topics: Anaerobiosis; Animals; Assisted Circulation; Coronary Vessels; Creatine Kinase; Electrocardiography; | 1974 |
Rational therapeutic approach to cardiogenic shock.
Topics: Anticoagulants; Blood Gas Analysis; Blood Volume; Cardiac Catheterization; Dopamine; Electrocardiogr | 1974 |
Cardiogenic shock.
Topics: Arrhythmias, Cardiac; Assisted Circulation; Central Venous Pressure; Dopamine; Emergencies; Hemodyna | 1974 |
The physiologic basis for treatment of shock associated with myocardial infarction.
Topics: Aged; Blood Pressure; Cardiac Output; Dextrans; Female; Hemodynamics; Humans; Hypotension; Isoproter | 1967 |
A review of current concepts and research in shock.
Topics: Blood Transfusion; Extracellular Space; Homeostasis; Humans; Hypoxia; Isoproterenol; Mephentermine; | 1968 |
Advances in medicine.
Topics: Acute Kidney Injury; Asthma; Blindness; Catecholamines; Contraceptives, Oral; Coronary Disease; Guan | 1968 |
[Modern trends in physiopathology and therapy of shock caused by myocardial infarct].
Topics: Adrenal Cortex Hormones; Digitalis Glycosides; Glucagon; Humans; Isoproterenol; Myocardial Infarctio | 1969 |
Power failure in acute myocardial infarction.
Topics: Angiocardiography; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Assisted Circulation; Blood Pressur | 1970 |
Pathophysiology and therapy of the shock of myocardial infarction.
Topics: Acute Disease; Animals; Coronary Vessels; Digitalis Glycosides; Dilatation; Disease Models, Animal; | 1970 |
The treatment of arrhythmias following acute myocardial infarction.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atropine; Bradycardia; Coronary Care Units; Digitalis Gly | 1971 |
Prevention and treatment of ventricular dysrhythmias.
Topics: Arrhythmias, Cardiac; Atropine; Coronary Care Units; Electric Countershock; Heart Block; Humans; Iso | 1971 |
The patient in shock. I.
Topics: Aged; Anesthesia, Epidural; Anesthesia, General; Arrhythmias, Cardiac; Arteries; Blood Pressure; Cal | 1971 |
Management of arrhythmias in acute myocardial infarction.
Topics: Acid-Base Equilibrium; Adams-Stokes Syndrome; Arrhythmias, Cardiac; Atropine; Bradycardia; Cardiac O | 1971 |
Shock in myocardial infarction--medical treatment.
Topics: Animals; Blood Pressure; Coronary Vessels; Digitalis Glycosides; Dogs; Dopamine; Glucagon; Glucose; | 1970 |
The pluricausal cardiopathies.
Topics: Animals; Anti-Bacterial Agents; Antimalarials; Calcinosis; Cardiac Glycosides; Deficiency Diseases; | 1969 |
Management of cardiac dysrhythmias complicating acute myocardial infarction.
Topics: Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Atropine; Bradycardia; Bretylium Compound | 1968 |
7 trials available for isoproterenol and Cardiovascular Stroke
| Article | Year |
|---|---|
[Prevention of sudden death in myocardial infarct: do experimental results help to understand the clinical reality? The case of the clinical trial SWORD (Survival With ORal D-sotalol)].
Topics: Acute Disease; Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Drug Therapy, Combination; Femal | 1996 |
The effect of antilipolytic agents on cyclic AMP, free fatty acid and total catecholamine concentrations in plasma.
Topics: Acute Disease; Animals; Catecholamines; Clinical Trials as Topic; Cyclic AMP; Dogs; Fatty Acids, Non | 1976 |
[Determination of myocardial contractility using ultrasonic echography].
Topics: Cardiac Output; Clinical Trials as Topic; Coronary Disease; Echocardiography; Heart Function Tests; | 1975 |
Letter: F.F.A., lipolysis, and myocardial infarction.
Topics: Animals; Clinical Trials as Topic; Dogs; Fatty Acids, Nonesterified; Heart; Humans; Hypolipidemic Ag | 1974 |
Use of drugs in cardiogenic shock due to acute myocardial infarction.
Topics: Acute Disease; Blood Pressure; Central Venous Pressure; Chlorpromazine; Clinical Trials as Topic; De | 1972 |
Coronary perfusion versus cold ischemic arrest during aortic valve surgery. A randomized study.
Topics: Adult; Aged; Aortic Valve; Arrhythmias, Cardiac; Cardiac Catheterization; Cardiac Output; Creatine K | 1974 |
Effect of drugs on myocardial contractility in the intact dog and in experimental myocardial infarction.
Topics: Animals; Clinical Trials as Topic; Dogs; Heart; Isoproterenol; Metaraminol; Methoxamine; Muscle Cont | 1968 |
1033 other studies available for isoproterenol and Cardiovascular Stroke
| Article | Year |
|---|---|
Visnagin prevents isoproterenol-induced myocardial injury by attenuating oxidative stress and inflammation and upregulating Nrf2 signaling in rats.
Topics: Adrenergic beta-Agonists; Animals; Inflammation; Isoproterenol; Khellin; Male; Myocardial Infarction | 2021 |
Cardioprotective Potential of Garlic Oil and Its Active Constituent, Diallyl Disulphide, in Presence of Carvedilol during Chronic Isoprenaline Injection-Mediated Myocardial Necrosis in Rats.
Topics: Allyl Compounds; Animals; Antioxidants; Cardiotonic Agents; Carvedilol; Catalase; Disease Models, An | 2021 |
L-carnitine protects cardiac damage by reducing oxidative stress and inflammatory response via inhibition of tumor necrosis factor-alpha and interleukin-1beta against isoproterenol-induced myocardial infarction.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Carnitine; Disease Models, Animal; Fibrosis; Inflam | 2021 |
Effects of pinealectomy and crocin treatment on rats with isoproterenol-induced myocardial infarction.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cardiotonic Agents; Carotenoids; Catalase; Glutathi | 2022 |
Protective Effects and Mechanisms of Recombinant Human Glutathione Peroxidase 4 on Isoproterenol-Induced Myocardial Ischemia Injury.
Topics: Animals; Apoptosis; Biomarkers; Cell Line; Disease Models, Animal; Electrocardiography; Humans; Isop | 2021 |
In Vivo and In Vitro Cardioprotective Effect of Gossypin Against Isoproterenol-Induced Myocardial Infarction Injury.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Cardiotox | 2022 |
Effect of chronic alcohol consumption on myocardial apoptosis in the rat model of isoproterenol-induced myocardial injury and investigation on the cardioprotective role of calpain inhibitor 1.
Topics: Alcohol Drinking; Alcoholism; Animals; Apoptosis; Calpain; Cardiolipins; Caspase 3; Cytochromes c; D | 2022 |
Ghrelin ameliorated inflammation and oxidative stress in isoproterenol induced myocardial infarction through the endothelial nitric oxide synthase (eNOS)/nuclear factor erythroid 2-related factor-2 (NRF2)/heme oxygenase-1 (HO-1) signaling pathway.
Topics: Animals; Ghrelin; Heme Oxygenase-1; Inflammation; Isoproterenol; Myocardial Infarction; Myocytes, Ca | 2021 |
Cardiac aorta-derived extracellular matrix scaffold enhances critical mediators of angiogenesis in isoproterenol-induced myocardial infarction mice.
Topics: Animals; Aorta; Cell Survival; Extracellular Matrix; Isoproterenol; Male; Malondialdehyde; Mice; Mus | 2021 |
Alpha-terpineol prevents myocardial damage against isoproterenol-MI induced in Wistar-Kyoto rats: new possible to promote cardiovascular integrity.
Topics: Animals; Antioxidants; Biomarkers; Cardiotonic Agents; Cardiotoxicity; Cardiovascular Diseases; Cycl | 2022 |
Thymoquinone attenuates isoproterenol-induced myocardial infarction by inhibiting cytochrome C and matrix metalloproteinase-9 expression.
Topics: Animals; Apoptosis; Benzoquinones; Biomarkers; Cytochromes c; Gene Expression Regulation, Enzymologi | 2022 |
Pharmacological evaluation of Vitis vinifera and Zingiber zerumbet on electrocardiographic, biochemical alterations and antioxidant status in isoproterenol-induced myocardial infarction in rats.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Blood Cell Count; Blood Pressure; Cardiotonic Agent | 2021 |
Ethyl pyruvate attenuates isoproterenol-induced myocardial infarction in rats: Insight to TNF-α-mediated apoptotic and necroptotic signaling interplay.
Topics: Animals; Isoproterenol; Myocardial Infarction; Myocardium; Oxidative Stress; Pyruvates; Rats; Tumor | 2022 |
Antithrombotic Activity of the Antiplatelet Agent Angipur on the Model of Arterial Thrombosis in Rats with Isoproterenol-Induced Myocardial Infarction.
Topics: Animals; Fibrinolytic Agents; Isoproterenol; Myocardial Infarction; Platelet Aggregation Inhibitors; | 2022 |
Nerolidol attenuates isoproterenol-induced acute myocardial infarction in rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, Drug; | 2022 |
Topics: Animals; Artocarpus; Hemoglobins; Isoproterenol; Male; Myocardial Infarction; Oxygen; Plant Extracts | 2022 |
Indole-3-carbinol ameliorated the isoproterenol-induced myocardial infarction via multimodal mechanisms in Wistar rats.
Topics: Animals; Indoles; Isoproterenol; Myocardial Infarction; Rats; Rats, Wistar | 2022 |
Metabolomics analysis delineates the therapeutic effects of hydroethanolic extract of Cucumis sativus L. seeds on hypertension and isoproterenol-induced myocardial infarction.
Topics: Animals; Cucumis sativus; Hypertension; Isoproterenol; Metabolomics; Myocardial Infarction; Myocardi | 2022 |
Attenuation of isoprenaline-induced myocardial infarction by Rheum turkestanicum.
Topics: Animals; Creatine Kinase; Dose-Response Relationship, Drug; Isoproterenol; L-Lactate Dehydrogenase; | 2022 |
Preventive effects of (-) epicatechin on tachycardia, cardiac hypertrophy, and nuclear factor- κB inflammatory signaling pathway in isoproterenol-induced myocardial infarcted rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Body Weight; Cardiomegaly; Catechin; Isoproterenol; | 2022 |
Metabolomics based mechanistic insights to vasorelaxant and cardioprotective effect of ethanolic extract of Citrullus lanatus (Thunb.) Matsum. & Nakai. seeds in isoproterenol induced myocardial infraction.
Topics: Animals; Cardiomegaly; Chromatography, Liquid; Citrullus; Ethanol; Humans; Isoproterenol; Metabolomi | 2022 |
Anethole's effects against myocardial infarction: The role of TLR4/NFκB and Nrf2/HO1 pathways.
Topics: Allylbenzene Derivatives; Animals; Anisoles; Antioxidants; Apoptosis; Heme Oxygenase-1; Inflammation | 2022 |
Valencene post-treatment exhibits cardioprotection via inhibiting cardiac hypertrophy, oxidative stress, nuclear factor- κB inflammatory pathway, and myocardial infarct size in isoproterenol-induced myocardial infarcted rats; A molecular study.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Biomarkers; Body Weight; Cardiomegaly; Inflammation | 2022 |
Potential cardioprotective effect of octreotide via NOXs mitigation, mitochondrial biogenesis and MAPK/Erk1/2/STAT3/NF-kβ pathway attenuation in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Biomarkers; Isoproterenol; Myocardial Infarction; Myocardium; Octreotide; Organelle Biogene | 2022 |
Geraniol enhances peroxiredoxin-1, and prevents isoproterenol-induced oxidative stress and inflammation associated with myocardial infarction in experimental animal models.
Topics: Acyclic Monoterpenes; Animals; Antioxidants; Inflammation; Isoproterenol; Lipid Peroxidation; Lipid | 2022 |
The effects of exercise training on heart, brain and behavior, in the isoproterenol-induced cardiac infarct model in middle-aged female rats.
Topics: Animals; Brain; Female; Humans; Isoproterenol; Myocardial Infarction; Myocardium; Rats; Rats, Wistar | 2022 |
A novel synthetised sulphonylhydrazone coumarin (E)-4-methyl-N'-(1-(3-oxo-3H-benzo[f]chromen-2- yl)ethylidene)benzenesulphonohydrazide protect against isoproterenol-induced myocardial infarction in rats by attenuating oxidative damage, biological changes
Topics: Animals; Antioxidants; Body Weight; Cardiotonic Agents; Catalase; Coumarins; Electrocardiography; Gl | 2022 |
In vivo evaluation and molecular docking studies of Schinus molle L. fruit extract protective effect against isoproterenol-induced infarction in rats.
Topics: Anacardiaceae; Animals; Antioxidants; bcl-2-Associated X Protein; Biomarkers; Caspase 3; Catechin; F | 2022 |
Effect of Fraxetin on Oxidative Damage Caused by Isoproterenol-Induced Myocardial Infarction in Rats.
Topics: Animals; Antioxidants; Coumarins; Glutathione; Isoproterenol; Lipid Peroxidation; Mice; Myocardial I | 2022 |
Thymoquinone Produces Cardioprotective Effect in β-Receptor Stimulated Myocardial Infarcted Rats via Subsiding Oxidative Stress and Inflammation.
Topics: Animals; Benzoquinones; Cardiotonic Agents; Heart; Inflammation; Isoproterenol; Lipid Peroxidation; | 2022 |
Bergapten mediated inflammatory and apoptosis through AMPK/eNOS/AKT signaling pathway of isoproterenol-induced myocardial infarction in Wistar rats.
Topics: 5-Methoxypsoralen; AMP-Activated Protein Kinases; Animals; Anti-Inflammatory Agents; Antioxidants; A | 2022 |
S-limonene protects the heart in an experimental model of myocardial infarction induced by isoproterenol: Possible involvement of mitochondrial reactive oxygen species.
Topics: Animals; Antioxidants; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Heart Injuries; Isoproter | 2022 |
Evaluation of rosmarinic acid against myocardial infarction in maternally separated rats.
Topics: Animals; Body Weight; Brain-Derived Neurotrophic Factor; Cinnamates; Corticosterone; Depsides; Fluox | 2022 |
Thymoquinone regulates nitric oxide synthase enzymes and receptor-interacting serine-threonine kinases in isoproterenol-induced myocardial infarcted rats.
Topics: Animals; Benzoquinones; Isoproterenol; Myocardial Infarction; Myocardium; Myocytes, Cardiac; Nitric | 2022 |
β-caryophyllene modulates B-cell lymphoma gene-2 family genes and inhibits the intrinsic pathway of apoptosis in isoproterenol-induced myocardial infarcted rats; A molecular mechanism.
Topics: Animals; Antioxidants; Apoptosis; Body Weight; Chlorides; Glucuronidase; Isoproterenol; Lipid Peroxi | 2022 |
Comparative Efficacy of Levosimendan, Ramipril, and Sacubitril/ Valsartan in Isoproterenol-induced Experimental Heart Failure: A Hemodynamic and Molecular Approach.
Topics: Antioxidants; Calcium; Collagen; Heart Failure; Hemodynamics; Humans; Isoproterenol; Myocardial Infa | 2023 |
Network Pharmacology-Based Combined with Experimental Validation Study to Explore the Underlying Mechanism of
Topics: Agrimonia; Animals; Antioxidants; Aspartic Acid; bcl-2-Associated X Protein; Caspase 3; Creatine Kin | 2022 |
Cardioprotective Role of Scopoletin on Isoproterenol-Induced Myocardial Infarction in Rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Body Weight; Cardiotonic Agents; Isoproterenol; Myo | 2023 |
Protocatechuic acid reverses myocardial infarction mediated by β-adrenergic agonist via regulation of Nrf2/HO-1 pathway, inflammatory, apoptotic, and fibrotic events.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Isoproterenol; Myocardial Infarction; Myocytes, Car | 2023 |
Protective effects of Lacticaseibacillus rhamnosus on isoprenaline-induced myocardial infarction in rats.
Topics: Animals; Creatine Kinase; Humans; Interleukin-10; Isoproterenol; Lacticaseibacillus; Lacticaseibacil | 2023 |
Evidence of the Cardioprotective Effects of
Topics: Animals; Ethanol; Isoproterenol; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Verbenaceae | 2023 |
Vanillin and pentoxifylline ameliorate isoproterenol-induced myocardial injury in rats
Topics: Animals; Inflammation; Isoproterenol; Myocardial Infarction; Myocardium; Oxidative Stress; Pentoxify | 2023 |
The myokine decorin improves the cardiac function in a rat model of isoprenaline-induced myocardial infarction.
Topics: Animals; Caspase 3; Decorin; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats; Rats, Wis | 2023 |
Microbiome-metabolome reveals that the Suxiao Jiuxin pill attenuates acute myocardial infarction associated with fatty acid metabolism.
Topics: Animals; Drugs, Chinese Herbal; Fatty Acids; Isoproterenol; Metabolome; Metabolomics; Microbiota; My | 2023 |
The effect of bempedoic acid an ATP-citrate lyase inhibitor on cardiovascular risk factors in rats with experimentally induced myocardial infarction and hyperlipidemia.
Topics: Adenosine Triphosphate; Animals; Cardiovascular Diseases; Cholesterol, LDL; Enzyme Inhibitors; Fatty | 2022 |
Protective effects of β-caryophyllene on mitochondrial damage and cardiac hypertrophy pathways in isoproterenol-induced myocardial infarcted rats.
Topics: Animals; Antioxidants; Biomarkers; Body Weight; Cardiomegaly; Isoproterenol; Mitochondria, Heart; My | 2023 |
Effects of Taraxerol on Oxidative and Inflammatory Mediators in Isoproterenol-Induced Cardiotoxicity in an Animal Model.
Topics: Animals; Antioxidants; Cardiotoxicity; Disease Models, Animal; Inflammation Mediators; Isoproterenol | 2023 |
Curdione inhibits ferroptosis in isoprenaline-induced myocardial infarction via regulating Keap1/Trx1/GPX4 signaling pathway.
Topics: Animals; Ferroptosis; Glutathione; Isoproterenol; Kelch-Like ECH-Associated Protein 1; Mice; Molecul | 2023 |
Cardioprotective effects of Schisantherin A against isoproterenol-induced acute myocardial infarction through amelioration of oxidative stress and inflammation via modulation of PI3K-AKT/Nrf2/ARE and TLR4/MAPK/NF-κB pathways in rats.
Topics: Animals; Body Weight; Inflammation; Isoproterenol; Myocardial Infarction; NF-E2-Related Factor 2; NF | 2023 |
Effect of essential oil of Alpinia zerumbet on cardiovascular and autonomic function in rats with isoproterenol induced acute myocardial infarction.
Topics: Alpinia; Animals; Isoproterenol; Myocardial Infarction; Oils, Volatile; Plant Leaves; Rats; Rats, Wi | 2023 |
Anti-inflammatory, cardioprotective effect of gypenoside against isoproterenol-induced cardiac remodeling in rats via alteration of inflammation and gut microbiota.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cytokines; Gastrointestinal Microbiome; | 2023 |
Punicalagin attenuates myocardial oxidative damage, inflammation, and apoptosis in isoproterenol-induced myocardial infarction in rats: Biochemical, immunohistochemical, and in silico molecular docking studies.
Topics: Animals; Antioxidants; Apoptosis; Cytokines; Hydrolyzable Tannins; Inflammation; Isoproterenol; Mole | 2023 |
β-caryophyllene blocks reactive oxygen species-mediated hyperlipidemia in isoproterenol-induced myocardial infarcted rats.
Topics: Animals; Antioxidants; Body Weight; Cholesterol; Hyperlipidemias; Isoproterenol; Lipoproteins, LDL; | 2023 |
Cardioprotective effects of (
Topics: Animals; Benzopyrans; Biomarkers; Cardiotonic Agents; Coumarins; Disease Models, Animal; Electrocard | 2019 |
Anti-Ischemic Activity of Triamine ALM-802 under Conditions of Endothelial Dysfunction.
Topics: Animals; Electrophysiology; Hyperhomocysteinemia; Isoproterenol; Male; Myocardial Infarction; Ranola | 2019 |
Cardioprotective potential of
Topics: Animals; Antioxidants; Isoproterenol; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Spinaci | 2022 |
Pharmacodynamics and pharmacokinetics of Danshen in isoproterenol-induced acute myocardial ischemic injury combined with Honghua.
Topics: Administration, Oral; Animals; Carthamus tinctorius; China; Disease Models, Animal; Drug Combination | 2020 |
Effect of lncRNA GAS5 on rats with acute myocardial infarction through regulating miR-21.
Topics: Acute Disease; Animals; Disease Models, Animal; Injections, Subcutaneous; Isoproterenol; MicroRNAs; | 2019 |
Cardio protective role of wogonin loaded nanoparticle against isoproterenol induced myocardial infarction by moderating oxidative stress and inflammation.
Topics: Animals; Antioxidants; Biomarkers; Cardiotonic Agents; Cytokines; Drug Liberation; Flavanones; Heme | 2020 |
Protective Effect of Sciadopitysin against Isoproternol-Induced Myocardial Infarction in Rats.
Topics: Animals; Biflavonoids; Cardiotonic Agents; Heart; Isoproterenol; Male; Myocardial Infarction; Myocar | 2020 |
Gold nanoparticles synthesized from Euphorbia fischeriana root by green route method alleviates the isoprenaline hydrochloride induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Catalase; Creatine Kinase; Cytokines; Euphorbia; Gold; Green Chemistry Techno | 2020 |
Protective role of poly(lactic-co-glycolic) acid nanoparticle loaded with resveratrol against isoproterenol-induced myocardial infarction.
Topics: Animals; Antioxidants; Biocompatible Materials; Cardiotonic Agents; Disease Models, Animal; Isoprote | 2020 |
Rosuvastatin and retinoic acid may act as 'pleiotropic agents' against β-adrenergic agonist-induced acute myocardial injury through modulation of multiple signalling pathways.
Topics: Adrenergic beta-Agonists; Animals; Anticholesteremic Agents; Antineoplastic Agents; Body Weight; Hea | 2020 |
Therapeutic Potential of Biochanin-A Against Isoproterenol-Induced Myocardial Infarction in Rats.
Topics: Animals; Cardiotonic Agents; Genistein; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarcti | 2020 |
(E)-N'-(1-(7-Hydroxy-2-Oxo-2H-Chromen-3-Yl) Ethylidene) Benzohydrazide, a Novel Synthesized Coumarin, Ameliorates Isoproterenol-Induced Myocardial Infarction in Rats through Attenuating Oxidative Stress, Inflammation, and Apoptosis.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Benzopyrans; Biomarkers; Coumarins; Hydrazones; Inflam | 2020 |
Protective effects and chemical composition of Corchorus olitorius leaf fractions against isoproterenol-induced myocardial injury through p65NFkB-dependent anti-apoptotic pathway in rats.
Topics: Animals; Apoptosis; Cardiotonic Agents; Corchorus; Disease Models, Animal; Dose-Response Relationshi | 2020 |
The role of 5-HT7 receptors on isoproterenol-induced myocardial infarction in rats with high-fat diet exacerbated coronary endothelial dysfunction.
Topics: Animals; Cell Line; Cell Proliferation; Diet, High-Fat; Endothelium, Vascular; Heart; Isoproterenol; | 2020 |
Design and Development of Novel Pyrazole-Thiadiazole Derivatives as NF-ĸB Inhibitor and Cardioprotective Effect against Isoproterenol Induced Myocardial Infarction in Sprague-Dawley Rats.
Topics: Animals; Apoptosis; Cardiotonic Agents; Heart; Isoproterenol; Myocardial Infarction; Myocardium; Myo | 2020 |
Gentianella acuta prevents acute myocardial infarction induced by isoproterenol in rats via inhibition of galectin-3/TLR4/MyD88/NF-кB inflammatory signalling.
Topics: Animals; Apoptosis; Cardiotonic Agents; Cytokines; Galectin 3; Gentianella; Inflammation; Isoprotere | 2021 |
Beneficial effects of benfotiamine, a NADPH oxidase inhibitor, in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Biomarkers; Cardiotoxins; Disease Models, Animal; Electrocardiography; Enzyme Inhibitors; H | 2020 |
Alterations of medial prefrontal cortex bioelectrical activity in experimental model of isoprenaline-induced myocardial infarction.
Topics: Animals; Brain Waves; Disease Models, Animal; Electrocardiography; Electrocorticography; Electroence | 2020 |
The Expression of microRNA in Adult Rat Heart with Isoproterenol-Induced Cardiac Hypertrophy.
Topics: Aging; Animals; Atrial Natriuretic Factor; Base Sequence; Cardiomegaly; Gene Expression Regulation, | 2020 |
Role of nitric oxide in mediating the cardioprotective effect of agomelatine against isoproterenol-induced myocardial injury in rats.
Topics: Acetamides; Animals; Cardiotonic Agents; Isoproterenol; Male; Myocardial Infarction; Myocardium; NAD | 2020 |
Ex vivo and in vivo studies of Viola tricolor Linn. as potential cardio protective and hypotensive agent: Inhibition of voltage-gated Ca
Topics: Animals; Calcium Channels; Cardiotonic Agents; Hypotension; Isoproterenol; Male; Myocardial Infarcti | 2020 |
Fasudil protects against isoproterenol-induced myocardial infarction in mice via inhibiting Rho/ROCK signaling pathway.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Dose-Response Relationship, Drug; Injections | 2020 |
Cardioprotective effects of memantine in myocardial ischemia: Ex vivo and in vivo studies.
Topics: Animals; Cardiomegaly; Cardiotonic Agents; Isoproterenol; Lipid Peroxidation; Male; Malondialdehyde; | 2020 |
Hirudin protects against isoproternol-induced myocardial infraction by alleviating oxidative via an Nrf2 dependent manner.
Topics: Animals; Apoptosis; Cardiotonic Agents; Cell Hypoxia; Cell Line; Cell Survival; Creatine Kinase, MB | 2020 |
Intermittent β-adrenergic blockade downregulates the gene expression of β-myosin heavy chain in the mouse heart.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Down-Regulation; Female; Isoproteren | 2020 |
Protective effect of alpha-pinene against isoproterenol-induced myocardial infarction through NF-κB signaling pathway.
Topics: Adrenergic beta-Agonists; Animals; Anti-Inflammatory Agents; Bicyclic Monoterpenes; Cardiotonic Agen | 2020 |
Preparation of Ginkgolide Solid Dispersions with Low-Molecular-Weight Chitosan and Assessment of their Protective Effect on Isoproterenol- Induced Myocardial Injury.
Topics: Administration, Oral; Animals; Area Under Curve; Biological Availability; Cardiotonic Agents; Chitos | 2020 |
Sinapic acid safeguards cardiac mitochondria from damage in isoproterenol-induced myocardial infarcted rats.
Topics: Adrenergic beta-Agonists; Animals; Biomarkers; Cardiotonic Agents; Coumaric Acids; Isoproterenol; Ma | 2020 |
Arbutin prevents alterations in mitochondrial and lysosomal enzymes in isoproterenol-induced myocardial infarction: An in vivo study.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arbutin; Cathep | 2021 |
Protective Effects of Allicin on ISO-Induced Rat Model of Myocardial Infarction via JNK Signaling Pathway.
Topics: Animals; Antioxidants; Apoptosis; Disease Models, Animal; Disulfides; Isoproterenol; JNK Mitogen-Act | 2020 |
Novel thiazole-pyrazolone hybrids as potent ACE inhibitors and their cardioprotective effect on isoproterenol-induced myocardial infarction.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Apoptosis Regulatory Proteins; Cytokin | 2020 |
Beneficial effect of sodium thiosulfate extends beyond myocardial tissue in isoproterenol model of infarction: Implication for nootropic effects.
Topics: Animals; Behavior, Animal; Disease Models, Animal; Heart; Hydrogen Sulfide; Isoproterenol; Male; Mit | 2020 |
The protective effect of piperine against isoproterenol-induced inflammation in experimental models of myocardial toxicity.
Topics: Adrenergic beta-Agonists; Alkaloids; Animals; Benzodioxoles; Cardiomegaly; Cytokines; Endothelium; F | 2020 |
Protective Effect of Boric Acid and Omega-3 on Myocardial Infarction in an Experimental Rat Model.
Topics: Animals; Boric Acids; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Da | 2021 |
Regenerative Potential of a Suspension and Spheroids of Multipotent Mesenchymal Stromal Cells from Human Umbilical Cord on the Model of Myocardial Infarction in Rats.
Topics: Animals; Disease Models, Animal; Endomyocardial Fibrosis; Heart Ventricles; Humans; Isoproterenol; M | 2020 |
Ameliorative effect of ferruginol on isoprenaline hydrochloride-induced myocardial infarction in rats.
Topics: Abietanes; Animals; Antioxidants; Biomarkers; Catalase; Disease Models, Animal; Glutathione Peroxida | 2021 |
Ivabradine improves survival and attenuates cardiac remodeling in isoproterenol-induced myocardial injury.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Heart Failure; Isoproterenol; Ivabradine; Male; | 2021 |
Adrenergic supersensitivity and impaired neural control of cardiac electrophysiology following regional cardiac sympathetic nerve loss.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium; Cardiac Electrophysiology; Heart; Isoprot | 2020 |
Anti-inflammatory and anti-apoptotic effect of zingiberene on isoproterenol-induced myocardial infarction in experimental animals.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Humans; Inflammation; Isoproterenol; Male; Models, Ani | 2021 |
Type 2 MI induced by a single high dose of isoproterenol in C57BL/6J mice triggers a persistent adaptive immune response against the heart.
Topics: Adaptive Immunity; Adoptive Transfer; Animals; Dendritic Cells; Disease Models, Animal; Female; Fibr | 2021 |
Early nebivolol treatment is beneficial in myocardial infarction in rats partly through β3-adrenoceptor remodelling.
Topics: Adrenergic beta-Antagonists; Animals; Isoproterenol; Male; Myocardial Infarction; Nebivolol; Rats; R | 2021 |
Kuanxiong aerosol inhibits apoptosis and attenuates isoproterenol-induced myocardial injury through the mitogen-activated protein kinase pathway.
Topics: Aerosols; Animals; Apoptosis; bcl-2-Associated X Protein; Cardiotonic Agents; Caspase 3; Down-Regula | 2021 |
Calycosin reduces infarct size, oxidative stress and preserve heart function in isoproterenol-induced myocardial infarction model.
Topics: Animals; Antioxidants; Apoptosis; Apoptosis Regulatory Proteins; Cardiovascular Agents; Disease Mode | 2020 |
Protective effects of myrrh essential oil on isoproterenol-induced myocardial infarction in rats through antioxidant, anti-inflammatory, Nrf2/HO-1 and apoptotic pathways.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Biomarkers; Blood Pressure; Cardiotonic | 2021 |
Effect of engineered superparamagnetic iron oxide nanoparticles in targeted cardiac precursor cell delivery by MRI.
Topics: Animals; Antibodies, Monoclonal; Cell Separation; Drug Delivery Systems; Echocardiography; Injection | 2021 |
The cardioprotective effect of microRNA-103 inhibitor against isoprenaline-induced myocardial infarction in mice through targeting FADD/RIPK pathway.
Topics: Animals; Cardiotonic Agents; Fas-Associated Death Domain Protein; Isoproterenol; Male; Mice; MicroRN | 2021 |
Cardiopreventive capacity of a novel (E)-N'-(1-(7-methoxy-2-oxo-2H-chromen-3-yl) ethylidene)-4-methylbenzenesulfonohydrazide against isoproterenol-induced myocardial infarction by moderating biochemical, oxidative stress, and histological parameters.
Topics: Animals; Benzenesulfonates; Cardiotonic Agents; Isoproterenol; Male; Myocardial Infarction; Myocardi | 2021 |
Nootkatone attenuates myocardial oxidative damage, inflammation, and apoptosis in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Apoptosis; Heart; Inflammation; Isoproterenol; Male; Myocardial Infarction; Myocardium; Oxi | 2021 |
Attenuation of lipid metabolic abnormalities, proinflammatory cytokines, and matrix metalloproteinase expression by biochanin-A in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Cytokines; Inflammation; Interleukin-6; Isoproterenol; Lipids; Matrix Metalloproteinase 2; | 2022 |
Human amniotic membrane mesenchymal stem cells exert cardioprotective effects against isoproterenol (ISO)-induced myocardial injury through suppression of inflammation and modulation of inflammatory MAPK/NF-κB pathway.
Topics: Amnion; Humans; Inflammation; Isoproterenol; Mesenchymal Stem Cells; Myocardial Infarction; NF-kappa | 2022 |
Nanostructured lipid carriers of isradipine for effective management of hypertension and isoproterenol induced myocardial infarction.
Topics: Administration, Oral; Animals; Antioxidants; Drug Carriers; Hypertension; Isoproterenol; Isradipine; | 2022 |
Translocator Protein Modulation by 4'-Chlorodiazepam and NO Synthase Inhibition Affect Cardiac Oxidative Stress, Cardiometabolic and Inflammatory Markers in Isoprenaline-Induced Rat Myocardial Infarction.
Topics: Animals; Benzodiazepinones; Biomarkers; Carrier Proteins; Enzyme Inhibitors; Glutathione Peroxidase; | 2021 |
Passiflora edulis (var. Flavicarpa) Juice Supplementation Mitigates Isoproterenol-induced Myocardial Infarction in Rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Dietary Supplements; Isoproterenol; Myocardial Infarction | 2021 |
Time-dependent influence of infliximab on hemodynamic responses and cardiac injuries of isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Body Weight; Disease Models, Animal; Heart Injuries | 2021 |
Nuciferine from Nelumbo nucifera Gaertn. attenuates isoproterenol-induced myocardial infarction in Wistar rats.
Topics: Animals; Antioxidants; Aporphines; Body Weight; Isoproterenol; Myocardial Infarction; Myocardium; Ne | 2022 |
Andrographolide protects against isoproterenol-induced myocardial infarction in rats through inhibition of L-type Ca
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Cardiotonic Agents; | 2021 |
Rosuvastatin and low-dose carvedilol combination protects against isoprenaline-induced myocardial infarction in rats: Role of PI3K/Akt/Nrf2/HO-1 signalling.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anticholesteremic Agents; Apoptosis; | 2021 |
Inhibition of double stranded RNA dependent protein kinase (PKR) abrogates isoproterenol induced myocardial ischemia in vitro in cultured cardiomyocytes and in vivo in wistar rats.
Topics: Animals; Cell Line; Disease Models, Animal; eIF-2 Kinase; Fibrosis; Heart; Humans; Isoproterenol; Ma | 2021 |
The cardioprotective effect of astaxanthin against isoprenaline-induced myocardial injury in rats: involvement of TLR4/NF-κB signaling pathway.
Topics: Animals; Cardiotonic Agents; Isoproterenol; Male; Malondialdehyde; Myocardial Infarction; Myocardium | 2021 |
Thymoquinone dose-dependently attenuates myocardial injury induced by isoproterenol in rats via integrated modulations of oxidative stress, inflammation, apoptosis, autophagy, and fibrosis.
Topics: Animals; Antioxidants; Apoptosis; Autophagy; Benzoquinones; Cardiotonic Agents; Disease Progression; | 2021 |
Exploring cardioprotective potential of esculetin against isoproterenol induced myocardial toxicity in rats: in vivo and in vitro evidence.
Topics: Adrenergic beta-Agonists; Animals; Arsenic; Biphenyl Compounds; Cardiotonic Agents; Cell Line; Cell | 2021 |
Lutein exerts its cardioprotective effect against the experimental model of isoprenaline-induced myocardial infarction via MIAT/miR-200a/Nrf2/TXINP pathway.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Isoproterenol; Lutein; MicroRNAs; Myocardial In | 2021 |
Aqueous extract from leaf of Artocarpus altilis provides cardio-protection from isoproterenol induced myocardial damage in rats: Negative chronotropic and inotropic effects.
Topics: Animals; Artocarpus; Cardiotonic Agents; Dose-Response Relationship, Drug; Herb-Drug Interactions; I | 2017 |
Comprehensive metabonomic analysis of heart tissue from isoproterenol-induced myocardial infarction rat based on reversed-phase and hydrophilic interaction chromatography coupled to mass spectrometry.
Topics: Animals; Chromatography, High Pressure Liquid; Heart; Hydrophobic and Hydrophilic Interactions; Isop | 2017 |
The Protective Effect of Apigenin on Myocardial Injury in Diabetic Rats mediating Activation of the PPAR-γ Pathway.
Topics: Anilides; Animals; Apigenin; Blotting, Western; Cardiotonic Agents; Creatine Kinase, MB Form; Diabet | 2017 |
Protective Role of N-Acetylcysteine on Isoprenaline-Induced Myocardial Injury: Histological, Immunohistochemical and Morphometric Study.
Topics: Acetylcysteine; Actins; Animals; Collagen; Cytoprotection; Disease Models, Animal; Immunohistochemis | 2018 |
Cardioprotective Effects of Malvidin Against Isoproterenol-Induced Myocardial Infarction in Rats: A Mechanistic Study.
Topics: Animals; Anthocyanins; Antioxidants; Catalase; Enzyme-Linked Immunosorbent Assay; Glutathione Peroxi | 2017 |
Astaxanthin Prevented Oxidative Stress in Heart and Kidneys of Isoproterenol-Administered Aged Rats.
Topics: Animals; Antioxidants; Cardiomegaly; Heart; Isoproterenol; Kidney; Lipid Peroxidation; Male; Myocard | 2018 |
Trace Element Determination and Cardioprotection of Terminalia pallida Fruit Ethanolic Extract in Isoproterenol Induced Myocardial Infarcted Rats by ICP-MS.
Topics: Animals; Ethanol; Fruit; Isoproterenol; Male; Minerals; Myocardial Infarction; Plant Extracts; Rats; | 2018 |
In vivo and molecular docking studies using whole extract and phytocompounds of Aegle marmelos fruit protective effects against Isoproterenol-induced Myocardial infarction in rats.
Topics: Aegle; Animals; Cardiotonic Agents; Fruit; Isoproterenol; Male; Molecular Docking Simulation; Myocar | 2017 |
Molecular assessment of protective effect of Vitex negundo in ISO induced myocardial infarction in rats.
Topics: Animals; Cardiotonic Agents; Isoproterenol; Male; Myocardial Infarction; NF-kappa B; Proto-Oncogene | 2017 |
Protective effect of diethylcarbamazine inhibits NF-κB activation in isoproterenol-induced acute myocardial infarction rat model through the PARP pathway.
Topics: Animals; Casein Kinases; Cyclooxygenase 2; Diethylcarbamazine; Disease Models, Animal; I-kappa B Pro | 2017 |
Cardiopreventive effect of ethanolic extract of Date Palm Pollen against isoproterenol induced myocardial infarction in rats through the inhibition of the angiotensin-converting enzyme.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Cardiotonic Agents; Disease Models, A | 2017 |
Cardiaprotective effect of crocetin by attenuating apoptosis in isoproterenol induced myocardial infarction rat model.
Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Biomarkers; Cardiotonic Agents; Carotenoids; Caspase | 2017 |
Cardioprotective effect of nesfatin-1 against isoproterenol-induced myocardial infarction in rats: Role of the Akt/GSK-3β pathway.
Topics: Animals; Apoptosis; Calcium-Binding Proteins; Cardiotonic Agents; Disease Models, Animal; DNA-Bindin | 2017 |
Anthocyanin rich extract of Brassica oleracea L. alleviates experimentally induced myocardial infarction.
Topics: Animals; Animals, Newborn; Anthocyanins; Antioxidants; Apoptosis; Brassica; Caveolin 3; Gene Express | 2017 |
Protective effects of ethanolic peel and pulp extracts of Citrus macroptera fruit against isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Citrus; Disease Models, Animal; Fruit; Isoproterenol; Mal | 2017 |
Diosmin Prevents Isoproterenol-Induced Heart Mitochondrial Oxidative Stress in Rats.
Topics: Animals; Antioxidants; Biomarkers; Calcium Signaling; Cardiotoxicity; Cytoprotection; Diosmin; Disea | 2018 |
The Effects of Periostin in a Rat Model of Isoproterenol: Mediated Cardiotoxicity.
Topics: Animals; Apoptosis; Cardiotoxicity; Cell Adhesion Molecules; Cell Proliferation; Cytoprotection; Dis | 2018 |
Histological and immunohistochemical study of cardiac telocytes in a rat model of isoproterenol-induced myocardial infarction with a reference to the effect of grape seed extract.
Topics: Animals; Antioxidants; Disease Models, Animal; Grape Seed Extract; Heart Ventricles; Immunohistochem | 2017 |
Inhibition of NADPH oxidase by apocynin promotes myocardial antioxidant response and prevents isoproterenol-induced myocardial oxidative stress in rats.
Topics: Acetophenones; Animals; Antioxidants; Cardiotonic Agents; Drug Evaluation, Preclinical; Isoprotereno | 2017 |
Renin Inhibition by Aliskiren Protects Rats Against Isoproterenol Induced Myocardial Infarction.
Topics: Amides; Animals; Biomarkers; Cardiotonic Agents; Catalase; Creatine Kinase, MB Form; Dose-Response R | 2018 |
A molecular mechanism on the antiapoptotic effects of zingerone in isoproterenol induced myocardial infarcted rats.
Topics: Animals; Antioxidants; Apoptosis; Caspases; fas Receptor; Guaiacol; Isoproterenol; Male; Myocardial | 2018 |
Oligomeric proanthocyanidins protect myocardium by mitigating left ventricular remodeling in isoproterenol-induced postmyocardial infarction.
Topics: Animals; Antioxidants; Bone Morphogenetic Protein 4; Cardiovascular Agents; Collagen; Disease Models | 2018 |
Novel Mesenchymal Stem Cell Strategy in Alleviating Toll-Like Receptor-4, p53 and Nrf2 Signaling in Isoproterenol-Induced Myocardial Infarction in Rat Model.
Topics: Animals; Apoptosis; Cells, Cultured; Disease Models, Animal; Isoproterenol; Male; Mesenchymal Stem C | 2018 |
Resident fibroblast expansion during cardiac growth and remodeling.
Topics: Animals; Animals, Newborn; Basic Helix-Loop-Helix Transcription Factors; Cell Line; Cell Lineage; Ce | 2018 |
Effect of Atractylodes macrocephala rhizoma on isoproterenol‑induced ventricular remodeling in rats.
Topics: Animals; Antioxidants; Atractylodes; Biomarkers; Heart Ventricles; Hemodynamics; Isoproterenol; Male | 2018 |
Periostin normalizes levels of cardiac markers in rats with experimental isoproterenol cardiotoxicity.
Topics: Alanine Transaminase; Animals; Antioxidants; Cardiotoxicity; Catalase; Cell Adhesion Molecules; Isop | 2017 |
Raspberry ketone protects against isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Butanones; Cardiotonic Agents; Isoproterenol; Myoca | 2018 |
Cardioprotective Mechanisms of Exenatide in Isoprenaline-induced Myocardial Infarction: Novel Effects on Myocardial α-Estrogen Receptor Expression and IGF-1/IGF-2 System.
Topics: Animals; Apoptosis; Cytoprotection; Disease Models, Animal; Estradiol; Estrogen Receptor alpha; Exen | 2018 |
Effect of Kaempferol Pretreatment on Myocardial Injury in Rats.
Topics: Animals; Antioxidants; Biomarkers; Cytoprotection; Disease Models, Animal; Dose-Response Relationshi | 2018 |
Vitexin protects isoproterenol induced post myocardial injury by modulating hipposignaling and ER stress responses.
Topics: Animals; Antioxidants; Apigenin; Apoptosis; Cardiotonic Agents; Caspase 3; Endoplasmic Reticulum Str | 2018 |
Imaging of isoproterenol-induced myocardial injury with
Topics: Animals; Biological Transport; Cell Line; Disease Models, Animal; Dose-Response Relationship, Drug; | 2018 |
Protective Effects of Olive Leaf Extract on Acrolein-Exacerbated Myocardial Infarction via an Endoplasmic Reticulum Stress Pathway.
Topics: Acrolein; Animals; Apoptosis; Biological Products; Biomarkers; Cell Line; Cytoprotection; Disease Pr | 2018 |
A Strategy for Optimizing the Combination of Active Components Based on Chinese Medicinal Formula Sheng-Mai-San for Myocardial Ischemia.
Topics: Animals; Creatine Kinase, MB Form; Cyclooctanes; Disease Models, Animal; Drug Combinations; Drugs, C | 2018 |
Cardioprotective effect of vitamin D
Topics: Adrenergic beta-Agonists; Animals; Blood Glucose; Cardiotonic Agents; Diabetes Mellitus, Experimenta | 2019 |
Cardioprotective effect of rosuvastatin against isoproterenol-induced myocardial infarction injury in rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Glutathione; Glutathione P | 2018 |
Sacubitril and valsartan protect from experimental myocardial infarction by ameliorating oxidative damage in Wistar rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Aminobutyrates; Animals; Antihypertensive Agents; Antiox | 2019 |
Sitagliptin prevents isoproterenol-induced myocardial infarction in rats by modulating nitric oxide synthase enzymes.
Topics: Animals; Blood Glucose; Fasting; Isoproterenol; Male; Myocardial Infarction; Myocardium; Nitric Oxid | 2018 |
Cardioprotective and Anti-Aggregatory Effects of Levosimendan on Isoproterenol-Induced Myocardial Injury in High-Fat-Fed Rats Involves Modulation of PI3K/Akt/mTOR Signaling Pathway and Inhibition of Apoptosis: Comparison to Cilostazol.
Topics: Animals; Apoptosis; Cilostazol; Diet, High-Fat; Disease Models, Animal; Heart Rate; Inflammation Med | 2018 |
Cardioprotective effect of Amaranthus tricolor extract in isoprenaline induced myocardial damage in ovariectomized rats.
Topics: Amaranthus; Animals; Cardiotonic Agents; Disease Models, Animal; Female; Isoproterenol; Myocardial I | 2018 |
Catalpol pretreatment attenuates cardiac dysfunction following myocardial infarction in rats.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Drugs, Chinese Herbal; Iridoid Glucosides; Isop | 2018 |
Paradoxical effects of atorvastatin in isoproterenol-induced cardiotoxicity in rats: Role of oxidative stress and inflammation.
Topics: Animals; Antioxidants; Atorvastatin; Biomarkers; Cardiotonic Agents; Cardiotoxicity; Heart; Inflamma | 2018 |
Cyanobacteria as Nanogold Factories: Chemical and Anti-Myocardial Infarction Properties of Gold Nanoparticles Synthesized by
Topics: Animals; Antioxidants; Aquatic Organisms; Biomarkers; Biotechnology; Blood Pressure; Cardiotonic Age | 2018 |
Combined and individual strategy of exercise generated preconditioning and low dose copper nanoparticles serve as superlative approach to ameliorate ISO-induced myocardial infarction in rats.
Topics: Androstadienes; Animals; Cardiotonic Agents; Copper; Creatine Kinase, MB Form; Glycogen Synthase Kin | 2018 |
Effects of low dose of aliskiren on isoproterenol-induced acute myocardial infarction in rats.
Topics: Amides; Animals; Apoptosis; Cardiotonic Agents; Fumarates; Isoproterenol; Male; Myocardial Infarctio | 2018 |
Effect of ethanolic extract of Cyperus rotundus L. against isoprenaline induced cardiotoxicity.
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarker | 2016 |
Protective effects of α-bisabolol on altered hemodynamics, lipid peroxidation, and nonenzymatic antioxidants in isoproterenol-induced myocardial infarction: In vivo and in vitro evidences.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Creatine Kinase; Creatine Kinase, MB Form; Hemodyna | 2018 |
Cardioprotective role of FA against isoproterenol induced cardiac toxicity.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; Cardiotonic Agents; Cardioto | 2018 |
Anti-fibrotic Actions of Roselle Extract in Rat Model of Myocardial Infarction.
Topics: Animals; Atrial Natriuretic Factor; Cardiovascular Agents; Collagen Type I; Collagen Type III; Disea | 2019 |
α-Bisabolol abrogates isoproterenol-induced myocardial infarction by inhibiting mitochondrial dysfunction and intrinsic pathway of apoptosis in rats.
Topics: Animals; Apoptosis; Isoproterenol; Male; Mitochondria, Heart; Mitochondrial Proteins; Monocyclic Ses | 2019 |
Pitavastatin ameliorates myocardial damage by preventing inflammation and collagen deposition via reduced free radical generation in isoproterenol-induced cardiomyopathy.
Topics: Animals; Antioxidants; Aspartate Aminotransferases; Catalase; Collagen; Creatine Kinase, MB Form; Fr | 2019 |
Protective effect of syringaldehyde on biomolecular oxidation, inflammation and histopathological alterations in isoproterenol induced cardiotoxicity in rats.
Topics: Adenosine Triphosphatases; Animals; Antioxidants; Benzaldehydes; Biomarkers; Cardiotoxicity; Erythro | 2018 |
Evaluation of Paeonia emodi for its cardioprotective potentials: An investigative study towards possible mechanism.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Cardiotonic Agents; Creati | 2019 |
Cardioprotective Effects of Curcumin-Nisin Based Poly Lactic Acid Nanoparticle on Myocardial Infarction in Guinea Pigs.
Topics: Adrenergic beta-Agonists; Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; C | 2018 |
Suppression of isoproterenol-induced cardiotoxicity in rats by raspberry ketone via activation of peroxisome proliferator activated receptor-α.
Topics: Animals; Apolipoprotein C-II; Butanones; Cardiotonic Agents; Caspase 3; Electrocardiography; Gene Ex | 2019 |
The relationship between visfatin and cardiac markers on induced myocardial infarction in rats.
Topics: Animals; Biomarkers; Disease Models, Animal; Female; Heart; Isoproterenol; Myocardial Infarction; My | 2019 |
Berbamine ameliorates isoproterenol-induced myocardial infarction by inhibiting mitochondrial dysfunction and apoptosis in rats.
Topics: Animals; Apoptosis; Benzylisoquinolines; Isoproterenol; Male; Mitochondria; Myocardial Infarction; O | 2019 |
Nanoyttria attenuates isoproterenol-induced cardiac injury.
Topics: Animals; Cardiotoxicity; Cytokines; Gene Expression Regulation; Heart; Heart Injuries; Hydroxyprolin | 2018 |
Resveratrol protects against isoproterenol induced myocardial infarction in rats through VEGF-B/AMPK/eNOS/NO signalling pathway.
Topics: Animals; Dose-Response Relationship, Drug; Isoproterenol; Male; Myocardial Infarction; Myocytes, Car | 2019 |
LncRNA MALAT1 protects cardiomyocytes from isoproterenol-induced apoptosis through sponging miR-558 to enhance ULK1-mediated protective autophagy.
Topics: Adrenergic beta-Agonists; Animals; Apoptosis; Autophagy; Autophagy-Related Protein-1 Homolog; Cell L | 2019 |
Effects of nimodipine, vinpocetine and their combination on isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Biomarkers; Cardiotonic Agents; Heart; Isoproterenol; Male; Myocardial Infarc | 2019 |
Role of MAPK/NF-κB pathway in cardioprotective effect of Morin in isoproterenol induced myocardial injury in rats.
Topics: Animals; Antioxidants; Apoptosis; Flavonoids; Heart; Isoproterenol; Male; MAP Kinase Signaling Syste | 2019 |
Attenuation of isoproterenol-induced cardiotoxicity in rats by Narirutin rich fraction from grape fruit.
Topics: Adrenergic beta-Agonists; Animals; Cardiotoxicity; Citrus paradisi; Disaccharides; Flavanones; Heart | 2019 |
Pretreatment with β-glucan attenuates isoprenaline-induced myocardial injury in rats.
Topics: Animals; Antioxidants; Apoptosis; beta-Glucans; Biomarkers; Cardiotonic Agents; Catalase; Heart; Iso | 2019 |
Linagliptin Suppresses Electrical and Structural Remodeling in the Isoproterenol Induced Myocardial Injury Model.
Topics: Animals; Antioxidants; Atrial Remodeling; Cardiotonic Agents; Dipeptidyl Peptidase 4; Dipeptidyl-Pep | 2019 |
The protective impact of betaine on the tissue structure and renal function in isoproterenol-induced myocardial infarction in rat.
Topics: Animals; Betaine; Cardiotonic Agents; Isoproterenol; Kidney; Male; Myocardial Infarction; Myocytes, | 2019 |
Cardioprotective Effect of Rhapontigenin in Isoproterenol-Induced Myocardial Infarction in a Rat Model.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Cardiotonic Agents; Disease Models, Anim | 2019 |
The protective effect of kaempferol on heart via the regulation of Nrf2, NF-κβ, and PI3K/Akt/GSK-3β signaling pathways in isoproterenol-induced heart failure in diabetic rats.
Topics: Animals; Cardiotonic Agents; Diabetes Mellitus, Experimental; Glycogen Synthase Kinase 3 beta; Heart | 2019 |
Phloroglucinol averts isoprenaline hydrochloride induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Biomarkers; Cardiotonic Agents; Electrocardiography; Heart; Isoproterenol; Li | 2019 |
(3R)‑5,6,7‑trihydroxy‑3‑isopropyl‑3‑methylisochroman‑1‑one attenuates cardiac dysfunction via the apelin/APJ signaling pathway.
Topics: Animals; Apelin; Apelin Receptors; bcl-2-Associated X Protein; Blood Pressure; Body Weight; Caspase | 2019 |
Ursolic acid modulates MMPs, collagen-I, α-SMA, and TGF-β expression in isoproterenol-induced myocardial infarction in rats.
Topics: Actins; Animals; Cardiotonic Agents; Collagen Type I; Isoproterenol; Lysosomes; Male; Matrix Metallo | 2019 |
Ameliorative effects of cerebrolysin against isoproterenol-induced myocardial injury in male rats.
Topics: Amino Acids; Animals; Antioxidants; Catalase; Glutathione Peroxidase; Heart; Isoproterenol; Lipid Pe | 2019 |
Comprehensive Analysis of Animal Models of Cardiovascular Disease using Multiscale X-Ray Phase Contrast Tomography.
Topics: Adrenergic beta-Agonists; Animals; Coronary Vessels; Disease Models, Animal; Heart; Heart Failure; I | 2019 |
β-Caryophyllene as a Potential Protective Agent Against Myocardial Injury: The Role of Toll-Like Receptors.
Topics: Adaptor Proteins, Signal Transducing; Animals; Biological Products; Blood Pressure; Creatine Kinase; | 2019 |
Oleic Acid Prevents Isoprenaline-Induced Cardiac Injury: Effects on Cellular Oxidative Stress, Inflammation and Histopathological Alterations.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Cardiotoxicity; Disease Models, Animal; Inflammatio | 2020 |
Cardioprotective effect of ranolazine in nondiabetic and diabetic male rats subjected to isoprenaline-induced acute myocardial infarction involves modulation of AMPK and inhibition of apoptosis.
Topics: Acute Disease; AMP-Activated Protein Kinases; Animals; Apoptosis; Blood Glucose; Cardiotonic Agents; | 2019 |
Cardioprotective effects of cerebrolysin on the lesion severity and inflammatory factors in a rat model of isoproterenol-induced myocardial injury.
Topics: Amino Acids; Animals; Biomarkers; Cardiotonic Agents; Cell Survival; Coronary Circulation; Interleuk | 2019 |
Effects of Curcumin Nanoparticles in Isoproterenol-Induced Myocardial Infarction.
Topics: Adrenergic beta-Agonists; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Curcumin; | 2019 |
Cardioprotective effects induced by hydroalcoholic extract of leaves of Alpinia zerumbet on myocardial infarction in rats.
Topics: Alpinia; Animals; Blood Pressure; Cardiotonic Agents; Creatine Kinase; Heart Rate; Isoproterenol; Ma | 2019 |
Cyanobacteria as Nanogold Factories II: Chemical Reactivity and anti-Myocardial Infraction Properties of Customized Gold Nanoparticles Biosynthesized by
Topics: Animals; Cyanobacteria; Cyanothece; Gold; Isoproterenol; Light; Male; Metal Nanoparticles; Myocardia | 2019 |
Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats.
Topics: Administration, Oral; Animals; Arterial Pressure; Cardiotonic Agents; Disease Models, Animal; Dose-R | 2012 |
Cardio protective effect of vitamin A against isoproterenol-induced myocardial infarction.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Catalase; Creatine Kinase; Glutathione; | 2012 |
Examining the relationship between exercise tolerance and isoproterenol-based cardiac reserve in murine models of heart failure.
Topics: Adrenergic beta-Agonists; Animals; Cardiotonic Agents; Disease Models, Animal; Exercise Test; Exerci | 2013 |
(-) Epicatechin prevents alterations in lysosomal glycohydrolases, cathepsins and reduces myocardial infarct size in isoproterenol-induced myocardial infarcted rats.
Topics: Animals; Catechin; Cathepsin B; Cathepsin D; Glycoside Hydrolases; Isoproterenol; Lysosomes; Male; M | 2013 |
The novel Mas agonist, CGEN-856S, attenuates isoproterenol-induced cardiac remodeling and myocardial infarction injury in rats.
Topics: Animals; Cardiomegaly; Cardiotonic Agents; CHO Cells; Collagen; Cricetinae; Cricetulus; Fibronectins | 2013 |
Tomato lycopene attenuates myocardial infarction induced by isoproterenol: electrocardiographic, biochemical and anti-apoptotic study.
Topics: Animals; Antioxidants; Apoptosis; Cardiotonic Agents; Carotenoids; Caspase 3; Disease Models, Animal | 2012 |
Preventive effects of p-coumaric acid on cardiac hypertrophy and alterations in electrocardiogram, lipids, and lipoproteins in experimentally induced myocardial infarcted rats.
Topics: Animals; Cardiomegaly; Cholesterol; Coumaric Acids; Electrocardiography; Fatty Acids, Nonesterified; | 2013 |
Intravenous human umbilical cord blood improves electrophysiological and metabolic properties in ISO induced myocardial necrosis in rats.
Topics: Animals; Antioxidants; Blood Pressure; Cardiotoxins; Creatine Kinase; Dose-Response Relationship, Dr | 2013 |
Screening and identifying the myocardial-injury protective ingredients from Sheng-Mai-San.
Topics: Animals; Biomarkers; Cardiovascular Agents; Chromatography, Liquid; Creatine Kinase; Cytoprotection; | 2013 |
Licorice treatment prevents oxidative stress, restores cardiac function, and salvages myocardium in rat model of myocardial injury.
Topics: Animals; Glycyrrhiza; Heart; Hemodynamics; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infar | 2015 |
Myocardial Ablation of G Protein-Coupled Receptor Kinase 2 (GRK2) Decreases Ischemia/Reperfusion Injury through an Anti-Intrinsic Apoptotic Pathway.
Topics: Animals; Apoptosis; bcl-X Protein; Cytochromes c; G-Protein-Coupled Receptor Kinase 2; Hemodynamics; | 2013 |
SERCA2 activity is involved in the CNP-mediated functional responses in failing rat myocardium.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 2013 |
Antioxidant activity of ethanolic extract of Terminalia chebula fruit against isoproterenol-induced oxidative stress in rats.
Topics: Animals; Antioxidants; Ascorbic Acid; Ceruloplasmin; Ethanol; Fruit; Glutathione; Heart; Iron; Isopr | 2005 |
Regulation of antioxidant system, lipids and fatty acid β-oxidation contributes to the cardioprotective effect of sodium tanshinone IIA sulphonate in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Disease Models, Animal; Fatty Acids; Gene Expression Regu | 2013 |
Reduction of coenzyme q10 content: a possible effect of isoproterenol on heart failure and myocardial infarction in rat.
Topics: Animals; Heart Failure; Hemodynamics; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarction | 2014 |
Diosmin exhibits anti-hyperlipidemic effects in isoproterenol induced myocardial infarcted rats.
Topics: Animals; Biomarkers; Diosmin; Heart Ventricles; Hypolipidemic Agents; Isoproterenol; Lipid Metabolis | 2013 |
The metabolic disturbances of isoproterenol induced myocardial infarction in rats based on a tissue targeted metabonomics.
Topics: Animals; Biomarkers; Disease Models, Animal; Isoproterenol; Male; Mass Spectrometry; Metabolic Netwo | 2013 |
Cardioprotective effect of methanolic extract of Marrubium vulgare L. on isoproterenol-induced acute myocardial infarction in rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Electrocardiography; Heart; Isoproterenol; Lipid Peroxida | 2013 |
[Effects of the umbilical blood stem cells in experimental injury of myocardium].
Topics: Animals; Cord Blood Stem Cell Transplantation; Cryopreservation; Female; Fetal Blood; Humans; Isopro | 2013 |
Metabolic pathways involved in Xin-Ke-Shu protecting against myocardial infarction in rats using ultra high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry.
Topics: Administration, Oral; Animals; Biomarkers; Cardiotonic Agents; Chromatography, High Pressure Liquid; | 2014 |
Eugenia jambolana pretreatment prevents isoproterenol-induced myocardial damage in rats: evidence from biochemical, molecular, and histopathological studies.
Topics: Animals; Biomarkers; C-Reactive Protein; Glutathione; Heart; Humans; Isoproterenol; Male; Malondiald | 2014 |
Preventive effects of selenium yeast, chromium picolinate, zinc sulfate and their combination on oxidative stress, inflammation, impaired angiogenesis and atherogenesis in myocardial infarction in rats.
Topics: Animals; Atherosclerosis; Cardiotonic Agents; Drug Therapy, Combination; Dyslipidemias; Inflammation | 2013 |
Cardioprotective effect of rhizomes of Acorus gramineus against isoproterenol-induced cardiac damage in pigs.
Topics: Acorus; Animals; Antioxidants; Biomarkers; Cardiotonic Agents; Cytoprotection; Disease Models, Anima | 2014 |
Effects of LDL and oxidized LDL on cardiac function in isoproterenol-induced myocardial infarction in rat.
Topics: Animals; Cholesterol, Dietary; Electrocardiography; Hemodynamics; Isoproterenol; Lipid Peroxidation; | 2014 |
Cardioprotective effect of mumie (shilajit) on experimentally induced myocardial injury.
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Heart | 2014 |
Red ginseng (Panax ginseng) decreases isoproterenol-induced cardiac injury via antioxidant properties in porcine.
Topics: Animals; Antioxidants; Ginsenosides; Humans; Isoproterenol; Male; Malondialdehyde; Myocardial Infarc | 2014 |
Isoproterenol‑mediated heme oxygenase‑1 induction inhibits high mobility group box 1 protein release and protects against rat myocardial ischemia/reperfusion injury in vivo.
Topics: Adrenergic beta-Agonists; Animals; Creatine Kinase; Disease Models, Animal; Heme Oxygenase-1; Hemody | 2014 |
Soluble epoxide hydrolase inhibitor, t-TUCB, protects against myocardial ischaemic injury in rats.
Topics: Animals; Antioxidants; Benzoates; Biomarkers; Cardiotonic Agents; Epoxide Hydrolases; Heart; Heart C | 2014 |
[The influence of dietary omega-3 polyunsaturated fatty acids on functional parameters of myocardial mitochondria during isoproterenol-induced heart injury].
Topics: Administration, Oral; Animals; Calcium; Disease Models, Animal; Fatty Acids, Omega-3; Isoproterenol; | 2014 |
Cardioprotective effect of embelin on isoproterenol-induced myocardial injury in rats: possible involvement of mitochondrial dysfunction and apoptosis.
Topics: Animals; Antioxidants; Apoptosis; Benzoquinones; Biomarkers; Blotting, Western; Cardiotonic Agents; | 2014 |
Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction.
Topics: AMP-Activated Protein Kinases; Animals; Hemodynamics; Interleukin-6; Isoproterenol; Male; Metformin; | 2014 |
Effects of carnosine on prooxidant-antioxidant status in heart tissue, plasma and erythrocytes of rats with isoproterenol-induced myocardial infarction.
Topics: Animals; Carnosine; Erythrocytes; Glutathione Peroxidase; Isoproterenol; Lipid Peroxidation; Male; M | 2014 |
Elevated adropin: a candidate diagnostic marker for myocardial infarction in conjunction with troponin-I.
Topics: Adrenergic beta-Agonists; Animals; Biomarkers; Blood Proteins; Isoproterenol; Myocardial Infarction; | 2014 |
Can early myocardial infarction-related deaths be diagnosed using postmortem urotensin receptor expression levels?
Topics: Animals; Autopsy; Biomarkers; Disease Models, Animal; Forensic Genetics; Isoproterenol; Male; Myocar | 2014 |
Hesperidin blunts streptozotocin-isoproternol induced myocardial toxicity in rats by altering of PPAR-γ receptor.
Topics: Anilides; Animals; Catalase; Creatine Kinase, MB Form; Diabetes Mellitus, Experimental; Female; Glut | 2014 |
Cardiac sympathetic afferent denervation attenuates cardiac remodeling and improves cardiovascular dysfunction in rats with heart failure.
Topics: Adrenergic beta-Agonists; Afferent Pathways; Animals; Apoptosis; Blotting, Western; Cardiomegaly; Ca | 2014 |
Interleukin-1β blockade improves left ventricular systolic/diastolic function and restores contractility reserve in severe ischemic cardiomyopathy in the mouse.
Topics: Animals; Antibodies, Monoclonal; Disease Models, Animal; Echocardiography; Interleukin-1beta; Isopro | 2014 |
The effect of caffeic acid phenethyl ester on isoproterenol-induced myocardial injury in hypertensive rats.
Topics: Animals; Antioxidants; Blood Pressure; Caffeic Acids; Disease Models, Animal; Hypertension; Injectio | 2014 |
Regulation of signal transducer and activator of transcription 3 and apoptotic pathways by betaine attenuates isoproterenol-induced acute myocardial injury in rats.
Topics: Animals; Apoptosis; Betaine; Biomarkers; Cardiotonic Agents; Dose-Response Relationship, Drug; Isopr | 2015 |
Pre-treatment with α-tocopherol and Terminalia arjuna ameliorates, pro-inflammatory cytokines, cardiac and apoptotic markers in myocardial infracted rats.
Topics: alpha-Tocopherol; Animals; Apoptosis; bcl-2-Associated X Protein; Cardiotonic Agents; Chromatography | 2015 |
The plant histaminase: a promising enzyme with antioxidant properties versus histamine release in isoprenaline-induced myocardial infarction in rats.
Topics: Amine Oxidase (Copper-Containing); Animals; Antioxidants; Cardiotonic Agents; Catalase; Creatine Kin | 2014 |
Assessment of the prophylactic role of aspirin and/or clopidogrel on experimentally induced acute myocardial infarction in hypercholesterolemic rats.
Topics: Animals; Aspirin; C-Reactive Protein; Cholesterol; Clopidogrel; Creatine Kinase; Diet, High-Fat; Dru | 2014 |
Beneficial role of tamoxifen in isoproterenol-induced myocardial infarction.
Topics: Adrenergic beta-Agonists; Animals; Collagen; Female; Heart Ventricles; Hemodynamics; Isoproterenol; | 2014 |
Benidipine prevents oxidative stress, inflammatory changes and apoptosis related myofibril damage in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Biomarkers; Cytoprotection; Dihydropyrid | 2015 |
Preventive effects of zingerone on altered lipid peroxides and nonenzymatic antioxidants in the circulation of isoproterenol-induced myocardial infarcted rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Guaiacol; Isoproterenol; Lipid Peroxidation; Male; Myocar | 2015 |
Tacrolimus ameliorates functional disturbances and oxidative stress in isoproterenol-induced myocardial infarction.
Topics: Administration, Cutaneous; Animals; Disease Models, Animal; Drug Administration Schedule; Electrocar | 2014 |
Quantitative proteomics for cardiac biomarker discovery using isoproterenol-treated nonhuman primates.
Topics: Animals; Biomarkers; Female; Isoproterenol; Macaca fascicularis; Macaca mulatta; Male; Muscle Protei | 2014 |
A biochemical and 2, 3, 5-triphenyl tetrazolium chloride staining study on the preventive effects of zingerone (vanillyl acetone) in experimentally induced myocardial infarcted rats.
Topics: Adenosine Triphosphatases; Animals; Biomarkers; Coloring Agents; Disease Models, Animal; Electrocard | 2015 |
Cardioprotective Effect of Hydrogen-rich Saline on Isoproterenol-induced Myocardial Infarction in Rats.
Topics: Analysis of Variance; Animals; Biomarkers; Biopsy, Needle; Cardiotonic Agents; Cytokines; Disease Mo | 2015 |
Antihyperlipidaemic, antihypertrophic, and reducing effects of zingerone on experimentally induced myocardial infarcted rats.
Topics: Animals; Cardiomegaly; Guaiacol; Hyperlipidemias; Hypolipidemic Agents; Isoproterenol; Male; Myocard | 2015 |
Preventive effect of phytic acid on lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats.
Topics: Acetylglucosaminidase; Animals; Antioxidants; Cathepsin B; Cathepsin D; Cytoprotection; Disease Mode | 2015 |
Comparison of Cardiomyocyte Differentiation Potential Between Type 1 Diabetic Donor- and Nondiabetic Donor-Derived Induced Pluripotent Stem Cells.
Topics: Action Potentials; Adrenergic beta-Agonists; Biomarkers; Cell Differentiation; Cell- and Tissue-Base | 2015 |
Enhanced β-adrenergic cardiac reserve in Trpm4⁻/⁻ mice with ischaemic heart failure.
Topics: Adrenergic beta-Agonists; Animals; Electrocardiography; Heart Failure; Hypertrophy, Left Ventricular | 2015 |
SERCA-2a is involved in the right ventricular function following myocardial infarction in rats.
Topics: Animals; Disease Models, Animal; Gene Expression Regulation; Heart Failure; Isometric Contraction; I | 2015 |
Superiority of zinc complex of acetylsalicylic acid to acetylsalicylic acid in preventing postischemic myocardial dysfunction.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Coordination Complexes; Electrocardiograp | 2015 |
β-Adrenergic stimulation and rapid pacing mutually promote heterogeneous electrical failure and ventricular fibrillation in the globally ischemic heart.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Cardiac Pacing, Artificial; Death, Sudden, Car | 2015 |
Thymol attenuates inflammation in isoproterenol induced myocardial infarcted rats by inhibiting the release of lysosomal enzymes and downregulating the expressions of proinflammatory cytokines.
Topics: Animals; Anti-Inflammatory Agents; C-Reactive Protein; Cytokines; Down-Regulation; Electrocardiograp | 2015 |
Adipose stem cell sheets improved cardiac function in the rat myocardial infarction, but did not alter cardiac contractile responses to β-adrenergic stimulation.
Topics: Adipocytes; Animals; Atrial Natriuretic Factor; Atrial Remodeling; Bucladesine; Cardiomegaly; Cell D | 2015 |
Dietary Chitosan Supplementation Ameliorates Isoproterenol-Induced Aberrations in Membrane-Bound ATPases and Mineral Status of Rat Myocardium.
Topics: Adenosine Triphosphatases; Animals; Calcium; Cardiotonic Agents; Cell Membrane; Chitosan; Dietary Su | 2015 |
Racing to the flatline: heart rate and β-adrenergic stimulation quicken the pace.
Topics: Adrenergic beta-Agonists; Animals; Cardiac Pacing, Artificial; Female; Heart Conduction System; Hear | 2015 |
Protective effects of Labisia pumila var. alata on biochemical and histopathological alterations of cardiac muscle cells in isoproterenol-induced myocardial infarction rats.
Topics: Administration, Oral; Animals; Cardiotonic Agents; Cell Membrane; Disease Models, Animal; Dose-Respo | 2015 |
Histone deacetylase inhibition enhances tissue plasminogen activator release capacity in atherosclerotic man.
Topics: Aged; Female; Forearm; Histone Deacetylase Inhibitors; Humans; Isoproterenol; Male; Middle Aged; Myo | 2015 |
Protective Effect of Hydroxytyrosol Against Cardiac Remodeling After Isoproterenol-Induced Myocardial Infarction in Rat.
Topics: Animals; Cardiotonic Agents; Isoproterenol; Male; Myocardial Infarction; Phenylethyl Alcohol; Rats; | 2016 |
Protective effects of the standardized extract of Zingiber officinale on myocardium against isoproterenol-induced biochemical and histopathological alterations in rats.
Topics: Animals; Cardiotonic Agents; Dose-Response Relationship, Drug; Isoproterenol; Male; Myocardial Infar | 2015 |
Edaravone protects rats against oxidative stress and apoptosis in experimentally induced myocardial infarction: Biochemical and ultrastructural evidence.
Topics: Animals; Antioxidants; Antipyrine; Apoptosis; C-Reactive Protein; Caspase 3; Creatine Kinase, MB For | 2015 |
Cardioprotective effect of linseed oil against isoproterenol-induced myocardial infarction in Wistar rats: a biochemical and electrocardiographic study.
Topics: Animals; Body Weight; Cardiotonic Agents; Electrocardiography; Enzymes; Fatty Acids; Flax; Isoproter | 2015 |
Preventive effects of oleuropein against cardiac remodeling after myocardial infarction in Wistar rat through inhibiting angiotensin-converting enzyme activity.
Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Dose-Response Relations | 2015 |
Cardioprotective Effects of Tualang Honey: Amelioration of Cholesterol and Cardiac Enzymes Levels.
Topics: Animals; Antioxidants; Aspartate Aminotransferases; Cardiotonic Agents; Cholesterol; Creatine Kinase | 2015 |
Comparative evaluation of HMG CoA reductase inhibitors in experimentally-induced myocardial necrosis: Biochemical, morphological and histological studies.
Topics: Adenosine Triphosphatases; Animals; Atorvastatin; Blood Glucose; Cardiotonic Agents; Catalase; Chole | 2015 |
Apigenin Attenuates β-Receptor-Stimulated Myocardial Injury Via Safeguarding Cardiac Functions and Escalation of Antioxidant Defence System.
Topics: Animals; Antioxidants; Apigenin; Biomarkers; Catalase; Creatine Kinase, MB Form; Cytoprotection; Dis | 2016 |
Protective effect of a polysaccharide from Salvia miltiorrhiza on isoproterenol (ISO)-induced myocardial injury in rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Cardiotonic Agents; Creati | 2015 |
Plant Natural Products Calycosin and Gallic Acid Synergistically Attenuate Neutrophil Infiltration and Subsequent Injury in Isoproterenol-Induced Myocardial Infarction: A Possible Role for Leukotriene B4 12-Hydroxydehydrogenase?
Topics: Alcohol Oxidoreductases; Animals; Astragalus Plant; Biological Products; Cell Survival; Chromatograp | 2015 |
Cardioprotective effects of timosaponin B II from Anemarrhenae asphodeloides Bge on isoproterenol-induced myocardial infarction in rats.
Topics: Anemarrhena; Animals; Biomarkers; Blotting, Western; Cardiotonic Agents; Disease Models, Animal; Iso | 2015 |
Anti-inflammatory, Antithrombotic and Cardiac Remodeling Preventive Effects of Eugenol in Isoproterenol-Induced Myocardial Infarction in Wistar Rat.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents; Antioxidants; Biomarker | 2016 |
Anti-platelet effects of nimesulide in isoproterenol-induced myocardial ischaemia and infarction in rabbits.
Topics: Animals; Disease Models, Animal; Isoproterenol; Myocardial Infarction; Platelet Activating Factor; P | 2015 |
The effects of Melissa officinalis (lemon balm) pretreatment on the resistance of the heart to myocardial injury.
Topics: Animals; Dose-Response Relationship, Drug; Heart Rate; Isoproterenol; Male; Melissa; Myocardial Infa | 2016 |
Amelioration of Isoproterenol-Induced Oxidative Damage in Rat Myocardium by Withania somnifera Leaf Extract.
Topics: Animals; Antioxidants; Biomarkers; Glutathione Peroxidase; Humans; Isoproterenol; Lipid Peroxidation | 2015 |
Protective Effects of Cardamom in Isoproterenol-Induced Myocardial Infarction in Rats.
Topics: Animals; Antioxidants; Biomarkers; Cardiotonic Agents; Catalase; Creatine Kinase, MB Form; Disease M | 2015 |
Bone marrow mononuclear cells enhance anti-inflammatory effects of pravastatin against isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Bone Marrow Cells; Combined Modality Therapy; Cytokine | 2016 |
Baicalin ameliorates isoproterenol-induced acute myocardial infarction through iNOS, inflammation and oxidative stress in rat.
Topics: Animals; Apoptosis; Casein Kinases; Caspase 3; Creatine Kinase, MB Form; Enzyme Inhibitors; Flavonoi | 2015 |
[The Action of Apelin-12 and Its Analog on Hemodynamics and Cardiac Contractile Function of Rats With Isoproterenol-Induced Myocardial Lesion].
Topics: Animals; Disease Models, Animal; Hemodynamics; Intercellular Signaling Peptides and Proteins; Isopro | 2015 |
Amelioration of inflammation by phenolic rich methanolic extract of Ocimum sanctum Linn. leaves in isoproterenol induced myocardial infarction.
Topics: Animals; Antioxidants; Disease Models, Animal; Inflammation; Isoproterenol; Leukotriene B4; Male; Me | 2015 |
Thymol, a dietary monoterpene phenol abrogates mitochondrial dysfunction in β-adrenergic agonist induced myocardial infarcted rats by inhibiting oxidative stress.
Topics: Adrenergic beta-Agonists; Animals; Dose-Response Relationship, Drug; Injections, Subcutaneous; Isopr | 2016 |
Molecular and biochemical evidence on the protective effects of embelin and carnosic acid in isoproterenol-induced acute myocardial injury in rats.
Topics: Abietanes; Animals; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Benzoquinones; Cardiotonic Ag | 2016 |
Effect of exercise training and myocardial infarction on force development and contractile kinetics in isolated canine myocardium.
Topics: Adrenergic beta-Agonists; Animals; Dogs; Heart; Heart Ventricles; Isoproterenol; Kinetics; Myocardia | 2016 |
Edaravone, a potent free radical scavenger and a calcium channel blocker attenuate isoproterenol induced myocardial infarction by suppressing oxidative stress, apoptotic signaling and ultrastructural damage.
Topics: Animals; Antipyrine; Apoptosis; C-Reactive Protein; Calcium Channel Blockers; Caspase 3; Dihydropyri | 2016 |
Protective Effect of Adansonia digitata against Isoproterenol-Induced Myocardial Injury in Rats.
Topics: Adansonia; Animals; Antioxidants; Female; Fruit; Heart; Isoproterenol; Myocardial Infarction; Myocar | 2016 |
Activation of β1-adrenoceptor triggers oxidative stress mediated myocardial membrane destabilization in isoproterenol induced myocardial infarcted rats: 7-hydroxycoumarin and its counter action.
Topics: Adenosine Triphosphatases; Animals; Cell Membrane; Dose-Response Relationship, Drug; Isoproterenol; | 2016 |
Protective Effects of 7-Hydroxycoumarin on Dyslipidemia and Cardiac Hypertrophy in Isoproterenol-Induced Myocardial Infarction in Rats.
Topics: Adrenergic beta-Agonists; Animals; Cardiomegaly; Dyslipidemias; Hydroxymethylglutaryl CoA Reductases | 2016 |
Histamine H3 Receptor Agonist Imetit Attenuated Isoproterenol Induced Renin Angiotensin System and Sympathetic Nervous System Overactivity in Myocardial Infarction of Rats.
Topics: Angiotensin II; Animals; Antioxidants; Cardiotonic Agents; Histamine Agonists; Histamine H3 Antagoni | 2016 |
Paeonol and danshensu combination attenuates apoptosis in myocardial infarcted rats by inhibiting oxidative stress: Roles of Nrf2/HO-1 and PI3K/Akt pathway.
Topics: Acetophenones; Animals; Apoptosis; Blotting, Western; Cardiotonic Agents; Creatine Kinase, MB Form; | 2016 |
Dietary Phenolic Acids of Macrotyloma uniflorum (Horse Gram) Protect the Rat Heart Against Isoproterenol-Induced Myocardial Infarction.
Topics: Animals; Antioxidants; Fabaceae; Heart; Hydroxybenzoates; Isoproterenol; Male; Myocardial Infarction | 2016 |
Cardioprotective effect of pioglitazone in diabetic and non-diabetic rats subjected to acute myocardial infarction involves suppression of AGE-RAGE axis and inhibition of apoptosis.
Topics: Adrenergic beta-Agonists; Animals; Apoptosis; Cardiotonic Agents; Diabetes Mellitus, Type 2; Diabeti | 2016 |
Chronic oral administration of low-dose combination of fenofibrate and rosuvastatin protects the rat heart against experimentally induced acute myocardial infarction.
Topics: Administration, Oral; Animals; Cardiotonic Agents; Drug Administration Schedule; Drug Therapy, Combi | 2016 |
Cardioprotective effect of resveratrol analogue isorhapontigenin versus omega-3 fatty acids in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Biomarkers; Cardiotonic Agents; Diet | 2016 |
Mechanisms underlying the cardioprotective effect of Salvianic acid A against isoproterenol-induced myocardial ischemia injury in rats: Possible involvement of L-type calcium channels and myocardial contractility.
Topics: Action Potentials; Animals; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Signaling; C | 2016 |
Renal denervation improves cardiac function in rats with chronic heart failure: Effects on expression of β-adrenoceptors.
Topics: Adrenergic beta-Agonists; Animals; Chronic Disease; Collagen Type I; Coronary Vessels; Heart; Heart | 2016 |
Sundarban Honey Confers Protection against Isoproterenol-Induced Myocardial Infarction in Wistar Rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Body Weight; Creatine Kina | 2016 |
Standardized Chinese Formula Xin-Ke-Shu inhibits the myocardium Ca(2+) overloading and metabolic alternations in isoproterenol-induced myocardial infarction rats.
Topics: Animals; Biomarkers; Calcium; Drugs, Chinese Herbal; Heart; Isoproterenol; Male; Medicine, Chinese T | 2016 |
Molecular and biochemical evidence on the protective effects of quercetin in isoproterenol-induced acute myocardial injury in rats.
Topics: Animals; Calpain; Cardiotonic Agents; Gene Expression Regulation, Enzymologic; Isoproterenol; Male; | 2017 |
Inhibition of RhoA/Rho kinase by ibuprofen exerts cardioprotective effect on isoproterenol induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Electrocardiography; Gene Expression Regulation, Enzymolo | 2016 |
Anti-inflammatory and anti-thrombotic effects of zingerone in a rat model of myocardial infarction.
Topics: Animals; Anti-Inflammatory Agents; Biomarkers; Disease Models, Animal; Fibrinolytic Agents; Glyceral | 2016 |
Chlorogenic acid a dietary polyphenol attenuates isoproterenol induced myocardial oxidative stress in rat myocardium: An in vivo study.
Topics: Animals; Antioxidants; Biomarkers; Chlorogenic Acid; Disease Models, Animal; Dose-Response Relations | 2016 |
Impact of cardiac-specific expression of CD39 on myocardial infarct size in mice.
Topics: Animals; Antigens, CD; Apyrase; Calcium; Disease Models, Animal; Echocardiography; Gene Expression; | 2017 |
Kampeferol protects against oxidative stress and apoptotic damage in experimental model of isoproterenol-induced cardiac toxicity in rats.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Cardiotoxicity; Catalase; Glutathione; Heart; Interleu | 2016 |
Phosphodiesterase 2 Protects Against Catecholamine-Induced Arrhythmia and Preserves Contractile Function After Myocardial Infarction.
Topics: Animals; Arrhythmias, Cardiac; Cardiotonic Agents; Catecholamines; Cyclic Nucleotide Phosphodiestera | 2017 |
Epigallocatechin-3-gallate prevents cardiac apoptosis by modulating the intrinsic apoptotic pathway in isoproterenol-induced myocardial infarction.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Body Weight; Catechin; Cytoprotection; Isoproterenol; | 2017 |
Piperine modulates isoproterenol induced myocardial ischemia through antioxidant and anti-dyslipidemic effect in male Wistar rats.
Topics: Alkaloids; Animals; Antioxidants; Benzodioxoles; Biomarkers; Heart; Isoproterenol; Lipid Peroxidatio | 2017 |
Effect of vitamin D on isoprenaline-induced myocardial infarction in rats: possible role of peroxisome proliferator-activated receptor-γ.
Topics: Animals; Biomarkers; Electrocardiography; Isoproterenol; Male; Myocardial Infarction; Oxidative Stre | 2017 |
Cardioprotective activity of Ginkgo biloba Phytosomes in isoproterenol-induced myocardial necrosis in rats: a biochemical and histoarchitectural evaluation.
Topics: Adrenergic beta-Agonists; Animals; Ginkgo biloba; Heart; Isoproterenol; Myocardial Infarction; Myoca | 2008 |
(-)Epigallocatechingallate protects the mitochondria against the deleterious effects of lipids, calcium and adenosine triphosphate in isoproterenol induced myocardial infarcted male Wistar rats.
Topics: Adenosine Triphosphate; Adrenergic beta-Agonists; Animals; Calcium; Catechin; Cholesterol; Fatty Aci | 2008 |
Cardioprotective effect of 'Marutham' a polyherbal formulation on isoproterenol induced myocardial infarction in Wistar rats.
Topics: Animals; Cardiotonic Agents; Hyperlipidemias; Isoproterenol; Lipids; Lipoproteins; Male; Membrane Pr | 2008 |
Combined transplantation of endothelial progenitor cells and mesenchymal stem cells into a rat model of isoproterenol-induced myocardial injury.
Topics: Angiopoietin-2; Animals; Cardiotonic Agents; Disease Models, Animal; Endothelium, Vascular; Female; | 2008 |
Melatonin receptor-mediated protection against myocardial ischaemia/reperfusion injury: role of its anti-adrenergic actions.
Topics: Adrenergic Antagonists; Animals; Colforsin; Cyclic AMP; Guanylate Cyclase; Heart; Indoles; Isoproter | 2008 |
Cardioprotective effect of aqueous extract of Embelia ribes Burm fruits against isoproterenol-induced myocardial infarction in albino rats.
Topics: Animals; Antioxidants; Blood Pressure; Embelia; Flavonoids; Glutathione; Hemodynamics; Isoproterenol | 2008 |
Protective effect of aspartate and glutamate on cardiac mitochondrial function during myocardial infarction in experimental rats.
Topics: Animals; Aspartic Acid; Disease Models, Animal; Enzyme Activation; Glutamic Acid; Glutathione; Gluta | 2008 |
Naringin ameliorates mitochondrial lipid peroxides, antioxidants and lipids in isoproterenol-induced myocardial infarction in Wistar rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Disease Models, Animal; Flavanones; Isoproterenol; Lipid | 2009 |
Effect of Commiphora mukul extract on cardiac dysfunction and ventricular function in isoproterenol-induced myocardial infarction.
Topics: Animals; Blood Pressure; Commiphora; Isoproterenol; Male; Myocardial Infarction; Plant Extracts; Rat | 2008 |
Effect of green tea and vitamin E combination in isoproterenol induced myocardial infarction in rats.
Topics: Adenosine Triphosphatases; Analysis of Variance; Animals; Antioxidants; Drug Synergism; Isoprotereno | 2009 |
PKA rapidly enhances proteasome assembly and activity in in vivo canine hearts.
Topics: Animals; Cyclic AMP-Dependent Protein Kinases; Dogs; Enzyme Activation; In Vitro Techniques; Isoprot | 2009 |
Preventive effect of S-allylcysteine on membrane-bound enzymes and glycoproteins in normal and isoproterenol-induced cardiac toxicity in male Wistar rats.
Topics: Adenosine Triphosphatases; alpha-Tocopherol; Animals; Antioxidants; Blood Proteins; Cell Membrane; C | 2008 |
[Expression and implication of angiotensin II type 1 receptor in myocardial fibrosis of rats].
Topics: Animals; Aspartate Aminotransferases; Cardiomyopathies; Cell Differentiation; Creatine Kinase; Fibro | 2008 |
Cardioprotective effect of gallic acid on cardiac troponin-T, cardiac marker enzymes, lipid peroxidation products and antioxidants in experimentally induced myocardial infarction in Wistar rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Biomarkers; Cardiotonic Ag | 2009 |
Activation of muscarinic receptors elicits inotropic responses in ventricular muscle from rats with heart failure through myosin light chain phosphorylation.
Topics: Animals; Blood Pressure; Calcium; Carbachol; Cardiac Myosins; Cardiotonic Agents; Disease Models, An | 2009 |
Mechanism of protective action of mangiferin on suppression of inflammatory response and lysosomal instability in rat model of myocardial infarction.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Hydrolases; Isoproterenol; Lysosomes; Male; Myo | 2009 |
Antilipoperoxidative and membrane stabilizing effect of diosgenin, in experimentally induced myocardial infarction.
Topics: Animals; Antioxidants; Cell Membrane; Diosgenin; Hydrolases; Isoproterenol; Lipid Peroxidation; Lyso | 2009 |
Preventive effect of S-allyl cysteine sulphoxide (Alliin) on mitochondrial dysfunction in normal and isoproterenol induced cardiotoxicity in male Wistar rats: a histopathological study.
Topics: Animals; Cysteine; Isoproterenol; Male; Mitochondria; Mitochondrial Diseases; Mitochondrial Proteins | 2009 |
Antioxidant defense of betaine against isoprenaline-induced myocardial infarction in rats.
Topics: Alanine Transaminase; Analysis of Variance; Animals; Antioxidants; Aspartate Aminotransferases; Beta | 2010 |
Protective effect of betaine on changes in the levels of lysosomal enzyme activities in heart tissue in isoprenaline-induced myocardial infarction in Wistar rats.
Topics: Acid Phosphatase; Animals; Betaine; Cardiotonic Agents; Enzyme Activation; Glycoside Hydrolases; Hea | 2009 |
Investigation of effects of Lacidipine, Ramipril and Valsartan on DNA damage and oxidative stress occurred in acute and chronic periods following isoproterenol-induced myocardial infarct in rats.
Topics: Animals; Antihypertensive Agents; Biomarkers; Dihydropyridines; DNA Damage; Guanine; Isoproterenol; | 2009 |
Moringa oleifera leaf extract prevents isoproterenol-induced myocardial damage in rats: evidence for an antioxidant, antiperoxidative, and cardioprotective intervention.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Blood Pressure; Heart; Heart Rate; Isoproterenol; L | 2009 |
Cardioprotective potential of myricetin in isoproterenol-induced myocardial infarction in Wistar rats.
Topics: Animals; Aspartate Aminotransferases; Biomarkers; Catalase; Creatine Kinase; Disease Models, Animal; | 2009 |
Effects of Muntingia calabura L. on isoproterenol-induced myocardial infarction.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Case-Control Studies; Herbal Medicine; H | 2009 |
Protective effect of betaine on changes in the levels of membrane-bound ATPase activity and mineral status in experimentally induced myocardial infarction in Wistar rats.
Topics: Adenosine Triphosphatases; Animals; Betaine; Calcium; Cardiotonic Agents; Isoproterenol; Lipid Perox | 2009 |
Oestrogen confers cardioprotection by suppressing Ca2+/calmodulin-dependent protein kinase II.
Topics: Adrenergic beta-Agonists; Animals; Apoptosis; Benzylamines; Calcium Signaling; Calcium-Calmodulin-De | 2009 |
Cardioprotective effect of salvianolic acid A on isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Aspartate Aminotransferases; Biomarkers; Caffeic Acids; Cardiotonic Agents; C | 2009 |
Gallic acid prevents lysosomal damage in isoproterenol induced cardiotoxicity in Wistar rats.
Topics: Acetylglucosaminidase; Adrenergic beta-Agonists; Animals; Antioxidants; beta-Galactosidase; Biomarke | 2009 |
Ascorbic acid prevents acute myocardial infarction induced by isoproterenol in rats: role of inducible nitric oxide synthase production.
Topics: Animals; Antioxidants; Ascorbic Acid; Cyclooxygenase 2; Immunohistochemistry; Isoproterenol; Male; M | 2009 |
Cardioprotective actions of ascorbic acid during isoproterenol-induced acute myocardial infarction in rats.
Topics: Animals; Antioxidants; Ascorbic Acid; Blood Pressure; Cardiotonic Agents; Disease Models, Animal; Do | 2009 |
Role of Sida cordifolia L. leaves on biochemical and antioxidant profile during myocardial injury.
Topics: Animals; Antioxidants; Catalase; Creatine Kinase, MB Form; Heart; Isoproterenol; L-Lactate Dehydroge | 2009 |
Metabolomic profiling of rat serum associated with isoproterenol-induced myocardial infarction using ultra-performance liquid chromatography/time-of-flight mass spectrometry and multivariate analysis.
Topics: Animals; Biomarkers; Chromatography, High Pressure Liquid; Isoproterenol; Lipid Metabolism; Lipids; | 2009 |
MicroRNA-1 downregulation by propranolol in a rat model of myocardial infarction: a new mechanism for ischaemic cardioprotection.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Cyclic AMP-Dep | 2009 |
Evaluation of cardioprotective activity of Ginkgo biloba and Ocimum sanctum in rodents.
Topics: Animals; Antioxidants; Cardiotonic Agents; Dose-Response Relationship, Drug; Ginkgo biloba; Isoprote | 2009 |
Combined effects of quercetin and alpha-tocopherol on lipids and glycoprotein components in isoproterenol induced myocardial infarcted Wistar rats.
Topics: alpha-Tocopherol; Animals; Glycoproteins; Isoproterenol; Lipid Metabolism; Male; Myocardial Infarcti | 2009 |
Beta1-adrenergic receptors stimulate cardiac contractility and CaMKII activation in vivo and enhance cardiac dysfunction following myocardial infarction.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Animals; Apoptosis; Calcium-Calmoduli | 2009 |
Myocardial salvaging effect of telmisartan in experimental model of myocardial infarction.
Topics: Animals; Benzimidazoles; Benzoates; Biomarkers; Body Weight; Cardiotonic Agents; Catalase; Disease M | 2009 |
Pharmacological activation of soluble guanylate cyclase protects the heart against ischemic injury.
Topics: Adrenergic beta-Agonists; Animals; Benzoates; Cardiotonic Agents; Cyclic AMP; Cyclic GMP; Cyclooxyge | 2009 |
Exercise training provides cardioprotection via a reduction in reactive oxygen species in rats submitted to myocardial infarction induced by isoproterenol.
Topics: Animals; Biomarkers; Catalase; Creatine Kinase, MB Form; Disease Models, Animal; Isoproterenol; Male | 2009 |
The phenotype and potential origin of nestin+ cardiac myocyte-like cells following infarction.
Topics: Adrenergic beta-Agonists; Animals; Cell Differentiation; Cell Movement; Connexin 43; Disease Models, | 2009 |
Preventive effect of amiodarone during acute period in isoproterenol-induced myocardial injury in Wistar rats.
Topics: Amiodarone; Animals; Cardiotonic Agents; Disease Models, Animal; Isoproterenol; Male; Myocardial Inf | 2009 |
Preventive effect of low molecular weight glycosaminoglycan from Amussium pleuronectus (Linne) on oxidative injury and cellular abnormalities in isoproterenol-induced cardiotoxicity in Wistar rats.
Topics: Animals; Antioxidants; Glycosaminoglycans; Heart; Isoproterenol; Male; Molecular Weight; Mollusca; M | 2010 |
Preventive effect of crocin of Crocus sativus on hemodynamic, biochemical, histopathological and ultrastuctural alterations in isoproterenol-induced cardiotoxicity in rats.
Topics: Animals; Antioxidants; Carotenoids; Creatine Kinase, MB Form; Crocus; Dose-Response Relationship, Dr | 2010 |
Cardiac biomarkers in a model of acute catecholamine cardiotoxicity.
Topics: Animals; Antioxidants; Ascorbic Acid; Biomarkers; Blood Pressure; Calcium; Catecholamines; Disease M | 2009 |
Isoproterenol induces in vivo functional and metabolic abnormalities: similar to those found in the infarcted rat heart.
Topics: Adrenergic beta-Agonists; Animals; Blood Pressure; Disease Models, Animal; Fatty Acid Transport Prot | 2009 |
Pharmacodynamic interaction of captopril with garlic in isoproterenol-induced myocardial damage in rat.
Topics: Animals; Captopril; Cardiotonic Agents; Female; Garlic; Herb-Drug Interactions; Isoproterenol; Myoca | 2010 |
Influence of betel quid on effect of calcium channel blockers on isoprenaline induced myocardial necrosis in mice.
Topics: Animals; Areca; Body Weight; Calcium; Calcium Channel Blockers; Isoproterenol; L-Lactate Dehydrogena | 2009 |
Pretreatment with a combination of quercetin and alpha-tocopherol ameliorates adenosine triphosphatases and lysosomal enzymes in myocardial infarcted rats.
Topics: Adenosine Triphosphatases; alpha-Tocopherol; Animals; Antioxidants; Ca(2+) Mg(2+)-ATPase; Cell Membr | 2010 |
Aspartate and glutamate prevents isoproterenol-induced cardiac toxicity by alleviating oxidative stress in rats.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Aspartic Acid; Cardiotonic Agents; Disease Models, An | 2011 |
Protective effect of fish oil on changes in the activities of membrane-bound ATPases and mineral status in experimentally induced myocardial infarction in Wistar rats.
Topics: Adenosine Triphosphatases; Animals; Cardiotonic Agents; Cell Membrane; Fish Oils; Isoproterenol; Lip | 2010 |
Protective effect of caffeic acid on cardiac markers and lipid peroxide metabolism in cardiotoxic rats: an in vivo and in vitro study.
Topics: Animals; Ascorbic Acid; Biomarkers; Caffeic Acids; Isoproterenol; Lipid Peroxidation; Male; Myocardi | 2010 |
Impact of selenium on NFκB translocation in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Female; Isoproterenol; Myocardial Infarction; NF-kappa B; Oxidative Stress; P | 2010 |
Protective effect of sesamol against myocardial infarction caused by isoproterenol in Wistar rats.
Topics: Alanine Transaminase; Animals; Antioxidants; Ascorbic Acid; Aspartate Aminotransferases; Benzodioxol | 2010 |
Melatonin protects against isoproterenol-induced myocardial injury in the rat: antioxidative mechanisms.
Topics: Animals; Antioxidants; Aspartate Aminotransferases; Blotting, Western; Catalase; Glutathione; Glutat | 2010 |
Caffeic acid protects rat heart mitochondria against isoproterenol-induced oxidative damage.
Topics: Adenosine Triphosphate; Animals; Caffeic Acids; Calcium; Cholesterol; Electron Transport Complex IV; | 2010 |
Cardioprotective effects of aqueous extract of Oxalis corniculata in experimental myocardial infarction.
Topics: Animals; Cardiotonic Agents; Disease Models, Animal; Free Radical Scavengers; Isoproterenol; Magnoli | 2011 |
Pomegranate (Punica granatum L.) juice supplementation attenuates isoproterenol-induced cardiac necrosis in rats.
Topics: Adenosine Triphosphatases; Adrenergic beta-Agonists; Animals; Antioxidants; Beverages; Creatine Kina | 2010 |
Cardioprotective effect of matrine on isoproterenol-induced cardiotoxicity in rats.
Topics: Alkaloids; Animals; Antioxidants; Cardiotonic Agents; Drugs, Chinese Herbal; Heart; Isoproterenol; M | 2010 |
Cardioprotective effect of melatonin against isoproterenol induced myocardial infarction in rats: A biochemical, electrocardiographic and histoarchitectural evaluation.
Topics: Animals; Antioxidants; Cardiotonic Agents; Disease Models, Animal; Electrocardiography; Inflammation | 2010 |
Inhibition of secretory phospholipase A2 activity attenuates acute cardiogenic pulmonary edema induced by isoproterenol infusion in mice after myocardial infarction.
Topics: Animals; Indoleacetic Acids; Infusions, Intravenous; Isoproterenol; Leukotriene B4; Lung; Male; Mice | 2010 |
Cardioprotective activity of Cladosiphon okamuranus fucoidan against isoproterenol induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Heart; Isoproterenol; Lipid Peroxidation; Lipids; Male; Myocardial Infarction | 2010 |
Effects of caffeic acid phenethyl ester on isoproterenol-induced myocardial infarction in rats.
Topics: Adrenergic beta-Antagonists; Animals; Aspartate Aminotransferases; Caffeic Acids; Cardiotonic Agents | 2010 |
Drug-disease interaction: reduced verapamil response in isoproterenol-induced myocardial injury in rats.
Topics: Animals; Blotting, Western; Calcium Channel Blockers; Calcium Channels, L-Type; Disease Models, Anim | 2010 |
Ramipril-like activity of Spondias mombin linn against no-flow ischemia and isoproterenol-induced cardiotoxicity in rat heart.
Topics: Anacardiaceae; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiovascular Agents; Catalase; C | 2010 |
Flavonoid rich fraction of Dioscorea bulbifera Linn. (Yam) enhances mitochondrial enzymes and antioxidant status and thereby protects heart from isoproterenol induced myocardial infarction.
Topics: Animals; Antioxidants; Biphenyl Compounds; Cardiotonic Agents; Creatine Kinase, MB Form; Dioscorea; | 2010 |
A novel phytochemical, digoxigenin-3-O-rutin in the amelioration of isoproterenol-induced myocardial infarction in rat: a comparison with digoxin.
Topics: Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; Biomarkers; Cardiotonic Ag | 2012 |
Pyruvate attenuates cardiac dysfunction and oxidative stress in isoproterenol-induced cardiotoxicity.
Topics: Adrenergic beta-Agonists; Animals; Cardiotonic Agents; Disease Models, Animal; Heart; Hemodynamics; | 2012 |
Preventive effects of vanillic acid on lipids, bax, bcl-2 and myocardial infarct size on isoproterenol-induced myocardial infarcted rats: a biochemical and in vitro study.
Topics: Animals; bcl-2-Associated X Protein; Biphenyl Compounds; Creatine Kinase, MB Form; Disease Models, A | 2011 |
Cardiomyocytes from phorbol myristate acetate-activated mesenchymal stem cells restore electromechanical function in infarcted rat hearts.
Topics: Analysis of Variance; Animals; Blotting, Western; Cell- and Tissue-Based Therapy; Connexin 43; Cytok | 2011 |
Comments on Vennila and Pugalendi. Vennila L, Pugalendi KV. Protective effect of sesamol against myocardial infarction caused by isoproterenol in Wistar rats. Redox Rep 2010; 15: 36-42.
Topics: Alanine Transaminase; Animals; Antioxidants; Ascorbic Acid; Aspartate Aminotransferases; Benzodioxol | 2010 |
Time-dependent responses of rat troponin I and cardiac injury following isoproterenol administration.
Topics: Animals; Biomarkers; Cardiotonic Agents; Disease Models, Animal; Heart; Isoproterenol; Male; Myocard | 2011 |
Impact of selenium on the leukotriene B4 synthesis pathway during isoproterenol-induced myocardial infarction in experimental rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Calcium; Calcium-Transporting ATPases; Epoxide Hyd | 2012 |
An oral formulation of angiotensin-(1-7) produces cardioprotective effects in infarcted and isoproterenol-treated rats.
Topics: Administration, Oral; Analysis of Variance; Angiotensin I; Animals; Blood Pressure; Cardiomegaly; Ca | 2011 |
Ellagic acid ameliorates isoproterenol induced oxidative stress: Evidence from electrocardiological, biochemical and histological study.
Topics: Animals; Blood Pressure; Cardiotonic Agents; Electrocardiography; Ellagic Acid; Isoproterenol; Male; | 2011 |
Effect of Inula racemosa root extract on cardiac function and oxidative stress against isoproterenol-induced myocardial infarction.
Topics: Animals; Catalase; Creatine Kinase, MB Form; Glutathione; Glutathione Peroxidase; Heart Rate; Hemody | 2011 |
Sesamol attenuates isoproterenol-induced acute myocardial infarction via inhibition of matrix metalloproteinase-2 and -9 expression in rats.
Topics: Acute Disease; Animals; Antioxidants; Benzodioxoles; Blood Pressure; Creatine Kinase, MB Form; Elect | 2011 |
Effect of 20(S)-protopanaxatriol and its epimeric derivatives on myocardial injury induced by isoproterenol.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Cardiomyopathies; Creatine Kinase; Glutathione Pero | 2011 |
An in vivo and in vitro study on the protective effects of N-acetylcysteine on mitochondrial dysfunction in isoproterenol treated myocardial infarcted rats.
Topics: Acetylcysteine; Animals; Antioxidants; Creatine Kinase; Data Interpretation, Statistical; Disease Mo | 2013 |
Pretreatment with morin, a flavonoid, ameliorates adenosine triphosphatases and glycoproteins in isoproterenol-induced myocardial infarction in rats.
Topics: Adenosine Triphosphatases; Animals; Biomarkers; Disease Models, Animal; Flavonoids; Glycoproteins; I | 2012 |
Pharmacodynamics of ellagic acid on cardiac troponin-T, lyosomal enzymes and membrane bound ATPases: mechanistic clues from biochemical, cytokine and in vitro studies.
Topics: Adenosine Triphosphatases; Animals; Biphenyl Compounds; Creatine Kinase; Cytokines; Ellagic Acid; En | 2011 |
Ganoderma lucidum ameliorate mitochondrial damage in isoproterenol-induced myocardial infarction in rats by enhancing the activities of TCA cycle enzymes and respiratory chain complexes.
Topics: Animals; Antioxidants; Citric Acid Cycle; Creatine Kinase; Drugs, Chinese Herbal; Electron Transport | 2013 |
A biochemical, electrocardiographic, electrophoretic, histopathological and in vitro study on the protective effects of (-)epicatechin in isoproterenol-induced myocardial infarcted rats.
Topics: Animals; Antioxidants; Biomarkers; Biphenyl Compounds; Cardiotonic Agents; Catechin; Dose-Response R | 2011 |
Cardioprotective effect of water and ethanol extract of Salvia miltiorrhiza in an experimental model of myocardial infarction.
Topics: Administration, Oral; Animals; Biomarkers; Camphanes; Cardiotonic Agents; Disease Models, Animal; Dr | 2012 |
Preventive effects of N-acetyl cysteine on lipids, lipoproteins and myocardial infarct size in isoproterenol induced myocardial infarcted rats: an in vivo and in vitro study.
Topics: Acetylcysteine; Animals; Biomarkers; Free Radical Scavengers; Isoproterenol; Lipoproteins; Liver; Ma | 2012 |
Shortened Ca2+ signaling refractoriness underlies cellular arrhythmogenesis in a postinfarction model of sudden cardiac death.
Topics: Adrenergic beta-Agonists; Animals; Benzylamines; Caffeine; Calcium Channel Agonists; Calcium Signali | 2012 |
The autoimmune nature of post-infarct myocardial healing: oral tolerance to cardiac antigens as a novel strategy to improve cardiac healing.
Topics: Animals; Autoantigens; Autoimmunity; Cytokines; Disease Models, Animal; Female; Forkhead Transcripti | 2012 |
Insulin like growth factor-1 (IGF-1) causes overproduction of IL-8, an angiogenic cytokine and stimulates neovascularization in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Insulin-Like Growth Factor I; Interleukin-8; Isoproterenol; Male; Myocardial Infarction; My | 2011 |
Overexpression of apolipoprotein B attenuates pathologic cardiac remodeling and hypertrophy in response to catecholamines and after myocardial infarction in mice.
Topics: Animals; Apolipoproteins B; Cardiomegaly; Echocardiography; Heart; Humans; Isoproterenol; Male; Mice | 2012 |
Effect of ursolic acid treatment on apoptosis and DNA damage in isoproterenol-induced myocardial infarction.
Topics: Animals; Apoptosis; Blotting, Western; DNA Damage; DNA Fragmentation; Electrophoresis, Polyacrylamid | 2012 |
Effective components screening and anti-myocardial infarction mechanism study of the Chinese medicine NSLF6 based on "system to system" mode.
Topics: Animals; Cell Membrane Permeability; Cell Movement; Cell Proliferation; Creatine Kinase; Discriminan | 2012 |
Comparing effects of lacidipine, ramipril, and valsartan against experimentally induced myocardial infarcted rats.
Topics: Administration, Oral; Animals; Cardiotonic Agents; Dihydropyridines; Dose-Response Relationship, Dru | 2012 |
Protective effect of morin on cardiac mitochondrial function during isoproterenol-induced myocardial infarction in male Wistar rats.
Topics: Animals; Antioxidants; Cell Membrane; Electron Transport Complex IV; Enzyme Activation; Flavonoids; | 2012 |
Sympathetic stimulation increases dispersion of repolarization in humans with myocardial infarction.
Topics: Action Potentials; Adult; Aged; Arrhythmias, Cardiac; Blood Pressure; Cardiomyopathies; Catheter Abl | 2012 |
Anti-inflammatory and anti-apoptotic effects of Crataegus oxyacantha on isoproterenol-induced myocardial damage.
Topics: Animals; Anti-Inflammatory Agents; Apoptosis; Catalase; Crataegus; Creatine Kinase; Cyclooxygenase 2 | 2012 |
Cardioprotective effect of HPLC standardized ethanolic extract of Terminalia pallida fruits against isoproterenol-induced myocardial infarction in albino rats.
Topics: Adenosine Triphosphatases; Animals; Antioxidants; Biomarkers; Cardiovascular Agents; Chromatography, | 2012 |
[Effect of compatibilities and proportions of shuanglong formula on acute myocardial infarction in rats].
Topics: Animals; Disease Models, Animal; Drugs, Chinese Herbal; Electrocardiography; Isoproterenol; Male; My | 2011 |
Coptisine exert cardioprotective effect through anti-oxidative and inhibition of RhoA/Rho kinase pathway on isoproterenol-induced myocardial infarction in rats.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Animals; Antioxidants; Apoptosis; Berberine; Cardioto | 2012 |
Morin protects heart from beta-adrenergic-stimulated myocardial infarction: an electrocardiographic, biochemical, and histological study in rats.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Biomarkers; Electrocardiography; Flavonoids; Isopro | 2012 |
Dexrazoxane provided moderate protection in a catecholamine model of severe cardiotoxicity.
Topics: Animals; Calcium; Cardiotonic Agents; Disease Models, Animal; Hemodynamics; Iron; Iron Chelating Age | 2012 |
Amaranthus viridis Linn., a common spinach, modulates C-reactive protein, protein profile, ceruloplasmin and glycoprotein in experimental induced myocardial infarcted rats.
Topics: Amaranthus; Animals; Blood Proteins; C-Reactive Protein; Ceruloplasmin; Glycoproteins; Isoproterenol | 2012 |
The cardiac expression of Mas receptor is responsive to different physiological and pathological stimuli.
Topics: Angiotensin I; Animals; Cardiomegaly; Desoxycorticosterone; Hypertension; Isoproterenol; Male; Motor | 2012 |
Increased expression of calcium-sensing receptors in atherosclerosis confers hypersensitivity to acute myocardial infarction in rats.
Topics: Animals; Aorta, Abdominal; Apoptosis; Apoptosis Regulatory Proteins; Atherosclerosis; Cholesterol; C | 2012 |
The plating of rat scar myofibroblasts on matrigel unmasks a novel phenotype; the self assembly of lumen-like structures.
Topics: Actins; Animals; Carbocyanines; Cell Culture Techniques; Cell Differentiation; Cell Separation; Cell | 2012 |
Protective effects of N-acetyl cysteine on membrane-bound adenosine triphosphatases and minerals in isoproterenol-induced myocardial-infarcted rats: an in vivo and in vitro study.
Topics: Acetylcysteine; Adenosine Triphosphatases; Animals; Cardiotonic Agents; Cell Membrane; Enzyme Activa | 2012 |
Protective efficacy of ellagic acid on glycoproteins, hematological parameters, biochemical changes, and electrolytes in myocardial infarcted rats.
Topics: Animals; Blood Glucose; Blood Proteins; Cardiotonic Agents; Electrolytes; Ellagic Acid; Glycoprotein | 2012 |
Rosuvastatin promotes angiogenesis and reverses isoproterenol-induced acute myocardial infarction in rats: role of iNOS and VEGF.
Topics: Acute Disease; Animals; Body Weight; Electrocardiography; Fluorobenzenes; Heart Ventricles; Isoprote | 2012 |
Blockers of sulfonylureas receptor 1 subunits may lead to cardiac protection against isoprenaline-induced injury in obese rats.
Topics: Animals; ATP-Binding Cassette Transporters; Cell Size; Gene Expression Regulation; Gliclazide; Heart | 2012 |
The mechanism of beta-adrenergic preconditioning: roles for adenosine and ROS during triggering and mediation.
Topics: Adenosine; Animals; Ethanolamines; Extracellular Signal-Regulated MAP Kinases; Formoterol Fumarate; | 2012 |
Turbinaria conoides (J. Agardh) sulfated polysaccharide protects rat's heart against myocardial injury.
Topics: Adenosine Triphosphatases; Animals; Calcium; Cell Membrane; Creatine Kinase; Disease Models, Animal; | 2012 |
Maslinic acid protects against isoproterenol-induced cardiotoxicity in albino Wistar rats.
Topics: Animals; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Humans; Isoproterenol; Male; Myocardial In | 2012 |
Protective effects of thymol on altered plasma lipid peroxidation and nonenzymic antioxidants in isoproterenol-induced myocardial infarcted rats.
Topics: Animals; Antioxidants; Cardiotonic Agents; Creatine Kinase, MB Form; Dose-Response Relationship, Dru | 2012 |
Effect of ursolic acid on cardiac marker enzymes, lipid profile and macroscopic enzyme mapping assay in isoproterenol-induced myocardial ischemic rats.
Topics: Animals; Biomarkers; Cardiotonic Agents; Cholesterol; Cholesterol, LDL; Cholesterol, VLDL; Creatine | 2012 |
Protective effects of sinapic acid on lysosomal dysfunction in isoproterenol induced myocardial infarcted rats.
Topics: Animals; beta-Galactosidase; Cardiotonic Agents; Cathepsin B; Cathepsin D; Coumaric Acids; Creatine | 2012 |
Efficacy of sesamol on plasma and tissue lipids in isoproterenol-induced cardiotoxicity in Wistar rats.
Topics: Animals; Antioxidants; Benzodioxoles; Disease Models, Animal; Dose-Response Relationship, Drug; Hypo | 2012 |
Preconditioning with diosgenin and treadmill exercise preserves the cardiac toxicity of isoproterenol in rats.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Diosgenin; Disease Models, Animal; Free Radicals; G | 2013 |
Preventive effects of Egyptian sweet marjoram (Origanum majorana L.) leaves on haematological changes and cardiotoxicity in isoproterenol-treated albino rats.
Topics: Animals; Blood Coagulation; Cardiotonic Agents; Disease Models, Animal; Dose-Response Relationship, | 2013 |
The effect of c-fos on acute myocardial infarction and the significance of metoprolol intervention in a rat model.
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Agonists; Animals; Female; Gene Expression; | 2013 |
Cardioprotective effect of lycopene against isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Carotenoids; Creatine Kinase, MB Form; Glutathione; Heart; Hemodynamics; Isoproterenol; Lip | 2013 |
Short-term treatment with metformin suppresses toll like receptors (TLRs) activity in isoproterenol-induced myocardial infarction in rat: are AMPK and TLRs connected?
Topics: Adrenergic beta-Agonists; AMP-Activated Protein Kinases; Animals; Gene Expression Regulation; Hypogl | 2012 |
Cardioprotective effect of paeonol and danshensu combination on isoproterenol-induced myocardial injury in rats.
Topics: Acetophenones; Animals; Antioxidants; bcl-2-Associated X Protein; Biomarkers; Body Weight; Cardioton | 2012 |
Preventive effects of p-coumaric acid on lysosomal dysfunction and myocardial infarct size in experimentally induced myocardial infarction.
Topics: Animals; Antioxidants; Coumaric Acids; Disease Models, Animal; Free Radical Scavengers; Isoprotereno | 2013 |
Protective effects of sinapic acid on cardiac hypertrophy, dyslipidaemia and altered electrocardiogram in isoproterenol-induced myocardial infarcted rats.
Topics: Animals; Antioxidants; Cardiomegaly; Coumaric Acids; Dyslipidemias; Electrocardiography; Hydroxymeth | 2013 |
The functional activity of inhibitory G protein (G(i)) is not increased in failing heart ventricle.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Carbachol; Cardiotonic Agents; GTP-Binding Pro | 2013 |
Preventive effects of (-) epicatechin on altered adenosine triphosphatases and minerals in isoproterenol-induced myocardial infarcted rats.
Topics: Adenosine Triphosphatases; Animals; Catechin; Isoproterenol; Lipid Peroxidation; Male; Minerals; Myo | 2012 |
(-) Epicatechin attenuates mitochondrial damage by enhancing mitochondrial multi-marker enzymes, adenosine triphosphate and lowering calcium in isoproterenol induced myocardial infarcted rats.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Biomarkers; Calcium; Catechin; Citric Acid Cycle; Cre | 2013 |
Protective effect of neferine against isoproterenol-induced cardiac toxicity.
Topics: Animals; Benzylisoquinolines; Biomarkers; Cardiotonic Agents; Drugs, Chinese Herbal; Enzymes; Heart; | 2013 |
Folic acid and vitamin B(12) supplementation attenuates isoprenaline-induced myocardial infarction in experimental hyperhomocysteinemic rats.
Topics: Animals; Blood Pressure; Creatine Kinase; Folic Acid; Glutathione; Heart Rate; Hemodynamics; Hyperho | 2002 |
Overexpression of Na+/Ca2+ exchanger gene attenuates postinfarction myocardial dysfunction.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Disease Models, Animal; Disease Progression; Electrocard | 2002 |
Protein kinase A phosphorylation of the cardiac calcium release channel (ryanodine receptor) in normal and failing hearts. Role of phosphatases and response to isoproterenol.
Topics: Animals; Calcium; Calcium-Binding Proteins; Cyclic AMP-Dependent Protein Kinases; Disease Models, An | 2003 |
Toxic cardiac effects of catecholamines: role of beta-adrenoceptor downregulation.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Binding, Competitive; Blood Pressure | 2002 |
Overexpression of Na+/Ca2+ exchanger attenuates postinfarcted myocardial dysfunction.
Topics: Adrenergic beta-Agonists; Animals; Disease Models, Animal; Gene Expression Regulation; Hemodynamics; | 2002 |
Effect of fish oil on mitochondrial respiration in isoproterenol induced myocardial infarction in rats.
Topics: Animals; Fish Oils; Isoproterenol; Lipid Peroxidation; Male; Mitochondria, Heart; Myocardial Infarct | 2002 |
Effect of isoproterenol on lipid peroxidation and antioxidant enzymes of myocardial tissue of mice and protection by quinidine.
Topics: Animals; Anti-Arrhythmia Agents; Antioxidants; Aspartate Aminotransferases; Body Weight; Cardiotonic | 2003 |
Impaired beta-adrenergic response and decreased L-type calcium current of hypertrophied left ventricular myocytes in postinfarction heart failure.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Calcium Channels, L-Type; Colforsin; Disease M | 2003 |
Combined sodium and calcium channel blockade in prevention of lethal arrhythmias.
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Death, Sudde | 2003 |
[Variation of endogeneous ET, CGRP and NO in myocardial ischemia in rats and the regulatory effect of xinshuping].
Topics: Animals; Calcitonin Gene-Related Peptide; Cardiotonic Agents; Drug Combinations; Drugs, Chinese Herb | 2002 |
Effect of D-003 on isoproterenol-induced myocardial necrosis in rats.
Topics: Animals; Aspirin; Disease Models, Animal; Fatty Acids; Isoproterenol; Male; Myocardial Infarction; M | 2003 |
Inotropic responses to isoproterenol in congestive heart failure subsequent to myocardial infarction in rats.
Topics: Adenosine Monophosphate; Adrenergic beta-Agonists; Animals; Colforsin; Coronary Vessels; Heart Failu | 1995 |
Effect of L-arginine and L-lysine on lysosomal hydrolases and membrane bound phosphatases in experimentally induced myocardial infarction in rats.
Topics: Animals; Arginine; Cell Membrane; Disease Models, Animal; Hydrolases; Isoproterenol; Lysine; Lysosom | 2003 |
Protective effects of melatonin against myocardial injury induced by isoproterenol in rats.
Topics: Animals; Cardiotonic Agents; Heart; Isoproterenol; Male; Melatonin; Myocardial Infarction; Myocardiu | 2003 |
Asystole complicating acute myocardial infarction; survival with the aid of a cardiac pacemaker and intravenous administration of isoproterenol.
Topics: Administration, Intravenous; Arrhythmias, Cardiac; Heart Arrest; Humans; Isoproterenol; Myocardial I | 1958 |
An infarct-like myocardial lesion and other toxic manifestations produced by isoproterenol in the rat.
Topics: Animals; Isoproterenol; Myocardial Infarction; Rats; Sympathomimetics | 1959 |
The effect of breed, age, and sex on myocardial necrosis produced by isoproterenol in the rat.
Topics: Aging; Animals; Cardiomyopathies; Disease; Heart Diseases; Isoproterenol; Myocardial Infarction; Myo | 1959 |
Stokes-Adams attacks complicating acute myocardial infarction; their treatment with continuous intravenous infusion of isopropylnorepinephrine.
Topics: Adams-Stokes Syndrome; Heart; Heart Block; Humans; Infusions, Intravenous; Isoproterenol; Myocardial | 1959 |
Use of isoproterenol in the treatment of complete heart block complicating acute myocardial infarction.
Topics: Atrioventricular Block; Heart; Heart Block; Humans; Isoproterenol; Myocardial Infarction; Sympathomi | 1961 |
Severe myocardial necrosis produced by isoproterenol in the rat.
Topics: Animals; Isoproterenol; Myocardial Infarction; Myocardium; Rats; Sympathomimetics | 1959 |
[Action of a monoamine oxidase inhibitor (Niamid) on various experimental vascular lesions in the rabbit (allergic arteritis, myocardial necrosis caused by isoproterenol, aortic medionecrosis, venous and arterial thrombosis)].
Topics: Animals; Aorta; Arteritis; Isoproterenol; Monoamine Oxidase Inhibitors; Myocardial Infarction; Myoca | 1962 |
Isoproterenol-induced myocardial infarction in animals.
Topics: Animals; Cardiovascular Diseases; Isoproterenol; Myocardial Infarction; Sympathomimetics | 1962 |
The pathogenesis of atrial infarction. Experimental data.
Topics: Infarction; Isoproterenol; Myocardial Infarction | 1962 |
[Influence of amine oxidase inhibitors, vasodilator and tranquilizing agents on experimental isoproterenol-induced myocardial necrosis].
Topics: Humans; Isoproterenol; Monoamine Oxidase Inhibitors; Myocardial Infarction; Oxidoreductases; Sympath | 1962 |
[Experimental infarct-like changes of the myocardium under the influence of isadrine (isopropylnoradrenaline)].
Topics: Isoproterenol; Myocardial Infarction; Myocardium | 1963 |
[Experimental induction of necroses in the myocardium with isadrine (isopropylnoradrenalin)].
Topics: Isoproterenol; Myocardial Infarction; Myocardium; Necrosis | 1963 |
THE SIGNIFICANCE OF SINUS BRADYCARDIA IN ACUTE MYOCARDIAL INFARCTION.
Topics: Anterior Wall Myocardial Infarction; Arrhythmia, Sinus; Bradycardia; Electrocardiography; Humans; Is | 1963 |
THE SIGNIFICANCE OF FACTORS MODIFYING THE DEVELOPMENT OF ISOPROTERENOL-INDUCED MYOCARDIAL NECROSIS.
Topics: Adrenal Cortex Hormones; Adrenalectomy; Diet; Dietary Carbohydrates; Dietary Fats; Estrogens; Estron | 1963 |
ISOPROTERENOL-INDUCED HEART NECROSIS, AN EXPERIMENTAL MODEL FOR THE STUDY OF ANGINA PECTORIS AND MYOCARDIAL INFARCT.
Topics: Angina Pectoris; Aspartate Aminotransferases; Heart; Isocarboxazid; Isoproterenol; L-Lactate Dehydro | 1963 |
SURGICAL TREATMENT OF COMPLETE HEART BLOCK. AN ANALYSIS OF 36 CASES.
Topics: Atropine; Chlorothiazide; Diabetes Mellitus; Ephedrine; Geriatrics; Heart Block; Heart Failure; Huma | 1964 |
ISOPROTERENOL-INDUCED MYOCARDIAL NECROSIS. A HISTOCHEMICAL AND ELECTRON MICROSCOPIC STUDY.
Topics: Coronary Disease; Electron Transport Complex IV; Electrons; Fluorescence; Glycogen; Heart Diseases; | 1964 |
DIRECT WIRE ELECTRICAL STIMULATION FOR ACUTE POSTSURGICAL AND POSTINFARCTION COMPLETE HEART BLOCK.
Topics: Drug Therapy; Electric Stimulation; Electrocardiography; Heart Block; Humans; Isoproterenol; Myocard | 1964 |
[TREATMENT OF VENTRICULAR TACHYCARDIA WITH ALUPENT].
Topics: Drug Therapy; Electrocardiography; Isoproterenol; Metaproterenol; Myocardial Infarction; Procainamid | 1965 |
HEMODYNAMIC DETERMINANTS OF THE AMPLITUDE OF THE FIRST HEART SOUND.
Topics: Animals; Aortic Diseases; Atropine; Dogs; Electrocardiography; Epinephrine; Heart Auscultation; Hear | 1965 |
TREATMENT OF SHOCK IN MAN BASED ON HEMODYNAMIC DIAGNOSIS.
Topics: Blood; Blood Gas Analysis; Blood Pressure; Blood Pressure Determination; Blood Transfusion; Blood Vo | 1965 |
STEROIDS PRODUCED IN VITRO BY ADRENAL GLANDS OF NORMAL AND ARTERIOSCLEROTIC RATS DURING AND AFTER DRUG-INDUCED MYOCARDIAL NECROSIS.
Topics: Adrenal Cortex Hormones; Adrenal Glands; Aldosterone; Arteriosclerosis; Heart Failure; In Vitro Tech | 1965 |
THE COURSE OF HEALING OF EXPERIMENTAL MYOCARDIAL INFARCTION IN THE RAT.
Topics: Cardiovascular Diseases; Cicatrix; Isoproterenol; Myocardial Infarction; Pathology; Pharmacology; Ra | 1965 |
CARDIAC ABNORMALITIES ASSOCIATED WITH CAROTID-SINUS SYNDROME.
Topics: Arrhythmias, Cardiac; Atropine; Carotid Sinus; Denervation; Drug Therapy; Electrocardiography; Human | 1965 |
[ON THE PATHOGENESIS AND PHARMACOLOGICAL INFLUENCE OF MYOCARDIAL NECROSES CAUSED BY ISOPRENALINE POISONING].
Topics: Heart Diseases; Isoproterenol; Myocardial Infarction; Rats; Research; Toxicology | 1964 |
Protection, by coronary ligature, against isoproterenol-induced myocardial necroses.
Topics: Coronary Vessels; Heart; Isoproterenol; Ligation; Myocardial Infarction; Myocardium; Necrosis; Sympa | 1960 |
Biochemical changes on the cardioprotective effect of nicorandil and amlodipine during experimental myocardial infarction in rats.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Amlodipine; Animals; Cardiovascular Agents; Drug Syne | 2003 |
Angiotensin receptor blockade improves myocardial beta-adrenergic receptor signaling in postinfarction left ventricular remodeling: a possible link between beta-adrenergic receptor kinase-1 and protein kinase C epsilon isoform.
Topics: Adrenergic beta-Agonists; Angiotensin II Type 1 Receptor Blockers; Animals; Isoproterenol; Male; Myo | 2004 |
Phosphorylation of eukaryotic translation initiation factor 2Bepsilon by glycogen synthase kinase-3beta regulates beta-adrenergic cardiac myocyte hypertrophy.
Topics: Adenoviridae; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Animals, Newborn; Atri | 2004 |
Chronic oral administration of raw garlic protects against isoproterenol-induced myocardial necrosis in rat.
Topics: Animals; Antioxidants; Catalase; Dose-Response Relationship, Drug; Female; Garlic; Glutathione; Glut | 2003 |
Ca2+/calmodulin-dependent protein kinase II phosphorylation regulates the cardiac ryanodine receptor.
Topics: Adrenergic beta-Agonists; Amino Acid Sequence; Animals; Benzylamines; Calcium-Calmodulin-Dependent P | 2004 |
Cardiomyocyte-specific overexpression of nitric oxide synthase 3 improves left ventricular performance and reduces compensatory hypertrophy after myocardial infarction.
Topics: Adrenergic beta-Agonists; Animals; Enzyme Induction; Fibrosis; Humans; Hypertrophy; Hypertrophy, Lef | 2004 |
NFATc3-induced reductions in voltage-gated K+ currents after myocardial infarction.
Topics: Action Potentials; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cyclosporine; DNA | 2004 |
Wine polyphenols induce hypotension, and decrease cardiac reactivity and infarct size in rats: involvement of nitric oxide.
Topics: Administration, Oral; Aldehydes; Animals; Blood Pressure; Blotting, Western; Carbachol; Coronary Cir | 2004 |
Dispersion of ventricular mRNA of RyR2 and SERCA2 associated with arrhythmogenesis in rats.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Berberine; Calcium Channels, L-Type; Calcium- | 2004 |
Effect of Calotropis procera latex on isoproterenol induced myocardial infarction in albino rats.
Topics: Administration, Oral; Alanine Transaminase; Animals; Aspartate Aminotransferases; Calotropis; Cardio | 2004 |
Improvement of cardiac function and beta-adrenergic signal transduction by propionyl L-carnitine in congestive heart failure due to myocardial infarction.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Cardiotonic Agent | 2004 |
Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Free Radicals; Isoproterenol; Lipid Peroxidation; Liver; Male; Myocardial Inf | 2004 |
Cardioprotection from ischemia and reperfusion injury by Withania somnifera: a hemodynamic, biochemical and histopathological assessment.
Topics: Animals; Blood Pressure; Catalase; Creatine Kinase; Female; Glutathione; Glutathione Peroxidase; Hea | 2004 |
Cardioprotective effect of tincture of Crataegus on isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Crataegus; Fruit; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarction; Myocardiu | 2004 |
Comparative account of certain enzymes in the serum of homo-iothermal vertebrates subjected to production of myocardial infarction by isoproterenol hydrochloride.
Topics: Acetylcholinesterase; Alanine Transaminase; Animals; Aspartate Aminotransferases; Columbidae; Diseas | 2003 |
Effect of garlic (Allium sativum) on lipid peroxidation in experimental myocardial infarction in rats.
Topics: Allyl Compounds; Animals; Garlic; Glutathione Transferase; Isoproterenol; Lipid Peroxidation; Male; | 2004 |
Protective effect of Terminalia chebula against experimental myocardial injury induced by isoproterenol.
Topics: Adrenergic beta-Agonists; Alanine Transaminase; Animals; Aspartate Aminotransferases; Fruit; Heart; | 2004 |
Role of Arogh, a polyherbal formulation to mitigate oxidative stress in experimental myocardial infarction.
Topics: Antioxidants; Catalase; Glutathione; Glutathione Peroxidase; Glutathione Transferase; Isoproterenol; | 2004 |
Treatment of acute myocardial infarction by hepatocyte growth factor gene transfer: the first demonstration of myocardial transfer of a "functional" gene using ultrasonic microbubble destruction.
Topics: Animals; Capillaries; Cicatrix; Disease Models, Animal; Gene Expression Regulation; Gene Transfer Te | 2004 |
Thyroid hormone analog, DITPA, improves endothelial nitric oxide and beta-adrenergic mediated vasorelaxation after myocardial infarction.
Topics: Acetylcholine; Animals; Cattle; Cells, Cultured; Coronary Vessels; Diiodothyronines; Endothelium, Va | 2004 |
Role of myocardial neuronal nitric oxide synthase-derived nitric oxide in beta-adrenergic hyporesponsiveness after myocardial infarction-induced heart failure in rat.
Topics: Adrenergic beta-Agonists; Animals; Autocrine Communication; Caveolin 3; Caveolins; Dobutamine; Enzym | 2004 |
Isoproterenol-induced myocardial infarction in rabbits. Protection by propranolol or labetalol: a proposed non-invasive procedure.
Topics: Adrenergic beta-Antagonists; Animals; Electrocardiography; Isoproterenol; Labetalol; Lipid Peroxides | 2004 |
Chronic treatment with allopurinol boosts survival and cardiac contractility in murine postischemic cardiomyopathy.
Topics: Actin Cytoskeleton; Adrenergic beta-Agonists; Allopurinol; Animals; Antioxidants; Calcium Signaling; | 2004 |
Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
Topics: Adenylyl Cyclases; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Enalap | 2004 |
Myocardial infarction non-invasively induced in rabbits by administering isoproterenol and vasopressin: protective effects exerted by verapamil.
Topics: Animals; Blood Pressure; Calcium Channel Blockers; Disease Models, Animal; Electrocardiography; Hear | 2004 |
Targeted expression of cyclin D2 results in cardiomyocyte DNA synthesis and infarct regression in transgenic mice.
Topics: Age Factors; Animals; Animals, Newborn; Cardiomegaly; Coronary Disease; Cyclin D1; Cyclin D2; Cyclin | 2005 |
Impact of beta-myosin heavy chain expression on cardiac function during stress.
Topics: Animals; Body Weight; Cardiac Output, Low; Cardiomegaly; Cardiotonic Agents; Chronic Disease; Dobuta | 2004 |
Inhibition of catecholamine-induced cardiac fibrosis by an aldosterone antagonist.
Topics: Adrenergic beta-Agonists; Aldosterone; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Anim | 2005 |
Comparative effects of Aegle marmelos extract and alpha-tocopherol on serum lipids, lipid peroxides and cardiac enzyme levels in rats with isoproterenol-induced myocardial infarction.
Topics: Adrenergic beta-Agonists; Aegle; alpha-Tocopherol; Animals; Antioxidants; Biomarkers; Female; Isopro | 2005 |
Protective effects of dantrolene against myocardial injury induced by isoproterenol in rats: biochemical and histological findings.
Topics: Adrenergic beta-Agonists; Animals; Dantrolene; Disease Models, Animal; Heart; Isoproterenol; Male; M | 2005 |
The role of beta-adrenergic receptor signaling in cardioprotection.
Topics: Animals; Cardiotonic Agents; Cyclic AMP-Dependent Protein Kinases; GTP-Binding Protein alpha Subunit | 2005 |
Diverse phenotypes of outward currents in cells that have survived in the 5-day-infarcted heart.
Topics: Adrenergic beta-Agonists; Animals; Cell Survival; Dogs; Electric Conductivity; In Vitro Techniques; | 2005 |
Defective excitation-contraction coupling in hearts of rats with congestive heart failure.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Echocardiography; Heart Failure; Isoproterenol; Male; My | 2005 |
2APB- and JTV519(K201)-sensitive micro Ca2+ waves in arrhythmogenic Purkinje cells that survive in infarcted canine heart.
Topics: Adrenergic beta-Agonists; Aniline Compounds; Animals; Boron Compounds; Calcium; Calcium Channel Bloc | 2004 |
Carvedilol blockade of alpha1- and beta-adrenoceptor induced inotropic responses in rats with congestive heart failure.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Carbaz | 2005 |
Antioxidant activity of DHC-1, an herbal formulation, in experimentally-induced cardiac and renal damage.
Topics: Animals; Antioxidants; Bacopa; Cisplatin; Female; Glycyrrhiza; Isoproterenol; Kidney Diseases; Male; | 2005 |
Animal models of cardiac fibrosis.
Topics: Aldosterone; Angiotensin II; Animals; Disease Models, Animal; Fibroblasts; Fibrosis; Heart Diseases; | 2005 |
Inhibition of iNOS protects the aging heart against beta-adrenergic receptor stimulation-induced cardiac dysfunction and myocardial ischemic injury.
Topics: Adrenergic beta-Agonists; Aging; Animals; Isoproterenol; Male; Myocardial Infarction; Myocardial Isc | 2006 |
Liver architecture maintenance by tincture of Crataegus against isoproterenol-induced myocardially infarcted rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Crataegus; Fruit; | 2005 |
Protective effect of taurine on myocardial antioxidant status in isoprenaline-induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Glutathione; Glutathione Peroxidase; Glutathione Transferase; Heart; Injectio | 2005 |
Preventive effect of Aegle marmelos leaf extract on isoprenaline-induced myocardial infarction in rats: biochemical evidence.
Topics: Administration, Oral; Aegle; Animals; Antioxidants; Aorta; Calcium-Transporting ATPases; Cell Membra | 2005 |
Scar myofibroblasts of the infarcted rat heart express natriuretic peptides.
Topics: Adrenomedullin; Angiotensin II; Animals; Animals, Newborn; Atrial Natriuretic Factor; Cells, Culture | 2006 |
Synergistic interactions of ferulic acid with ascorbic acid: its cardioprotective role during isoproterenol induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Ascorbic Acid; Coumaric Acids; Drug Interactions; Drug Synergism; Free Radica | 2006 |
Cardioprotective effect of mangiferin on isoproterenol induced myocardial infarction in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cardiotonic Agents; Dose-Response Relati | 2006 |
Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
Topics: Adrenergic beta-Agonists; Animals; Anisomycin; Apoptosis; Enzyme Activators; Imidazoles; In Vitro Te | 2006 |
[Significance of isuprel infusion in unexplained syncope after myocardial infarction].
Topics: Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Cardiotonic Agents; Electrophysiologic Techniq | 2006 |
Effect of atorvastatin treatment on isoproterenol-induced myocardial infarction in rats.
Topics: Adenosine Triphosphatases; Animals; Atorvastatin; Body Weight; Catalase; Glutathione; Heart; Heptano | 2006 |
Chronic beta-adrenergic receptor stimulation induces cardiac apoptosis and aggravates myocardial ischemia/reperfusion injury by provoking inducible nitric-oxide synthase-mediated nitrative stress.
Topics: Adrenergic beta-Agonists; Animals; Apoptosis; Blotting, Western; C-Reactive Protein; Heart; Immunohi | 2006 |
Role of mangiferin on biochemical alterations and antioxidant status in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Creatine Kinase, MB Form; Electrophoresis, Agar Gel; Isoproterenol; L-Lactate | 2006 |
Attenuation of abnormalities in the lipid metabolism during experimental myocardial infarction induced by isoproterenol in rats: beneficial effect of ferulic acid and ascorbic acid.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Ascorbic Acid; Cardiotonic Agents; Coumaric Acids; | 2006 |
Cardioprotective activity of A.V. Circulo in isoproterenol-induced myocardial necrosis.
Topics: Administration, Oral; Animals; Cardiotonic Agents; Female; Isoproterenol; Male; Myocardial Infarctio | 2005 |
Modulatory effect of fish oil on the myocardial antioxidant defense system in isoproterenol-induced myocardial infarction.
Topics: Animals; Antioxidants; Body Weight; Catalase; Ceruloplasmin; Creatine Kinase; DNA; Fish Oils; Glutat | 2006 |
Preventive effect of rutin, a bioflavonoid, on lipid peroxides and antioxidants in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Ascorbic Acid; Aspartate Aminotransferases; Catalase; Creatine Kinase, MB For | 2006 |
Effect of mangiferin on mitochondrial energy production in experimentally induced myocardial infarcted rats.
Topics: Animals; Antioxidants; Blood Glucose; Disease Models, Animal; Energy Metabolism; Glutathione; Isopro | 2006 |
PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway.
Topics: Animals; Cardiomegaly; Collagen Type III; Electrocardiography; Enzyme Inhibitors; Glycogen Synthase | 2006 |
Pretreatment with alcoholic extract of Crataegus oxycantha (AEC) activates mitochondrial protection during isoproterenol - induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Citric Acid Cycle; Crataegus; Isoproterenol; Lipid Peroxidation; Male; Mitoch | 2006 |
Correlation between oxidative stress and alteration of intracellular calcium handling in isoproterenol-induced myocardial infarction.
Topics: Animals; Antioxidants; Calcium Signaling; Glutathione; Isoproterenol; Lipid Peroxidation; Male; Mito | 2006 |
Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo.
Topics: Adrenergic beta-Agonists; Animals; Apoptosis; Calcium; Calcium Channel Blockers; Calcium-Binding Pro | 2006 |
Antilipoperoxidative and antioxidant effects of S-allyl cysteine sulfoxide on isoproterenol-induced myocardial infarction in Wistar rats.
Topics: Animals; Antioxidants; Creatine Kinase; Cysteine; Isoproterenol; Lipid Peroxidation; Male; Myocardia | 2006 |
Preventive effect of naringin on lipids, lipoproteins and lipid metabolic enzymes in isoproterenol-induced myocardial infarction in Wistar rats.
Topics: Animals; Flavanones; Hydroxymethylglutaryl CoA Reductases; Isoproterenol; Lipid Metabolism; Lipoprot | 2006 |
Intermedin1-53 protects the heart against isoproterenol-induced ischemic injury in rats.
Topics: Adrenomedullin; Animals; Calcitonin Receptor-Like Protein; Cyclic AMP; Dose-Response Relationship, D | 2006 |
Differential changes in beta-adrenoceptor signal transduction in left and right ventricles of infarcted rats.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Calcium; Heart Ventricles; Intracellular Fluid | 2006 |
Synergistic salubrious effect of ferulic acid and ascorbic acid on membrane-bound phosphatases and lysosomal hydrolases during experimental myocardial infarction in rats.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Ascorbic Acid; Cardiotonic Agents; C | 2006 |
Efficacy of mangiferin on serum and heart tissue lipids in rats subjected to isoproterenol induced cardiotoxicity.
Topics: Adrenergic beta-Agonists; Animals; Cardiotonic Agents; Cholesterol; Fatty Acids, Nonesterified; Hear | 2006 |
Preventive effect of naringin on lipid peroxides and antioxidants in isoproterenol-induced cardiotoxicity in Wistar rats: biochemical and histopathological evidences.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Ascorbic Acid; Ceruloplasmin; Enzymes; Flavanones; | 2006 |
Antioxidant activity of Pepticare, a herbomineral formulation, in experimentally induced renal and cardiac damage.
Topics: Animals; Antioxidants; Catalase; Cisplatin; Creatine Kinase, MB Form; Dose-Response Relationship, Dr | 2006 |
Anti-ischemic effects of nimesulide, a cyclooxygenase-2 inhibitor on the ischemic model of rabbit induced by isoproterenol.
Topics: Adrenergic beta-Agonists; Animals; Coronary Circulation; Creatine Kinase; Cyclooxygenase 2 Inhibitor | 2006 |
S-allylcysteine ameliorates isoproterenol-induced cardiac toxicity in rats by stabilizing cardiac mitochondrial and lysosomal enzymes.
Topics: Adrenergic beta-Agonists; alpha-Tocopherol; Animals; Antineoplastic Agents; Cysteine; Electrocardiog | 2007 |
Preventive effect of naringin on cardiac markers, electrocardiographic patterns and lysosomal hydrolases in normal and isoproterenol-induced myocardial infarction in Wistar rats.
Topics: Acetylglucosaminidase; Alanine Transaminase; Animals; Antioxidants; Aspartate Aminotransferases; bet | 2007 |
Cardioprotective effect of squalene on lipid profile in isoprenaline-induced myocardial infarction in rats.
Topics: Animals; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Fatty Acids, Nonesterified; Isoproterenol; | 2006 |
Ethanolic Zingiber officinale R. extract pretreatment alleviates isoproterenol-induced oxidative myocardial necrosis in rats.
Topics: Animals; Antioxidants; Biomarkers; Ethanol; Female; Isoproterenol; Lipid Peroxidation; Male; Myocard | 2006 |
Influence of ovariectomy in the right ventricular contractility in heart failure rats.
Topics: Animals; Cardiac Output, Low; Cardiotonic Agents; Estrogens; Female; Heart Ventricles; Isoproterenol | 2007 |
Protective effect of n-3 polyunsaturated fatty acids concentrate on isoproterenol-induced myocardial infarction in rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Cardiotonic Agents; Cholesterol; Cholest | 2007 |
Preventive effect of naringin on isoproterenol-induced cardiotoxicity in Wistar rats: an in vivo and in vitro study.
Topics: Animals; Benzothiazoles; Biphenyl Compounds; Blood Glucose; Ca(2+) Mg(2+)-ATPase; Calcium-Transporti | 2007 |
Preventive effect of rutin on lipids, lipoproteins, and ATPases in normal and isoproterenol-induced myocardial infarction in rats.
Topics: Adenosine Triphosphatases; Animals; Ca(2+) Mg(2+)-ATPase; Calcium-Transporting ATPases; Cholesterol; | 2007 |
Enhanced beta-adrenergic response in rat papillary muscle by inhibition of inducible nitric oxide synthase after myocardial infarction.
Topics: Adrenergic beta-Agonists; Animals; Dose-Response Relationship, Drug; Enzyme Inhibitors; Isoprotereno | 2007 |
Cardioprotective effect of Azadirachta indica A. Juss. on isoprenaline induced myocardial infarction in rats.
Topics: Animals; Azadirachta; Cardiotonic Agents; Isoproterenol; Male; Myocardial Infarction; Plant Extracts | 2008 |
Preventive effect of S-allyl cysteine sulfoxide (alliin) on lysosomal hydrolases and membrane-bound ATPases in isoproterenol-induced myocardial infarction in Wistar rats.
Topics: Adenosine Triphosphatases; Animals; Cell Membrane; Cysteine; Enzyme Activation; Hydrolases; Isoprote | 2007 |
Serotonin increases L-type Ca2+ current and SR Ca2+ content through 5-HT4 receptors in failing rat ventricular cardiomyocytes.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Calcium Channels, L-Type; Calcium Signaling; C | 2007 |
Troponin T and histological characteristics of rat myocardial infarction induced by isoproterenol.
Topics: Animals; Body Weight; Cardiotonic Agents; Creatine Kinase; Heart; Isoproterenol; Male; Myocardial In | 2007 |
Susceptibility to systolic dysfunction in the myocardium from chronically infarcted spontaneously hypertensive rats.
Topics: Animals; Apoptosis; Cardiotonic Agents; Coronary Vessels; Disease Models, Animal; Hypertension; Isop | 2008 |
Cardioprotective effect of alpha-mangostin, a xanthone derivative from mangosteen on tissue defense system against isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Biomarkers; Cardiotonic Agents; Garcinia mangostana; Isoproterenol; Lipid Per | 2007 |
Preventive effect of naringin on cardiac mitochondrial enzymes during isoproterenol-induced myocardial infarction in rats: a transmission electron microscopic study.
Topics: Animals; Cardiotonic Agents; Flavanones; Isoproterenol; Male; Microscopy, Electron, Transmission; Mi | 2007 |
Protective effect of (-)-epigallocatechin-gallate (EGCG) on lipid peroxide metabolism in isoproterenol induced myocardial infarction in male Wistar rats: a histopathological study.
Topics: Animals; Catechin; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarction; Myocardium; Rats; | 2008 |
Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart.
Topics: Adrenergic beta-Agonists; Animals; Coronary Circulation; Coronary Vessels; Disease Models, Animal; D | 2008 |
Protective effect of S-allyl cysteine sulphoxide (alliin) on glycoproteins and hematology in isoproterenol induced myocardial infarction in male Wistar rats.
Topics: Adrenergic beta-Agonists; Animals; Blood Cell Count; Blood Chemical Analysis; Blood Coagulation; Car | 2008 |
(-)-Epigallocatechin gallate (EGCG) prevents isoprenaline-induced cardiac marker enzymes and membrane-bound ATPases.
Topics: Adenosine Triphosphatases; Alanine Transaminase; Animals; Aspartate Aminotransferases; Biomarkers; C | 2008 |
Preventive effect of (-)epigallocatechin-gallate (EGCG) on lysosomal enzymes in heart and subcellular fractions in isoproterenol-induced myocardial infarcted Wistar rats.
Topics: Animals; Cardiovascular Agents; Catechin; Disease Models, Animal; Heart; Isoproterenol; Lysosomes; M | 2008 |
Targeted inhibition of cardiomyocyte Gi signaling enhances susceptibility to apoptotic cell death in response to ischemic stress.
Topics: Adrenergic beta-Agonists; Animals; Apoptosis; Cells, Cultured; GTP-Binding Protein alpha Subunit, Gi | 2008 |
Isoproterenol-induced cardiotoxicity in sprague-dawley rats: correlation of reversible and irreversible myocardial injury with release of cardiac troponin T and roles of iNOS in myocardial injury.
Topics: Adrenergic beta-Antagonists; Animals; Apoptosis; Cell Count; Disease Models, Animal; Dose-Response R | 2008 |
Electrocardiography in two models of isoproterenol-induced left ventricular remodeling.
Topics: Action Potentials; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Electrocardiog | 2008 |
Protective role of curcumin in myocardial oxidative damage induced by isoproterenol in rats.
Topics: Adrenergic beta-Agonists; Alanine Transaminase; Animals; Aspartate Aminotransferases; Cardiotonic Ag | 2007 |
Cardioprotective effect of fluvastatin on isoproterenol-induced myocardial infarction in rat.
Topics: Adrenergic beta-Agonists; Animals; Antioxidants; Body Weight; Electrocardiography; Fatty Acids, Mono | 2008 |
Protective effects of N-acetylcysteine in isoproterenol-induced myocardium injury in rats.
Topics: Acetylcysteine; Animals; Creatine Kinase, MB Form; Cytokines; Gene Expression Regulation; Isoprotere | 2009 |
Temporal gene expression profiling indicates early up-regulation of interleukin-6 in isoproterenol-induced myocardial necrosis in rat.
Topics: Adrenergic beta-Agonists; Animals; Disease Models, Animal; Gene Expression Profiling; Heart; Injecti | 2008 |
New aspects of cyclooxygenase-2 inhibition in myocardial infarction and ischaemia.
Topics: Adrenergic beta-Agonists; Animals; Cardiotonic Agents; Creatine Kinase; Cyclooxygenase 2; Cyclooxyge | 2005 |
(-)Epigallocatechin-gallate (EGCG) prevents mitochondrial damage in isoproterenol-induced cardiac toxicity in albino Wistar rats: a transmission electron microscopic and in vitro study.
Topics: Animals; Antioxidants; Catalase; Catechin; Free Radical Scavengers; Glutathione; In Vitro Techniques | 2008 |
Haemodynamic effects of propranolol.
Topics: Adult; Aged; Atropine; Heart Rate; Humans; Hypertension; Isoproterenol; Middle Aged; Myocardial Infa | 1967 |
Left ventricular contraction and the therapy of cardiogenic shock.
Topics: Blood Flow Velocity; Blood Pressure; Blood Viscosity; Blood Volume; Cardiac Output; Dextrans; Digita | 1967 |
Isoproterenol conversion of tachyarrhythmia during acute myocardial infarction.
Topics: Electric Countershock; Electrocardiography; Humans; Injections, Intravenous; Isoproterenol; Male; Mi | 1967 |
Cardiomyopathies.
Topics: Brain Diseases; Cardiomyopathies; Electrolytes; Isoproterenol; Myocardial Infarction; Myocarditis; N | 1967 |
Hemodynamic studies in cardiogenic shock. Treatment with isoproterenol and metaraminol.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Electrocardiography; Female; Hemodynamics; Humans; Hypo | 1967 |
Effect of isoproterenol and norepinephrine on myocardial function in experimental cardiogenic shock.
Topics: Animals; Blood Pressure; Coronary Vessels; Dogs; Heart Rate; Isoproterenol; Lactates; Myocardial Inf | 1967 |
Changing treatment of shock following acute myocardial infarction--a critical evaluation.
Topics: Acute Disease; Assisted Circulation; Digitalis; Hemodynamics; Humans; Isoproterenol; Myocardial Infa | 1967 |
[Resuscitation in the auriculo-ventricular block of acute myocardial infarct].
Topics: Electric Countershock; Glucocorticoids; Heart Block; Humans; Isoproterenol; Myocardial Infarction | 1967 |
Treatment of arrhythmias following myocardial infarction.
Topics: Arrhythmias, Cardiac; Digitalis; Electric Countershock; Humans; Isoproterenol; Lidocaine; Metaramino | 1967 |
The coronary care unit. A year's experience in a community hospital.
Topics: Aged; Anticoagulants; Atropine; Bradycardia; Community Health Services; Diet Therapy; Digitalis Glyc | 1967 |
Ineffectiveness of isoproterenol in shock due to acute myocardial infarction.
Topics: Aged; Arteries; Blood Pressure; Cardiac Output; Female; Humans; Isoproterenol; Male; Middle Aged; My | 1967 |
The treatment of cardiogenic shock. 3. The use of isoproterenol in cardiogenic shock.
Topics: Aged; Hemodynamics; Humans; Isoproterenol; Middle Aged; Myocardial Infarction; Shock | 1967 |
Impaired beta-adrenergic stimulation in the uninvolved ventricle post-acute myocardial infarction: reversible defect due to excessive circulating catecholamine-induced decline in number and affinity of beta-receptors.
Topics: Adenylyl Cyclases; Animals; Catecholamines; Coronary Circulation; Female; Guinea Pigs; Isoproterenol | 1981 |
Cardiac contractile and metabolic effects mediated via the myocardial H2-receptor adenylate cyclase system. Characterization of two new specific H2-receptor agonists, impromidine and dimaprit, in the guinea pig and human myocardium.
Topics: Adenylyl Cyclases; Animals; Cimetidine; Cyclic AMP; Dimaprit; Dose-Response Relationship, Drug; Fema | 1981 |
Effects of sulfinpyrazone, aspirin and propranolol on the isoproterenol-induced myocardial necrosis.
Topics: Animals; Aspirin; Body Weight; Creatine Kinase; Cyclic AMP; Heart; Isoproterenol; Male; Myocardial I | 1981 |
An overall review on prenylamine mechanisms of action in experimental models of myocardial damage.
Topics: Angina Pectoris; Animals; Calcium; Cebus; Disease Models, Animal; Electrocardiography; Female; Heart | 1982 |
Modification of "depressed fast channel dependent slow conduction" by lidocaine and verapamil in the presence or absence of catecholamines--evidence for alteration of preferential ionic channels for slow conduction.
Topics: Action Potentials; Animals; Catecholamines; Guinea Pigs; Heart Conduction System; In Vitro Technique | 1983 |
Ventricular fibrillation threshold and myocardial cyclic AMP production in rats sensitive or resistant to isoproterenol.
Topics: Animals; Cyclic AMP; Drug Resistance; Electrocardiography; Isoproterenol; Male; Myocardial Infarctio | 1984 |
Management of acute myocardial infarction with natural physiological agents.
Topics: Acute Disease; Adenosine; Animals; Carnitine; Collateral Circulation; Dipyridamole; Dogs; Epoprosten | 1983 |
Ribose prevents the propranolol-induced reduction of myocardial adenine nucleotide biosynthesis.
Topics: Adenine Nucleotides; Animals; Female; Heart; Isoproterenol; Myocardial Infarction; Myocardium; Propr | 1984 |
Myocardial hypertrophy in the rat. Correlation between two experimental models.
Topics: Animals; Cardiomegaly; Disease Models, Animal; Heart; Hypoxia; Isoproterenol; Male; Myocardial Infar | 1980 |
Repetitive, monomorphic ventricular tachycardia: clinical and electrophysiologic characteristics in patients with and patients without organic heart disease.
Topics: Adolescent; Adult; Aged; Cardiac Pacing, Artificial; Electrocardiography; Exercise Test; Female; Hum | 1984 |
Depletion of myocardial potassium as a function of age and experimental necrosis.
Topics: Aging; Animals; Female; Isoproterenol; Myocardial Infarction; Myocardium; Necrosis; Potassium; Rats; | 1984 |
Newer concepts in the pathophysiology of ischemic heart disease.
Topics: Animals; Coronary Circulation; Coronary Disease; Creatine Kinase; Dogs; Heart Rate; Humans; Isoprote | 1984 |
Effect of experimental infarct on the mortality rate in alloxan-diabetic rats.
Topics: Alloxan; Animals; Creatine Kinase; Diabetes Mellitus, Experimental; Insulin, Long-Acting; Isoprotere | 1984 |
Pharmacological studies on propafenone and its main metabolite 5-hydroxypropafenone.
Topics: Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Anticonvulsants; Calcium Channel Blockers; Dogs | 1984 |
Changes in soluble and insoluble glycoproteins in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Female; Glycoproteins; Isoproterenol; Myocardial Infarction; Rats; Rats, Inbred Strains; So | 1984 |
[Effect of essential oil of Litsea eubeba (LOUR.) Pers on experimental myocardial infarction in rabbits and myocardial necrosis induced by isoprenaline in rats].
Topics: Animals; China; Electrocardiography; Fatty Acids, Nonesterified; Female; Isoproterenol; Male; Myocar | 1983 |
Effect of ethanol administration on changes in metabolism of glycosaminoglycans in heart & aorta in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Aorta; Ethanol; Glycosaminoglycans; Isoproterenol; Male; Myocardial Infarction; Myocardium; | 1983 |
Effect of ethanol administration on changes in the metabolism of glycoproteins in the heart produced in isoproterenol induced myocardial infarction in rats.
Topics: Animals; Ethanol; Glycoproteins; Heart; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats | 1983 |
An ultrastructural study of endocardial endothelium alterations in catecholamine-induced infarct-like necrosis.
Topics: Animals; Endocardium; Endothelium; Isoproterenol; Male; Microscopy, Electron; Microscopy, Electron, | 1983 |
Effects of amrinone on experimental acute myocardial ischaemic injury.
Topics: Aminopyridines; Amrinone; Animals; Carbon Dioxide; Cardiotonic Agents; Dogs; Electrocardiography; He | 1980 |
Effects of antiplatelet and calcium antagonist drugs on infarct size in rats.
Topics: Acute Disease; Animals; Aspirin; Blood Platelets; Calcium; Creatine Kinase; Isoproterenol; Lysine; M | 1980 |
Detection of acute myocardial infarction in spontaneously hypertensive rats by 99mTc-pyrrolidino methyl tetracycline.
Topics: Animals; Disease Models, Animal; Female; Hypertension; Isoproterenol; Male; Myocardial Infarction; M | 1983 |
Mesenteric blood flow response to dopamine infusion during myocardial infarction in the awake dog.
Topics: Animals; Blood Flow Velocity; Dogs; Dopamine; Infusions, Intra-Arterial; Isoproterenol; Myocardial I | 1983 |
Hormonal and metabolic changes during acute myocardial infarction in normotensive vs hypertensive rats.
Topics: Animals; Body Weight; Bromocriptine; Electrocardiography; Female; Heart Rate; Hormones; Hypertension | 1983 |
Reperfusion injury. A possible link between catecholamine-induced and ischemic myocardial alterations.
Topics: Animals; Catecholamines; Cell Membrane Permeability; Coronary Circulation; Coronary Disease; Horsera | 1983 |
Comparative effects of acetylsalicylic acid (ASA) and sulfinpyrazone on isoproterenol-induced heart damage.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Aspirin; Blood Urea Nitrogen; Creatine Kinase; Isoproterenol; | 1981 |
Morphological variants of acute myocardial necrosis and their relationship to coronary artery thrombosis.
Topics: Animals; Arteriosclerosis; Coronary Disease; Coronary Vessels; Fibrinogen; Humans; Isoproterenol; My | 1980 |
Uptake of 67Ga in the heart of rats treated with isoproterenol.
Topics: Animals; Aspartate Aminotransferases; Creatine Kinase; Gallium Radioisotopes; Glucosephosphate Dehyd | 1982 |
Elevated blood taurine levels after myocardial infarction of cardiovascular surgery: is there any significance?
Topics: Animals; Cardiac Surgical Procedures; Coronary Artery Bypass; Creatine Kinase; Dogs; Heart; Humans; | 1981 |
Newer concepts in the pathophysiology of ischemic heart disease.
Topics: Animals; Cardiac Glycosides; Collateral Circulation; Coronary Circulation; Coronary Disease; Dogs; H | 1982 |
Method for evaluating the effects of antiarrhythmic drugs on ventricular tachycardias with different electrophysiologic characteristics and different mechanisms in the infarcted canine heart.
Topics: Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Dogs; Electrophysiology; Female; Isopro | 1982 |
Beneficial effects of exercise on l-isoproterenol induced myocardial infarction in male rats.
Topics: Animals; Electrocardiography; Exercise Therapy; Isoproterenol; Male; Myocardial Infarction; Rats; Ra | 1982 |
Changes in glycoproteins in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Disease Models, Animal; Glycoproteins; Isoproterenol; Male; Myocardial Infarction; Myocardi | 1982 |
[Enhancing hemodynamic effect of intraaortic balloon pumping (IABP) using cardiogenic agents in canine myocardial infarction].
Topics: Animals; Assisted Circulation; Dipyridamole; Dogs; Hemodynamics; Intra-Aortic Balloon Pumping; Isopr | 1982 |
Quantitative assessment of infarct size in isoproterenol-infarcted rats.
Topics: Animals; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats; Rats, Inbred Strains | 1982 |
Effect of norepinephrine on isolated coronary artery of normal and myocardial infarcted pigs.
Topics: Animals; Arteries; Coronary Vessels; Epinephrine; Isoproterenol; Myocardial Infarction; Norepinephri | 1982 |
Effect of indigenous drug (Pushkarmula) on experimentally induced myocardial infarction in rats.
Topics: Animals; Inula; Inulin; Isoproterenol; Male; Medicine, Ayurvedic; Myocardial Infarction; Plant Extra | 1982 |
Metabolism of glycosaminoglycans in the heart of rats subjected to isoproterenol-induced myocardial infarction.
Topics: Animals; Glycosaminoglycans; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats; Rats, Inb | 1982 |
Relative role of caloric restriction and exercise training upon susceptibility to isoproterenol-induced myocardial infarction in male rats.
Topics: Animals; Aspartate Aminotransferases; Body Weight; Creatine Kinase; Diet, Reducing; Isoproterenol; L | 1981 |
Allopurinol amelioration of the pathophysiology of acute myocardial infarction in rats.
Topics: Allopurinol; Animals; Isoproterenol; Male; Myocardial Infarction; Rats | 1981 |
Reduction in the severity of myocardial infarction by sulfinpyrazone.
Topics: Animals; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats; Sulfinpyrazone | 1981 |
Abnormal electrocardiographic activity revealed by isolated rat heart preparations at various times after experimental myocardial infarction.
Topics: Animals; Electrocardiography; In Vitro Techniques; Isoproterenol; Male; Myocardial Infarction; Myoca | 1981 |
Changes in myocardial & aortic lipids, lipolytic activity & fecal excretion of sterols & bile acids in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Aorta; Bile Acids and Salts; Feces; Female; Heart; Isoproterenol; Lipase; Lipid Metabolism; | 1981 |
Effect of perhexilene on 86Rb uptake in experimental myocardial infarction.
Topics: Animals; Biological Transport, Active; Disease Models, Animal; Female; Heart; Isoproterenol; Male; M | 1981 |
Changes in the magnesium content of tissues following myocardial damage in rats.
Topics: Animals; Isoproterenol; Magnesium; Male; Myocardial Infarction; Rats; Tissue Distribution | 1981 |
[Determination of tissue creatine phosphokinase as a direct enzymatic method for evaluation of the area of necrosis in rats with isoproterenol-induced infarctions].
Topics: Animals; Creatine Kinase; Isoproterenol; Myocardial Infarction; Myocardium; Necrosis; Rats; Rats, In | 1981 |
Transient tachycardia- and bradycardia-dependent left anterior and left posterior hemiblocks. Effects of isoproterenol.
Topics: Aged; Bradycardia; Bundle-Branch Block; Electrocardiography; Female; Humans; Isoproterenol; Male; My | 1981 |
[Effect of nifedipine on experimental myocardial infarct induced by isoproterenol].
Topics: Animals; Isoproterenol; Myocardial Infarction; Nifedipine; Pyridines; Rats; Rats, Inbred Strains | 1981 |
Effect of phenelzine, a monoamine oxidase inhibitor, on isoproterenol-induced myocardial damage.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Heart; Isoproterenol; Male; Myocardial I | 1980 |
Effect of extent of myocardial damage on the behavior of myocardial zinc in albino rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Heart; Isoproterenol; L-Lactate Dehydrog | 1980 |
[Comparative study using colloidal lanthanum of defects in cardiomyocyte membrane permeability in deep ischemia and in isoproterenol exposure].
Topics: Animals; Cell Membrane Permeability; Colloids; Coronary Disease; Dogs; Isoproterenol; Lanthanum; Mic | 1980 |
[Isoproterenol induces ST-segment elevation without wall motion aggravation and myocardial ischemia in experimental myocardial infarction].
Topics: Animals; Cardiotonic Agents; Coronary Circulation; Dogs; Electrocardiography; Female; Hemodynamics; | 1995 |
Effect of interventions that increase cyclic AMP levels on susceptibility to ventricular fibrillation in unanesthetized dogs.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Adenylyl Cyclases; Anesthesia; | 1994 |
[Ca2+]i transients in hypertensive and postinfarction myocytes.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Cardiac Pacing, Artificial; Cell Separation; Diastole; F | 1995 |
Relation between myocardial beta-adrenoceptor density and hemodynamic and neurohumoral changes in a rat model of chronic myocardial infarction: effects of ibopamine and captopril.
Topics: Adrenergic beta-Agonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chronic Dise | 1995 |
Effect of nitrendipine, nimodipine and nisoldipine on experimentally induced myocardial infarction in rats.
Topics: Animals; Aspartate Aminotransferases; Calcium Channel Blockers; Female; Heart; Isoproterenol; L-Lact | 1995 |
Oligotide, a new single-stranded oligodeoxyribonucleotide, preserves postsynaptic beta-adrenergic and cholinergic receptor functions in rabbit hearts after acute infarction.
Topics: Acetylcholine; Animals; Drug Evaluation, Preclinical; Endothelium, Vascular; Epoprostenol; Infusions | 1995 |
Effect of isoproterenol on serum potassium and magnesium.
Topics: Adult; Aged; Cardiac Complexes, Premature; Cardiac Pacing, Artificial; Cardiomyopathy, Dilated; Diag | 1993 |
Characteristics of the beta-adrenergic receptor complex in the epicardial border zone of the 5-day infarcted canine heart.
Topics: Adenylyl Cyclases; Animals; Dogs; Female; GTP-Binding Proteins; Immunoblotting; Iodocyanopindolol; I | 1995 |
Isoproterenol-induced redistribution of endosomes in cardiac myocytes.
Topics: Animals; Cells, Cultured; Endosomes; Frozen Sections; Heart; Hydrogen-Ion Concentration; Immunohisto | 1994 |
Effects of catecholamines on the residual sodium channel dependent slow conduction in guinea pig ventricular muscles under normoxia and hypoxia.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium Channels; Catecholamines; Dose-Response Re | 1995 |
Effects of oxodipine and nitrendipine on the size of experimental myocardial infarct in the rat.
Topics: Administration, Oral; Animals; Calcium Channel Blockers; Dihydropyridines; Female; Heart; Isoprotere | 1994 |
Effects of metoprolol on left ventricular function in rats with myocardial infarction.
Topics: Animals; Blood Pressure; Coronary Vessels; Diastole; Disease Models, Animal; Dose-Response Relations | 1994 |
Regional myocardial downregulation of the inhibitory guanosine triphosphate-binding protein (Gi alpha 2) and beta-adrenergic receptors in a porcine model of chronic episodic myocardial ischemia.
Topics: Adenylyl Cyclases; Animals; Base Sequence; Cell Membrane; Coronary Circulation; Disease Models, Anim | 1993 |
Collagen levels in isoproterenol induced myocardial infarction in rats.
Topics: Animals; Collagen; Female; Isoproterenol; Myocardial Infarction; Myocardium; Rats; Rats, Wistar; Tim | 1993 |
[Changes in myocardial metallothionein on isoproterenol-induced myocardial injury].
Topics: Animals; Copper; Isoproterenol; Male; Metallothionein; Myocardial Infarction; Myocardium; Rats; Rats | 1993 |
Effect of aspirin on mitochondrial lipids in experimental myocardial infarction in rats.
Topics: Administration, Oral; Animals; Aspirin; Calcium-Transporting ATPases; Cholesterol; Fatty Acids; Isop | 1993 |
Effect of curcumin on certain lysosomal hydrolases in isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Cathepsin D; Curcumin; Female; Intracellular Membranes; Isoproterenol; Lysosomes; Myocardia | 1996 |
Calcium currents in postinfarction rat cardiac myocytes.
Topics: Animals; Calcium; Dihydropyridines; Electric Conductivity; Heart; Isoproterenol; Isradipine; Male; M | 1995 |
Diminished responsiveness to cardiac beta 1-adrenoceptor agonists in rats with chronic heart failure following myocardial infarction.
Topics: Adrenergic beta-1 Receptor Agonists; Adrenergic beta-Agonists; Animals; Cardiac Output; Chronic Dise | 1995 |
Altered pharmacologic responsiveness of reduced L-type calcium currents in myocytes surviving in the infarcted heart.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1996 |
Angiotensin II and contraction of isolated myocytes from human, guinea pig, and infarcted rat hearts.
Topics: Adult; Aged; Angiotensin II; Animals; Cell Separation; Female; Guinea Pigs; Humans; Isoenzymes; Isop | 1996 |
Protective role of curcumin against isoproterenol induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Cell Membrane; Creatine Kinase; Curcumin; Electrocardiography; Female; Glutat | 1996 |
Influence of cardiac dysfunction on fast sodium current regulation by Forskolin.
Topics: Action Potentials; Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Cardiotonic Agents; Colfors | 1996 |
Impairment of cGMP- and cAMP-mediated vasorelaxations in rats with chronic heart failure.
Topics: Animals; Aorta, Thoracic; Cardiac Output, Low; Chronic Disease; Cyclic AMP; Cyclic GMP; Enzyme Inhib | 1996 |
Differential regulation of natriuretic peptide genes in infarcted rat hearts.
Topics: Animals; Atrial Natriuretic Factor; Creatine Kinase; Disease Models, Animal; Gene Expression Regulat | 1997 |
Effect of alpha-tocopherol on isoproterenol induced myocardial infarction in rats--electrocardiographic biochemical and histological evidences.
Topics: Animals; Aorta; Cardiotonic Agents; Drug Interactions; Electrocardiography; Heart Rate; Isoprotereno | 1996 |
Usefulness of isoproterenol in the induction of clinical sustained ventricular tachycardia during electrophysiological study.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Aged; Atenolol; Cardiac Pacing, Artificial; E | 1997 |
Autonomic effects on noise recorded during signal-averaged electrocardiography.
Topics: Adrenergic alpha-Agonists; Adrenergic Antagonists; Adrenergic beta-Antagonists; Adult; Artifacts; At | 1997 |
Myocardial infarction and regulatory myosin light chain.
Topics: Animals; Calcium; Calmodulin; Cardiotonic Agents; Cell Survival; Coronary Vessels; Heart Rate; Isopr | 1997 |
Low-dose aspirin improves in vivo hemodynamics in conscious, chronically infarcted rats.
Topics: Adrenergic beta-Agonists; Animals; Aspirin; Drug Administration Schedule; Heart Rate; Hemodynamics; | 1998 |
Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study.
Topics: Animals; Blood Pressure; Cardiotonic Agents; Edema; Electrophysiology; Energy Metabolism; Heart; Hea | 1997 |
Porphyrin loading of lipofuscin granules in inflamed striated muscle.
Topics: Animals; Coproporphyrins; Cytoplasmic Granules; Fluorescence; Humans; Image Processing, Computer-Ass | 1998 |
Effect of alpha-tocopherol on mitochondrial electron transport in experimental myocardial infarction in rats.
Topics: Animals; Citric Acid Cycle; Cytochromes; Electron Transport; Isoproterenol; Lipid Peroxidation; Lipi | 1998 |
Effect of alpha-tocopherol on lipid peroxidation in isoproterenol induced myocardial infarction in rats.
Topics: Animals; Antioxidants; Free Radicals; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarction | 1997 |
Desensitization of cardiac beta-adrenoceptor signaling with heart failure produced by myocardial infarction in the rat. Evidence for the role of Gi but not Gs or phosphorylating proteins.
Topics: Adrenergic beta-Agonists; Animals; Arrestins; Autoradiography; beta-Adrenergic Receptor Kinases; bet | 1999 |
Antioxidant activity of AO-8, a herbal formulation in vitro and in vivo experimental models.
Topics: Animals; Antioxidants; Carbon Tetrachloride Poisoning; Chemical and Drug Induced Liver Injury; Free | 1999 |
Effects of propranolol treatment on left ventricular function and intracellular calcium regulation in rats with postinfarction heart failure.
Topics: Adrenergic beta-Antagonists; Aequorin; Animals; Calcium; Cardiotonic Agents; Coronary Circulation; E | 1999 |
Inducible nitric oxide synthase and tumor necrosis factor in animal models of myocardial necrosis induced by coronary artery ligation or isoproterenol injection.
Topics: Animals; Biomarkers; Blotting, Northern; Coronary Vessels; Disease Models, Animal; Heart Ventricles; | 1999 |
Ionic basis of ventricular arrhythmias in remodeled rat heart during long-term myocardial infarction.
Topics: Action Potentials; Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Analysis of Variance; Animal | 1999 |
Effects of endothelial and inducible nitric oxide synthases inhibition on circulatory function in rats after myocardial infarction.
Topics: Adrenergic beta-Agonists; Analysis of Variance; Animals; Dose-Response Relationship, Drug; Enzyme In | 1999 |
Differential effects of mibefradil, verapamil, and amlodipine on myocardial function and intracellular Ca(2+) handling in rats with chronic myocardial infarction.
Topics: Adrenergic beta-Agonists; Aequorin; Amlodipine; Animals; Calcium; Calcium Channel Blockers; Chronic | 1999 |
Effects of the calcium channel antagonist mibefradil on haemodynamic parameters and myocardial Ca(2+)-handling in infarct-induced heart failure in rats.
Topics: Adrenergic beta-Agonists; Analysis of Variance; Animals; Blood Pressure; Calcium; Calcium Channel Bl | 1999 |
Cardioprotective effect of magnesium chloride in experimental acute myocardial infarction.
Topics: Animals; Calcium Channel Blockers; Cardiovascular Agents; Creatine Kinase; Female; Isoproterenol; Ma | 1999 |
Na(+)/H(+) exchange inhibition attenuates hypertrophy and heart failure in 1-wk postinfarction rat myocardium.
Topics: Adrenergic beta-Agonists; Animals; Cardiac Output, Low; Cardiomegaly; Guanidines; Hemodynamics; Isop | 2000 |
Inducible nitric oxide synthase activation after ischemia/reperfusion contributes to myocardial dysfunction and extent of infarct size in rabbits: evidence for a late phase of nitric oxide-mediated reperfusion injury.
Topics: Adrenergic beta-Agonists; Animals; Enzyme Activation; Enzyme Inhibitors; Guanidines; Hemodynamics; I | 1999 |
Comparison of isoproterenol-induced changes in lysosomal enzyme activity in vivo and in vitro.
Topics: Acetylglucosaminidase; Acid Phosphatase; Animals; Carcinoma, Hepatocellular; Cathepsin D; Glucuronid | 1999 |
Reduction of infarct size by selective stimulation of prostaglandin EP(3)receptors in the reperfused ischemic pig heart.
Topics: Action Potentials; Adenylyl Cyclases; Adrenergic beta-Agonists; Alprostadil; Animals; Arrhythmias, C | 2000 |
Altered cardiac collagen and associated changes in diastolic function of infarcted rat hearts.
Topics: Adrenergic beta-Agonists; Animals; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal | 2000 |
beta-adrenergic blockade in developing heart failure: effects on myocardial inflammatory cytokines, nitric oxide, and remodeling.
Topics: Adrenergic beta-Antagonists; Animals; Cytokines; Gene Expression; Interleukin-1; Interleukin-6; Isop | 2000 |
[A patient with myocardial infarction loosing her sight].
Topics: Aged; Epinephrine; Female; Glaucoma, Angle-Closure; Humans; Isoproterenol; Myocardial Infarction; Sy | 1997 |
Dyssynchronous Ca(2+) sparks in myocytes from infarcted hearts.
Topics: Action Potentials; Adrenergic beta-Agonists; Animals; Calcium; Calcium Channels, L-Type; Calcium Sig | 2000 |
Vascular beta-adrenergic receptor system is dysfunctional after myocardial infarction.
Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Animals; Aorta; Aurora Kinases; Blood Pressur | 2001 |
Cardioprotective effects of Picrorrhiza kurroa against isoproterenol-induced myocardial stress in rats.
Topics: Animals; Cardiotonic Agents; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Isoproterenol; Lipid P | 2001 |
Enhanced in vivo and in vitro contractile responses to beta(2)-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; | 2001 |
No loss in the in vivo efficacy of ischemic preconditioning in middle-aged and old rabbits.
Topics: Aging; Analysis of Variance; Animals; Cardiotonic Agents; Hemodynamics; Ischemic Preconditioning, My | 2001 |
Cardioprotective potential of ocimum sanctum in isoproterenol induced myocardial infarction in rats.
Topics: Animals; Cardiotonic Agents; Cell Membrane; Dose-Response Relationship, Drug; Female; Glutathione; H | 2001 |
Effect of an orally active Na+/H+ exchange inhibitor, SMP-300, on experimental angina and myocardial infarction models in rats.
Topics: Administration, Oral; Angina Pectoris; Animals; Azocines; Coronary Disease; Electrocardiography; Iso | 2002 |
Reduced level of serine(16) phosphorylated phospholamban in the failing rat myocardium: a major contributor to reduced SERCA2 activity.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Calcium-Binding Proteins; Calcium-Transporting ATPases; | 2002 |
Synergistic effect of nicorandil and amlodipine on mitochondrial function during isoproterenol-induced myocardial infarction in rats.
Topics: Amlodipine; Animals; Calcium Channel Blockers; Creatine Kinase; Drug Synergism; Isoproterenol; L-Lac | 2002 |
99mTc-glucarate for detection of isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Cardiotonic Agents; Glucaric Acid; Isoproterenol; Male; Myocardial Infarction; Organotechne | 2002 |
Effect of diabetes mellitus on hemodynamic and cardiometabolic correlates in experimental myocardial infarction.
Topics: Analysis of Variance; Animals; Body Weight; Diabetes Mellitus, Experimental; Disease Models, Animal; | 2001 |
Antiarrhythmic efficacy of combined I(Ks) and beta-adrenergic receptor blockade.
Topics: Acetamides; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; | 2002 |
Effects of metabolic and pharmacologic interventions on myocardial infarct size following coronary occlusion.
Topics: Acute Disease; Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Animals; Assisted Circulation | 1976 |
The effect of beta-blockade on ST segment elevation after acute myocardial infarction in man with some experimental observations.
Topics: Acute Disease; Adrenergic beta-Antagonists; Coronary Circulation; Heart Rate; Humans; Isoproterenol; | 1976 |
[Protective drug actions in experimental myocardial infarct].
Topics: Adrenergic beta-Antagonists; Animals; Indomethacin; Isoproterenol; Male; Mechlorethamine; Myocardial | 1976 |
[Use of dopamine in the treatment of cardiogenic shock. Preliminary results].
Topics: Aged; Diuresis; Dopamine; Female; Furosemide; Glucagon; Humans; Isoproterenol; Male; Middle Aged; My | 1975 |
Interaction of anesthesia, beta-receptor blockade, and blood loss in dogs with induced myocardial infarction.
Topics: Acetylcholine; Adrenergic beta-Antagonists; Anesthesia, General; Animals; Coronary Circulation; Dogs | 1976 |
Arrhythmias in myocardial infarction.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Bradycardia; Cardiac Complexes, Premature; D | 1976 |
[Catecholamine in the myocardium; a fluorescence histochemical study].
Topics: Animals; Atrioventricular Node; Cardiomegaly; Catecholamines; Dogs; Heart Atria; Heart Block; Heart | 1975 |
Experimental myocardial infarction with left ventricular failure in the isolated perfused rat heart. Effects of isoproterenol and pacing.
Topics: Animals; Blood Pressure; Cardiac Output; Cardiomegaly; Disease Models, Animal; Heart; Heart Failure; | 1975 |
Quantitation of isoprenaline-induced changes in the ventricular myocardium.
Topics: Animals; Body Weight; Cardiomegaly; Collagen; Dose-Response Relationship, Drug; Heart; Heart Ventric | 1975 |
Role of hypertension in ischemic heart disease and cerebral vascular disease in the cynomolgus monkey with coarctation of the aorta.
Topics: Animals; Aortic Coarctation; Blood Pressure; Cardiomegaly; Cardiovascular Diseases; Cerebral Arterie | 1977 |
[Severe diphtheria with acute myocardial infarction (author's transl)].
Topics: Cardiomegaly; Child; Diphtheria; Diphtheria Antitoxin; Female; Humans; Hydrocortisone; Isoproterenol | 1979 |
[Myocardial hypertrophy in the course of experimental infarct in the rat].
Topics: Animals; Cardiomegaly; Isoproterenol; Myocardial Infarction; Myocardium; Radioisotopes; Rats; Thalli | 1979 |
[Catecholamines for treatment of severe heart failure (author's transl)].
Topics: Catecholamines; Coronary Circulation; Dobutamine; Dopamine; Epinephrine; Heart Failure; Humans; Isop | 1979 |
[Treatment of coronary shock].
Topics: Adrenergic beta-Antagonists; Cardiac Glycosides; Coronary Care Units; Electric Countershock; Humans; | 1975 |
[Protective action of drugs against myocardial damage in rats].
Topics: Adrenergic beta-Antagonists; Animals; Anti-Arrhythmia Agents; Anti-Inflammatory Agents; Disease Mode | 1975 |
Prehospital brady-asystolic cardiac arrest.
Topics: Aged; Arrhythmias, Cardiac; Atropine; Bicarbonates; Bradycardia; Electrocardiography; Epinephrine; F | 1978 |
Effect of isoproterenol on regional myocardial perfusion and tissue oxygenation in acute myocardial infarction.
Topics: Adenosine Triphosphate; Animals; Coronary Circulation; Dogs; Heart; Hemodynamics; Isoproterenol; Lac | 1979 |
Reticuloendothelial system function following isoproterenol-induced myocardial injury.
Topics: Animals; Isoproterenol; Liver; Male; Mononuclear Phagocyte System; Myocardial Infarction; Phagocytos | 1979 |
Exercise stress testing and systolic time intervals.
Topics: Angina Pectoris; Coronary Disease; Electrocardiography; Exercise Test; Heart Rate; Humans; Infusions | 1979 |
Effect of gonadectomy on isoproterenol-induced myocardial infarction.
Topics: Adrenal Glands; Animals; Aspartate Aminotransferases; Body Weight; Creatine Kinase; Female; Heart; I | 1979 |
Effect of CCL4-induced cirrhosis on the pathophysiologic course of acute myocardial infarction in nonarteriosclerotic vs arteriosclerotic male rats.
Topics: Alanine Transaminase; Animals; Arteriosclerosis; Aspartate Aminotransferases; Body Weight; Carbon Te | 1979 |
Opposing effects of deoxycorticosterone and spironolactone on isoprenaline-induced myocardial infarction.
Topics: Animals; Body Weight; Corticosterone; Desoxycorticosterone; Isoproterenol; Lipids; Male; Myocardial | 1979 |
A temporal profile of changes in myocardial manganese after isoprenaline induced cardiac necrosis in albino rats.
Topics: Animals; Aspartate Aminotransferases; Disease Models, Animal; Electrocardiography; Isoproterenol; L- | 1979 |
Functional characterization of left ventricular segmental responses during the initial 24 h and 1 wk after experimental canine myocardial infarction.
Topics: Animals; Dogs; Dopamine; Electrocardiography; Heart Ventricles; Isoproterenol; Myocardial Contractio | 1979 |
Isoprenaline-induced myocardial infarction in spontaneously hypertensive rats.
Topics: Animals; Heart Failure; Hypertension; Isoproterenol; Liver; Male; Myocardial Infarction; Myocardium; | 1979 |
On significance of plasma fibrinogen level to assess severity of myocardial damage--an experimental study.
Topics: Animals; Cardiomyopathies; Female; Fibrinogen; Isoproterenol; Male; Myocardial Infarction; Myocardiu | 1979 |
Myocardial infarction in spontaneously hypertensive rats with superimposed adrenal-regeneration hypertension.
Topics: Adrenal Glands; Animals; Blood Urea Nitrogen; Body Weight; Corticosterone; Enzymes; Female; Hyperten | 1979 |
Prophylaxis of ventricular fibrillation after acute experimental coronary occlusion by chronic beta-adrenoceptor blockade with atenolol.
Topics: Animals; Arrhythmias, Cardiac; Atenolol; Dogs; Drug Administration Schedule; Heart Rate; Isoproteren | 1979 |
Myocardial infarction complicated by heart block--treatment and long-term prognosis.
Topics: Aged; Female; Heart Block; Humans; Isoproterenol; Male; Middle Aged; Myocardial Infarction; Pacemake | 1979 |
[The role of the platelets in myocardial infarction induced by isoproterenol in the rat (author's transl)].
Topics: Animals; Aspirin; Calcium; Coronary Circulation; Coronary Vessels; Isoproterenol; Myocardial Infarct | 1979 |
[The role of calcium in the pathogenesis of experimental infarct induced with isoproterenol in the rat. Preliminary findings. I].
Topics: Animals; Calcium; Isoproterenol; Male; Myocardial Infarction; Rats; Verapamil | 1979 |
[Experimental infarcts induced with the combination of DOCA and isoproterenol in rats].
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Creatine Kinase; Desoxycorticosterone; I | 1977 |
[Experimental infarcts in rats due to 1-3-4 dihydroxyphenyl-isopropyl-aminoethanol chlorhydrate].
Topics: Animals; Electrocardiography; Isoproterenol; Myocardial Infarction; Rats; Transaminases | 1977 |
Pathogenesis of isoproterenol-induced myocardial lesions: its reation to human 'coagulative myocytolysis'.
Topics: Animals; Autoradiography; Histocytochemistry; Humans; Isoproterenol; Microscopy, Electron; Myocardia | 1978 |
A temporal profile of myocardial zinc changes after isoproterenol induced cardiac necrosis.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Electrocardiography; Heart; Isoprotereno | 1978 |
[Myocardial lesions caused by catecholamines (isoproterenol). Study with optical and electronic microscopy].
Topics: Animals; Humans; Isoproterenol; Microscopy, Electron; Mitochondria, Heart; Myocardial Infarction; Ne | 1978 |
Protective effects of clofibrate on isoproterenol-induced myocardial infarction in arteriosclerotic and non-arteriosclerotic rats.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Blood Glucose; Blood Urea Nitrogen; Clof | 1978 |
Subcutaneous isoproterenol: a convenient rat model for early detection of myocardial necrosis.
Topics: Animals; Disease Models, Animal; Dose-Response Relationship, Radiation; Isoproterenol; Myocardial In | 1978 |
Experimental catecholamine-induced acute myocardial necrosis.
Topics: Acute Disease; Animals; Catecholamines; Dogs; Heart; Hemodynamics; Infusions, Parenteral; Isoprotere | 1978 |
Effects of pharmacological intervention on infarct size following induced myocardial infarction in rats.
Topics: Animals; Creatine Kinase; Hyaluronoglucosaminidase; Insulin; Isoproterenol; Male; Myocardial Infarct | 1978 |
[Prevention of the myocardial damaging effect of isadrin by curantil].
Topics: Animals; Coronary Disease; Dipyridamole; Electrocardiography; Female; Isoproterenol; Male; Myocardia | 1978 |
Repeated myocardial infarction in non-arteriosclerotic and arteriosclerotic Sprague-Dawley rats.
Topics: Animals; Arteriosclerosis; Blood Glucose; Blood Urea Nitrogen; Body Weight; Corticosterone; Isoprote | 1978 |
Age-dependent variations in the intensity of isoprenaline-induced myocardial lesions in rats.
Topics: Age Factors; Animals; Isoproterenol; Myocardial Infarction; Oxytetracycline; Rats; Technetium | 1978 |
Effect of verapamil on the transmural energy metabolism in the isoproterenol-induced myocardial lesion.
Topics: Adenosine Triphosphate; Animals; Calcium; Energy Metabolism; Heart; Isoproterenol; Lactates; Male; M | 1978 |
Immunofluorescent and migration inhibition studies in rats with experimental myocardial infarction.
Topics: Animals; Antibodies; Antibody Specificity; Cell Migration Inhibition; Fluorescent Antibody Technique | 1976 |
Measurement of stroke volume from pulmonary artery pressure record in man.
Topics: Blood Pressure; Cardiac Catheterization; Cardiac Output; Cardiomyopathy, Hypertrophic; Catecholamine | 1975 |
Effect of zinc on acute and chronic isoproterenol induced heart injury.
Topics: Adrenal Glands; Animals; Calcium; Collagen; Heart; Isoproterenol; Male; Myocardial Infarction; Myoca | 1977 |
Contrasting effects of dopamine and isoproterenol in experimental myocardial infarction.
Topics: Animals; Blood Pressure; Coronary Circulation; Dogs; Dopamine; Electrocardiography; Heart Rate; Isop | 1977 |
Evaluation of precordial orthogonal vectorcardiographic lead ST-segment magnitude in the assessment of myocardial ischemic injury.
Topics: Animals; Dogs; Evaluation Studies as Topic; Heart Conduction System; Isoproterenol; Methoxamine; Myo | 1977 |
The effect of dobutamine on cardiac oxygen balance, regional blood flow, and infarction severity after coronary artery narrowing in dogs.
Topics: Animals; Catecholamines; Coronary Circulation; Coronary Vessels; Dobutamine; Dogs; Heart; Heart Rate | 1977 |
Effects of exercise on the severity of isoproterenol-induced myocardial infarction.
Topics: Animals; Body Weight; Creatine Kinase; Exercise Test; Isoproterenol; Male; Myocardial Infarction; My | 1977 |
Combined effects of acute cerebrovascular ischemia and myocardial infarction in arteriosclerotic, male Sprague-Dawley rats.
Topics: Adrenal Cortex Hormones; Adrenal Glands; Animals; Arteriosclerosis; Blood Glucose; Blood Urea Nitrog | 1977 |
Localization by autoradiography of tritiated isoproterenol in "infarct-like" lesions of rat myocardium.
Topics: Animals; Autoradiography; Disease Models, Animal; Isoproterenol; Myocardial Infarction; Myocardium; | 1976 |
Haemodynamics and treatment of right ventricular infarction.
Topics: Aged; Blood Pressure; Dextrans; Female; Heart Ventricles; Hemodynamics; Humans; Isoproterenol; Male; | 1976 |
Proceedings: Effects of tachycardia and isoprenaline on coronary blood flow: observations on pathogenesis of myocardial infarction.
Topics: Animals; Coronary Circulation; Dogs; Heart Rate; Isoproterenol; Myocardial Infarction; Stimulation, | 1976 |
[Comparative effects of norepinephrine, isoproterenol and dopamine on myocardial function and metabolism during experimental myocardial infarction (author's transl)].
Topics: Animals; Coronary Circulation; Dogs; Dopamine; Drug Evaluation; Heart; Isoproterenol; Myocardial Inf | 1976 |
Coronary steal: its role in detrimental effect of isoproterenol after acute coronary occlusion in dogs.
Topics: Adenosine; Animals; Blood Pressure; Collateral Circulation; Coronary Circulation; Disease Models, An | 1976 |
[Modification of the isoprenaline-induced myocardial necrosis using trapidil].
Topics: Animals; Cardiomyopathies; Disease Models, Animal; Isoproterenol; Male; Myocardial Infarction; Necro | 1976 |
Isoprenaline-induced changes in regional myocardial perfusion in the pathogenesis of myocardial necrosis.
Topics: Animals; Coronary Circulation; Dose-Response Relationship, Drug; Isoproterenol; Male; Myocardial Inf | 1976 |
Comparative effects of cortisone, dianabol and enovid on isoprenaline-induced myocardial infarction in arteriosclerotic vs nonarteriosclerotic rats.
Topics: Adrenal Glands; Animals; Arteriosclerosis; Body Weight; Cortisone; Dose-Response Relationship, Drug; | 1976 |
Effect of biotin on biochemical changes following isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Biotin; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats | 1976 |
[Quantitative analysis of isoproterenol induced rat heart necrosis by point counting method].
Topics: Animals; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats | 1976 |
The role of myocardial membrane lipids in the development of cardiac necrosis.
Topics: Adenosine Triphosphate; Age Factors; Animals; Arachidonic Acids; Dietary Fats; Energy Metabolism; Fa | 1976 |
Effects of lipolytic and inotropic stimulation on myocardial ischemic injury.
Topics: Animals; Cardiac Output; Catecholamines; Coronary Disease; Dogs; Fatty Acids, Nonesterified; Humans; | 1976 |
Prenylamine inhibition of isoproterenol induced myocardial lesions. Histochemical and ultrastructural findings.
Topics: Animals; Calcium; Disease Models, Animal; Isoproterenol; Myocardial Infarction; Myocardium; Oxygen C | 1976 |
Proceedings: Quantification of isoproterenol-induced myocardial necroses and the protective effect of calcium-antagonistic compounds by point counting.
Topics: Animals; Calcium; Histological Techniques; Isoproterenol; Methods; Myocardial Infarction | 1975 |
Pathophysiology of subendocardial ischaemia.
Topics: Anemia; Animals; Aortic Valve Insufficiency; Aortic Valve Stenosis; Arteriosclerosis; Blood Flow Vel | 1975 |
[Key-role of intracellular calcium overload in acute necrosis of the myocardium. Cardioprotection with verapamil].
Topics: Adenosine Triphosphate; Animals; Calcium; Catecholamines; Dihydrotachysterol; Fludrocortisone; Heart | 1975 |
Metabolic response after isoproterenol-induced myocardial infarction in arteriosclerotic breeder vs nonarteriosclerotic virgin intact and gonadectomized male rats.
Topics: Animals; Arteriosclerosis; Blood Glucose; Castration; Fatty Acids, Nonesterified; Insulin; Isoproter | 1975 |
Evaluation of precordial electrocardiographic mapping as a means of assessing changes in myocardial ischemic injury.
Topics: Acute Disease; Animals; Creatine Kinase; Disease Models, Animal; Dogs; Electrocardiography; Evaluati | 1975 |
Cardiogenic shock and its current treatment.
Topics: Acute Disease; Adult; Aged; Assisted Circulation; Digitalis Glycosides; Dopamine; Female; Glucagon; | 1975 |
Proceedings: Influence on the running performance of isoprenaline damaged rats.
Topics: Animals; Aspartic Acid; Isoproterenol; Magnesium; Male; Myocardial Infarction; Physical Exertion; Po | 1975 |
An electrocardiographic pattern of acute myocardial infarction associated with excessive use of aerosolized isoproterenol.
Topics: Acute Disease; Adult; Aerosols; Animals; Asthma; Electrocardiography; Female; Hemodynamics; Humans; | 1975 |
Letter: Aerosolized isoproterenol and myocardial infarction analog.
Topics: Aerosols; Humans; Isoproterenol; Myocardial Infarction | 1975 |
Effects of hormonal pretreatment of cardiac necrosis in the Japanese quail.
Topics: Animals; Castration; Coturnix; Estradiol; Female; Hematocrit; Isoproterenol; Male; Myocardial Infarc | 1975 |
Prolyl hydroxylase and collagen metabolism after experimental mycardial infarction.
Topics: Animals; Collagen; Hydroxyproline; Isoproterenol; Male; Mixed Function Oxygenases; Myocardial Infarc | 1975 |
Morphological changes after simultaneous administration of isoproterenol (ISO) and K+,MG2+-Aspartate (KMg-ASP) as a physiological Ca2+ antagonist.
Topics: Animals; Aspartic Acid; Calcium; Dogs; Extracellular Space; Glycogen; Histocytochemistry; Isoprotere | 1975 |
[Influencing myocardial necroses induced by isoproterenol, the physiologic antagonist of calcium, in experiments (author's transl)].
Topics: Animals; Aspartic Acid; Calcium; Dogs; Isoproterenol; Male; Myocardial Infarction; Myocardium; Necro | 1975 |
Electrophysiologic and pharmacologic studies in a patient with acute myocardial infarction complicated by intraventricular and atrioventricular block.
Topics: Amiodarone; Bundle-Branch Block; Electrocardiography; Electrophysiology; Heart Block; Heart Conducti | 1975 |
Metabolic and histopathologic changes in arteriosclerotic versus nonarteriosclerotic rats following isoproterenol-induced myocardial infarction with superimposed diabetes.
Topics: Acute Disease; Animals; Arteriosclerosis; Diabetes Mellitus, Experimental; Disease Models, Animal; F | 1975 |
Myocardial metabolism at different environmental temperatures in experimental myocardial necrosis.
Topics: Adrenal Glands; Alanine Transaminase; Animals; Ascorbic Acid; Aspartate Aminotransferases; Cardiomyo | 1975 |
Membrane phospholipid metabolism in the isoproterenol-induced cardiomyopathy of the rat.
Topics: Animals; Cardiolipins; Cardiomyopathies; Cell Membrane; Cytidine Monophosphate; Isoproterenol; Liver | 1975 |
Role of free fatty acids in catecholamine-induced cardiac necrosis.
Topics: Animals; Blood Pressure; Creatine Kinase; Fatty Acids, Nonesterified; Female; Heart Rate; Isoprotere | 1975 |
The effects of isoprenaline on epicardial ST-segment elevation, lactate production, and myocardial blood flow following coronary artery ligation.
Topics: Acute Disease; Animals; Blood Pressure; Coronary Circulation; Dogs; Electrocardiography; Female; Hea | 1975 |
Serum prolactin levels in rats following isoproterenol-induced myocardial infarction.
Topics: Androgens; Animals; Arteriosclerosis; Female; Isoproterenol; Male; Myocardial Infarction; Prolactin; | 1975 |
Time-dependent changes of collateral coronary reactivity in the dog.
Topics: Animals; Catecholamines; Collateral Circulation; Coronary Circulation; Dogs; Female; Hypoxia; Isopro | 1975 |
Effect of conditioning on myocardial metabolism after myocardial infarction.
Topics: Alanine Transaminase; Animals; Aspartate Aminotransferases; Creatine Kinase; Fatty Acids, Nonesterif | 1975 |
Electrolytes in myocardial infarction.
Topics: Animals; Calcium; Cell Membrane Permeability; Disease Models, Animal; Humans; Isoproterenol; Magnesi | 1975 |
[Treatment of arrhythmia in general practice].
Topics: Ajmaline; Anti-Arrhythmia Agents; Aprindine; Arrhythmia, Sinus; Arrhythmias, Cardiac; Bradycardia; H | 1975 |
[Pharmacology of cornary dilator agent, trapymin. (2) Analysis of its mode of action].
Topics: Adenosine Triphosphate; Animals; Arrhythmias, Cardiac; Blood Glucose; Calcium Chloride; Catecholamin | 1975 |
Inotropic agents and infarct size. Theoretical and practical considerations.
Topics: Acute Disease; Animals; Cardiac Volume; Digitalis Glycosides; Heart; Heart Rate; Humans; Isoproteren | 1976 |
Autonomic manipulation influences both temporal and frequency analyses of late potentials.
Topics: Adrenergic beta-Antagonists; Atropine; Electrocardiography; Female; Heart Conduction System; Humans; | 1992 |
Captopril enhances intracellular calcium handling and beta-adrenergic responsiveness of myocardium from rats with postinfarction failure.
Topics: Animals; Calcium; Captopril; Heart; Heart Failure; Hemodynamics; Isoproterenol; Male; Myocardial Con | 1992 |
Captopril modifies the response of infarcted rat hearts to isoprenaline stimulation.
Topics: Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Captopril; | 1992 |
Triggered activity as arrhythmogenic mechanism after myocardial infarction: clinical and electrophysiologic study of one case.
Topics: Aged; Cardiac Pacing, Artificial; Electric Stimulation; Electrocardiography; Exercise Test; Female; | 1992 |
Effect of aspirin on isoproterenol induced myocardial infarction--a pilot study.
Topics: Administration, Oral; Animals; Aspirin; Creatine Kinase; Isoproterenol; L-Lactate Dehydrogenase; Lip | 1992 |
[Studies on early stage changes of peroxide lipid in isoproterenol-induced myocardial injury].
Topics: Animals; Blood Chemical Analysis; Isoproterenol; Lipid Peroxides; Male; Myocardial Infarction; Rats; | 1992 |
[The capacity for reactive DNA synthesis of the myocytes in the heart conduction system in experimental and clinical myocardial pathology].
Topics: Adult; Aged; Animals; Autoradiography; Cardiomegaly; Cell Nucleus; Cytophotometry; DNA; Female; Hear | 1992 |
Cardioprotective effect of cromakalim (potassium channel opener) in isoproterenol induced myocardial infarction in rats.
Topics: Animals; Aspartate Aminotransferases; Benzopyrans; Blood Coagulation; Cromakalim; Female; Glycogen; | 1992 |
Effect of aspirin on serum lipoprotein profile in rats subjected to myocardial stress by isoproterenol.
Topics: Animals; Aspirin; Isoproterenol; Lipoproteins; Male; Myocardial Infarction; Rats; Rats, Inbred Strai | 1992 |
Failure to reduce experimental myocardial infarct size with ibuprofen pre-treatment in rats.
Topics: Animals; Female; Heart; Ibuprofen; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats | 1992 |
Autonomic mechanisms in heart rate variability after isoproterenol-induced myocardial damage in rats.
Topics: Animals; Autonomic Nervous System; Cardiomyopathies; Electrocardiography; Fourier Analysis; Heart Ra | 1992 |
Effects of amiodarone on cardiac electrophysiology and inducibility of arrhythmias in chronically infarcted dogs: late arrhythmias, haemodynamics, and sympatholytic actions.
Topics: Action Potentials; Amiodarone; Animals; Arrhythmias, Cardiac; Chronic Disease; Dogs; Electrocardiogr | 1990 |
Cardiovascular responses to the stereoisomers of dobutamine in isolated rat hearts 48 hours after acute myocardial infarction.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Animals; Dobutamine; Dose-Response Relationship | 1991 |
Reduction of experimental myocardial infarct size by pre-treatment with magnesium sulfate in rats.
Topics: Animals; Catecholamines; Coronary Vessels; Eosine Yellowish-(YS); Female; Hematoxylin; Isoproterenol | 1991 |
Hypothyroidism renders protection against lethal ventricular arrhythmias in a conscious canine model of sudden death.
Topics: Animals; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Dogs; Electroencephalography; Electrophysiolo | 1991 |
Evaluation of cellular viability by quantitative autoradiographic study of myocardial uptake of a fatty acid analogue in isoproterenol-induced focal rat heart necrosis.
Topics: Animals; Autoradiography; Carbon Radioisotopes; Cell Survival; Fatty Acids; Heart; Iodobenzenes; Iso | 1991 |
In vivo labeling studies on the biosynthesis and degradation of collagen in experimental myocardial infarction.
Topics: Animals; Collagen; Female; Hydroxyproline; Isoproterenol; Myocardial Infarction; Proline; Radioactiv | 1991 |
Converting enzyme inhibition after experimental myocardial infarction in rats: comparative study between spirapril and zofenopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Enalapril; Hea | 1991 |
Effect of ethanol administration on metabolism of lipids in heart and aorta in isoproterenol induced myocardial infarction in rats.
Topics: Animals; Aorta; Ethanol; Isoproterenol; Lipid Metabolism; Male; Myocardial Infarction; Myocardium; R | 1991 |
Effect of coconut oil & safflower oil on lipids in isoproterenol induced myocardial infarction in rats.
Topics: Animals; Aorta; Coconut Oil; Cocos; Dietary Fats; Isoproterenol; Lipids; Male; Myocardial Infarction | 1991 |
[Variations in arrhythmogenic response to catecholamines in acute myocardial ischemia].
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Catecholamines; Dogs; Heart; In Vitro Techniques; | 1991 |
Influence of isoproterenol-induced myocardial infarction on certain glycohydrolases and cathepsins in rats.
Topics: Animals; Biomarkers; Cathepsins; Female; Glycoside Hydrolases; Isoproterenol; Lysosomes; Myocardial | 1991 |
Alterations in the heart lysosomal stability in isoproterenol induced myocardial infarction in rats.
Topics: Animals; Glucuronidase; Isoproterenol; Lysosomes; Myocardial Infarction; Myocardium; Rats | 1990 |
Changes in performance of the surviving myocardium after left ventricular infarction in rats.
Topics: Animals; Blood Pressure; Calcium; Cardiomegaly; Disease Models, Animal; Female; Heart; Isoproterenol | 1990 |
Beta-adrenergic-mediated influences on microscopic conduction in epicardial regions overlying infarcted myocardium.
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Dogs; Electric Conductivity; Electric Stimulation; | 1990 |
Effect of isoproterenol on induction of ventricular tachyarrhythmias in the normal and infarcted canine heart.
Topics: Animals; Dogs; Electrocardiography; Heart Rate; Isoproterenol; Myocardial Infarction; Tachycardia; V | 1990 |
Protective action of aspirin in experimental myocardial infarction induced by isoproterenol in rats and its effect on lipid peroxidation.
Topics: Animals; Aspirin; Isoproterenol; Lipid Peroxidation; Male; Myocardial Infarction; Rats; Rats, Inbred | 1990 |
Alternating Wenckebach periods in acute inferior myocardial infarction: clinical, electrocardiographic, and therapeutic characterization.
Topics: Adult; Aged; Atropine; Blood Pressure; Bradycardia; Electrocardiography; Female; Heart Block; Humans | 1986 |
Early myocardial infarction. A feasible histologic diagnostic procedure.
Topics: Animals; Isoproterenol; Myocardial Infarction; Myocardium; Rats; Staining and Labeling; Time Factors | 1986 |
[The efficacy of quinazopyrine, preparation E and riboxin in experimental myocardial infarct].
Topics: Animals; Cardiovascular Agents; Drug Evaluation, Preclinical; Heart; Inosine Diphosphate; Inosine Nu | 1989 |
Changes in plasma level of alpha-atrial natriuretic polypeptide (alpha-ANP) and responsiveness of the aorta to exogenous alpha-ANP subsequent to myocardial infarction in rats.
Topics: Animals; Aorta, Thoracic; Atrial Natriuretic Factor; Body Weight; Heart; In Vitro Techniques; Isopro | 1989 |
Elevated blood pressure and heart rate in rats exposed to a coal-derived complex organic mixture.
Topics: Administration, Inhalation; Animals; Blood Pressure; Coal Tar; Diphosphates; Disease Models, Animal; | 1989 |
Density of beta adrenoceptors in rat heart and lymphocytes 48 hours and 7 days after acute myocardial infarction.
Topics: Animals; Cell Membrane; Dobutamine; Heart; Heart Ventricles; Isoproterenol; Lymphocytes; Male; Myoca | 1989 |
Autonomic response to coronary occlusion in animals susceptible to ventricular fibrillation.
Topics: Animals; Autonomic Nervous System; Blood Pressure; Coronary Disease; Coronary Vessels; Death, Sudden | 1989 |
Effect of vitamin E on the severity of myocardial infarction induced by isoproterenol.
Topics: Animals; Enzymes; Isoproterenol; Lipids; Male; Myocardial Infarction; Rats; Rats, Inbred Strains; Vi | 1989 |
Effect of aspartate and glutamate on experimental myocardial infarction in rats.
Topics: Animals; Aspartic Acid; Female; Glutamates; Isoproterenol; Male; Myocardial Infarction; Rats | 1989 |
Reversal of changes of lipid peroxide, xanthine oxidase and superoxide dismutase by cardio-protective drugs in isoproterenol induced myocardial necrosis in rats.
Topics: Animals; Cardiovascular Agents; Isoproterenol; Lipid Peroxides; Male; Myocardial Infarction; Oxidore | 1989 |
A morphometrical method to estimate isoproterenol-induced infarct size in the rat.
Topics: Animals; Female; Isoproterenol; Myocardial Infarction; Myocardium; Necrosis; Nitroblue Tetrazolium; | 1989 |
Functional integrity of sympathetic efferent postganglionic axons in a region of stunned myocardium.
Topics: Animals; Autonomic Fibers, Postganglionic; Axons; Dogs; Efferent Pathways; Electric Stimulation; Fem | 1989 |
Effects of chronic myocardial infarction on responsiveness to isoprenaline and the state of myocardial beta adrenoceptors in rats.
Topics: Animals; Chronic Disease; Hemodynamics; In Vitro Techniques; Isoproterenol; Male; Myocardial Contrac | 1987 |
Effect of a synthetic short-chain ACTH 1-17 (HOE 433) on isoproterenol-induced myocardial infarction in rats.
Topics: Adrenocorticotropic Hormone; Animals; Aspartate Aminotransferases; Female; Isoproterenol; L-Lactate | 1988 |
Hypokalemia from beta 2-receptor stimulation by circulating epinephrine.
Topics: Adrenergic beta-Antagonists; Digoxin; Dose-Response Relationship, Drug; Epinephrine; Heart Rate; Hum | 1985 |
Isoprenaline-induced myocardial damage & the cardioprotective action of some beta-adrenoceptor blockers in albino rats.
Topics: Adrenergic beta-Antagonists; Animals; Female; Heart; Isoproterenol; Male; Myocardial Infarction; Myo | 1987 |
Correlation of type A behaviour with adrenergic receptor density: implications for coronary artery disease pathogenesis.
Topics: Adult; Aged; Arteriosclerosis; Blood Platelets; Coronary Disease; Cyclic AMP; Female; Humans; Interv | 1987 |
Islet cell damage and cardiac enzyme and isoenzyme changes in isoproterenol treated rats.
Topics: Animals; Female; Heart; Hexokinase; Insulin; Islets of Langerhans; Isoenzymes; Isoproterenol; L-Lact | 1985 |
The assessment of contractile reserve after thrombolytic therapy for acute myocardial infarction.
Topics: Adult; Blood Pressure; Female; Heart; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; Myocardi | 1986 |
Beneficial effects of defibrotide against myocardial ischemia and decline of beta-adrenoceptor function in the rabbit.
Topics: Animals; Creatine Kinase; Fibrinolytic Agents; Histamine; In Vitro Techniques; Isoproterenol; Ligati | 1986 |
Beta-adrenergic receptor properties of canine myocardium: effects of chronic myocardial infarction.
Topics: Adenylyl Cyclases; Animals; Coronary Circulation; Dogs; Endocardium; Fluorides; Isoproterenol; Myoca | 1986 |
[Effect of polypeptides isolated from the heart on the course of experimental myocardial infarct].
Topics: Animals; Cattle; Cytochrome c Group; Drug Evaluation, Preclinical; Drug Therapy, Combination; Female | 1987 |
Alterations in isoproterenol-induced cardiac metabolic changes by a quaternary analog of propranolol, UM-272.
Topics: Animals; Anti-Arrhythmia Agents; Creatine Kinase; Dose-Response Relationship, Drug; Energy Metabolis | 1985 |
Alprazolam decreases isoproterenol induced myocardial damage in the rat.
Topics: Alprazolam; Animals; Electrocardiography; Heart; Heart Rate; Isoproterenol; Male; Myocardial Infarct | 1988 |
Effect of adenosine and inosine on experimental myocardial infarction in rats.
Topics: Adenosine; Animals; Female; Inosine; Isoproterenol; Male; Myocardial Infarction; Myocardium; Rats | 1988 |
Cardioprotective effect of prostacyclin and 7-oxo-PGI2 in rats against chronic isoproterenol damage.
Topics: Animals; Epoprostenol; Heart; Isoproterenol; Male; Myocardial Infarction; Myocardium; Necrosis; Rats | 1987 |
Effects of alloxan-induced diabetes on ischemia-reperfusion injury in rabbit hearts.
Topics: Animals; Coronary Disease; Diabetes Mellitus, Experimental; Dose-Response Relationship, Drug; Heart; | 1988 |
Changes in levels of lipid peroxides and activities of superoxide dismutase and catalase in isoproterenol induced myocardial infarction in rats.
Topics: Animals; Catalase; Isoproterenol; Lipid Peroxides; Male; Myocardial Infarction; Rats; Rats, Inbred S | 1987 |
A method of analyzing regional myocardial function: mean wall stress-area strain relationship.
Topics: Animals; Cardiac Catheterization; Coronary Disease; Dogs; Heart Septum; Humans; Isoproterenol; Myoca | 1987 |
Studies on the calcium antagonistic action of tetrandrine: XIII. Protective effect of tetrandrine on myocardial hypoxia and necrosis induced by isoproterenol in rats.
Topics: Alkaloids; Animals; Benzylisoquinolines; Calcium Channel Blockers; Coronary Disease; Electrocardiogr | 1986 |
The co-operative action of hyaluronidase and urokinase on the isoproterenol-induced myocardial infarction in rats.
Topics: Animals; Drug Administration Schedule; Drug Therapy, Combination; Hyaluronoglucosaminidase; Injectio | 1986 |
ST-segment, T-wave, and U-wave changes during myocardial ischemia and after myocardial infarction.
Topics: Acute Disease; Adult; Aged; Coronary Circulation; Coronary Disease; Electrocardiography; Exercise Te | 1986 |
The effect of acute hypercholesterolemia on myocardial infarct size and the no-reflow phenomenon during coronary occlusion-reperfusion.
Topics: Acute Disease; Animals; Cholesterol, Dietary; Coronary Circulation; Coronary Disease; Female; Hyperc | 1987 |
Autonomic control of ventricular tachycardia: direct effects of beta-adrenergic blockade in 24 hour old canine myocardial infarction.
Topics: Animals; Coronary Vessels; Dogs; Female; Heart Conduction System; Hemodynamics; Injections, Intra-Ar | 1987 |
Effect of administration of vitamin A, ascorbic acid and nicotinamide adenine dinucleotide + flavin adenine dinucleotide on severity of myocardial infarction induced by isoproterenol in rats.
Topics: Animals; Ascorbic Acid; Flavin-Adenine Dinucleotide; Isoproterenol; Male; Myocardial Infarction; NAD | 1985 |
Effect of administration of carnitine on the severity of myocardial infarction induced by isoproterenol in rats.
Topics: Animals; Aspartate Aminotransferases; Carnitine; Cholesterol; Creatine Kinase; Fatty Acids; Female; | 1986 |
Comparison in the same patient of two programmed ventricular stimulation protocols to induce ventricular tachycardia.
Topics: Cardiac Pacing, Artificial; Electric Stimulation; Humans; Isoproterenol; Myocardial Infarction; Pros | 1985 |
Effect of age and myocardial infarction on serum and heart lactic dehydrogenase.
Topics: Age Factors; Animals; Heart; Isoproterenol; L-Lactate Dehydrogenase; Myocardial Infarction; Myocardi | 1985 |
Effect of verapamil, nifedipine and diltiazem on experimental myocardial infarction in rats.
Topics: Animals; Calcium Channel Blockers; Diltiazem; Female; Isoproterenol; Male; Myocardial Infarction; Ni | 1985 |
Prolonged protective effects following propranolol withdrawal against isoproterenol-induced myocardial infarction in normotensive and hypertensive rats.
Topics: Animals; Blood Pressure; Corticosterone; Creatine Kinase; Female; Humans; Isoproterenol; L-Lactate D | 1985 |
[The effects of TA-064, dopamine and isoproterenol on the acutely ischemic myocardium].
Topics: Animals; Cardiotonic Agents; Dogs; Dopamine; Drug Evaluation; Ethanolamines; Isoproterenol; Myocardi | 1985 |
[Intravenous isoproterenol administration for diagnosing ischemic heart disease in women: a comparison with the data from bicycle ergometry and selective coronary angiography].
Topics: Adult; Cardiomyopathy, Hypertrophic; Coronary Angiography; Coronary Disease; Exercise Test; Female; | 1985 |
Acute myocardial histopathology in normal and arteriosclerotic rats during isoproterenol-induced infarction.
Topics: Acidosis; Animals; Arteriosclerosis; Female; Hypoxia; Isoproterenol; Male; Myocardial Infarction; My | 1970 |
Clinical cardiovascular pharmacology of dobutamine. A selective inotropic catecholamine.
Topics: Aortic Valve; Blood Pressure; Cardiac Output; Catecholamines; Coronary Disease; Female; Heart; Heart | 1974 |
Hemodynamic effects of adrenergic stimulating and blocking agents in cardiogenic shock and low output state after myocardial infarction.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Adrenergic beta-Agonists; Animals; Blood Pr | 1973 |
[The production of tachycardiac arrhythmia through extrasystoles. Mechanism and therapy].
Topics: Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Electrocardiography; Humans; Isoproterenol; Li | 1967 |
Catecholamines and the heart.
Topics: Animals; Arrhythmias, Cardiac; Catecholamines; Dogs; Heart; Humans; Isoproterenol; Myocardial Infarc | 1969 |
[Ventricular tachycardia with variable focus and dyskaliemia].
Topics: Aged; Alcoholism; Bradycardia; Cardiac Complexes, Premature; Electrocardiography; Female; Heart Bloc | 1969 |
Myocardial necrosis induced by isoproterenol in rats. Changes in serum protein, lipoprotein, lipids and glucose during active necrosis and repair in arteriosclerotic and nonarteriosclerotic animals.
Topics: Alpha-Globulins; Animals; Arteriosclerosis; Beta-Globulins; Blood Glucose; Blood Proteins; Fatty Liv | 1968 |
[Role of ischemia in left ventricular function disorders in the initial stage of myocardial infarct].
Topics: Aged; Cardiac Catheterization; Cardiac Output; Digitalis Glycosides; Echocardiography; Female; Heart | 1973 |
Regional myocardial function during acute coronary artery occlusion and its modification by pharmacologic agents in the dog.
Topics: Animals; Blood Pressure; Coronary Disease; Dogs; Heart; Heart Rate; Hemodynamics; Isoproterenol; Myo | 1974 |
Long-term conservative therapy of chronic AV block.
Topics: Aged; Autopsy; Bundle-Branch Block; Chronic Disease; Digitalis; Diuretics; Female; Follow-Up Studies | 1974 |
[A chronic model of necrotic cardiopathy induced by repeated administration of isadrin to experimental animals].
Topics: Animals; Cardiomegaly; Isoproterenol; Models, Biological; Myocardial Infarction; Myocardium; Rabbits | 1967 |
Behaviour of 86Rb in normal rat myocardial tissue and in tissue injured by ischaemic necrosis.
Topics: Animals; Coronary Vessels; Isoproterenol; Myocardial Infarction; Myocardium; Radioisotopes; Rats; Ru | 1968 |
Myocardial connective tissue metabolism in response to injury. Histological and chemical studies of mucopolysaccharide and collagen in rat hearts after isoproterenol-induced infaraction.
Topics: Animals; Arteriosclerosis; Cicatrix; Collagen; Connective Tissue; Female; Glycosaminoglycans; Hexosa | 1969 |
Potassium, sodium and chlorides in the heart of rats with isoprenaline-induced experimental necrosis of the myocardium.
Topics: Animals; Chlorides; Electrolytes; Heart; Hyperkalemia; Isoproterenol; Male; Myocardial Infarction; M | 1968 |
Sulfur 35 uptake in acid mucopolysaccharides of the rat heart following injury.
Topics: Animals; Blood Proteins; Cicatrix; Glycosaminoglycans; Isoproterenol; Male; Myocardial Infarction; M | 1973 |
A study of system and regional hemodynamic changes in experimental myocardial infarction, with reference to the effects of catecholamine.
Topics: Animals; Blood Pressure; Carotid Arteries; Catecholamines; Coronary Circulation; Coronary Vessels; D | 1974 |
[Action of various vasoactive amines on the normal and pathological cardiac function, mainly cardiogenic shock].
Topics: Angiotensin II; Animals; Coronary Disease; Dogs; Electrocardiography; Epinephrine; Heart; Heart Rate | 1966 |
[Auriculo-ventricular block during the acute phase of myocardial infarction. Apropos of 46 cases].
Topics: Adrenal Cortex Hormones; Arrhythmia, Sinus; Cerebral Ventriculography; Electric Stimulation; Electro | 1969 |
[Thoughts on 125 cases of complete auriculo-ventricular blocks].
Topics: Aged; Atrial Fibrillation; Bradycardia; Cardiac Catheterization; Electric Countershock; Ephedrine; E | 1969 |
Experimental left ventricular akinesis: results of excision.
Topics: Acetylcholine; Angiocardiography; Angiotensin II; Animals; Blood Pressure; Cardiac Output; Cineangio | 1970 |
Left ventricular akinesis: experimental production, haemodynamic effects, and results of excision.
Topics: Acetylcholine; Angiocardiography; Angiotensin II; Animals; Blood Pressure; Cardiac Output; Cineangio | 1972 |
Editorial: Calcium responses ("calcium spikes").
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Caffeine; Calcium; Coronary Disease; Cyclic AMP; E | 1974 |
Effect of various types of sympathicolytics on isoproterenol-induced myocardial lesions.
Topics: Animals; Dibenzylchlorethamine; Ethanolamines; Guanethidine; Heart; Isoproterenol; Myocardial Infarc | 1966 |
[Group discussion: progress in cardiopathology].
Topics: Adrenergic beta-Antagonists; Coronary Angiography; Coronary Vessels; Extracorporeal Circulation; Glu | 1971 |
[Influence of various drugs on infarct-like heart lesions induced in the rat by subcutaneous injections of isoproterenol].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Analgesics; Animals; Anti-Arrhythmia Agen | 1972 |
[Prevention and therapy of arrhythmias due to myocardial infarct].
Topics: Adrenergic beta-Antagonists; Ajmaline; Arrhythmias, Cardiac; Hemodynamics; Humans; Isoproterenol; My | 1972 |
Blood-gas measurements in early diagnosis of shock and pulmonary edema complicating acute myocardial infarction. II. Oxygen tension in mixed venous blood, arterio-venous oxygen difference, and acid-base balance.
Topics: Acid-Base Equilibrium; Adrenergic alpha-Antagonists; Arteries; Carbon Dioxide; Heart Failure; Humans | 1972 |
The antiarrhythmic properties of UM-272, the dimethyl quaternary derivative of propranolol.
Topics: Adrenergic beta-Antagonists; Anesthetics, Local; Animals; Anura; Arrhythmias, Cardiac; Cardanolides; | 1973 |
Editorial: Accomplices in crime.
Topics: Acute Disease; Adenosine; Animals; Collateral Circulation; Coronary Circulation; Dogs; Drug Synergis | 1974 |
Sinus bradycardia. Autonomic influences and clinical assessment.
Topics: Adams-Stokes Syndrome; Adolescent; Adult; Aged; Atropine; Autonomic Nervous System; Bradycardia; Dip | 1974 |
The pathophysiology of tachycardia-dependent paroxysmal atrioventricular block after acute myocardial ischemia. Experimental and clinical observations.
Topics: Adams-Stokes Syndrome; Aged; Animals; Bundle of His; Coronary Disease; Coronary Vessels; Disease Mod | 1974 |
Effects of methylprednisolone administration in acute myocardial infarction.
Topics: Adenylyl Cyclases; Animals; Calcium; Carotid Arteries; Cats; Coronary Circulation; Coronary Vessels; | 1974 |
Progressive electrocardiographic changes in male and female arteriosclerotic and non-arteriosclerotic rats during the course of isoproterenol-induced myocardial infarction.
Topics: Animals; Arteriosclerosis; Breeding; Electrocardiography; Female; Heart; Heart Rate; Isoproterenol; | 1974 |
Clinical appraisal of shock following acute myocardial infarction.
Topics: Acid-Base Equilibrium; Aged; Anuria; Blood Pressure; Body Temperature; Central Venous Pressure; Conf | 1974 |
Proceedings: The effects of practolol in the early stages of experimental myocardial infarction.
Topics: Animals; Dogs; Heart; Heart Rate; Hemodynamics; Isoproterenol; Myocardial Infarction; Myocardium; Ox | 1974 |
Failure of free fatty acids to influence degree of myocardial injury following acute coronary artery occlusion in pigs.
Topics: Acute Disease; Animals; Blood Pressure; Coronary Disease; Fatty Acids, Nonesterified; Heart Rate; Is | 1974 |
[A new method of evaluation of ventricular contractility].
Topics: Adolescent; Adult; Cardiomyopathies; Child; Female; Heart Function Tests; Heart Valve Diseases; Hear | 1974 |
Effects of isoproterenol, propranolol and artificial pacing on hemodynamics and energy liberation of the infarcted heart in dogs.
Topics: Animals; Blood Pressure; Coronary Vessels; Depression, Chemical; Dogs; Dose-Response Relationship, D | 1974 |
Effect of beta receptor-stimulating drugs on the cardiovascular and respiratory function of critically ill patients with serious heart disorders.
Topics: Albuterol; Arrhythmias, Cardiac; Asthma; Blood Pressure; Cardiovascular System; Female; Heart; Heart | 1974 |
[Experimental and clinical studies on effects of glucagon on the ischmic heart].
Topics: Adolescent; Adult; Animals; Child; Coronary Disease; Dogs; Female; Glucagon; Heart; Humans; Isoprote | 1974 |
Cardiac performance and metabolism in shock due to acute myocardial infarction in man: response to catecholomines and mechanical cardiac assist.
Topics: Aged; Blood Flow Velocity; Blood Pressure; Catecholamines; Coronary Circulation; Coronary Vessels; F | 1972 |
[Atrioventricular blockade and its treatment in acute myocardial infarct].
Topics: Acute Disease; Administration, Oral; Aged; Atropine; Electric Stimulation Therapy; Electrocardiograp | 1973 |
Coronary revascularization in patients receiving propranolol.
Topics: Angina Pectoris; Coronary Artery Bypass; Emergencies; Heart Rate; Heart Ventricles; Humans; Isoprote | 1974 |
Right to left shunt in patients with acute myocardial infarction. A proposed mechanism.
Topics: Blood Pressure; Body Surface Area; Carbon Dioxide; Cardiac Catheterization; Cardiac Output; Collater | 1972 |
[Microcirculatory aspect of myocardial lesions induced by catecholamine infusion. Ultrastructural study with diffusion tracers. I. Isoproterenol].
Topics: Animals; Coronary Circulation; Diffusion; Ferritins; Heart; Isoproterenol; Microcirculation; Microsc | 1973 |
Simple and safe bedside method for serial measurement of left ventricular ejection fraction, cardiac output, and pulmonary blood volume.
Topics: Blood Volume Determination; Bronchial Neoplasms; Cardiac Catheterization; Cardiac Output; Heart; Hea | 1974 |
Immunofluorescent studies in isoproterenol-induced myocardial necrosis in rats.
Topics: Animals; Antibodies; Disease Models, Animal; Fluorescent Antibody Technique; Injections, Subcutaneou | 1974 |
[Potassium variations in the coronary sinus after circumflex artery ligation. Effects of premedication with isoproteronol and of ventilation with a helium mixture].
Topics: Acute Disease; Animals; Arteries; Coronary Circulation; Dogs; Heart; Helium; Hydrogen-Ion Concentrat | 1972 |
Effect of isoproterenol on the abnormal T wave.
Topics: Action Potentials; Adolescent; Adult; Aged; Arrhythmias, Cardiac; Atropine; Diagnosis, Differential; | 1972 |
[Myocardial damage following overdosage with isoprenaline aerosol spray].
Topics: Adult; Aerosols; Asthma; Female; Humans; Isoproterenol; Myocardial Infarction; Respiratory Therapy; | 1972 |
[Myocardial infarct: possibilities and limitations of intensive care].
Topics: Aged; Blood Pressure; Cardiac Output; Coronary Care Units; Dopamine; Heart Rate; Humans; Isoproteren | 1972 |
Force-velocity and hydraulic indices in analysis of normal and marginally ischemic myocardium: effects of isoproterenol and levarteronal (norepinephrine) infusion.
Topics: Animals; Cardiac Output; Coronary Circulation; Dogs; Heart Ventricles; Ischemia; Isoproterenol; Myoc | 1972 |
Pathophysiologic changes in arteriosclerotic and nonarteriosclerotic rats, following isoproterenol-induced myocardial infarction.
Topics: Adrenal Glands; Alanine Transaminase; Aldosterone; Animals; Arteriosclerosis; Aspartate Aminotransfe | 1972 |
Myocardial loss of functional magnesium. II. In cardiomyopathies of diverse etiology.
Topics: Adult; Age Factors; Aging; Animals; Calcium; Cricetinae; Heart; Heart Diseases; Heart Failure; Human | 1972 |
Complete heart block in acute myocardial infarction: drug therapy.
Topics: Arrhythmias, Cardiac; Atropine; Evaluation Studies as Topic; Glucocorticoids; Heart Block; Heart Fai | 1973 |
Deleterious effects of increased heart rate on infarct size in the conscious dog.
Topics: Animals; Atropine; Constriction; Coronary Vessels; Creatine Kinase; Dogs; Heart Block; Heart Rate; I | 1973 |
[Isuprel and electrodiagnosis of coronary insufficiency].
Topics: Adult; Angina Pectoris; Coronary Disease; Electrocardiography; Female; Humans; Isoproterenol; Male; | 1973 |
Effect of inhibition of lipolysis on infarct size after experimental coronary artery occlusion.
Topics: Animals; Blood Pressure; Coronary Circulation; Creatine Kinase; Dogs; Electrocardiography; Fatty Aci | 1973 |
Interrelation between alterations in pulmonary mechanics and hemodynamics in acute myocardial infarction.
Topics: Acute Disease; Adult; Aged; Airway Obstruction; Airway Resistance; Blood Pressure; Body Water; Femal | 1973 |
[Method of epicardial ECG registration].
Topics: Animals; Coronary Disease; Dipyridamole; Dogs; Electrocardiography; Heart; Isoproterenol; Ligation; | 1973 |
Early estimation of myocardial damage in conscious dogs and patients with evolving acute myocardial infarction.
Topics: Acute Disease; Animals; Arterial Occlusive Diseases; Arteries; Coronary Vessels; Creatine Kinase; Do | 1973 |
Prophylactic uses of antiarrhythmic drugs in acute myocardial infarction.
Topics: Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atropine; Humans; Injections, Intravenous; Isoproteren | 1973 |
Investigations on protection of the ischemic myocardium.
Topics: Animals; Assisted Circulation; Creatine Kinase; Digitalis Glycosides; Dogs; Electrocardiography; Glu | 1973 |
Drug-induced changes in blood flow in normal and ischaemic regions of the canine myocardium.
Topics: Amino Alcohols; Animals; Blood Pressure; Coronary Circulation; Coronary Vessels; Dipyridamole; Dogs; | 1973 |
Drug therapy in cardiogenic shock.
Topics: Cardiac Output; Digitalis Glycosides; Dopamine; Glucagon; Hemodynamics; Humans; Isoproterenol; Metap | 1973 |
Changes in myocardial thiamine in arteriosclerotic and non-arteriosclerotic rats subjected to isoprenaline induced myocardial infarction.
Topics: Adrenal Glands; Animals; Arteriosclerosis; Breeding; Female; Isoproterenol; Kidney; Male; Myocardial | 1973 |
Effect of exercise on arrhythmias following experimental acute myocardial infarction.
Topics: Animals; Coronary Vessels; Dogs; Electrocardiography; Exercise Test; Heart Ventricles; Isoproterenol | 1973 |
Effects of glucagon and isoproterenol on severity of acute myocardial ischemic injury.
Topics: Alcohols; Animals; Blood Pressure; Coronary Disease; Depression, Chemical; Dogs; Electrocardiography | 1973 |
[Diagnostic test using isoproterenol after myocardial infarct. Preliminary report].
Topics: Adult; Aged; Angiography; Coronary Angiography; Electrocardiography; Exercise Test; Humans; Isoprote | 1973 |
Calorigenic effects of isoproterenol during production of myocardial necrosis in the rat.
Topics: Animals; Heart Diseases; Isoproterenol; Male; Metabolism; Motor Activity; Muscle Contraction; Myocar | 1973 |
[Method for hemodynamic and metabolic evaluation of patients needing intensive therapy. In reference to the experiences of Dr. Siegel and coworkers].
Topics: Glucagon; Heart Failure; Hemodynamics; Humans; Intensive Care Units; Isoproterenol; Liver Cirrhosis; | 1973 |
Quantitative biochemical changes in rats following isoproterenol-induced myocardial infarction.
Topics: Alanine Transaminase; Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Blood Proteins; Bl | 1973 |
[Studies on the therapy of shock in acute myocardial infarct].
Topics: Acute Disease; Aged; Dopamine; Female; Humans; Isoproterenol; Male; Middle Aged; Myocardial Infarcti | 1973 |
Treatment of nontraumatic cardiac emergencies.
Topics: Adams-Stokes Syndrome; Arrhythmias, Cardiac; Atropine; Bradycardia; Electric Countershock; Emergency | 1974 |
Myocardial glycoprotein changes with isoproterenol-induced necrosis and repair in the rat.
Topics: Animals; Aspartate Aminotransferases; Glycoproteins; Isoproterenol; Myocardial Infarction; Myocardiu | 1974 |
Adrenocortical changes associated with methylandrostenediol-induced hypertension and isoproterenol-induced myocardial infarction in arteriosclerotic versus nonarteriosclerotic rats.
Topics: Adrenal Glands; Anabolic Agents; Animals; Aorta; Arteriosclerosis; Cholesterol; Corticosterone; Fema | 1974 |
Modification of experimental myocardial infarct size by cardiac drugs.
Topics: Animals; Blood Pressure; Cardiac Catheterization; Cardiac Volume; Coronary Circulation; Coronary Ves | 1974 |
Isoproterenol-induced myocardial infarction in the gerbil (Meriones unguiculatus).
Topics: Adrenal Glands; Animals; Blood Glucose; Blood Urea Nitrogen; Cholesterol; Creatine Kinase; Disease M | 1974 |
The demonstration of energy dependence of the isoproterenol-induced transcellular Ca2+ current in isolated perfused guinea pig hearts--an explanation for mechanical failure of ischemic myocardium.
Topics: Action Potentials; Animals; Biological Transport; Caffeine; Calcium; Cell Membrane; Cell Membrane Pe | 1974 |
[Myocardial necrosis induced with isoproterenol in rat heart].
Topics: Animals; Carbon Radioisotopes; Heart; Hypoxia; Isoproterenol; Myocardial Infarction; Myocardium; Nec | 1974 |
Effect of exercise on myocardial infarction in young vs. old male rats: electrocardiograph changes.
Topics: Age Factors; Alanine Transaminase; Animals; Aspartate Aminotransferases; Creatine Kinase; Electrocar | 1974 |
Vasopressors for treating shock.
Topics: Bacteria; Chloramphenicol; Epinephrine; Humans; Isoproterenol; Metaraminol; Methoxamine; Morphine; M | 1974 |
[Clinics and therapy of schock in myocardial infarct].
Topics: Digitalis Glycosides; Electrocardiography; Epinephrine; Heart Arrest; Humans; Isoproterenol; Mephent | 1969 |
[Clinical and experimental studies on the immunologic aspects of myocardial infarct].
Topics: Agglutination Tests; Anemia; Angina Pectoris; Animals; Antibody Formation; Antigen-Antibody Reaction | 1970 |
Myocardial infarction following coronary ligation in dogs. Hemodynamic effects of isoproterenol and acetylstrophanthidin.
Topics: Animals; Coronary Vessels; Dogs; Female; Heart; Hemodynamics; Isoproterenol; Ligation; Male; Myocard | 1967 |
[Auricular standstill. Apropos of 4 cases with endocavitary or esophageal leads].
Topics: Aged; Arrhythmias, Cardiac; Atrial Flutter; Electric Countershock; Electrocardiography; Heart Atria; | 1967 |
A coronary care unit: results of the first year of operation.
Topics: Acute Disease; Adult; Aged; Anticoagulants; Arrhythmias, Cardiac; Digitoxin; Electrocardiography; Fe | 1968 |
[Treatment of conduction disorders associated with the acute phase of infarct].
Topics: Acute Disease; Adult; Electrocardiography; Female; Heart Block; Humans; Hydrocortisone; Injections, | 1968 |
[Quantitative and qualitative investigations on the myosin of the rat heart using polarization microscopy].
Topics: Animals; Edema; Heart; Isoproterenol; Male; Microscopy, Polarization; Muscle Proteins; Myocardial In | 1969 |
[Protective action of a delayed preparation of trinitroglycerin on experimental cardiac infarct induced by isoproterenol in rats].
Topics: Animals; Isoproterenol; Male; Myocardial Infarction; Nitroglycerin; Rats | 1969 |
[Hemodynamic study of shock in myocardial infarct].
Topics: Aged; Digoxin; Female; Glucagon; Hemodynamics; Humans; Isoproterenol; Male; Myocardial Infarction; S | 1971 |
Clinical studies on apexcardiogram. II. Cardiac movement in thyroid dysfunction and coronary heart disease from the point of apexcardiogram.
Topics: Adolescent; Adult; Angina Pectoris; Arteriosclerosis; Coronary Disease; Electrocardiography; Female; | 1971 |
Hemodynamic evaluation of left ventricular function in shock complicating myocardial infarction.
Topics: Adult; Aged; Blood Pressure; Cardiac Output; Dextrans; Digoxin; Electrocardiography; Epinephrine; He | 1972 |
On relationships between synthesis of DNA and incorporation of deoxythymidine into DNA during myocardial infarctions induced in rats by isoproterenol.
Topics: Adenine; Animals; Aspartic Acid; Carbon Dioxide; Carbon Isotopes; Cytosine; DNA; Female; Formates; G | 1972 |
Effect of isoproterenol,l-norepinephrine, and intraaortic counterpulsation on hemodynamics and myocardial metabolism in shock following acute myocardial infarction.
Topics: Acute Disease; Aged; Aorta; Assisted Circulation; Blood Pressure; Cardiac Output; Coronary Circulati | 1972 |
Myocardial and plasma lactate changes in arteriosclerotic and non-arteriosclerotic rats during isoproterenol-induced infarction.
Topics: Animals; Arteriosclerosis; Autopsy; Female; Isoproterenol; Lactates; Male; Myocardial Infarction; My | 1972 |
Validity of isoproterenol-induced myocardial lactate production: an internal control.
Topics: Cardiac Catheterization; Heart; Humans; Isoproterenol; Lactates; Myocardial Infarction; Myocardium; | 1972 |
Cardiac arrhythmias in anesthesia and in acute myocardial infarction.
Topics: Anesthesia; Arrhythmias, Cardiac; Atropine; Bradycardia; Digitalis Glycosides; Electrocardiography; | 1972 |
Experimental cardiac necrosis in the Japanese quail (Cotournix cotournix).
Topics: Animals; Birds; Body Weight; Female; Heart; Isoproterenol; Male; Myocardial Infarction; Sex Factors; | 1972 |
Mortality of heart block complicating acute myocardial infarction managed without artificial pacemakers.
Topics: Aged; Electrocardiography; Female; Glucose; Heart Block; Humans; Insulin; Isoproterenol; Male; Middl | 1972 |
Effects of intraaortic balloon counterpulsation on the severity of myocardial ischemic injury following acute coronary occlusion. Counterpulsation and myocardial injury.
Topics: Acute Disease; Animals; Assisted Circulation; Coronary Circulation; Coronary Disease; Coronary Vesse | 1972 |
Haemodynamic effects of isoprenaline in acute myocardial infarction.
Topics: Acute Disease; Adult; Blood Pressure; Cardiac Output; Cardiac Volume; Female; Heart Failure; Heart R | 1972 |
Precordial S-T segment elevation mapping: an atraumatic method for assessing alterations in the extent of myocardial ischemic injury. The effects of pharmacologic and hemodynamic interventions.
Topics: Animals; Arteries; Blood Pressure; Coronary Vessels; Dogs; Electrocardiography; Female; Heart Rate; | 1972 |
[Experimental study on drugs for the treatment of myocardial infarction].
Topics: Angiography; Animals; Benzyl Compounds; Body Weight; Carboxylic Acids; Dipyridamole; Disease Models, | 1972 |
Quantification of function in normal and infarcted regions of the left ventricle.
Topics: Animals; Biometry; Blood Pressure; Cineradiography; Electrocardiography; Female; Heart; Heart Ventri | 1972 |
Calcium as mediator of isoproterenol-induced myocardial necrosis.
Topics: Animals; Calcium; Heart; Injections, Intraperitoneal; Isoproterenol; Myocardial Infarction; Myocardi | 1972 |
Acute enzyme and metabolic changes in arteriosclerotic vs nonarteriosclerotic rats following isoproterenol-induced myocardial infarction.
Topics: Alanine Transaminase; Animals; Arteriosclerosis; Aspartate Aminotransferases; Blood Glucose; Blood U | 1971 |
Clinical experience with a new cardiac assist device. The dual-chambered intra-aortic balloon assist.
Topics: Aorta; Cardiac Output; Coronary Vessels; Extracorporeal Circulation; Glucagon; Heart-Lung Machine; H | 1971 |
Cigarette smoke: effects on lactate extraction in the presence of severe coronary atherosclerosis.
Topics: Adult; Aged; Angina Pectoris; Animals; Arrhythmias, Cardiac; Cardiac Catheterization; Coronary Disea | 1971 |
Sinus arrest in acute myocardial infarction.
Topics: Adult; Aged; Arrhythmia, Sinus; Electrocardiography; Female; Heart Arrest; Humans; Hypotension; Inje | 1971 |
Effect of isoproterenol on rat plasma creatine phosphokinase activity.
Topics: Animals; Creatine Kinase; Isoenzymes; Isoproterenol; Male; Muscles; Myocardial Infarction; Myocardiu | 1971 |
[Cardiogenic shock].
Topics: Cardiac Volume; Digitalis Glycosides; Heart Rate; Hemodynamics; Humans; Isoproterenol; Myocardial In | 1971 |
Metabolic and histopathological consequences of a fatty liver during the acute stages of myocardial infarction in rats.
Topics: Acute Disease; Adrenal Glands; Alanine Transaminase; Aldosterone; Animals; Aspartate Aminotransferas | 1971 |
Quantitative assessment of the extent of myocardial infarction in the conscious dog by means of analysis of serial changes in serum creatine phosphokinase activity.
Topics: Animals; Blood Flow Velocity; Cardiac Output; Constriction; Coronary Vessels; Creatine Kinase; Dogs; | 1971 |
[Result report of a control by an apparatus of 208 myocardial infarct patients in an intensive care station. Preliminary report].
Topics: Adult; Aged; Arrhythmias, Cardiac; Atropine; Austria; Digitalis Glycosides; Electric Countershock; E | 1971 |
Treatment of arrhythmias associated with acute myocardial infarction.
Topics: Arrhythmias, Cardiac; Atropine; Bradycardia; Digitalis Glycosides; Humans; Isoproterenol; Lidocaine; | 1971 |
[Intracellular overloading with calcium as a decisive causative factor in the pathogenesis of noncoronary myocardial necroses].
Topics: Animals; Calcium; Isoproterenol; Myocardial Infarction; Myocardium; Necrosis; Rats | 1971 |
Myocardial resistance to isoprenaline in rats: variations with time.
Topics: Animals; Body Weight; Coronary Vessels; Drug Resistance; Heart; Injections, Subcutaneous; Isoprotere | 1971 |
Serum enzyme activities following administration of purified basic proteins from rattlesnake venoms.
Topics: Alkaline Phosphatase; Animals; Aspartate Aminotransferases; Blood Proteins; Enzyme Induction; Fructo | 1971 |
Study on the idiopathic cardiomyopathy. Diagnostic value of the apexcardiogram, 131 Cs scintiscanning of the heart and plasma hydroxyproline.
Topics: Adult; Amyl Nitrite; Autopsy; Cardiomyopathies; Cesium Isotopes; Child; Collagen; Collagen Diseases; | 1971 |
Acute coronary care: a year's experience at Napier Hospital.
Topics: Anticoagulants; Arrhythmias, Cardiac; Atropine; Digoxin; Electric Countershock; Heart Arrest; Humans | 1968 |
Experimental studies on the healing of cardiac necrosis.
Topics: Animals; Connective Tissue; Female; Isoproterenol; Ligation; Male; Myocardial Infarction; Myocardium | 1969 |
Experimental "metabolic" cardiopathies and their relationship to human heart diseases. Concluding remarks.
Topics: Animals; Cardiomyopathies; Heart Diseases; Heart Failure; Humans; Ischemia; Isoproterenol; Myocardia | 1969 |
The significance of atrial rate in patients with atrioventricular conduction abnormalities complicating acute myocardial infarction.
Topics: Adult; Aged; Atropine; Carotid Sinus; Electrocardiography; Female; Heart Atria; Heart Block; Heart C | 1969 |
[Problems in the treatment of cardiogenic shock in myocardial infarct].
Topics: Assisted Circulation; Humans; Isoproterenol; Morphine; Myocardial Infarction; Oxygen; Plasma Substit | 1969 |
Management of acute myocardial infarction complicated by advanced atrioventricular block. Role of artificial pacing.
Topics: Adult; Aged; Arrhythmias, Cardiac; Electrocardiography; Heart Block; Humans; Isoproterenol; Middle A | 1969 |
Treatment of shock following myocardial infarction.
Topics: Atropine; Cardiac Glycosides; Furosemide; Humans; Isoproterenol; Metaraminol; Myocardial Infarction; | 1969 |
Serum creatine phosphokinase activity following isoproterenol-induced myocardial infarction in male and female rats with and without arteriosclerosis.
Topics: Animals; Arteriosclerosis; Creatine Kinase; Female; Isoproterenol; Male; Myocardial Infarction; Orga | 1970 |
The effects of dimethylsulfoxide (DMSO) on the healing of experimental myocardial necrosis.
Topics: Animals; Dimethyl Sulfoxide; Disease Models, Animal; Isoproterenol; Male; Myocardial Infarction; Myo | 1970 |
[Central venous pressure].
Topics: Aged; Blood Pressure Determination; Blood Volume; Central Venous Pressure; Digitalis; Diuretics; Hum | 1970 |
Hemodynamics, coronary blood flow, and myocardial metabolism in coronary shock; response of 1-norepinephrine and isoproterenol.
Topics: Aged; Arteries; Blood Flow Velocity; Blood Pressure; Coronary Vessels; Female; Heart; Hemodynamics; | 1970 |
[Use of isoproterenol in patients with myocardial infarction].
Topics: Aged; Humans; Isoproterenol; Male; Myocardial Infarction | 1970 |
Treatment of acute myocardial infarction. 3. Bradyarrhythmias.
Topics: Acute Disease; Arrhythmias, Cardiac; Atropine; Bradycardia; Heart Block; Heart Massage; Humans; Isop | 1970 |
Experimental myocardial infarction. V. Reaction to impaired circumflex flow in the presence of established anterior myocardial infarction in intact conscious dogs.
Topics: Animals; Cardiac Output; Coronary Disease; Coronary Vessels; Dogs; Heart; Heart Rate; Hypotension; I | 1970 |
Thiamine deficiency and experimental cardiac necrosis.
Topics: Animals; Isoproterenol; Myocardial Infarction; Rats; Thiamine Deficiency | 1970 |
Isoproterenol-induced myocardial infarction in rats. Distribution of corticosterone.
Topics: Adrenal Glands; Animals; Brain Chemistry; Carbon Isotopes; Chromatography; Corticosterone; Dialysis; | 1970 |
[Current treatment of atrioventricular conduction disorders].
Topics: Anti-Inflammatory Agents; Atropine; Ephedrine; Heart Block; Humans; Isoproterenol; Lactates; Metapro | 1970 |
[Model of cardiogenic collapse (shock) in experimental myocardial infarct].
Topics: Animals; Cats; Coronary Disease; Coronary Vessels; Isoproterenol; Myocardial Infarction; Shock, Card | 1970 |
Stimulation of DNA synthesis and AMP deaminase activity in rat hearts during isoproterenol-induced myocardial infarction.
Topics: Adenosine Monophosphate; Aminohydrolases; Animals; DNA; DNA Repair; Female; Heart Atria; Heart Ventr | 1970 |
Factors influencing infarct size following experimental coronary artery occlusions.
Topics: Animals; Blood Pressure; Bretylium Compounds; Coronary Disease; Creatine Kinase; Dogs; Electric Stim | 1971 |
Myocardial and serum lactate changes during isoproterenol-induced infarction.
Topics: Acidosis; Animals; Coronary Vessels; Glycolysis; Isoproterenol; Lactates; Male; Myocardial Infarctio | 1971 |
Bretylium tosylate in the management of refractory ventricular fibrillation.
Topics: Adult; Age Factors; Aged; Angina Pectoris; Aortic Valve Insufficiency; Aortic Valve Stenosis; Bretyl | 1971 |
Conservative treatment of AV block in acute myocardial infarction. Results in 105 consecutive patients.
Topics: Acute Disease; Adult; Aged; Bundle-Branch Block; Female; Heart Block; Humans; Injections, Intravenou | 1971 |
Cineangiography of the coronary arteries: clinical function and anatomic correlation in patients with chronic chest pain.
Topics: Adult; Age Factors; Angina Pectoris; Arteries; Blood Pressure; Cardiac Catheterization; Cardiac Outp | 1971 |
[Therapy of acute myocardial infarct with particular reference to arrhythmia and myocardial contractibility disorders].
Topics: Adult; Aged; Aging; Arrhythmias, Cardiac; Atropine; Cardiac Glycosides; Cortisone; Electric Counters | 1971 |
Plasma insulin in heart disease.
Topics: Cardiac Surgical Procedures; Heart Diseases; Heart Failure; Humans; Insulin; Insulin Secretion; Isop | 1971 |
[Atrio-ventricular block in acute myocardial infarct].
Topics: Adrenal Cortex Hormones; Arrhythmias, Cardiac; Atropine; Electrocardiography; Heart Block; Humans; I | 1971 |
Effect of decapitation on blood levels of creatine phosphokinase.
Topics: Amputation, Surgical; Animals; Creatine Kinase; Female; Head; Isoproterenol; Male; Methods; Myocardi | 1971 |
[Therapy of cardiogenic shock after heart infarct].
Topics: Bicarbonates; Dextrans; Digitalis Glycosides; Humans; Isoproterenol; Morphine; Myocardial Infarction | 1967 |
[Indications for the parenteral administration of isoproterenol].
Topics: Adams-Stokes Syndrome; Arrhythmias, Cardiac; Asthma; Electrocardiography; Heart Arrest; Heart Rate; | 1967 |
[Fluorescence microscopic and enzyme histochemical findings in toxically induced heart muscle necrosis].
Topics: Animals; Coronary Disease; Cytoplasmic Granules; Diagnosis, Differential; Heart; Histocytochemistry; | 1967 |
Artificial pacing in management of complete heart block complicating acute myocaerdial infarction.
Topics: Glucose; Heart Block; Humans; Insulin; Isoproterenol; Methods; Myocardial Infarction; Pacemaker, Art | 1968 |
Reducing mortality in myocardial infarction.
Topics: Arrhythmias, Cardiac; Electrocardiography; Heart Arrest; Humans; Hydrocortisone; Isoproterenol; Lido | 1968 |
Comparison of norepinephrine and isoproterenol in experimental coronary shock. Observations on the effects of dextran infusion.
Topics: Animals; Cardiac Output; Dextrans; Dogs; Embolism; Hemodynamics; Isoproterenol; Lidocaine; Myocardia | 1968 |
Electrical pacing for heart block complicating acute myocardial infarction.
Topics: Acute Disease; Adams-Stokes Syndrome; Aged; Arrhythmias, Cardiac; Cardiac Catheterization; Cardiac O | 1968 |
[Beta-receptor stimulation in infarction shock?].
Topics: Humans; Isoproterenol; Myocardial Infarction; Resorcinols; Sympathomimetics | 1968 |
Treatment of bradycardia and hypotension syndrome in patients with acute myocardial infarction.
Topics: Atropine; Blood Pressure; Bradycardia; Cardiac Output; Hemodynamics; Humans; Hypotension; Isoprotere | 1968 |
Complete heart block complicating myocardial infarction: experience with 33 patients.
Topics: Adams-Stokes Syndrome; Adult; Aged; Aspartate Aminotransferases; Atropine; Cardiac Catheterization; | 1968 |
Therapy of atrioventricular block.
Topics: Atropine; Digitalis Glycosides; Electrocardiography; Heart Block; Heart Conduction System; Humans; I | 1968 |
Cardiac tamponade as a result of infusion. A complication of transvenous pacing.
Topics: Cardiac Tamponade; Electrocardiography; Heart Failure; Humans; Isoproterenol; Male; Middle Aged; Myo | 1968 |
Obstetrical anesthesia in myocardial infarction and complete heart block.
Topics: Adult; Anesthesia, Obstetrical; Female; Heart Block; Humans; Isoproterenol; Myocardial Infarction; P | 1968 |
[Behavior of some enzymatic activities of the myocardium and blood in infarct caused by isoproterenol].
Topics: Animals; Aspartate Aminotransferases; Clinical Enzyme Tests; Creatine Kinase; Fructose-Bisphosphate | 1968 |
Myocardial necrosis induced by isoproterenol in rats. Changes in serum protein, lipoprotein, lipids and glucose druing active necrosis and repair in arteriosclerotic and nonarteriosclerotic animals.
Topics: Animals; Blood Glucose; Blood Proteins; Fatty Liver; Female; Isoproterenol; Lipids; Lipoproteins; Ma | 1968 |
[Central venous pressure in control of cardiogenic shock].
Topics: Arrhythmias, Cardiac; Blood Pressure; Cardiac Tamponade; Digitalis Glycosides; Humans; Isoproterenol | 1968 |
[Myocardial infarct and disorders of cardiac rhythm].
Topics: Arrhythmias, Cardiac; Coronary Care Units; Humans; Isoproterenol; Lidocaine; Myocardial Infarction; | 1968 |
Current status of the treatment of shock complicating acute myocardial infarction.
Topics: Digitalis Glycosides; Dopamine; Humans; Hydrocortisone; Hyperbaric Oxygenation; Hypotension; Isoprot | 1969 |
Effects of isoproterenol on hemodynamic alterations, myocardial metabolism, and coronary flow in experimental acute myocardial infarction with shock.
Topics: Animals; Blood Pressure; Cardiac Output; Coronary Vessels; Dogs; Electrocardiography; Embolism; Hear | 1969 |
[On the therapy of shock using isoprenaline].
Topics: Adult; Aged; Aortic Aneurysm; Barbiturates; Blood Volume; Cardiac Output; Female; Humans; Isoprotere | 1969 |
Acute changes in liver lipids during myocardial infarction induced by isoproterenol.
Topics: Animals; Cholesterol; Injections, Subcutaneous; Isoproterenol; Lipids; Liver; Male; Myocardial Infar | 1969 |
[Stimulation of b-receptors in infarct shock].
Topics: Humans; Isoproterenol; Metaproterenol; Myocardial Infarction; Resorcinols; Shock, Traumatic | 1969 |
Treatment of shock associated with myocardial infarction.
Topics: Albumins; Arrhythmias, Cardiac; Dextrans; Digitalis Glycosides; Dopamine; Heart-Lung Machine; Humans | 1969 |
Aortic pressure loading in dogs with myocardial infarction.
Topics: Animals; Aorta; Blood Pressure; Cardanolides; Cardiac Catheterization; Cardiac Output; Coronary Vess | 1969 |
Treatment of arrhythmias in myocardial infarction.
Topics: Arrhythmias, Cardiac; Atropine; Bradycardia; Digitalis Glycosides; Electric Countershock; Electrocar | 1969 |
[Cardiogenic shock following myocardial infarct. Therapeutic results with isoprenaline and low-molecular dextran].
Topics: Aged; Dextrans; Female; Humans; Isoproterenol; Male; Middle Aged; Molecular Weight; Myocardial Infar | 1969 |
Glucagon: its enhancement of atrioventricular nodal pacemaker activity and failure to increase ventricular automaticity in dogs.
Topics: Animals; Dogs; Glucagon; Heart Block; Heart Conduction System; Heart Ventricles; Hemostasis; Isoprot | 1969 |
Myocardial contractility following cardiopulmonary bypass with and without myocardial ischemia.
Topics: Animals; Coronary Vessels; Dogs; Extracorporeal Circulation; Heart; Heart Ventricles; Ischemia; Isop | 1969 |
Myocardial revascularization with internal mammary artery implantation: current status.
Topics: Aneurysm; Angina Pectoris; Angiography; Arteriosclerosis; Blood Flow Velocity; Collateral Circulatio | 1969 |
Reevaluation of the treatment of shock secondary to cardiac infarction.
Topics: Adrenal Cortex Hormones; Animals; Blood Flow Velocity; Blood Pressure; Blood Volume; Cardiac Output; | 1969 |
Ventricular tachycardia after experimental myocardial infarction: effects of adrenergic amines and increased aortic pressure.
Topics: Animals; Blood Pressure; Coronary Vessels; Dogs; Electrocardiography; Epinephrine; Heart Rate; Isopr | 1965 |
Acute cardiac infarct like necrosis in high altitude adapted rats.
Topics: Acclimatization; Altitude; Animals; Heart; Isoproterenol; Male; Myocardial Infarction; Myocardium; N | 1965 |
[On treatment of rhythmic disorders in recent myocardial infarct].
Topics: Aged; Atrial Fibrillation; Atrial Flutter; Electric Countershock; Electrocardiography; Female; Heart | 1966 |
Cardio-pulmonary resuscitation. A report on two years' experience.
Topics: Acidosis; Adolescent; Adult; Aged; Bicarbonates; Child; Child, Preschool; Electric Countershock; Hea | 1966 |